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A clinical and immunological study of adrenal insufficiency. By W. J. Irvine.
Department of Therapeutics, Royal Infirmary, Edinburgh
The patients included in this study were subdivided into those in whom the
adrenal insufficiency was idiopathic (15 patients), tuberculous (7 patients) or secon¬
dary to hypopituitarism (11 patients). A tuberculous aetiology was established by
the presence of adrenal calcification on X-ray of the abdomen.
Four of the patients in the idiopathic group had associated thyroid disease;
two gave a history of thyrotoxicosis, one had hypothyroidism and one had a goitre
that was probably of the Hashimoto type. The patient with the Hashimoto goitre
also had rheumatoid arthritis and a family history of pernicious anaemia. A fifth
patient had latent pernicious anaemia; another patient had a family history of
hypothyroidism; two further patients had diabetes mellitus. This contrasts with the
absence of these diseases in the patients with tuberculous adrenal insufficiency or
in their relatives. One patient in the hypopituitary group had a family history of
pernicious anaemia.
Complement-fixing antibodies to adrenal, stomach and thyroid were found in
8, 6 and 5 of the 15 patients with idiopathic adrenal insufficiency, and antibodies
to thyroglobulin in 9 of these patients. Two patients had no detectable levels of any
of these antibodies and two patients possessed all four types of antibody. In the
tuberculous group only one patient had a low titre of antibody to thyroglobulin and
two of the hypopituitary patients, including the patient with a family history of
pernicious anaemia, had complement-fixing antibody to gastric mucosa. The fluores¬
cent antibody technique verified the results obtained by the complement-fixation
method; it localized the site of antigen-antibody reaction in the adrenal to the
cytoplasm of the secretory cells of the adrenal cortex, in the thyroid to the cyto¬
plasm of the thyroid secretory epithelium, and in the gastric mucosa to the cytoplasm
of the parietal cells. Absorption procedures and control studies with liver tissue
established the specificity of the separate antigen-antibody reactions for the in¬
dividual tissues.
Augmented histamine tests and/or gastric biopsies were carried out on thirteen
of the idiopathic group, six of the tuberculous group and eight of the hypopituitary
patients. Achlorhydria or minimal acid secretion was found in all three groups,
while other patients in each group had gastric acid values that were either within or
approached the normal range. The presence of gastric antibodies was associated with
a histamine-fast achlorhydria in seven out of the nine cases in which they were
detected. The autoimmune nature of gastric antibody was demonstrated in the one
patient in whom a sufficient number of parietal cells persisted. The degree of atrophic
gastritis was considered to be more severe in the idiopathic group.
It is concluded that idiopathic adrenal insufficiency is associated with a funda¬
mental disorder of immunological homeostasis or tolerance and that the occurrence of
circulating antibodies is not simply the result of tissue damage. Chronic thyroiditis,
pernicious anaemia and idiopathic adrenal insufficiency may be basically similar in
their pathogenesis, only differing in the tissue that is principally affected.
The author gratefully acknowledges the support of the Medical Research Council
and the invaluable help of Dr Howard Davies, Dr Irvine Delamore and Dr A. Wynn
Williams.
A clinical and immunological study of adrenocortical insufficiency
(Addison's disease)
W. J. IRVINE, A. G. STEWART and LAURA SCARTH
Reprinted from
Clinical and Experimental Immunology




Clin. exp. Immunol. (1967), 2, 31-69.
A CLINICAL AND IMMUNOLOGICAL STUDY OF
ADRENOCORTICAL INSUFFICIENCY
(ADDISON'S DISEASE)
W. J. IRVINE, A. G. STEWART and LAURA SCARTH
Medical Research Council, Clinical Endocrinology Research Unit, 2 Forrest Road:
Endocrine Clinic, Royal Infirmary: Department of Therapeutics, University: Edinburgh
(Received 23 July 1966; accepted 10 August 1966)
SUMMARY
Fifty-one patients with adrenocortical insufficiency were subdivided into three
groups according to the nature of their adrenal disease; twelve patients with
idiopathic, twenty-three patients with probable idiopathic and sixteen patients
with tuberculous adrenal insufficiency. The importance of objective confirmation
of a clinical diagnosis of adrenal insufficiency is stressed and the difficulties of
classification of many patients with adult onset adrenal insufficiency are dis¬
cussed. Idiopathic and probable idiopathic adrenal insufficiency had a sex ratio
that was predominantly female (2-5:1) with a mean age of onset of 33 years.
Antibodies to adrenal cortex were detected by themethodsof immunofluorescence
and complement fixation. They were detected in the serum of 80% (20:25) of the
females with idiopathic or probable idiopathic adrenal insufficiency and in only
10% (1:10) of the males. The titre of the adrenal antibody was low (<32) as
tested either by immunofluorescence or complement fixation. The serum of only
one patient with tuberculous adrenal insufficiency reacted with adrenal tissue in the
complement fixation test but the immunofluorescence method showed that this
serum reacted with the vascular endothelium and not the secretory cells. No corre¬
lation was observed between the duration of the clinical illness and the presence,
or absence, or titre of the adrenal antibody. Adrenal antibody was not detected in
the sera of fifty-one control subjects matched for age and sex. Four of sixty-nine
patients with lymphadenoid goitre, one out of ninety-three patients with diabetes
mellitus and none of 230 patients with thyrotoxicosis, primary hypothyroidism or
pernicious anaemia had antibody in the serum specific for adrenocortical secretory
cells.
There is a clinical and immunological overlap between idiopathic adrenal
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insufficiency and other diseases associated with autoimmune phenomena—
thyroid disease, atrophic gastritis and hypoparathyroidism.
It is concluded that idiopathic adrenal insufficiency belongs to a group of
diseases that are characterized clinically by onset predominantly in females, by
aggregation in the same group of patients, by familial tendency, by the presence of
organ-specific antibodies in the serum and histologically by lymphocytic infiltration
and atrophy. While only one tissue of the group may be predominantly affected, the
other tissues are frequently the site of subclinical disease. There is no set order
in which the different tissues are affected. Serological evidence of adrenalitis is
rare in patients with thyroid disease or pernicious anaemia, but thyroiditis and
gastritis are common in patients with adrenalitis.
Two autopsies on patients with idiopathic adrenal insufficiency are described.
One case had the classical features of adrenal atrophy with gross reduction in
size of the glands, islets of secretory epithelial cells and a moderate degree of
lymphocytic infiltration. In the other case, the adrenal glands were only slightly less
than normal in size, there were few adrenal epithelial cells and a dense lymphocytic
infiltration and some fibrosis. The histology resembled that of the thyroid in
Hashimoto goitre.
If the term 'autoimmune' adrenalitis is to be substituted for idiopathic adrenal
insufficiency, it should be on the understanding that while autoimmune mech¬
anisms may be of primary importance in the pathogenesis of adrenal disease this
has yet to be proven.
INTRODUCTION
Adrenal antibodies have been detected in the sera of a proportion of patients with adrenal
insufficiency (Anderson et at., 1957; Mead, 1962; Blizzard et at., 1962). Irvine (1963a)
in a preliminary communication reported that antibodies specific for adrenal occurred
in the sera of some patients with idiopathic adrenal insufficiency but not in the sera of
patients with adrenal insufficiency of tuberculous origin. The present paper presents a more
detailed clinical and immunological assessment of patients with idiopathic and non-idio-
pathic adrenal insufficiency.
PATIENTS STUDIED
Fifty-one patients with primary adrenocortical insufficiency (Addison's disease) were
studied. Diagnostic criteria were reviewed using where possible adequate adrenal stimula¬
tion with adrenocorticotrophin (ACTH) or with /?x('Synacthen', Ciba) by infusion
as described by Landon et at. (1964). Any patient was excluded from the present study who
did not have Addison's disease when reviewed, or where the diagnosis seemed in reasonable
doubt. Thirty-three of the fifty-one patients studied have been seen personally and most
of them have been supervised regularly over a period of years at the Endocrine Clinic,
Royal Infirmary, Edinburgh. On clinical, biochemical and radiological assessment, and
independent of the immunological findings reported in this paper, the patients were
subdivided into three groups (Tables 1-4).
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(1) Idiopathic adrenal insufficiency
I n addition to the usual clinical and laboratory criteria of the disease, eleven of the twelve
patients in this group were known to have no response to adequate adrenal stimulation by
measurement of plasma Cortisol (Mattingly, 1962) or urinary excretion of 17-hydroxy-
corticosteroids (17-OHCS). In the remaining patient, the clinical diagnosis was confirmed
at autopsy (case 1 of post-mortem studies). None of these patients had any personal history
of tuberculosis and none had radiological evidence of adrenal calcification.
(2) Probable idiopathic adrenal insufficiency
The diagnosis of primary adrenal insufficiency in the twenty-three patients in this group
was based on the classical clinical features, substantiated in most instances by studies of
urinary 17-OHCS excretion, ability to excrete a water load before and after cortisone, and
by insulin sensitivity. While a number of patients in this group received ACTH, the dosage
was either unknown or inadequate and it is not possible at the present time to be certain
of the potency of the preparation used. None of the patients in this group were known to
have had adequate adrenal stimulation studies. In none of these patients was there any
evidence of adrenal calcification but in an occasional case (e.g. No. 18) the possibility of
tuberculosis of the adrenal could not be entirely excluded.
(3) Tuberculous adrenal insufficiency
There were sixteen patients in this group, nine of whom had radiological evidence of
adrenal calcification as illustrated in Fig. 1. In seven of these nine patients there was
clinical and radiological evidence of gross tuberculous disease in other organs of the body.
In one (No. 39) there was evidence of a minimal lung lesion and, in the remaining patient
(No. 44), there was no evidence of past tuberculosis other than adrenal calcification.
In the other seven patients in this group there was no radiological evidence of adrenal
calcification; six of these patients had evidence of gross tuberculous infection elsewhere
in the body. The remaining patient (No. 46) had an acid-alcohol fast bacilluria with a
small chest wall abcess, but mycobacterium tuberculosis was not cultured.
In Group I patient No. 6 had experienced intermittent bronchospasm for many years and
a faint apical opacity had occasionally been reported in the chest X-ray. The Mantoux
reaction was reported to be just positive at 1:1000 dilution, and tuberculosis had occurred
in one relative. Although there was no past history of any pertinent illness it is possible
that this patient had tuberculous adrenal insufficiency. Patient No. 18 in Group II also
had a positive Mantoux reaction and a history of tuberculosis in a relative. Her sister was
said to have had erythema nodosum shortly before the patient's original admission and
the patient herselfwas noted to have a pleural friction rub at that time. Although no tubercle
bacilli were isolated she received antituberculous chemotherapy, and now has no radio¬
logical evidence of tubercle.
The Wassermann reaction was negative in all patients with idiopathic or probable
idiopathic adrenal insufficiency except in patients Nos. 8 and 26. Patient No. 8 was stated
to have had 'syphilitic labyrinthitis' in 1937 at the age of 47 and had a positive Wassermann
reaction in 1958 but at autopsy (case 1 of post-mortem studies) there was no evidence of
syphilis. Patient No. 26 was reported to have a weakly positive Wassermann and Kahn
test on one occasion at a routine medical examination but he had no symptoms or signs
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suggestive of syphilis. He received a course of penicillin and all subsequent Wassermann
and Kahn tests were negative.
The age and sex distribution of the patients studied is summarized in Table 1.
The clinical features and the critera for classifying the patients into the respective
sub-groups are summarized in Tables 2-4.
Fig. 1. Adrenal calcification on straight X-ray of abdomen.
Table 1. Adrenal insufficiency
Age (years) Age (years)
at diagnosis of at time of
Type No. of adrenal insufficiency present study Sex ratio
patients Female:Male
Range Mean Range Mean
Idiopathic 12 7-74 36 9-74 42 3-0:1-0
Probable idiopathic 23 15-63 33 19-66 43 2-3:1-0
Tuberculous 16 12-69 38 21-72 49 0-6:1-0
The sera of fifty-one blood donors, who were selected according to sex and age to match
the fifty-one patients with adrenal insufficiency, and the sera of sixty-nine consecutive
patients with lymphadenoid goitre, eighty-seven with primary hypothyroidism, eighty-nine
with thyrotoxicosis, fifty-four with pernicious anaemia and ninety-three with diabetes
meliitus were also studied.
The cord blood of two babies whose mothers had adrenal insufficiency were studied,
and the serum was available from nine relatives of four patients with adrenal insufficiency.
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The patients with adrenal insufficiency were repeatedly asked about the history of relevant
diseases in other members of their families, but in only a few instances were the relatives
seen and examined by ourselves.
METHODS
Fluorescent antibody technique
The indirect fluorescent antibody technique (Coons & Kaplan, 1950) was used. Air-dried,
unfixed sections of human adrenal, human gastric body mucosa, human thyrotoxic gland
and of rat liver were cut at 4 n using a Pearce cryostat at — 20°C.
Adrenal tissue was obtained from two patients. Adrenal No. 1 was from a boy (J.W.
aged 11 years) who underwent bilateral adrenalectomy for Cushing's disease. The diagnosis
of Cushing's disease was based on the clinical features and substantiated by a raised urinary
excretion of 17-OHCS and raised plasma levels of 11-OHCS with no diurnal variation.
As described in some 10% of patients with this condition (Williams, 1962) the adrenal
glands were of normal size, weight (4-5 and 5-0 g) and histology. The blood group was A Rh
positive. Adrenal No. 2 was from a female aged 55 years who underwent bilateral adrenal¬
ectomy for carcinomatosis having previously been treated with an anabolic steroid. She had
received 100 mg cortisone the day before operation and 75 mg cortisone on the day of
operation. The blood group was O Rh positive.
As soon as each adrenal gland had been excised, rectangular blocks of tissue of ap¬
proximately 2-3 mm thickness were cut at right angles to the surface of the gland, placed
in small glass vials and rapidly frozen to — 70°C in acetone-solid C02 mixture. The blocks
were stored in — 20°C until required for sectioning. They were mounted in the cryostat
so that they could be cut in cross-section. In this way it was ensured that each section of
adrenal contained capsule, zona glomerulosa, zona fasciculata, zona reticularis. Most but
not all of the sections contained medulla.
Mucosa from the body of human stomach was obtained from a patient undergoing
gastrectomy and human thyroid tissue was obtained at partial thyroidectomy for thyrotoxic
goitre after preparation with anti-thyroid drugs and potassium iodide. A biopsy of human
testicular tissue was obtained at prostatectomy and vasectomy; the histology of the testicular
tissue was normal.
The sections of the various tissues may be mounted on individual glass slides or grouped
conveniently on the same slide. The sections were air-dried by fan for 1 hr, stored at 4°C
and used within 3 days. During storage the sections were protected in polythene bags from
condensation and prior to use the sections were allowed to come to room temperature before
being removed from the polythene bag.
A number of different fluorescein-protein conjugates were studied and are described
under two headings. Fluorescein was used throughout in the form of fluorescein isothio-
cyanate (FITC).
(1) Various commercial preparations using polyvalent antisera. The most satisfactory of the
commercial preparations examined was prepared in the following manner. Normal human
globulin was injected intramuscularly with adjuvant into horse at intervals to maximum
titre. The horse serum was then fractionated with half-saturated ammonium sulphate.
After removal of all sulphate the globulin fraction was conjugated with FITC absorbed
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with liver powder and dialysed free of fluorescein. The antibody titre of the serum was
1:480 and the molar fluorescein-protein ratio was 8-8 pg/mg and the fluorescein to protein
absorption ratio was 0-87.
(2) Preparations using monovalent antisera. Anti-human IgG, anti-human IgM and
anti-human /J1C (each prepared in horse) were obtained from the Central Blood Trans¬
fusion Laboratory, Netherlands Red Cross, Amsterdam. The specificity of the IgG and
IgM anti-sera was verified by immunoelectrophoresis. For the purpose of conjugation the
globulin fraction of each antiserum was diluted to approximately 10 mg/ml with carbonate-
bicarbonate buffer at pH 9-0. Chromatographically pure Isomer I F1TC (Baltimore Bio¬
logical Laboratories) was used in a concentration of 20 mg/100 mg protein. The conjugation
was done at 4°C and the time of conjugation was 22 hr. Free fluorescein was removed by
filtration through Sephadex G-50 followed by overnight dialysis in phosphate buffered
saline at 4°C. The conjugates were used in a dilution that gave optimum specific fluorescein
staining with minimum non-specific staining. The fluorescein-protein absorption ratios
of the conjugates using anti-TgG, anti-IgM and anti-/?ic were 0-52, IT and 0-83 respectively.
The sera were stored at — 20°C. Undiluted serum after warming to room temperature
was applied to each section for 20 min at the same temperature. The sections were then
washed in phosphate buffer (pFI 7-2) for 30 min with continual gentle agitation, the buffer
being changed once during this procedure. The fluorescein-protein conjugate was applied
for 20 min. When the protein moiety of the conjugate was anti-human /J1C, the sections were
treated with fresh normal human serum for 20 min following the application of the test
serum. After application of the conjugate, all sections were given a final wash in phosphate
buffer pFI 7-2 for 1 hr with continuous agitation. In some instances the sections were then
counterstained with papain conjugated with rhodamine (Alexander & Potter, 1963). At the
end of the staining procedure the sections were mounted in 10% glycerol in saline and
examined under ultraviolet light within 2 hr using a Zeiss Universal microscope fitted with a
super-pressure mercury lamp F1BO.200 W, exciter filters BG 38 and BG 12, direct light or
dark ground condenser and 530 barrier filter. After preliminary comparisons of the
different conjugates, anti-IgG and anti-IgM conjugates were used separately in testing sera
for antibody to human adrenal, to epithelial cytoplasm of human thyrotoxic tissue, to
parietal cells in human gastric mucosa and for antinuclear factors using rat liver. Anti-/lic
conjugate was also used for detecting antibody to adrenal. All the sera from patients with
adrenal insufficiency were tested against sections of human adrenal gland No. 1 and ad¬
renal gland No. 2. All other sera were tested against adrenal gland No. 1. Test sera were
titrated for adrenocortical antibody using sections of adrenal No. 1, anti-lgG conjugate and
doubling dilutions of sera. The intensity of staining was assessed subjectively and recorded
as ++,+, + or negative.
Complement fixation tests
All sera were tested for complement fixing antibody against a saline extract of adrenal
gland No. 1 using the Takatsy microtitre technique (Irvine, 1966b) after initial chess-board
titration of adrenal antigen. Two M.H.D. of complement were used. The test was read
visually. Fifty per cent haemolysis with a serum dilution of 1:4 or greater was taken as a
positive result. The sera were inactivated at 56°C for \ hr and were initially screened in
doubling dilutions from 1:2 to 1 :32 and further titrations were done subsequently if
IV : 14
Adrenal insufficiency 41
required to define the end point. A control was included for each serum to test for anti¬
complementary activity.
All sera were also tested for complement fixing antibody to saline extracts of human
thyrotoxic tissue, mucosa of the body of pig stomach and rat liver. Both the manual
microtitre method and the AutoAnalyzer method were used for this purpose (Irvine, 1966b;
Irvine & Marwick, 1967).
The sheep red cells in Alsever solution, rabbit haemolytic serum and preserved guinea-
pig complement were obtained from Stayne Laboratories, High Wycombe, Buckingham¬
shire.
Absorption procedures
The specificity of the reactions to adrenal tissue observed by the immunofluorescent and
complement fixation techniques was studied by absorption of the antibody by saline extracts
of individual tissues (the human thyroid, pig stomach, rat liver and human adrenal No. 1).
The highest concentration of the tissue extract that was not anti-complementary was used.
Three parts of tissue extract to one part undiluted test serum were incubated with continual
mixing at room temperature for 3 hr and then centrifuged at 1750 g for 10 min. Samples
before and after absorption were then titrated by the manual microtitre complement fixation
test and the indirect immunofluorescent technique using anti-TgG conjugated with FITC.
Other serological procedures
Sera were screened and titrated for antibody to thyroglobulin by the tanned cell haemag-
glutination method (Fulthorpe et a/., 1961) using reagents supplied by Burroughs Well¬
come, Beckenham, Kent. The sera were also screened and titrated for antibody to intrinsic
factor using the radioisotope techniquewith charcoal absorption (Irvine, 1966a). The electro-
phoretic pattern of the serum using cellulose acetate and the erythrocyte sedimentation
rate were determined in the patients with idiopathic adrenal insufficiency.
Wassermann and Kahn tests were done and the ABO and Rh blood groups were
determined in all patients with adrenal insufficiency.
Gastric, thyroid, parathyroid andpancreatic function tests
Tests of gastric function were done on a proportion of the patients with adrenal in¬
sufficiency using the augmented histamine test (Kay, 1953). The dose of histamine acid
phosphate was 0-04 mg/kg body weight and was given subcutaneously and preceded by
an intramuscular injection of 50-100 mg mepyramine maleate \ hr before the injection of
histamine. The details of the technique of aspirating gastric juice were as described by
Makhlouf, McManus & Card (1964). The sample of gastric juice was estimated for acid
content using an automatic titrator (Radiometer, Copenhagen) to pH 7-0. The content
of intrinsic factor in the gastric juice was measured by radio immunoassay (Irvine, 1966a).
Schilling tests of vitamin B12 absorption (Schilling, 1953) and the level of vitamin B12
in the serum was estimated by the microbiological method using Lactobacillus leichntanii as
test organism and with the addition of cyanide to the serum (Girdwood, 1960).
Gastric biopsy using a Crosby capsule (Crosby & Kugler, 1957) was done on eighteen
of the patients with adrenal insufficiency.
Thyroid function was assessed by estimation of the serum protein bound iodine (PB1)




function was suspected clinically or indicated by an abnormal PBl, further studies were
done using standard radioisotope techniques.
RESULTS
Detection and characterization of adrenocortical antibody
The detection of antibody reactive with the secretory cells of the adrenal cortex is illus¬
trated in Figs. 2 and 3, using sera from two patients with idiopathic adrenal insufficiency and
from two control subjects. In each instance the fluorescent staining of the adrenocortical
secretory cells was given by the anti-IgG or anti-/?ic conjugates but not by theanti-IgM oranti-
IgA conjugates. This was true of all sera tested for adrenal antibody. The intensity of the
flluorescent staining was maximal in the zona glomerulosa. Specific staining of the zona
fasciculata and zona reticularis was also observed but thiswas less marked than that ofthe zona
glomerulosa. The fluorescent staining was confined to the cytoplasm of the adrenocortical
secretory cells, the nuclei not being stained unless antinuclear factors were also present. The
staining was finely granular and fairly evenly distributed throughout the cytoplasm of the
cells of the zona glomerulosa. In the zona fasciculata the staining was particularly pro¬
nounced in the region of the cell membranes and surrounding the secretory globules within
the cells. In the zona reticularis the pattern of immunofluorescence was again more even but
still disrupted by the presence of secretory droplets that were autofluorescent. Fourteen of
the total sera gave clear immunofluorescent staining of what appeared to be the vascular
endothelium in the adrenal cortex and the adrenal medulla (Fig. 5). The staining of the
vascular endothelium was given only with anti-IgG and anti-PiC conjugates and not with
anti-IgM or anti-IgA conjugate. Only one serum out of the total of 492 sera showed immuno¬
fluorescent staining of the cells of the adrenal medulla (Fig. 6).
Sections of adrenal gland No. 2 gave the same results for adrenocortical staining as
sections of adrenal gland No. 1 with the undiluted sera of the patients with adrenal in¬
sufficiency and using anti-IgG or anti-/Ilc conjugates. The immunofluorescent staining with
the Cushing adrenal (adrenal gland No. 1) was considered to be better than with the adrenal
gland removed from the patient with carcinomatosis (adrenal gland No. 2). Adrenal gland
No. 2 did not show the staining of vascular endothelium observed with sections of adrenal
gland No. 1.
In interpreting the immunofluorescence tests using adrenal tissue it is of particular
importance to use thin sections of fresh tissue and that the section particularly in the region
of the capsule and zona glomerulosa is complete and unbroken. Adrenal tissue is particu¬
larly liable to show background staining and every care must be taken in preparation of the
conjugate used to demonstrate the interaction of the antibody in the test serum with the
Fig. 2. (a) Indirect fluorescent antibody technique using an unfixed frozen section of an adrenal
gland from a patient with Cushing's disease. The serum was used in a dilution of 1:4 and was
from a patient with idiopathic adrenal insufficiency (No. 1). The antigen-antibody reaction
was detected using horse anti-human immunoglobulin IgG conjugated with fluorescein
isothiocyanate. Note that the intensity of the staining is greatest in the zona glomerulosa. (b)
The same as (a) but using normal serum diluted 1:4 instead of serum from a patient with
Addison's disease. Direct ultraviolet light, x 250.
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adrenal antigen. The commercial preparation obtained by conjugating horse anti-human
globulin serum with F1TC did not give satisfactory results with adrenal tissue, although the
same preparation may be adequate for detecting other types of antigen-antibody reaction.
Clear immunofluorescent staining of the adrenocortical cells was achieved using mono¬
valent anti-human immunoglobulin (IgG) conjugated with F1TC. The clarity of the result
increases with the thinness of the section of adrenal tissue. Only in one instance was there
difficulty in distinguishing a positive reaction from a negative reaction and the result had to
be labelled as +. The fluorescent staining given by a particular serum was highly reproduc¬
ible. Greater contrast between weak fluorescent staining and the low grade background
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Fig. 4. The titration of adrenal antibody in the sera of patients with primary adrenocortical
insufficiency using the methods of indirect immunofluorescence and complement fixation. The
immunofluorescent staining was in the secretory cells of the adrenal cortex using anti-IgG
conjugate. The serum of the patient in the tuberculous group that gave a positive complement
fixation test with a saline extract of adrenal stained the capillary and sinusoidal endothelium
in the indirect immunofluorescer.t test using anti-/fic conjugate, but did not stain the adreno¬
cortical secretory cells.
papain conjugated with rhodamine was effective in removing the small amount of non¬
specific fluorescein staining encountered with the anti-IgG conjugate. Provided the papain-
rhodamine was not used to excess, its use enhanced the clarity of the results. With adrenal
sections of 1-2 n thickness, undiluted test sera and anti-/?lc conjugate there was no non¬
specific staining. Using optics as described above, the adrenal secretory cells (particularly the
secretory globules in the zona fasciculata) show a pale brownish red autofluorescence.
Fig. 3. (a) Positive immunofluorescence in the secretory cells of the zona glomerulosa of adrenal
cortex in the indirect fluorescent antibody technique using the serum from a patient (No. 2)
with idiopathic adrenal insufficiency and anti IgG—F.I.T.C. conjugate, (b) Negative control.
Dark ground ultraviolet light, x 450.
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The presence of adrenal specific antibodies was confirmed using the method of comple¬
ment fixation. As shown in Fig. 4 there is a good correlation between the titre for adrenal
antibody as detected in the indirect immunofluorescent technique and the complement
fixation test (using 2 M.H.D. of complement in the manual microtitre method) in the
three groups of sera from patients with primary adrenal insufficiency. The maximum titre
observed by either procedure was 1:32. None of the sera were anti-complementary and
none gave a positive complement fixation test with rat liver. The one serum in the tuberculous
group in Fig. 4 that gave a positive complement fixation test with adrenal extract No. 1 gave
a negative immunofluorescent reaction with adrenocortical secretory cells but reacted
strongly with the capillary and sinusoidal endothelium of that adrenal as illustrated in Fig.
5. The blood group of this patient was group O Rh positive. This serum did not react with
rat liver, human thyrotoxic tissue, pig gastric mucosa nor did it contain anti-nuclear factors
or appear to be anti-complementary.
Absorption studies showed that the complement fixing adrenocortical antibody and the
immunofluorescent staining of adrenocortical secretory cells could be selectively absorbed
with a saline extract ofhuman adrenal but notwith similar extracts ofhuman thyroid or of pig
gastric mucosa, even although these thyroid and gastric extracts were capable of absorbing
thyroid and gastric antibodies, respectively.
It has not yet been possible to establish the autologous nature of the adrenocortical anti¬
body. There was no correlation found between the blood group (ABO and Rh) of the test
sera and that of the donor of the adrenal tissue with respect to the immunofluorescent
staining of the adrenocortical secretory cells.
The staining of the vascular endothelium in adrenal gland No. 1 (blood group A Rh
positive) shown by a few of the sera studied in the immunofluorescent test was not seen with
sections of adrenal gland No. 2 (blood group O Rh positive) nor with thyroid tissue from
another patient or with rat liver or kidney sections. These sera gave negative complement
fixation tests with saline extracts of thyroid, stomach and liver and they did not contain
antinuclear factors.
The concentration of y-globulin in the serum of the patients with idiopathic adrenal
insufficiency ranged from 0-6 to 1-4 g/100 ml and the average erythrocyte sedimentation rate
was 15 mm in the first hour (Westergren). In patients Nos. 3, 9, 15 and 18 the average in each
individual was between 20-39 mm. In these four patients the adrenocortical insufficiency
was of recent onset but there was no obvious correlation with antibody titres or plasma
electrophoretic pattern. In patient No. 15 the erythrocyte sedimentation rate was mildly but
persistently elevated from the onset of hypoparathyroidism to the development of adrenal
failure.
Fig. 5. Staining of capillary and sinusoidal endothelium in an unfixed section of human
adrenal gland No. 1 (Group A Rh positive) with the serum of patient No. 45, human comple¬
ment and anti-/?ic-FITC conjugate. The adrenocortical secretory cells are not stained. Direct
ultraviolet light, x 125.
Fig. 6. Staining of cells in the adrenal medulla observed with one serum (from a patient with
lymphadenoid goitre) out of the 492 sera studied. The staining of cells is in the form of a
ring surrounding the nucleus. Neither the adrenocortical cells nor the interstitial cells were
stained. Anti-/?iC conjugate. Dark ground ultraviolet light, x 530.
D
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Table 5. Serological findings in patients with idiopathic adrenal insufficiency
Case
No.




T.C.H. Fl. C.F. Fl. C.F. l.F.
1 + + 32 5 + 4 + neg neg neg neg
2 + + 32 neg neg neg + + 8 20 neg neg
3 + + 16 neg neg neg neg neg neg neg neg
4 + + 16 neg + neg neg neg neg neg neg
5 + + 8 neg + + 64 + + 64 neg neg neg
6 + 4 2500 + + 16 + + 8 neg neg neg
7 + 4 neg neg neg + + 32 neg neg neg
8 + neg neg + + 32 neg neg 39 neg neg
9 + neg neg neg neg neg neg neg neg neg
10 + neg neg + reg neg neg neg neg neg
11 ± neg neg neg neg neg neg neg neg neg
12 neg neg neg + 8 + + 8 6 neg neg
Fl., Immunofluorescence; C.F., complement fixation; T.C.H., tanned cell haemagglutination; I.F.,
intrinsic factor; ANF, antinuclear factors.
Table 6. Serological findings in patients with probable idiopathic adrenal insufficiency
Case
No.




T.C.H. Fl. C.F. Fl. C.F. I.F.
13 + + 8 neg neg neg neg neg neg neg neg
14 + + 8 2500 + 16 + + 128 neg neg neg
15 + + 8 25 neg neg + 8 27 >32 IgM
16 + + 8 neg + 8 neg neg neg neg neg
17 + + 8 neg neg neg neg neg neg neg neg
18 + + 4 neg - 32 neg neg neg neg neg
19 + + 4 neg + + 32 + + 16 neg neg neg
20 + + 4 250 + + 16 neg neg 880 neg neg
21 + + 4 neg neg neg neg neg neg neg neg
22 + + neg neg ncg neg neg neg neg neg neg
23 + neg neg neg neg + + 32 8 neg neg
24 neg neg neg + 16 + + 16 9 neg neg
25 neg neg neg neg neg neg neg neg neg neg
26 neg neg neg neg neg + + 8 neg neg neg
27 neg neg neg + + 32 + + 4 neg neg neg
28 neg neg 25 + neg + 4 neg neg neg
29 neg neg neg -t- 8 neg neg neg neg neg
30-35 neg neg neg neg neg neg neg neg neg neg
For abbreviations see Table 5.
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Incidence of adrenocortical antibody
The occurrence of adrenocortical antibody in the fifty-one patients with adrenal insuffi¬
ciency and in control subjects is shown in Tables 5-8. The incidence of adrenocortical anti¬
body according to the sex of the patients with adrenal insufficiency is summarized in Table 9.
Ten out of the twelve patients in the idiopathic group had detectable amounts of adrenal
antibody in the serum by the immunofluorescent method. The serum of one other patient in
Table 7. Serological findings in patients with tuberculous adrenal insufficiency
Case
No.
Adrenal cortex Thyroid Gastric
Liver ANF
Fl. C.F. T.C.H. Fl. C.F. Fl. C.F. I.F.
36 neg neg 25 + + neg neg neg neg neg neg
37 neg neg neg + 16 neg neg neg neg neg
38 neg neg neg neg neg + + 4 neg neg neg
39-44 neg neg neg neg neg neg neg neg neg neg
45 neg 8 neg neg neg neg neg negl t nes neg
46-51 neg neg neg neg neg neg ?j. neg neg I nes neg
For abbreviations see Table 5.








Idiopathic 12 10 — 7
Probable idiopathic 23 11 — 9
Tuberculous 16 — 1 1*
Controls (matched for age and sex) 51 — — —
Thyrotoxicosis 89 — 1 1*
Lymphadenoid goitre 69 2 2 2
Primary atrophic hypothyroidism 87 — 7 2*
Pernicious anaemia 54 — — —
Diabetes mellitus 93 4 3 1
* The antigen in this reaction was localized to capillary and sinusoidal endothelium
and not to adrenal secretory cells, using anti-/?lc conjugate in the indirect immuno¬
fluorescent technique.
the idiopathic group gave equivocal ( + ) staining of adrenal tissue with anti-lgG conjugate
but was negative with anti-/flc conjugate; the remaining serum in this group was negative.
No other patient with adrenal insufficiency nor any of the control patients gave doubtful
reactions. Antibody to the secretory cells of the adrenal cortex was detected in the sera of
eleven out of the twenty-three patients with probable idiopathic adrenal insufficiency but
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in none of the sixteen patients with tuberculous adrenal insufficiency using the fluorescent
method. The complement fixation test (using the serum diluted 1:4) was, as expected, less
















Fig. 7. The titre of adrenocortical antibody in the sera of patients with idiopathic and probable
idiopathic adrenocortical insufficiency correlated with the patient's age at the time of sero¬














Fig. 8. The titre of adrenocortical antibody in the sera of patients with idiopathic and probable
idiopathic adrenocortical insufficiency correlated with the patient's age at the time of diagnosis.
A, Male; •, female.
Table 9 and Fig. 7 illustrate that the incidence and titre of adrenocortical antibodies is
much higher in the female subjects with idiopathic or probable idiopathic adrenal insuffi¬
ciency than in the male subjects in these disease groups. The incidence of adrenal antibody in
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patients with idiopathic or probable idiopathic adrenal insufficiency was 80% in the twenty-
five female subjects compared to only 10% in the ten male subjects.
There is little or no correlation between the titre of adrenocortical antibody in the serum
and the age of the patients with idiopathic or probable idiopathic adrenal insufficiency at the
time of serological study (Fig. 7) or with the age of the patients at the time of diagnosis of
adrenal insufficiency (Fig. 8). A few elderly patients appear to have lower titres than the





Idiopathic F 9 0
M 1 2
Probable F 11 5
idiopathic M 0 7
Both groups F 20 5
combined M 1 9
younger patients, but there is no correlation between the titres of adrenocortical antibody
and the interval of time between the date ofdiagnosis of adrenal insufficiency and ofobtaining
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Fig. 9. The titre of adrenocortical antibody in the sera of patients with idiopathic and probable
idiopathic adrenocortical insufficiency correlated with interval between time of clinical
diagnosis and serological study. a, Male; •, female.
The cord blood of the baby of patient No. 13 with probable idiopathic adrenal in¬
sufficiency contained an identical titre of adrenal antibody to that in the patient herself.
The cord blood of patient No. 32, who also had probable idiopathic adrenal insufficiency
was negative for adrenal antibody in keeping with the negative result in the patient's blood.
IV : 25
52 W. J. Irvine, A. G. Stewart and Laura Scarth
Adrenal antibody was found in the serum of four out of sixty-nine consecutive patients
with lymphadenoid goitre attending the Endocrine Clinic. One of these patients (M.A.
female 55 years) was also suffering from rheumatoid arthritis of longstanding for which she
was being treated with phenylbutazone. Her blood pressure was 116/70 mmHg. There was
no buccal pigmentation but there was vitiligo on the arms. A second patient (B.E., female,
65 years) had pernicious anaemia as well as histologically proven lymphadenoid goitre.
A third patient (C.B., female, 58 years) had pernicious anaemia, diabetes mellitus,
rheumatoid arthritis and clinical and serological evidence of lymphadenoid goitre. The
fourth patient (M.B., female, 49 years) had histologically proven lymphadenoid goitre but
was not known to be suffering clinically from any other abnormality at the time of
writing, although parietal cell antibodies as well as thyroid and adrenal antibodies had
Table 10. Immunological survey in primary adrenal insufficiency
Sera positive for antibodies to:
Type of No. of Thyroid Stomach Thyroid Thyroid, A.N.F.
adrenal patients or stomach
disease Tg. Micr. Total P.C. I.F. Total stomach or IgG IgM
adrenal
Idiopathic 12 2 7 7 6 3 7 9 11
Probable idiopathic 23 4 9 10 8 4 9 12 16 — 1
Tuberculous 16 1 2 2 1 — 1 3 3 — —
Control subjects
(matched for age 51 2 4 5 4 — 4 8 8 — —
and sex)
Tg = Thyroglobulin; Micr = microsomal; P.C. = parietal cell; I.F. = intrinsic factor; adrenal =
adrenocortical secretory cells.
been demonstrated in her serum. In the first three of these patients a /l, _24 corticoptrophin
(Synacthen) test (Wood et at., 1965) showed a normal level and reserve of adrenocortical
function.
Adrenal antibody was also found in the serum of one of ninety-three patients .vith diabetes
mellitus. The patient was a male aged 37 years and his serum was positive for gastric parietal
cell antibody but negative for antibody to intrinsic factor and for thyroid cytoplasmic anti¬
body. The adrenal function of these latter two patients has not yet been tested. The sera of
eighty-nine patients with thyrotoxicosis, eighty-seven with primary atrophic hypothyroidism
and fifty-four with pernicious anaemia were negative for adrenal antibody.
Incidence ofother antibodies in patients with adrenal sufficiency
Table 10 summarizes the incidence of thyroid and gastric specific antibodies and of
antinuclear factors in the population studied. Only one patient out of the fifty-one with
adrenal insufficiency had antinuclear factor and this was in low titre and of IgM character¬
istic. The patient (No. 15) was a female aged 24 years who also suffered from hypopara¬
thyroidism and moniliasis and who gave a family history of rheumatoid arthritis.
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There was a high incidence of thyroid and gastric antibodies in the patients with idio¬
pathic or with probable idiopathic adrenal insufficiency. Antibody to thyroid cytoplasm
was more frequently present than antibody to thyroglobulin. Antibody to intrinsic factor
also had a high incidence in the idiopathic and in the probable idiopathic groups; seven
out of thirty-five patients in these combined groups had antibody to intrinsic factor.
Intrinsic factor antibody was not detected in any of the sera of the sixteen patients with
tuberculous adrenal insufficiency or of the fifty-one control subjects. Eleven out of twelve
patients with idiopathic and sixteen out of twenty-three patients with probable idiopathic
adrenal insufficiency had one or more organ-specific antibodies to adrenal, thyroid or
stomach. In contrast, the patients with tuberculous adrenal insufficiency had a much lower
incidence (three out of sixteen) of organ-specific antibodies of the type studied and this
incidence was comparable to that observed in the control subjects.
Table 11. Diseases associated with primary adrenal insufficiency




Thyrotoxicosis 1 2 —
Hypothyroidism 1 2 —
Euthyroid goitre — 1
Pernicious anaemia 2 1 -
Hypoparathyroidism 1 2 —
Moniliasis — 3 —
Diabetes mellitus 2 5 —
Rheumatoid arthritis — 1 —
Asthma 1 2 —
Eczema — 1 —
Schilder's disease 1 — —
Alopecia totalis — 1 1
Total affected 8 13 1
Total patients 12 23 16
Clinical and subclinical disease of other tissues in patients with adrenal insufficiency
The incidence of other clinical disorders in the patients with adrenal insufficiency is
summarized in Table 11. The incidence of thyroid diseases is particularly remarkable. The
diagnosis of disordered thyroid function was established in each case by clinical assess¬
ment and objective study using 13II uptake tests and serum PBI estimation, except in the
one case (No. 28) indicated by a query in Table 3. The patient with the euthyroid goitre
(No. 32) had a diffuse soft enlargement of the gland that was obvious on inspection and
readily palpable and was estimated to be about 40 g in size. The serum protein bound iodine
and radio-iodine uptake tests were normal.
One of the twelve patients with idiopathic adrenal insufficiency (No. 12) had evidence
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of latent pernicious anaemia. The serum vitamin B12 level was low at 108 pg/ml, the
Schilling test of vitamin B,2 absorption gave an equivocal result at 8-9% (normal^ 12-5%
using 0-5 /.fg/0-5 /.ic 58Co vitamin B12) and achlorhydria was demonstrated. A gastric biopsy
contained no parietal cells and there was a degree of lymphocytic infiltration in the gastric
mucosa that was considered greater than normal. Using the histological grading previously
described (Irvine et at., 1965) this patient's gastric biopsy was classified as P+ L++.
Another patient in this group (No. 8) had, in all probability, overt pernicious anaemia. The
details about this patient are given under case No. 1 of the post-mortem findings. A third
patient (No. 20) is of particular interest. Her serum had been sent from another hospital and
was found to contain antibody to intrinsic factor in high titre as well as antibody to adrenal
and antibodies to thyroid but not antibody to gastric parietal cells. While these studies were
in progress, the patient was found to have a macrocytic blood picture. Subsequent investiga¬
tion demonstrated a histamine fast achlorhydria (lowest pH, 7-7). The gastric secretion of
intrinsic factor was 8-0 ng units in the basal hour and 6-0 ng units in the post-histamine hour
establishing a diagnosis of Addisonian pernicious anaemia (Irvine, 1966a).
Three patients (Nos. 2, 15 and 20) with hypoparathyroidism were noted among the
thirty-five with idiopathic or probable idiopathic adrenal insufficiency. Two of these patients
also had moniliasis affecting the mouth, nails and vagina. The diagnosis ofhypoparathyroid¬
ism was established by the clinical features, repeatedly low serum calcium levels, Ellsworth-
Howard tests and response to therapy with calcium and vitamin D or A.T10 supplements.
The other patient with moniliasis (No. 32) had suffered from recurrent attacks of oral and
vaginal infection but had normal parathyroid function as determined by serial calcium
estimations during a low calcium diet with the addition of sodium phytate (Smith, Davies
& Fourman, 1960).
Seven out of thirty-five patients with idiopathic or probable idiopathic adrenal insuffi¬
ciency also had diabetes mellitus. All seven patients were receiving treatment with insulin
and the doses ranged from 20 to 72 units daily (average 42 units). One of the patients (No.
34) had diabetic retinopathy and neuropathy, but the incidence of diabetic complications
in other patients was not established.
It was noted that one patient (No. 30) with probable idiopathic adrenal insufficiency had
clinical, radiological and serological features consistent with mild rheumatoid arthritis.
Two patients (Nos. 6 and 13) had adult onset asthma, one patient (No. 16) had asthma and
eczema as a child, one (No. 11) had Schilder's disease and one (No. 20) had alopecia totalis.
A full description of the patient with Schilder's disease is to be reported by Forsyth and
Ingram (In preparation).
The only one of these conditions that occurred in the sixteen patients with tuberculous
adrenal insufficiency was alopecia totalis (No. 46). There is, therefore, a striking difference
in the incidence of associated diseases of the type listed in Table 11 among the patients
with idiopathic or probable idiopathic adrenal insufficiency as compared to patients with
tuberculous adrenal insufficiency.
A number of patients out of each of the three groups with adrenal insufficiency were
studied for evidence of subclinical gastritis. The results are shown in Table 12. The incidence
of achlorhydria and hypochlorhydria was significantly higher in the patients with idio¬
pathic or probable idiopathic adrenal insufficiency than in the tuberculous group. The




anaemia (Nos. 8 and 20) are included among the eleven patients with idiopathic or probable
idiopathic adrenal insufficiency who were shown to have achlorhydria. The other eight
patients who were demonstrated to have achlorhydria had normal vitamin B12 levels in the
serum and in the four instances that a Schilling test was done the result was normal. The
Schilling test was repeated 2 years later in one patient (No. 2) with antibody to intrinsic factor
in the serum and the result was again within the normal range (39% and 23%, respectively).
Quantitative figures for intrinsic factor secretion at these two intervals of time are not avail¬
able. A gastric biopsy was obtained from eighteen patients out of the fifty-one with adrenal
insufficiency; in general, the results correlated well with the figures obtained for the gastric
acid secretion. The concentration of parietal cells varied inversely with the acid secretion in
response to histamine and the degree of lymphocytic infiltration was noted to be increased in
patients with achlorhydria and hypochlorhydria as compared to those with a normal acid
secretion.
Table 12. Gastric function in primary adrenal insufficiency
Type of
adrenal insufficiency
Gastric acid secretion in post histamine hour
(mEq HC1)
Achlorhydria > 0<5 >5
Idiopathic 6* 2 1
Probable idiopathic 5 4 4
Tuberculous •— 2 5
* Including three patients with pernicious anaemia.
The level of protein bound iodine in the serum was measured in fourteen out of the thirty-
five patients with idiopathic or probable idiopathic adrenal insufficiency who did not have
any personal history of thyroid disease and the results were found to be normal. The level
of protein bound iodine in the serum of twelve of the patients with tuberculous adrenal
insufficiency who were so tested was also found to be normal. TSH stimulation tests to
determine the reserve of thyroid function were not included in the present study.
Family history of relevant diseases
The history in the families of patients with adrenal insufficiency of diseases listed in
Table 11 and of other diseases that may be associated with disordered immunological
reactions is given in Table 13. The brother of patient No. 11 was reported to have died of
Addison's disease. While there is a higher incidence of these diseases in the families of
patients with idiopathic and probable idiopathic adrenal insufficiency than in the families
of patients with tuberculous adrenal insufficiency, the difference is not striking and is of
doubtful significance.
The family history of patient No. 24 is of particular interest. Several of her maternal
relatives had diabetes mellitus and rheumatoid arthritis. Her mother was found to have
primary hypothyroidism (typical clinical features, serum protein bound iodine =1-0
Itg/100 ml, serum cholesterol = 420 mg/100 ml) at this clinic 7 years ago. It may be per¬
tinent that her father died from carcinoma of the stomach in view of the increased incidence
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of gastric carcinoma that is known to occur in pernicious anaemia (Kaplan & Rigler, 1945;
Mosbeck & Videbaek, 1950).
Sera were studied from three close relatives of a patient with idiopathic adrenal insuffi¬
ciency (No. 5) whose serum was positive for antibody to adrenal. None of these relatives
had demonstrable adrenal antibody. Six relatives of three patients with idiopathic or
probable idiopathic adrenal insufficiency (Nos. 11, 24 and 32) who did not have detectable
adrenal antibodies were likewise negative in this respect. Four of the total of nine relatives
had antibody to gastric parietal cells but all were negative for antibody to intrinsic factor.
One serum was positive to thyroglobulin.
Table 13. Family history of diseases in patients with adrenal insufficiency




Thyroid disease 2 5 2
Pernicious anaemia 1 2 —
Hypoparathyroidism — —
Moniliasis — I —
Diabetes mellitus 2 6 3
Rheumatoid arthritis 2 3 —
Asthma 2 4 2
Coeliac disease — 1 —
Bright's disease — — 1
Total affected 5 12 5
Total patients 12 23 16
Autopsy reports
Two cases of adrenal insufficiency coming to autopsy were available for study.
(1) D.M., case No. 7 of Tables 1 and 5. A Caucasian female aged 74 years. This patient
was admitted to hospital with a 3-month history of vomiting, weakness and central
abdominal pain. During the previous year she had lost 14 kg in weight. Some 30 years
previously she was thought to have had a syphilitic labyrinthitis. Eleven years previously a
macrocytic anaemia and histamine fast achlorhydria were demonstrated. There were no
symptoms of intestinal malabsorption and the patient was not known to be taking any
Fig. 10. (a) The histology of the adrenal gland of the patient D.M. aged 74 years who died with
idiopathic adrenal insufficiency (case No. 8 of Tables 2 and 5; autopsy report No. 1). Note
the disruption of the normal architecture of the adrenal cortex and the infiltration of the
tissue with lymphocytes. H & E, x 360.
(b) The histology of the adrenal gland of the patient R.M. male aged 63 years who died
with idiopathic adrenal insufficiency (autopsy report No. 2). Note the diffuse and heavy
infiltration of the gland epithelial cells. H & E, x 125.
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drugs that might have induced a macrocytic blood picture. Although no bone marrow,
serum vitamin B,2 or absorption studies were done, a diagnosis of pernicious anaemia was
made and the patient responded well to treatment with parenteral vitamin B12. The patient
continued to receive regular injections of vitamin B12 during the remainder of her life.
The skin was markedly pigmented, particularly the backs of the hands, creases and
pressure areas. Buccal pigmentation was also present. The blood presure was 110/75 mmHg.
The haemoglobin was 70%, the blood film and indices were normocytic and the reticulocyte
count was 1%. The serum sodium concentration was below normal limits at 127 mEq and
the serum potassium and bicarbonate concentrations were within normal limits at 4-5
and 25 mEq, respectively. No information was available with regard to urinary or plasma
steroid levels.
Shortly after admission the patient collapsed with a blood pressure of 80/40 mmHg
and in spite of treatment with hydrocortisone and desoxycortisone acetate the hypotension
persisted and the patient died following a series of fits 5 days later.
At autopsy (Dr Beswick) both adrenal glands were very small, the right being especially
minute (left adrenal = 3-5 g, right adrenal = 2-0 g together with some adherent fat and
connective tissue). The adrenal cortices were very narrow and depleted of lipid. Microscopy
of the left adrenal showed that the normal cortical layers could not be made out. The surviv¬
ing cortex consisted of nodular masses of large irregularly-arranged palely-eosinophilic cells.
In places cortical tissue was completely absent and replaced by vascular fibrous tissue.
Lymphocytic clusters were very numerous through the gland (Fig. 10a). The right adrenal
showed almost no glandular tissue whatever except for one small area of cortical cells
infiltrated with lymphocytes. Elsewhere the layers of the thickened capsule were separated
only by a little delicate connective tissue infiltrated by clusters of lymphocytes. The arteries
in both adrenal glands were somewhat thick-walled and had prominent elastic laminae.
Some of the arterioles were hyalinized and the veins had thickened muscular walls.
The pituitary was of normal size. On histological examination the anterior lobe of the
pituitary contained a few small fibrous scars and a cluster of lymphocytes. The thyroid
appeared grossly normal and weighed 20 g. Histologically the thyroid was somewhat
nodular and the vesicles varied in size but contained a normal content of colloid. In some
areas there was some patchy fibrosis and lymphocytic infiltration in the thyroid but this
was not conspicuous. The parathyroid glands were not examined. The pancreas showed
no abnormality. No thymus remnants were seen.
There was extensive bronchopneumonic consolidation in all lobes of both lungs and
histological examination showed congestion and an acute bronchitis. There was no evidence
of tuberculosis anywhere in the body nor was there any evidence of syphilitic infection.
In particular, the middle ears were normal. There was no gross abnormality seen in the
central nervous system apart from congestion and oedema and examination of the cardio¬
vascular system was not remarkable. The histology of the stomach was vitiated by the
presence of autolysis.
A sample of serum was obtained a few days before her death. It contained a low titre of
adrenocortical antibody both by the indirect fluorescent antibody technique and by
complement fixation. The serum also contained antibody to thyroid microsomal antigen
(positive immunofluorescence; complement fixation titre 1:32) and antibody to intrinsic
factor in a titre of 39 ng/ml. The serum was negative for antibody to thyroglobulin and for
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antibody to gastric parietal cell cytoplasm and for anti-nuclear factors and did not give
rise to non-specific autoimmune complement fixation reactions. Unfortunately, no un¬
fixed tissue was available for direct immunofluorescence studies.
(2) R.M., 63-year-old Caucasian male with a 3-month history of lassitude and weight
loss. Clinical examination revealed only evidence of weight loss. Blood pressure = 105/65
mmHg, haemoglobin = 70%. On two occasions the erythrocyte sedimentation rate was
noted to be raised at 30 and 50 mm in the first hour (Westergen). Malignancy was suspected.
X-ray of chest, barium meal and barium enema showed no abnormality. No definite
diagnosis was made and the patient died at home. No serum was available for immuno¬
logical study.
At autopsy (Dr Neil Maclean) the only macroscopic abnormality was in the adrenal
glands; they were below average size (left adrenal = 6-0; right adrenal = 5-4) and section¬
ing revealed that very little cortical tissue remained. Much of the gland was composed of
firm grey tissue. There was no macroscopic evidence of tuberculosis elsewhere in the body.
The pituitary and thyroid were of normal size (pituitary weight = 0-6 g). The testes, pancreas
and liver (1360 g) were considered to be below average size but no abnormality was noted
on sectioning of these organs, apart from a mild degree of brown atrophy in the liver. The
spleen weighed 140 g and showed no abnormality. No reference was made to the thymus
or parathyroids. The sternum, vertebrae and right iliac crest showed some osteoporosis
and these bones contained dark red reactive marrow.
On microscopic examination the adrenal glands were seen to be almost wholly destroyed.
Here and there surviving cortical and medullary cells were still recognizable but they formed
only a small proportion of the total gland. There was a heavy degree of lymphocytic
infiltration, but plasma cells were also present (Fig. 10b). In addition there were areas of
necrosis and fibrosis. No multi-nucleated giant cells or tubercle bacilli were identified
but epitheloid cells surrounded some of the necrotic areas. No excess of iron pigment could
be demonstrated in the adrenals.
There was no microscopic evidence of tuberculosis elsewhere in the body. Minor siderotic
lesions of the lungs had developed as a result of the patient's occupation of arc-welder.
The gastric mucosa showed some degree of lymphocytic infiltration together with large
lymphoid follicles but parietal cells were plentiful. Detailed analysis of the gastric histology
was prevented by autolysis. The thyroid, pancreas and pituitary were histologically normal.
The only other abnormality noted was the presence of foci of myofibrillar atrophy and of
associated lymphocytic infiltration in a portion of pectoral muscle.
DISCUSSION
A diagnosis of adrenal insufficiency necessitates the appraisal of the clinical features which
the patient presents together with the appropriate investigation of the patient's adrenal
function. The most specific test for adrenal insufficiency is the level of the plasma Cortisol
and the absence of a response in this level to adrenal stimulation by ACTH or /?1_24
corticotrophin (Synacthen, Ciba). The ideal time to do this investigation is when the diag¬
nosis of adrenal insufficiency is first suspected. Frequently, however, the diagnosis is made
clinically and in fear of impending adrenal crisis steroid therapy is commenced. The patient
improves clinically and further investigation may not be instituted. Particular care must
be taken to use ACTH in adequate dosage and for sufficient time in the assessment of
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potential adrenal function in a patient who has been treated with steroids for a prolonged
period. In such a patient a rise in the plasma 11-OHCS level may be obtained with Synacthen
stimulation, but lack of response should be followed by adequate ACTH testing. We have
shared the common experience of studying patients who were initially diagnosed on the
strength of the clinical features of Addison's disease, but who on investigation with plasma
Cortisol studies before and after ACTH were subsequently shown to have normal adrenal
function. For the purpose of scientific study clinical features alone are not in themselves
sufficient to label the patient as having adrenal insufficiency; patients diagnosed on clinical
features alone or together with laboratory tests that are not specific for primary adrenal
failure, such as urinary ketosteroid excretion, water tolerance, glucose tolerance, insulin
sensitivity, etc., should be placed in a category of 'probable adrenal insufficiency'.
The diagnosis of idiopathic adrenal insufficiency is made by the process of exclusion.
Among the known agents that may cause adrenal destruction are tuberculosis and rarely
histoplasmosis, sarcoidosis, syphilis, amyloidosis, haemorrhage, infarction, mycosis
fungoides, Hodgkin's disease or tumour. If the patient has radiological calcification of
the adrenal glands it may be assumed that the aetiology is other than idiopathic. We are
not aware of any description in the literature of calcification of the adrenal that has been
the site of simple atrophy. While tuberculosis is the commonest cause of adrenal calcification
it is conceivable that this might also be the result of some other pathology, e.g. haemorrhage
or infarction. The proportion of tuberculous adrenal glands that show radiological evidence
of calcification is not known. Figures from the older literature (Camp, Ball & Greene,
1932) are probably not applicable to the present day. Prior to satisfactory treatment of
adrenal insufficiency with steroid replacement, active tuberculosis may have destroyed
sufficient cortical tissue to cause death before fibro-caseation or calcification occurred.
With survival of the patient the incidence of calcification of the adrenal is likely to be
higher, particularly in patients who have been X-rayed many years after adrenal insufficiency
was diagnosed. In the absence of adrenal calcification it would seem logical to assume a
tuberculous aetiology if the patient has evidence of gross tuberculous infection elsewhere
in the body either preceding or coincident with the diagnosis of adrenal insufficiency.
The development of gross tuberculous infection after the diagnosis of adrenal insufficiency
could be due to the possibility that patients with adrenal insufficiency of whatever origin
may be more prone to tuberculous infection. Nine out of the sixteen patients in the tuber¬
culous group in the present study had radiological evidence of adrenal calcification.
A positive Wassermann reaction does not necessarily mean that the patient's adrenal
insufficiency is syphilitic in origin and a positive Mantoux test or radiological opacity on
chest X-ray does not necessarily mean that this adrenal insufficiency is due to tuberculosis.
This is exemplified by patient No. 8 who was known to have a positive Wasserman reaction
but who had no evidence of syphilis at autopsy and whose adrenal glands showed simple
atrophy. At the present time in Britain radiological evidence of the healed primary tuber¬
culous focus in the chest is a common occurrence in middle-aged and elderly persons. It
would therefore not be judicious to label adrenal insufficiency as tuberculous in origin
simply because there was a healed primary focus on chest X-ray or a positive Mantoux
reaction. For this reason we would not agree with the subdivision of patients with adrenal
insufficiency into idiopathic or tuberculous according to the presence or absence of radio¬
logical evidence of tuberculosis anywhere in the body as used by Goudie et at. (1966).
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The incidence of adrenocortical antibodies in the different subgroups of patients with
primary adrenal insufficiency will depend not only on the diagnostic criteria used to classify
the patients but also on the techniques employed for the detection of these antibodies. Anti¬
body to adrenal can be detected using the methods of immunofluorescence and complement
fixation. The sensitivity of the immunofluorescence method depends on the details of the
procedure adopted. With weak anti-sera, inappropriate conjugation with the fluorescent
dye, inadequate tissue sections or insufficient washing after application of the conjugate,
the background non-specific staining of the adrenal tissue may be so dense as to mask even
strong specific staining. In the present study the most satisfactory results were observed
with anti /11C conjugated to fluorescein iso-thiocyanate. It should also be noted that,
although the zona glomerulosa is readily recognizable and prominent in most human
adrenal glands, it may not be present in all sections and may exist only as small focal
collections of cells on the surface of the gland. In the sera of patients with idiopathic or
probable idiopathic adrenal insufficiency a good correlation was observed between the
titre of adrenocortical antibody as determined by immunofluorescence and by the comple¬
ment fixation method. One serum from a patient with tuberculous adrenal insufficiency gave
a positive complement fixation test with adrenal and failed to stain the secretory cells of
the adrenal cortex in the immunofluorescence method. Blizzard & Kyle (1963) record a
similar finding with the sera of two patients who were believed to have Addison's disease
of tuberculous rather than idiopathic origin. The fact that this serum gave strong staining
of the vascular endothelium with anti-/ilc-FlTC conjugate suggests that the positive com¬
plement fixation reaction with a saline extract of adrenal was directed against the interstitial
tissue of adrenal and not the secretory cells. The staining of the interstitial tissue (vascular
endothelium) of adrenal gland No. 1 is probably related to blood group A substance,
although this has not been definitely established. Its occurrence is of importance, at least in
a negative sense, in that such reactions may be responsible for 'false positive' complement
fixation tests with saline extracts of adrenal.
The adrenocortical antibody is IgG in character as determined by the use of monovalent
antisera in the immunofluorescent technique and by the observation that the antibody was
able to cross the placenta into the foetal circulation.
Blizzard & Kyle (1963) give some evidence that suggests there may be more than one
antibody to adrenal as detected by complement fixation. The observation that the pattern
of immunofluorescent staining of adrenal sections with the sera of patients with idiopathic
adrenal insufficiency is the same when anti-IgG or ant\-Plc conjugates were used suggests
that, if there are two antibodies to adrenal, the corresponding antigens have a similar
distribution within the gland. It is difficult but possible to grow human adrenal cells in
tissue culture (Irvine, 1960) and it would be interesting to correlate cytotoxicity experi¬
ments with the findings obtained with immunofluorescence and complement fixation in a
manner comparable to what has been done in relation to the problem of thyroiditis (Forbes
et al., 1962; Irvine, 1962; Kite el a/., 1965). The adrenocortical antigen is a particulate
component of the cytoplasm and is found predominantly in the microsomal but also in the
mitrochondrial fractions of a saline extract (Blizzard & Kyle, 1963; Goudie et al., 1966). It is
interesting to speculate why the staining should be of maximal intensity in the zona glomeru¬
losa. A number of steroid hormones are formed by the adrenal cortex, the most important
of which are the C21 steroids, Cortisol, corticosterone and aldosterone. Cortisol and
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corticosterone are products of the reticularis and fasciculata zones,while aldosterone is formed
by the zona glomerulosa. The adrenal cortical cells also form C19 compounds or androgens
and opinions vary as to the site of production of these hormones. Greep & Deane (1949)
demonstrated that injections of corticosterone into the intact rat result in depletion of the
sudanophilic material in the zona fasciculata and reticularis in a manner comparable to the
changes seen following hypophysectomy, while the lipids in the zona glomerulosa remained
essentially unaffected. It is conceivable that the content of adrenal antigen in the zona
fasciculata and reticularis was depleted in the glands which we studied as a result of the
administration of exogenous corticosteroid to the patient prior to removal of the adrenals.
On the other hand, the occurrence of maximum intensity of fluorescent staining in the zona
glomerulosa might be related to the type of metabolism that is characteristic of this layer
of adrenal cortex. It is possible that immunological techniques may prove helpful in analys¬
ing the different constitution of the zona glomerulosa compared to the zona fasciculata and
reticularis. The negative results of adrenal positive sera when tested against sections of
human testis indicate that the antigen in the adrenocortical cells is not common to all
steroid producing tissues.
No one has yet demonstrated that adrenocortical antibody in patients with adrenal in¬
sufficiency is an autoantibody and strictly speaking it would seem unwise to refer to these
antibodies as such until this point has been established. However, the similarity in the
immunological phenomena associated with thyroiditis (Roitt & Doniach, 1960), atrophic
gastritis (Irvine et at., 1965) and idiopathic adrenal insufficiency would make it probable
that the adrenocortical antibody is an autoantibody.
The incidence recorded in this study of adrenocortical antibodies in the sera of patients
with idiopathic adrenal insufficiency is very high, although it is admitted that the number of
patients in this group is small. All the female patients in this group were positive and one
of the three male patients in the group was positive. Even when the patients with probable
idiopathic adrenal insufficiency are included, the incidence of adrenocortical antibody is
still high in the female subjects at 80%. The titre of adrenal antibody in the serum of the
one positive male patient of the ten with idiopathic or probable idiopathic adrenal in¬
sufficiency was minimal. The sex distribution of the patients with idiopathic or probable
idiopathic adrenal insufficiency was predominantly female, while in the patients with
tuberculous adrenal insufficiency it was predominantly male. It is frequently stated that the
sex incidence in adrenal insufficiency is approximately equal (Sorkin, 1949; Thorn, Dor-
rance & Day, 1942; Dunlop, 1963; Goudie et at., 1966), but on analysis of these reports
there has been no or inadequate distinction made between adrenal insufficiency of tuber¬
culous or idiopathic origin. In Thorn's series, while there was an equal sex incidence in
patients with idiopathic adrenal insufficiency assessed clinically, of the fourteen patients
with adrenal insufficiency who came to autopsy, seven had simple atrophy of the adrenal
cortex and of these six were female. In the autopsy cases of simple adrenal atrophy reported
by Brenner (1928) and by Susman (1930) there were eight females and two males. The pre¬
ponderance of females among adult patients with idiopathic adrenal insufficiency is in
keeping with the criteria of an 'autoimmune disease'. The sex ratio may not be so pro¬
nounced, however, in favour of females as it is in thyroiditis or Addisonian pernicious
anaemia. The preponderance of adrenal antibody positive subjects among females, with a
low incidence among males, is not in keeping with thyroiditis or Addisonian pernicious
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anaemia for, although these diseases occur predominantly in females, males who do develop
these conditions tend to have the same incidence of thyroid and gastric antibodies as the
females. As in thyroiditis and gastritis so also in adrenalitis, there is no correlation between
the titre of the corresponding organ-specific antibody and the duration of the clinical disease
in a population of patients studied at one point in time.
The titres of adrenal antibody so far encountered (<1:32) are not high. The range is
less than that for parietal cell antibody in the sera of patients with pernicious anaemia and
certainly less than that for thyroid complement fixing antibody in patients with chronic
thyroiditis. In keeping with this fact is the absence of any gross quantitative abnormality
in the y-globulin fraction of the serum as determined by cellulose acetate electrophoresis
and the normal to slightly elevated levels of the erythrocyte sedimentation rate in patients
with idiopathic adrenal insufficiency.
The high incidence of other endocrinopathies (thyroid disease, hypoparathyroidism,
diabetes mellitus) and of atrophic gastritis in patients with idiopathic but not tuberculous
adrenal insufficiency is of interest. Schmidt (1926) was the first to describe two cases with
the symptoms of idiopathic adrenocortical insufficiency accompanied by lymphocellular
infiltration and germinal centres in the thyroid. Carpenter et al. (1964) reviewed the literature
on the association between thyroid and adrenal insufficiency and reported a further fifteen
cases, including ten instances of coexistent diabetes mellitus. As in our own experience,
thyroid changes were found much more commonly in patients with idiopathic adrenal
insufficiency than in patients with adrenal tuberculosis. This observation was also made
by Sloper (1953) who concluded that lymphoid infiltration in the thyroid of patients with
simple atrophy of the adrenal cortex was not dependent on the general hyperplasia of the
lymphatic tissue commonly associated with Addison's disease. The female to male ratio
in Schmidt syndrome is approximately 3:1. The occurrence of thyrotoxicosis in patients
with idiopathic adrenal insufficiency has previously been noted by Blizzard & Kyle (1963)
and by Irvine (1963b). Sorkin (1949) noted at autopsy that idiopathic atrophy of the
adrenal glands was present in twelve out of fourteen cases of combined Addison's disease
and diabetes mellitus and that adrenal tuberculosis occurred in only two. Beaven et al.
(1959) reviewed fifty-five cases in the literature of diabetes mellitus and Addison's disease
and added a further eight; the majority of these patients had idiopathic rather than tuber¬
culous adrenal insufficiency. Diffuse cerebral sclerosis with endocrine abnormalities has
been described in young males by Hoefnagel, van den Hoort & Ingbar (1962). In their
patient, there was a virtual absence of basophilic cells in the pituitary and the marked
atrophy of the adrenal cortices which was also present may have been secondary to this.
Blizzard & Kyle (1963) refer to a case of Schilder's disease associated with idiopathic
adrenal insufficiency. The patient included in the present paper is another example. It is of
interest that autoimmune phenomena may be present in demyelinating conditions.
(Lamoureux & Borduas, 1966).
The association between juvenile hypoadrenocorticism, hypoparathyroidism and super¬
ficial monilasis was first noted by Whitaker et al. (1956), and this association, particularly
in the younger patients with idiopathic adrenal insufficiency, has now been frequently
recorded (Blizzard & Kyle, 1963; Hung, Migeon & Parrott, 1963; Kunin et al., 1963;
Kenny & Holliday, 1964). The description of a possible association between pernicious
anaemia and adrenal insufficiency dates back to Addison himself (Addison, 1849). The
E
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association between pernicious anaemia and adrenal insufficiency had been reviewed by
Kra & Barile (1964) and has also been noted in cases of idiopathic adrenal insufficiency by
Hung et at. (1963) and by Morse, Cochrane & Landrisan (1961).
With regard to subclinical disease, atrophic gastritis associated with hypochlorhydria
or achlorhydria has been described in Addison's disease (Smith, Delamore & Wynn
Williams, 1961). The unsubstantiated statement has been made (Soffer, 1946; Sorkin, 1949)
that the achlorhydria of adrenal insufficiency is reversible. The present study emphasizes
that atrophic gastritis is particularly common and severe in patients with idiopathic adrenal
insufficiency and is less common and less severe in patients with tuberculous adrenal in¬
sufficiency. It also indicates that at least in some cases the gastritis is not reversible for it has
been shown that severe gastric atrophy with achlorhydria is commonly present many years
after adequate steroid replacement therapy has been instituted and maintained in patients
with idiopathic adrenal insufficiency.
A degree of lymphocytic infiltration of the pituitary was observed in autopsy No. 1 of the
present study and this has been previously observed by Susman (1930) and by Carpenter
et at. (1964). In autopsy No. 2, lymphocytic infiltration in skeletal muscle was noted. This,
and also lymphocytic infiltration of the meninges, has been described by Duff & Bernstein
(1933). In neither of the autopsies included in the present study was there any evidence of lym¬
phocytic infiltration of the liver or pancreas, which has been noted to occur by Susman (1930).
In a review of the microscopic sections of the adrenal glands of twenty-eight patients
found to have typical Hashimoto's disease at autopsy, Carpenter et at. (1964) found no
evidence of lesions resembling the changes of idiopathic adrenal atrophy. In the records of
autopsies in seventy-four patients with Hashimoto thyroiditis, Masi et at. (1965) could not
find any evidence that atrophy or lymphocytic infiltration of the adrenal glands was any
more common than that found in seventy-four control autopsies.
The incidence of other organic-specific antibodies is strikingly high in patients with
idiopathic as opposed to tuberculous adrenal insufficiency. This is in keeping with the high
incidence of associated clinical and subclinical conditions referred to above. The high
incidence of antibody to intrinsic factor is particularly remarkable. In general, the presence
of intrinsic factor antibody in the serum shows a very strong correlation with malabsorption
of vitamin BI2 due to failure of secretion of intrinsic factor by the gastric mucosa or an
inhibition of what little intrinsic factor is being secreted (Irvine, 1965; Fisher, Rees & Taylor,
1966). Seven out of the thirty-five patients with idiopathic or probable idiopathic adrenal
insufficiency in the present study had antibody to intrinsic factor in the serum and yet only
three had evidence of latent or overt pernicious anaemia. Tests for antibody to parathyroid
tissue were not included in the present study. Blizzard, Chee & Davis (1966) described
parathyroid antibodies in 38% of seventy-four patients with idiopathic hypoparathyroidism,
in 6% of 245 control patients and in as many as 26% of ninety-two patients with idiopathic
adrenal insufficiency. In keeping with the low incidence of Addison's disease in patients with
lymphadenoid goitre, sera of four out of sixty-nine patients with lymphadenoid goitre were
found to be positive for adrenocortical antibody, and all four of these patients were shown
to have normal adrenocortical function. Likewise, the incidence of adrenocortical antibodies
in consecutive patients with thyrotoxicosis, primary atrophic hypothyroidism, pernicious
anaemia and diabetes mellitus and in control subjects was low (only one positive recorded
out of 372 sera). It is possible that a certain type of diabetes mellitus may be associated with
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other endocrinopathies. Our findings do not offer many clues in this respect except that all
our patients were receiving moderate to high doses of insulin and at least one had diabetic
complications. Autoimmune phenomena to pancreas or insulin in diabetic subjects do not
appear to be clearly established (Chetty & Watson, 1965). Mancini et al. (1965) have
reported finding antibodies to insulin in two patients who had diabetes mellitus but who had
not been treated with insulin. However, the number of controls in the latter study was very
small.
On present evidence it may be stated that idiopathic adrenal insufficiency is part of the
syndrome of polyendocrinopathy including the thyroid gland, parathyroid gland and the
adrenal, and to which may be added atrophic gastritis and a tendency towards diabetes
mellitus. From a review of the literature the disease complex may also include steatorrhea
(Kunin et al., 1963). This syndrome may be manifest clinically in one or more of its facets
and there may be subclinical evidence of other facets of the syndrome. There is no fixed order
in which the different tissues may be involved; one or more of these conditions may be
clinically manifest before the adrenal insufficiency becomes apparent or the adrenal in¬
sufficiency may precede the others.
The rarity of idiopathic adrenalitis and of idiopathic hypoparathyroidism contrasts
with the comparatively common occurrence of thyroid disorders and of atrophic gastritis.
This fact requires some explanation if we are to argue that all these conditions have a
common pathological mechanism. It does appear that, if a patient has thyroiditis, he has
a good chance of having gastritis also and vice versa, but he has little chance of having
adrenalitis or parathyroid insufficiency. On the other hand, if the patient has adrenalitis
of idiopathic origin, he has a very good chance of having clinical or subclinical thyroid
disease, or gastritis with the corresponding organ-specific antibodies in the serum. There is,
therefore, some differential susceptibility of the target organs in this group of diseases.
One obvious correlation is the size of the glands involved, but this may be too simple a
basis on which to seek an explanation.
Familial aspects of Addison's disease have recently been reported by Hung et al. (1963).
Meakin, Nelson & Thorn (1959) reviewed the literature and found five cases of familial
Addison's disease documented by steroid studies or autopsy findings and reported another
case. Dunlop (1963) drew attention to the fact that all cases of familial Addison's disease
have so far proved to be idiopathic if autopsy was performed. While it is apparent from
Table 13 that a family history of other endocrinopathies and of diseases associated, or
possibly associated with, immunological abnormalities is a common feature in patients
with idiopathic adrenal insufficiency, these diseases also occurred in the family histories of
patients with tuberculosis of the adrenals. Thyroid disease, diabetes and asthma are all
common conditions; a much larger series of patients would need to be studied before the
suggestive findings reported here could be said to be adequately documented. A systematic
approach to the problem is required whereby as many of the relatives as possible are
interviewed and clinically examined.
The post-mortem studies on the two patients with idiopathic adrenal insufficiency
described in the present paper emphasize the similarity of the histology of simple adrenal
atrophy to that of other tissues (e.g. thyroid, stomach) which have been the site of a disease
process that is associated with autoimmune phenomena. While germinal centres were not
a feature, there was in both cases a heavy lymphocytic infiltration and a disruption of the
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normal architecture of the gland and some increase in fibrosis. As noted in thyroiditis
(Irvine & Muir, 1963) and gastritis (Irvine et at., 1965), the lymphocytes can be seen under
light microscopy to come into close relation with the adrenal epithelial cells. While the
majority of patients with simple atrophy of adrenal have very small glands which are
virtually fibrous and contain very few epithelial adrenal cells and some lymphocytic
infiltration (autopsy No. 1), it is of interest to note that the adrenal gland may be of con¬
siderable size and very densely infiltrated with lymphocytes in a manner comparable to the
enlarged but underactive Hashimoto goitre (autopsy No. 2). We believe that this is the
first description of such a case. Unfortunately a sample of this patient's serum was not
available for immunological study.
The immunology of adrenal insufficiency is of particular importance from the theoretical
point of view. Here we have a distinct difference between adrenal insufficiency due to simple
atrophy and that due to bacterial destruction. In the former there is a high incidence of
organ-specific antibodies (including those directed against the adrenal) while in the latter
these antibodies are virtually absent. This observation is of particular relevance when it is
recalled that tubercle bacilli have an adjuvant effect on the immunological system. As
previously argued (Irvine, 1964) there must therefore be some basic immunological difference
between these two categories of patients with adrenal insufficiency. A disorder of immuno¬
logical tolerance may be sited in the antibody forming system itself or possibly in the thymus.
There is little in the literature on the pathology of the thymus gland in patients with adrenal
insufficiency. An enlarged thymus gland was noted by Carpenter et at. (1964) in their
survey of the autopsy findings of twenty-four patients with Addison's disease, but that par¬
ticular patient had tuberculous disease of the adrenal. Duff & Bernstein (1933) noted the
presence of a cystic mediastinal tumour in the region of the thymus during the autopsy
on a patient with simple atrophy of the adrenals. Structures resembling germinal centres
were noted to be present in the tumour but no Hassell's corpuscles were seen and the cystic
spaces were filled with amorphous caseous material. In two other autopsies in their series
the thymus gland was of normal appearance. Wells (1930) noted a 'persistent' thymus in
only one of his five post-mortem cases of combined thyroiditis and suprarenal atrophy.
Several factors might influence the size and histology of the thymus in adrenal insufficiency;
a disorder of immunological tolerance in a manner comparable to thyroiditis (Gunn, Michie
& Irvine, 1964; Irvine & Sumerling, 1965), the change in the steroid status of the patient
and the existence of infection, particularly tuberculous infection.
Adrenalitis has been produced experimentally by immunizing guinea-pigs with homo¬
logous or autologous adrenal tissue and Freund's adjuvant (Colover & Glynn, 1958; Steiner
et at., I960; Witebsky & Milgrom, 1962). There appeared to be no correlation between the
titre of the adrenal antibodies as detected by complement fixation and the degree of histo¬
logical aberration (Terplan, Witebsky & Milgrom, 1963). Some but not all the guinea-pigs
injected with adrenal extract and Freund's adjuvant developed histological lesions in the
adrenal gland. The interpretation of this observation was complicated by an occasional
positive histological finding in the adrenals of control animals injected with adjuvant alone
(Witebsky & Milgrom, 1962). These results are closely comparable to what has been
observed in relation to experimental thyroiditis (Jones & Roitt, 1961). Comparable lesions
of the gastric mucosa, parathyroids and pancreas have not been convincingly produced in
experimental animals by immunological means. The adrenal antigen was shown to be
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probably protein in nature and associated with the 6-6 S sedimenting component (Shulman
et al., 1965).
Whatever the theoretical implications of the description of antibodies to the adrenal
cortex in idiopathic adrenal insufficiency, the detection of these antibodies may have some
clinical importance. The finding of adrenal antibody would suggest an idiopathic aetiology
for Addison's disease that is already diagnosed or clinically suspected. There may be a place
for screening patients with other endocrinopathies serologically to determine whether they
may have a tendency to develop overt adrenal insufficiency at a later date although the
number of positive results is likely to be small. As in the case of thyroiditis and gastritis, the
detection of adrenal antibody may prove to be a pointer to subclinical disease of the adrenal
gland. The finding of adrenocortical antibody in the serum of one out of ten patients with
Cushing's syndrome together with a description of lymphocytic infiltration in hyperlastic
human adrenal glands (Wegienka el al., 1966) suggests that adrenal specific antibody may
be associated with hyper- as well as hypo-function of the adrenal cortex in a manner
comparable to thyroid autoimmunity in thyrotoxicosis, Hashimoto goitre and primary
thyroid atrophy (Roitt & Doniach, 1960; Adams, 1965). Clearly a detailed clinical, immuno¬
logical and histological analysis of a larger number of patients with different types of
adrenal disorder is required.
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ADDISON'S DISEASE AND ADDISONIAN ANJEMIA
Sir,—In their article Dr. Meecham and Dr. Wyn Jones
(March II, p. 535) write: " It would be of interest to screen
patients with adrenal insufficiency for evidence of vitamin-Bu
deficiency "
We have made a clinical and immunological study of 51
patients with Addison's disease (12 with idiopathic, 23 with
probable idiopathic, and 16 with tuberculous, adrenal in¬
sufficiency) xj all sera were tested for antibodies to gastric
parietal cell by complement fixation and immunofluorescence
techniques, and were then screened and titrated for antibody to
intrinsic factor using radio-immunoassay with charcoal
absorption.2 Tests of gastric function were done on 29 of the
patients by the augmented histamine test meal.3 Schilling
tests of vitamin-B12 absorption4 were carried out, and the level
of vitamin BI2 in the serum was measured.5 Gastric biopsy,
using a Crosby capsule,6 was done on 18 of the patients. No
significant difference in steroid replacement dosage was found
in the 3 patient-groups.
Out of the 12 patients with idiopathic Addison's disease, 1
had frank pernicious anaemia (p.a.) and another had latent p.a.
Frank p.a. was also established in 1 patient whose Addison's
1. Irvine, W. J., Stewart, A. G., Scarth, L. Clin. exp. Immun. 1967, 2, 31.
2. Irvine, W. J. ibid. 1966, 1, 99.
3. Kay, A. W. Br. med.J. 1953, ii, 77.
4-. Schilling, R. F. J. Lab. din. Med. 1953, 42, 860.
5. Girdwood, R. H. Scott, med. J. 1960, 5, 10.
6. Crosby, W. H„ Kuglcr, H. W. Am. J. dig. Dis. 1957, 2, 236.
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GASTRIC FUNCTION IN PRIMARY ADRENAL INSUFFICIENCY
Gastric-acid secretion in post-histamine
Type of adrenal insufficiency hour (mEq. hydrochloric acid)
Achlorhydria >0<5 >5
Idiopathic 6* 2 1
Probable idiopathic 5 4 4
Tuberculous 2 5
# Including 3 patients with P.A.
disease was probably idiopathic, but p.a. was not recorded in
the tuberculous group. All 3 patients with p.a. were diagnosed
by the standard methods referred to above; in 1 the intrinsic
factor (i.f.) content of the gastric juice was assayed by radio¬
immunoassay,2 giving a result of 8 ng. units in the basal hour
and 6 ng. units in the post-histamine hour, which is well
within the p.a. range. All 3 patients had antibody to i.f. in the
serum but only 1 had parietal-cell antibody. 4 other patients
in the combined idiopathic and probable idiopathic groups,
but none of the patients with tuberculous Addison's disease,
had antibody to i.f. in the serum. These 4 all had parietal-
cell antibody in the serum and gastric analysis in 2 showed
histaminc-fast achlorhydria. 3 of the 4 are known to have
maintained normal vitamin-B,2 absorption for the period of
follow-up (1-3 years) despite the presence of i.f. antibody in
the serum.
The incidence of gastric parietal-cell antibody was 50% in
the idiopathic group, 35% in the probable idiopathic group,
and 6% in the tuberculous group. The incidence of achlor¬
hydria and hypochlorhydria (see accompanying table) was found
to be significantly higher in the patients with idiopathic or pro¬
bable idiopathic adrenal insufficiency than in the tuberculous
group. The 3 patients with p.a. are included among the 11
patients in the idiopathic groups shown to have achlorhydria.
The 8 patients with hypochlorhydria have normal vitamin Bla
levels in the serum, and in the 4 instances that a Schilling test
was done the result was normal. Gastric-biopsy results cor¬
related well with the figures obtained for gastric-acid secretion.
The concentration of parietal cells varied inversely with the
acid-secretion in response to histamine, and the degree of
lymphocytic infiltration was noted to be higher in patients with
achlorhydria and hypochlorhydria than in those with normal
acid secretion.
Antibodies to adrenal cortex were detected by immuno¬
fluorescence and complement fixation. They were detected in
the serum of 80% (20/25) of the females with idiopathic or
probable idiopathic adrenal insufficiency, and in only 10%
(1/10) of the males. No antibody to adrenal cortex was detected
in 54 patients with p.a.
Serological evidence of adrcnalitis is rare in patients with
p.a., but gastritis is common in those with adrenalitis. The
association of Addison's disease and addisonian anaimia is
being recognised more readily, p.a. has been reported in 7 of a
group of 118 patients with Addison's disease 6 of the 7 were
children. As to subclinical disease, atrophic gastritis assov
ciated with hypochlorhydria or achlorhydria has been des¬
cribed in Addison's disease.8 Dr. Meecham and Dr. Wyn
Jones suggest that cortisone treatment of their patient explained
the apparent ten-year remission in his p.a., perhaps by
encouraging some regeneration of gastric mucosa and improved
vitamin-Bl;, absorption. Our study indicates that, at least in
some cases, gastric atrophy with achlorhydria is commonly
present many years after steroid replacement dosage has been
instituted and maintained in patients with idiopathic adrenal
insufficiency. It is also evident that normal vitamin-B,2
absorption can continue in the presence of circulating anti¬
bodies to I.F.
M.R.C. Clinical Endocrinology Research Unit, J_ JRVINE
Endocrine Clinic, Royal Infirmary, . ' %
and Department of Therapeutics, ■
University, Edinburgh. LAURA SCARTH.
7. Blizzard, R. M., Chce, D., Davis, W. Clin. exp. Immun. 1967, 2, 19.
8. Smith, A. W. M., Delamorc, I. W., Wynn Williams, A. Gur, 1961,
2, 163.
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From an immunological point of view there are two types of human adrenal disorder that are
of interest; primary atrophy of the adrenal cortex and adrenal hyperplasia.
Primary atrophy of the adrenal cortex
During the past few years I have had the opportunity to study 51 patients with adrenocortical
insufficiency (Addison's disease). For scientific purposes the clinical diagnosis of Addison's
disease should be substantiated by an ACTH test of adrenal function. In the absence of an
adrenal stimulation test, patients with the clinical features of Addison's disease plus non¬
specific laboratory investigations such as urinary ketosteroid excretion, insulin sensitivity,
water tolerance, etc., should be described as having "probable adrenal insufficiency".
Tuberculosis is still a common cause of adrenal failure in middle aged and elderly adults.
Other causes include histoplasmosis, syphilis, haemorrhage, infarction, tumour, amyloidosis,
etc. During life, the diagnosis of idiopathic adrenal insufficiency (simple atrophy) is made by
the process of exclusion and it is sometimes difficult to be certain that one or other of the
pathologies just listed may not be responsible.
Radiological evidence of calcification of the adrenal excludes simple atrophy as a cause of
adrenal failure. Tuberculosis is the commonest cause of adrenal calcification. If there is evi¬
dence of gross tuberculous disease elsewhere in the body prior to or coincident with the
Addison's disease, then it is logical to assume a tuberculous cause for the adrenal failure
whether or not there is any adrenal calcification on X-ray. On the other hand, a positive Man-
toux test or a Gohn focus on chest X-ray would not, at least in Britain, necessarily indicate
that the adrenal failure in a patient with Addison's disease was due to tuberculosis and not
simple atrophy. Because of these unavoidable uncertainties, I have grouped the patients with
Addison's disease into three categories as shown in Table I. The age range and mean age of the
patients in the three groups are very similar. The sex ratio in the 35 patients with idiopathic
or probable idiopathic Addison's disease is 2.5 female to 1 male; males predominate in the
patients with adrenal tuberculosis.
TABLE I
Classification, age and sex ofpatients with adrenal insufficiency
No. of Age in years at Age in years at
Type patients diagnosis of time of Sex ratio
adrenal insufficiency present study
Range Mean Range Mean F M
Idiopathic 11 7-74 38 9-74 44 2.7:1.0
Probable idiopathic 24 12-63 32 17-66 41 2.4:1.0
Tuberculous 16 12-69 38 21-72 49 0.6:1.0
The histology of the adrenal in patients with idiopathic adrenal insufficiency is characterised




is disrupted. Instead, there are islets of adrenal epithelial cells surrounded by loose fibrous tis¬
sue. There is a variable amount of lymphocytic infiltration (Wells, 1930). The adrenal gland
of one autopsy that I had the opportunity of studying showed such dense lymphocytic infil¬
tration that the overall size of the adrenals was only slightly less than normal, yet there were
very few adrenal epithelial cells to be seen. There was no other pathology noted at the autopsy.
Except for the absence of germinal centres, the histology of the adrenal resembled that of the
thyroid in Hashimoto's goitre (Irvine, Stewart and Scarth, 1967).
Adrenal specific antibodies have been detected in the serum of a proportion of patients with
Addison's disease by complement fixation (Anderson, Goudie, Gray and Timbury, 1957) and
by immunofluorescence (Blizzard, Kyle, Chandler and Hung, 1962; Irvine, 1963; Goudie,
Anderson, Gray and White, 1966). Figure 1 demonstrates the presence of adrenal antibody in
the serum from a patient with idiopathic Addison's disease using the immunofluorescent
method. The most intense staining is in the zona glomerulosa. The zona fasciculata and reti¬
cularis also stain but less intensely. The adrenal medulla does not stain. Staining occurs only
in the cytoplasma of the adrenocortical secretory cells. The antigen is predominantly in the
microsomal and to a lesser extent in the mitochondrial fraction of the adrenal cells. The
specificity of the antibody has been determined by testing positive sera against liver and kidney
and by absorption procedureswith thyroid, gastric and adrenal tissues. It is organ-specific but
not species-specific. The antibody is an immune globulin of type IgG as determined by the
immunofluorescent method using monovalent antisera and by the observation that the adrenal
antibody is capable of crossing the placenta into the foetal circulation. An identical titre of
the adrenal antibody was detected in the cord blood and in the mother's blood (Irvine,
Stewart and Scarth, 1967).
Fig. 1. Indirect fluorescent antibody technique using an unfixed frozen section on an adrenal gland
from a patient with Cushing's disease. The serum was used in a dilution of 1:4 and was from a patient
with idiopathic adrenal insufficiency. The antigen-antibody reaction was detected using horse anti-
human immunoglobulin IgG conjugated with fluorescein isothiocyanate (direct ultraviolet light x 250)
(reduced 1/3 for reproduction).
The incidence of adrenal antibody in patients with Addison's disease, in controls matched
for age and sex and in a range of other conditions, is shown in Table II. With the exception of
one patient with tuberculosis of the adrenals whose serum gave a weak titre by complement
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TABLE II




































* The antigen in this reaction was localised to capillary and sinusoidal endothelium and not to
adrenal secretory cells, using anti (3i A/C conjugate in the indirect immunofluorescent technique.
N.D. = not done.
fixation but a negative immunofluorescence test to adrenal secretory cells, positive tests for
adrenal antibody only occurredwith the sera of patients with idiopathic or probable idiopathic
Addison's disease; 80% of the 25 females with idiopathic or probable idiopathic Addison's
disease were positive for adrenal antibody, whereas only 1 out of the 10 males in these two
groups was positive. The sera of all the 51 control subjects were negative by both tests. Out
of 291 sera from patients with thyrotoxicosis, lymphadenoid goitre, primary myxoedema,
pernicious anaemia and diabetes mellitus only 2 were positive for adrenal antibody. One was
from a patient aged 55 years with lymphadenoid goitre and rheumatoid arthritis. She had a
normal plasma level of 17-hydroxycorticosteroids and a normal response to intravenous
(31-24 corticotrophin (Wood, Frankland, James and Landon, 1965). The other was from a




ADRENAL ANTIBODIES IN ADDISON'S DISEASE
IDIOPATHIC PROBABLE IDIOPATHIC TUBERCULOUS
NEC I 16 32 NEC A 8 16 32 NEC
COMPLEMENT FIXATION TITRE —*
8 16 32
Fig. 2. The titration of adrenal antibodies in the sera of patients with adrenocortical insufficiency
using the methods of indirect immunofluorescence and complement fixation. The single positive
complement fixation test in the tuberculous group of patients was not directed against adrenal
secretory cells but to vascular endothelium.
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Figure 2 shows the titre of adrenal antibody in the three groups of patients with Addison's
disease. Along the vertical axis is the titre by immunofluorescence and along the horizontal
axis is the titre by complement fixation. There is, with exception of the one tuberculous patient
already referred to, a good correlation between the two methods for titrating this antibody.
This would suggest that both methods are detecting the same antibody or group of antibodies.
The titres of adrenal antibody so far encountered are not high. The range is less than that for
parietal cell antibody in patients with pernicious anaemia and certainly less than that for thy¬
roid complement fixing antibody in patients with chronic thyroiditis.
There is a difference between the idiopathic and the tuberculous groups in the incidence of
other organ-specific antibodies in the serum. Eight out of 11 patients with idiopathic and 13
out of 24 patients with probable idiopathic Addison's disease had either thyroid or gastric
or both types of these antibodies in the serum, while only 3 out of 16 patients with tuberculous
Addison's disease had these antibodies. The sera of all but one of the idiopathic group was
positive for antibody to thyroid, stomach or adrenal. The sera of 18 out of 24 of the probable
idiopathic group contained one or other of these antibodies, but only 3 of the 16 tuberculous
patients were similarly positive. The incidence in the tuberculous group was comparable to
that in the controls. Although parathyroid antibodies were not studied in the present series,
Blizzard, Chee and Davis (1966) reported an incidence of 26% in patients with idiopathic
Addison's disease.
TABLE III
Immunological survey in adrenal insufficiency
Type of No. of
adrenal disease patients
sera positive tor antibodies
Thyroid Stomach










Idiopathic 11 2 7 7 5 2 6 8 10 — —
Probable
idiopathic 24 4 9 10 9 5 10 13 18 — 1
Tuberculous 16 1 2 2 1 — 1 3 3 — —
Control sub¬
jects (matched
for age and sex) 51 N.D. 6 4 — 4 N.D.N.D.
(N.D. =not done)
Table III shows the type of thyroid and gastric antibodies that occur in the sera of patients
with Addison's disease. Thyroid cytoplasmic antibody is more common than is antibody to
thyroglobulin. Both types of gastric antibodies occur; antibody to parietal cells and antibody
to intrinsic factor. There is a correlation between parietal cell antibody in the serum and simple
atrophic gastritis (Irvine, Davies, Teitelbaum, Delamore and Williams, 1965) and a close
correlation has been described between antibody to intrinsic factor in the serum and malab¬
sorption of vitamin B12 due to lack of intrinsic factor (1 rvine, 1965; 1966). It is remarkable that
7 of the patients with idiopathic or probable idiopatic Addison's disease should have intrinsic
factor antibody. Three of these patients had pernicious anaemia; 3 of the other 4 patients
were known to have achlorhydria and all 4 had normal serum levels of vitamin B12.
A study was made of gastric function and histology in the different groups of patients with
Addison's disease. Table IV summarises the results of the gastric secretion of hydrochloric
acid in the posthistamine hour. Achlorhydria is a common finding in patients with idiopathic
or probable idiopathic Addison's disease but not in patients with adrenal tuberculosis. Hypo-
chlorhydria occurred in all three groups. Some patients, particularly the tuberculous, had at
least a moderate secretion of gastric acid 5 mEq.HCl).
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TABLE IV
Gastric function in adrenal insufficiency
Type of
adrenal insufficiency
Gastric acid secretion in post histamine hour
(mEq.HCl)
Achlorhydria >0<5 >5
Idiopathic 6* 2 1
Probable idiopathic 5 4 4
Tuberculous - 2 5
* including 2 patients with pernicious anaemia.
(from Irvine, Stewart and Scarth, Clinical and Experimental Immunology, 1967. Vol. 2, p. 31)
The gastric histology, studied by Crosby capsule, in 18 of the cases was in keeping with the
secretory studies insofar that a reduction in gastric acid secretion was paralleled by a reduction
in the number of parietal cells seen in the gastric biopsy. Atrophy was frequently accompanied
by an increased degree of lymphocytic infiltration with germinal centre formation. Likewise,
lymphocytic infiltration in the thyroid is common in patientswith idiopathic Addison's disease
but not in patients with adrenal tuberculosis (Schmidt, 1926; Sloper, 1953; Carpenter, Solo¬
mon, Silverberg, Bledsoe, Northcutt, Klinenberg, Bennett and McGehee Harvey, 1964).
TABLE V
Diseases associated with adrenal insufficiency




Thyrotoxicosis 1 2 -
Hypothyroidism 1 2 -
Euthyroid goitre - 1 -
Pernicious anaemia 2 1 -
Hypoparathyroidism - 3 -
Moniliasis - 3 -
Diabetes mellitus 2 5 -
Rheumatoid arthritis - 1 -
Asthma - 2 -
Eczema - 1 -
Schilder's disease 1 - -
Alopecia totalis - 1 1
Total affected 7 14 1
Total patients 11 24 16
Table V lists the diseases that occurred in the 51 patients with Addison's disease whose sero¬
logy I have been discussing. It would appear that idiopathic adrenocortical insufficiency is
part of a syndrome of polyendocrinopathy, moniliasis and atrophic gastritis. Other disorders
possibly associated with aberrant immunological features may also be part of this syndrome.
The predominantly female incidence, the histology of the adrenal atrophy, the detection of
organ-specific antibodies in the serum, the overlap clinically and immunologically with other
diseases associated with autoimmune phenomena, all point to idiopathic Addison's disease





Wegienka, Wuepper, Komary and Forsham (1966) have reported that, out of 10 patients
with Cushing's syndrome, 1 had antibody to adrenal in the serum. These authors also drew
attention to the lymphocytic infiltration that is not uncommon in the hyperplastic adrenal
gland. It is therefore possible that some cases of adrenal hyperplasia may be analogous immu¬
nologically to thyrotoxicosis. To be speculative, there may be an abnormal adrenal stimulating
substance, possibly antibody in nature, which may be of aetiological importance in some cases
of adrenal hyperplasia.
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in Adrenal Disorders
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During the past ten years evidence has accumula¬
ted that idiopathic adrenal insufficiency belongs
to the group of conditions that are associated
with organ-specific autoimmunity (Goudie et al.
1966, Nerup et al. 1966, Blizzard et al. 1967,
Irvine et al. 1967). The present paper summarizes
the clinical and immunological associations in 72
patients with primary adrenal insufficiency.
Patients studied
The patients with primary adrenal insufficiency
were classified into three groups:
Idiopathic {15): No adrenal calcification, no
history of tuberculosis and no evidence of gross
tuberculosis elsewhere in the body. Clinical
diagnosis of Addison's disease confirmed by a
satisfactory ACTH stimulation test.
Probably idiopathic {31): Same as above, but
equivocal history of tuberculosis or equivocal
minor lesion on chest X-ray. Clinical features
typical, but the diagnosis of Addison's disease
may not have been confirmed by an adequate
ACTH test.
Tuberculous {26): Unequivocal evidence of gross
tuberculosis with or without calcification of the
adrenals. Classical clinical features of primary
adrenal failure.
The details of investigation of the first 51
patients with Addison's disease included in the
present study have been reported previously
(Irvine et at. 1967).
Methods
The serological procedures used were as described
previously (Irvine et al. 1967). Tests for adrenal,
thyroid and gastric antibodies included immuno¬
fluorescence and complement fixation. Antibody
to thyroglobulin was detected by tanned cell
hemagglutination and by immunofluorescence
using fixed sections of human thyroid. Antibody
to intrinsic factor was detected by the albumin-
coated charcoal method. Antinuclear factor was
detected using polyvalent anti-human gamma¬
globulin in the immunofluorescent procedure
using sections of rat liver; mitochondrial anti¬
bodies were detected using sections of rat
kidney.
Results
The detection of adrenal-specific antibodies by
immunofluorescence is illustrated in Fig 1 and the
incidence of adrenal-specific antibodies in the 72
patients with primary adrenal insufficiency is
shown in Fig 2. The sera of 11 out of 15 patients
with primary idiopathic and 14 out of 31 with
probable idiopathic Addison's disease were
positive for antibody to adrenocortical secretory
cells. The antibody is localized to the cytoplasm
by the immunofluorescence test and is pre¬
dominantly in the microsomal fraction by ultra-
centrifugation and complement fixation analysis.
None of the 26 patients with tuberculous Addi¬
son's disease had antibody to adrenocortical
secretory cells. The one patient in this group with
a persistently positive complement fixation test
with adrenal tissue showed staining of the
vascular endothelium only when tested by
immunofluorescence using adrenal sections. In
this instance the complement fixation test was
probably not reacting with adrenocortical antigen
but with a blood group substance.
The age range and mean age of the patients in
the three groups was closely comparable. The sex
distribution of the patients with Addison's
disease is shown in Table 1. In the combined
idiopathic groups the female to male ratio is
2-5:1-0, while in the tuberculous group it is
0-9:1-0. In the idiopathic groups 23 out of the 33
females (70%) were positive for adrenocortical
antibody whereas only 2 out of the 13 males
(15%) were positive.
Sera reacting positively with adrenocortical
tissue were tested for specificity with human
ovarian tissue, but no reaction was observed.
Absorption procedures using thyroid and gastric
extracts confirmed the specificity of the antibody
for the adrenal gland (Irvine 1963). Tests with
liver and kidney sections by immunofluorescence
distinguished between mitrochondrial antibody
and antibody specific for the adrenal.
Table 2 shows the incidence of adrenocortical
antibodies in patients with conditions primarily
affecting other tissues and which are associated to
a greater or lesser extent with the occurrence of
autoantibodies. There is only a very low incidence
IV : 56
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Table 1
Sex incidence of adrenocortical antibodies in
primary adrenal insufficiency
Disease Adrenocorticalantibodies
group Sex Positive Negative Total
Idiopathic F 9 1 10
M 2 3 5
Probable idiopathic F 14 9 23
M 0 8 8
Tuberculous F 0 12 12
M 0 14 14
of adrenocortical antibodies in these disease
states and it is uncertain whether this is statistical¬
ly different from the 0% incidence in the 72
control subjects so far studied.
Table 3 shows the incidence of other types of
organ-specific antibodies in the patients with
Addison's disease and in the control subjects
matched for age and sex. In the idiopathic
groups, there is an increased incidence of thyroid
and of gastric antibodies, but the incidence in the
tuberculous group is comparable to that in the
control subjects. With regard to thyroid anti¬
bodies, microsomal antibody was more frequently
present than antibody to thyroglobulin. With
regard to gastric antibodies, antibody to intrinsic
Fig 1 Positive test for antibody to adrenocortical
secretory cells in the indirect fluorescent antibody
technique using the serum of a patient with idiopathic
Addison's disease and anti-IgG conjugate. Dark ground
ultraviolet light, x 155
factor occurred as well as antibody to parietal cell
cytoplasm. The patients with intrinsic factor
antibody included 3 who had evidence of perni¬
cious anaemia but pernicious anaemia in its frank
form had been excluded in the other 5. The
vitamin B12 metabolism in these 5 patients will be
followed with particular interest.
In the idiopathic group 63 % of the patients had
thyroid and/or gastric antibodies in the sera as
opposed to 15% of the tuberculous patients.
Table 2
Incidence of adrenocortical antibodies in other conditions
No. of No. of
patients positives
Thyrotoxicosis 89 -
Lymphadenoid goitre 79 3
Primary atrophic 87 -
hypothyroidism
Pernicious antemia 54 -
Diabetes mellitus 93 -
Steatorrhea 21 1
Adrenal, thyroid and/or gastric antibodies were
present in the sera of 76% of the patients in the
idiopathic groups as opposed to 15% in the
tuberculous patients.
When the patients in whom there is some doubt
about a possible tuberculous aetiology or in
whom the diagnosis of adrenal failure has not
been subject to the confirmation of an adequate
ACTH test were excluded, the corresponding
figure for the incidence of gastric or thyroid
antibodies is 73 % and for adrenal, thyroid and/or
gastric antibodies is 87% in patients with idio¬
pathic Addison's disease.
Gastric analysis and histology in patients with
Addison's disease: Gastric analysis using a
standard augmented histamine test (0-04 mg
body weight subcutaneously) was done in 31
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Fig 2 The titration ofadrenal antibody in the sera of 72
patients with primary adrenocortical insufficiency using
the methods of indirect immunofluorescence and
complement fixation
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(matched for age and sex)
Serapositivefor antibodies to:
No. of Thyroid,
patients Thyroid Stomach stomach or
Tg Micr Total PC IF Total adrenal
15 2 9 9 6 3 7 13
31 5 12 14 12 5 13 22
26 2 2 3 1 - 1 4
72 4 7 8 6 - 6 11
Tg= thyroglobulin; Micr=microsomal; PC= parietal cell;
IF= intrinsic factor; adrenal= adrenocortical secretory cells
patients. In addition, one patient with probable
idiopathic Addison's disease had achlorhydria as
determined by the tubeless Diagnex test (Table 4).
Achlorhydria and hypochlorhydria were a
common occurrence in patients with idiopathic or
probable idiopathic Addison's disease. Of the 7
patients with tuberculous Addison's disease
studied in this respect, 5 had a fair to good gastric
acid secretion (> 5 mEqHCl in the post-histamine
hour), only 2 had hypochlorhydria and none had
achlorhydria.
Gastric biopsies were obtained by Crosby
capsule in 18 of the patients with adrenal insuffi¬
ciency. A reduction in the number of parietal cells
and of oxyntic cells was noted in patients in
whom there was hypochlorhydria or achlor¬
hydria. Gastric atrophy was frequently accom¬
panied, particularly in the idiopathic groups, by
an increased degree of lymphocytic infiltration
with germinal centre formation.
Clinical conditions occurring in the patients with
Addison's disease: Overt disease of other tissues
occurring in the patients with Addison's disease is
listed in Table 5. There is a remarkable incidence
of thyroid disorders and of pernicious anaemia,
hypoparathyroidism, moniliasis and diabetes
mellitus. The patients with diabetes mellitus were
insulin dependent; thosewith hypoparathyroidism
and moniliasis were all young subjects. The 2
patients with rheumatoid arthritis were elderly.
Three patients suffered from asthma and one gave
a history of eczema in childhood. Two of the boys
with Addison's disease suffered from neurological
conditions; one had the demyelinating condition,
Schilder's disease, and another had mental
retardation and deafness. A woman aged 28 years
with probable idiopathic Addison's disease had
idiopathic epilepsy. Alopecia totalis occurred in
one patient with tuberculous Addison's disease as
well as in one patient with probable idiopathic
adrenal failure. With this exception all the above-
mentioned conditions were only detected in
patients in the idiopathic groups. Indeed, the
majority of patients with idiopathic or probable
idiopathic Addison's disease suffered from one or
more of the conditions listed.
Incidence of adrenal antibodies in other types of
adrenal disorder: Adrenal antibodies were not
detected in any of 15 patients with Cushing's
syndrome due to bilateral adrenal hyperplasia as
proven by subsequent bilateral adrenalectomy.
Adrenal antibodies were not detected in 3
patients with idiopathic hypopituitarism with
secondary adrenal failure, but were present in one
of 22 patients with hypopituitarism of known
tetiology (postpartum haemorrhage, chromophobe
adenoma and hypophysectomy):
Case 1 A woman aged 60 years gave a classical history
of postpartum haemorrhage at age 34 years with subse¬
quent failure of pituitary function as manifest by
Table 4
Gastric function in primary adrenal insufficiency
Type of
Gastric acid secretion in post-histamine
hour (mEqHCl)
adrenal insufficiency Achlorhydria >0 <5 >5
Idiopathic 6# 2 2
Probable idiopathic 7H 4 4
Tuberculous - 2 5
©Including 3 patients with pernicious anasmia
■ Including one patient with pernicious anasmia in whom
achlorhydria was demonstrated by Diagnex test
Table 5
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failure of lactation, amenorrhea and loss of body
hair. Absence of growth hormone secretion was
demonstrated following stimulation by insulin hypo¬
glycemia (Dr W M Hunter). Thyroid deficiency was
demonstrated by radioactive iodine studies but no
increase in 132I uptake by the thyroid could be induced
by repeated TSH stimulation. Likewise, only a
minimal increase in the urinary excretion of 11-
OHCS could be produced by 5 days' stimulation with
ACTH gel 40 units twice a day. This patient therefore
appeared to have pituitary failure secondary to post¬
partum haemorrhage, but also to have primary thyroid
and primary adrenal insufficiency. Her serum was
positive for antibody to adrenocortical secretory cells
by immunofluorescence and by complement fixation
(titre^l: 8).
In none of the patients with hypopituitarism
could antibodies reacting with human pituitary
tissue in the immunofluorescence test be detected.
Discussion
The pronounced difference in the incidence of
adrenal antibodies in patients with idiopathic
Addison's disease contrasts with the low incidence
in patients with tuberculous destruction of the
adrenal. This is important to the clinician in that
its finding indicates a diagnosis of autoimmune
adrenalitis and would tend to exclude tuberculosis
and possibly other causes of adrenal failure such
as haemorrhage, carcinomatosis, amyloidosis, &c.
Patients with idiopathic Addison's disease have a
high incidence of other clinical and subclinical
conditions, particularly associated with autoim¬
munity. The gastric function and histology studies
reported here demonstrate a high incidence of
subclinical atrophic gastritis, in addition to those
patients who have pernicious anaemia as well as
adrenal failure. Carpenter et al. (1964) have
reported an increased incidence of thyroiditis in
autopsy studies on patients with idiopathic
Addison's disease. This is in keeping with the
increased incidence of thyroid antibodies noted in
the present study in the idiopathic groups.
The fact that adrenal antibodies occur only in
idiopathic Addison's disease and not when it is
due to tuberculosis indicates that these antibodies
are not simply the consequence ofadrenal damage.
This observation supports the concept that the
group of organ-specific autoimmune diseases,
which include thyroid, stomach, adrenal and
parathyroid, are associated with a disorder of
immunological tolerance (Irvine 1964).
The preponderance of females to males in
idiopathic Addison's is in contrast to the appa¬
rently equal sex ratio in tuberculous Addison's
disease and is in keeping with the former being an
autoimmune condition. The higher incidence of
adrenal antibodies in the female subjects than in
the male subjects with idiopathic Addison's
disease is difficult to explain as a similar difference
in the incidence of antibodies according to sex is
not observed in relation to other conditions
associated with organ-specific autoimmunity.
The low incidence of adrenal antibodies in
patients with other types of organ-specific auto¬
immune disease correlates with the comparative
rarity of idiopathic Addison's disease and with
the observation that focal adrenalitis is not a
common histological finding at routine autopsies.
The finding of adrenal antibodies in high titre
in one patient with steatorrhoea lends some
support to the observation by Kunin et al. (1963)
that steatorrhoea may be associated in some way
with adrenal insufficiency, particularly in child¬
hood. The association of insulin-dependent
diabetes mellitus with the group of organ-specific
autoimmune diseases is emphasized. Further
attention should be paid to the possible associa¬
tion between neurological disorders and idio¬
pathic adrenal failure, particularly in children.
Although one case is reported in the present
paper of pituitary failure associated with primary
failure of thyroid and adrenal glands, there is as
yet no direct evidence for an autoimmune basis
for idiopathic pituitary failure. A degree of
lymphocytic infiltration of the pituitary has been
observed in patients with primary atrophy of the
adrenal (Susman 1930, Carpenter et at. 1964,
Irvine et al. 1967). It is therefore conceivable that
an autoimmune hypophysitis might exist.
There is no evidence in the present study that
bilateral adrenal hyperplasia may have an
autoimmune basis in a manner comparable to
thyrotoxicosis as suggested by Wegienka et al.
(1966).
It is suggested that the term 'idiopathic adrenal
failure' be replaced by the term 'chronic auto¬
immune adrenalitis'.
Acknowledgments: I am grateful to the many
physicians who kindly allowed me to study their
patients and to Miss Laura Scarth for her technical
assistance.
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Antibodies reactive with the theca interna
of the ovary, the interstitial cells of the
testis, and the adrenal cortex were detected in the sera
of 5 of 77 patients with idiopathic adrenal insufficiency.
All 5 of these patients had either complete failure of
menstruation or an early menopause. 1 of these 5 patients
also had antibody reactive with ova and spermatids, and 3
had antibody reactive with placental trophoblasts. Only 1
of the remaining 72 patients with idiopathic Addison's
disease was known to have premature failure of menstrua¬
tion. Antibody reactive with gonadal tissue was absent in
34 patients with tuberculous Addison's disease, 111
control subjects matched with the Addison's patients for
age and sex, 43 patients with gonadal dysgenesis that was
not associated with Addison's disease, 50 postmenopausal
females, and in 251 subjects with pernicious anaemia or
thyroid autoimmune disease. Antibody reactive only with
the theca interna of human ovary and with adrenal cortex
was found in 1 of 24 patients with Cushing's syndrome.
Primary gonadal failure may be part of a polyendocrino-
pathy of which idiopathic Addison's disease is an integral
part and which is characterised by the formation of
autoantibodies to the respective tissues.
Introduction
A high incidence of organ-specific autoantibodies in the
sera of patients with idiopathic Addison's disease is now
well recognised (Goudie et al. 1966, Nerup et al. 1966,
Blizzard et al. 1967, Irvine, Stewart, and Scarth 1967),
and Turkington and Lebovitz (1967) have described pre¬
mature ovarian failure in Addison's disease. We have
attempted to determine if antibodies reactive with ovarian
constituents are a feature of Addison's disease and, if so,




111 patients with Addison's disease were investigated
serologically. The patients were subdivided into those with
idiopathic and those with tuberculous adrenal failure and were
matched for age and sex with blood-donors. 324 patients with
gonadal dysgenesis, addisonian pernicious antemia, autoimmune
thyroid disease, or Cushing's syndrome, and a further 50 post¬
menopausal female controls aged fifty to fifty-nine were also
included (table i).
Methods
Each serum was tested against human adrenal gland, ovary,
testis, and placenta and also against rabbit ovary and testis.
Ovarian tissue was obtained by biopsy from 2 patients aged
forty-two and forty-four undergoing surgery for uterine
fibroids, and the testicular tissue was taken from 2 patients
aged sixty-one and sixty-two at orchidectomy for prostatic
carcinoma. Adrenal tissue was obtained from patients under¬
going bilateral adrenalectomy for diffuse metastatic carcinoma.
Ovaries from rabbits of a reproductive age at various stages of
the oestrous cycle were used since they contained a larger
number of ova and luteal cells than the human ovary tissue that
was available. Testicular tissue from young adult rabbits was
also used.
Sera were tested against these tissues using the indirect
immunofluorescence method with antihuman IgG conjugated
with fluorescein isothiocyanate as previously described (Irvine,
Stewart, and Scarth 1967). The intensity of the staining was
assessed subjectively as + +, +, or —. The immunoglobulin
specificity of positive reactions with steroid-producing tissues
was checked using antihuman IgA and antihuman IgM con¬
jugates. The tissue specificity was determined using sections of
human thyroid and gastric mucosa and rat kidney. The sera
of the patients with adrenal disorders were also tested for
















Idiopathic adrenal insufficiency 77 40 5
Tuberculous adrenal insufficiency. . 34 0 0
Controls (matched for age and sex) 111 0 0
Gonadal dysgenesis 49 0 0
Pernicious ana:mia 102 0 0
Lymphadenoid goitre 49 0 0
Primary hypothyroidism 50 0 0
Thyrotoxicosis 50 0 0
Cushing's syndrome 24 1 1
Post-menopausal females (aged 50-
59) 50 ° 0
antibody to thyroglobulin by the tanned-cell haemagglutination
method (Fulthorpe et al. 1961) and for intrinsic-factor
antibody 1 (Irvine 1966).
Sera giving positive immunofluorescence reactions with
steroid-producing tissues were titrated by the indirect immuno¬
fluorescence method using tissue sections and by complement
fixation using saline extracts of the various tissues. The
immunofluorescence method was also used to determine the
titre of antibody reacting with steroid-producing tissues before
and after the sera were absorbed with buffered saline extracts
of human adrenal, testis, placenta, thyroid, and stomach and
of rat liver. The saline tissue extracts were prepared as
previously described (Irvine, Stewart, and Scarth 1967). Equal
volumes of serum and extract were mixed at room temperature
for three hours.
Serology Results
The incidence of positive immunofluorescence tests
IV : 63
Immunofluorescent staining (indirect method using antihuman IgG
conjugated with fluorescein isothiocyanate, and dark-ground
ultraviolet microscopy):
(a) Graafian follicle of human ovary with the serum of patient E
(reduced to x/2 of x 260); (b) interstitial cells of human testis with the
serum of patient E (reduced to x/2 of x 375); and (c) human placental
trophoblasts with the serum of patient A (reduced to x/2 of X 260).







Mainclin calfeatures( dgeofs tr diagnosis)
Adrenal cortex (human)
Theca interna (rabbit and human)
Inter¬ stitial cells (rabbit)
Ova (rabbit)



























































with adrenal and with other steroid-producing tissues in
the 596 patients studied is summarised in table I. Sera
reactive with any of the steroid-producing tissues were
confined to those patients with idiopathic Addison's
disease, with the exception of 1 of 24 patients with
Cushing's syndrome that reacted with adrenal cortex and
human (but not rabbit) ovary and 1 of 50 thyrotoxic
patients that gave a weak reaction with rabbit ovary but
not with human steroid-producing tissues. 5 of the total
of 41 sera reacting with human adrenal cortex also
reacted with ovary, testis, or placenta (table II). Positive
immunofluorescence tests with theca interna and adjacent
layers of the follicular epithelium of human ovary, with
the interstitial cells of the rabbit testis, and with human
placental trophoblasts are shown in the figure.
The serum of patient A (table ii) gave a strongly positive
immunofluorescence test with all steroid-producing cells
(human or rabbit) and also reacted with ova and
spermatids. The sera of patients B and C reacted with
adrenal cortex, theca interna, interstitial cells of ovary and
testis, and with placental trophoblasts, but did not react
with germ cells. The sera from patients D and E reacted
with adrenal cortex, theca interna of the ovary, and
interstitial cells of the ovary and testis, but did not react
with placenta or germ cells. The serum of patient F
(Cushing's syndrome) reacted with adrenal cortex and
gave a positive immunofluorescence test with theca interna
of human ovary, but not with rabbit ovary nor with the
interstitial cells of testis.
The complement-fixation titres for antibody to human
adrenal, testis, and placenta are shown in table ill. Where
there was a reaction with more than one steroid-producing
tissue (i.e., all except patient F), the complement-fixation
titres were generally of the same order. This was also true
TABLE III COMPLEMENT-FIXATION TITRES FOR ANTIBODY TO STEROID-
PRODUCING TISSUES (HUMAN) IN THE SERA OF PATIENTS INCLUDED IN-
TABLE II
Patient
Adrenal extract Testis extract Placenta extract
j at dilution 1/16 at dilution 1/8 at dilution 1/16
A 32 16 32
B 8 16 8
C 4 8 8
D 16 8 —
E 64 64 -
F 32 — -
















































































































when the titres were determined by the indirect immuno¬
fluorescence method. The antibodies reactive with
steroid-producing tissues were all IgG, no fluorescence
being obtained with anti-IgA conjugates and only occa¬
sional weak fluorescence when anti-IgM conjugates was
used.
When the sera were absorbed with a saline extract of
human adrenal, the immunofluorescence titres were
greatly reduced or abolished not only with regard to
adrenal reactivity but also to ovary, testis, and placenta.
Likewise, with regard to patients A-E (table n), absorp¬
tion with human testis extract not only prevented the
immunofluorescence reaction with testicular tissue but
also reduced or abolished the reaction between the serum
and adrenal cortex, theca interna of the ovary, and
placenta. Absorption with testicular extracts had no effect
on the immunofluorescence reaction with ovary or adrenal
given by serum from patient F, or adrenal-antibody titres
in the sera of 2 patients who only had adrenal antibody
and whose serum did not react with other steroid-produc¬
ing tissues. Rabbit ovary was only weakly effective in
absorbing reactivity with human ovarian tissue. There
was insufficient human ovarian tissue for absorption
studies. Absorption with saline extracts of human thyroid,
human gastric mucosa, and rat liver had no effect on the
titres of antibody to steroid-producing tissue.
The complement-fixation chessboard titrations with the
sera in table II and adrenal extract showed two patterns.
Sera A, B, and C gave a biphasic pattern as shown for
serum B in table iv, while sera D, E, and F gave a mono-
phasic pattern as shown for serum D. All sera reactive
with testis gave a similar complement-fixation chessboard
titration with testis extract.
The incidence of antibodies to thyroid and stomach and
the absence of antinuclear factor and of mitochondrial
antibodies in the sera of patients included in table II are
shown in table v.
Clinical Findings
The main clinical findings of the 6 patients with anti¬
bodies reactive with steroid-producing tissues in addition
to adrenal are summarised in table II. Patients A and B
had primary amenorrhcea with no menarche. These
patients had the highest incidence of associated auto¬
immune disorders (idiopathic hypoparathyroidism, idio¬
pathic hypothyroidism, and addisonian pernicious anaemia)
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TABLE V—OTHER SEROLOGICAL FINDINGS IN PATIENTS INCLUDED IN
TABLE II
Patient














A — — + + + _
B + + + — + + — —
C
D :
~ + + — — —
E
F - - - - - -
besides their Addison's disease. The onset of adrenal
failure in these 2 patients was either before or about the
time that puberty would be expected. Patients C, D, and
E had a normal menarche, persistent amenorrhoea develop¬
ing four to fourteen years later but long before the meno¬
pause would be expected. In patients D and E, adrenal
failure was diagnosed before the onset of the amenorrhoea,
but in patient C the amenorrhoea preceded the diagnosis
of adrenal failure by five years. All these 5 patients were
on adequate replacement therapy for adrenocortical failure
and for their other conditions. Despite this, menstruation
did not return, except when cyclical oestrogen therapy was
used. A urinary total gonadotrophin excretion of >48
mouse units in twenty-four hours was demonstrated on at
least one occasion by the mouse-uterus test in patients A,
C, D, and E.
Patients A and B were the only ones to be below the
third percentile in height. Patient A had bilateral coxa
vara and bilateral shortening of the fourth metacarpal.
At laparotomy her ovaries were vestigial streaks and
on biopsy no follicles or tubules were seen in the region
of either ovary. The specimens consisted predominantly
of fibrous tissue, and no lymphocytic reaction was noted.
The chromosome constitution of patients A-E, as
determined by lymphocyte culture, was normal.
Patient F, with Cushing's syndrome, gave a history of
menorrhagia rather than amenorrhoea. The menstrual
history of the thyrotoxic patient whose serum reacted with
the theca interna of rabbit (but not human) ovary and
which did not react with other steroid-producing tissues
was not remarkable. The steroid-cell-antibody pattern in
these 2 patients is more limited than in any of the 5
patients with persistent amenorrhoea.
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Only 1 of the remaining patients with idiopathic or
tuberculous Addison's disease (whose sera were negative
for ovary, testis, or placenta) was known to have persistent
amenorrhcea at a young age. She was a twenty-six-year-
old girl with idiopathic Addison's disease and idiopathic
hypoparathyroidism diagnosed at age twenty-three and
twelve, respectively. Menarche happened at age eleven
and her periods were regular until age thirteen. At age
fourteen, her menstruation ceased and has not recurred.
Discussion
Extra-adrenal endocrine disorders in patients with
idiopathic Addison's disease have been well documented,
particularly with reference to thyroid diseases, diabetes
mellitus, addisonian pernicious anaemia, and idiopathic
hypoparathyroidism (Beaven et al. 1959, Carpenter et al.
1964, Irvine 1968). The demonstration of a high incidence
of organ-specific antibodies in this group of patients has
led to the hypothesis that these conditions may to some
extent have a common pathogenesis in which auto¬
immunity may play a relevant part (Blizzard et al. 1967,
Irvine, Stewart, and Scarth 1967).
Turkington and Lebovitz (1967) reported in a separate
series that of 32 patients with idiopathic adrenal in¬
sufficiency 7 had primary gonadal failure: 3 had atrophic
testes, 3 had premature menopause, and 1 had cystic
ovaries. Premature ovarian failure preceded the develop¬
ment of clinical Addison's disease by five to fourteen
years in all of their 3 patients with premature meno¬
pause. In our series, adrenal failure preceded ovarian
failure in 2 of the 3 patients who had premature meno¬
pause after a normal menarche. There seems to be
no set sequence for gonadal and adrenal failure. The
association between gonadal failure and adrenal failure of
the idiopathic (as opposed to the tuberculous) form accords
with the other endocrine disorders associated with
Addison's disease (Irvine 1968). In their own series and
in a review of earlier cases, Turkington and Lebovitz
(1967) noted that primary hypothyroidism was a common
additional feature in patients with gonadal and adrenal
failure. We have been impressed with the frequency of
idiopathic hypoparathyroidism and have noted addisonian
pernicious anaemia as well as primary atrophic hypo¬
thyroidism.
Antibodies reactive with the follicular epithelial cells
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and theca interna of the graafian follicles of the ovary
and with the interstitial cells of ovary and testis have
not previously been described in patients with premature
gonadal failure. Christy et al. (1962) described primary
failure of ovary, thyroid, and adrenocortical function
in a woman of forty, and later reported the presence
of thyroid and adrenal antibodies in her serum, but
antibody to ovary could not be detected by immuno¬
fluorescence tests (Blizzard et al. 1963). Vallotton and
Forbes (1966) described antibodies to the cytoplasm
of rabbit ova in 29 of 232 sera tested. In 9 of the 29
menstruation had ceased precociously at age thirty-nine
or earlier. These workers made no mention of anti¬
bodies to other components of ovary or to testis, adrenal,
or placenta. Although, in our series, one patient had
antibody reactive with ova and spermatids, this serum
also reacted with theca interna of ovary and the inter¬
stitial cells of ovary and of testis as well as with adrenal
cortex and placental trophoblasts. We have been unable
to confirm the findings of Vallotton and Forbes (1966,
1967) of antibodies to ova in patients with gonadal dys¬
genesis associated with chromosome abnormalities (Price
and Irvine 1968) in control patients or in patients in whom
a high incidence of organ-specific autoantibodies would be
expected. Anderson et al. (1968) reported 2 out of 40
patients with idiopathic adrenal insufficiency with anti¬
bodies to adrenocortical cells, interstitial and hilus cells of
ovary and of testis, cells of the theca interna of the
graafian follicle, and luteal cells of the ovary as well as
with placental trophoblasts. 1 of these patients was a
twenty-two-year-old male with associated steatorrhcea and
idiopathic hypoparathyroidism but no obvious evidence of
gonadal failure. The case-history of the other patient
was not mentioned. One of the most striking features in
our series was the strong correlation between premature
ovarian failure and the presence in the serum of antibodies
reactive with ovary and testis as well as adrenal.
The pattern of immunofluorescence staining given by
the various steroid-producing tissues and the results of the
absorption studies indicate that there are antigens shared
between the adrenal cortex, theca interna of the ovary,
and the interstitial cells of the ovary and testis and the
placental trophoblasts. From the variation in the immuno-
fluorescent reactions given by different sera, there would
seem to be more than one such antigen, but that all of
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these antigens are present in the adrenal cortex. This
would accord with the fact that both oestrogen and testos¬
terone synthesis happen in the adrenal cortex, and with
the observation that the different sera reactive with various
steroid-producing tissues gave more than one pattern in
complement fixation chessboard titration with the same
adrenal extract. The antigens are probably related to
enzymes involved in various metabolic pathways of steroid
synthesis: the antigen may or may not be a constituent of
more than one steroid-producing tissue, depending on the
nature of the enzyme.
If antigens are indeed shared between the gonads and
the adrenal cortex, one might expect to see ovarian and
testicular lesions after immunisation of animals with
adrenal extracts in Freund's adjuvant. We are not aware
of any histological work on the ovaries of women with
premature menopause but, with the advent of the laparo¬
scope, this should not be long in forthcoming.
Addendum
The sera of the 111 patients with Addison's disease, the
matched controls, the 24 patients with Cushing's disease,
the 49 patients with gonadal dysgenesis, and 14 females
who were doubly chromatin positive were tested by the
indirect immunofluorescent method against human corpus
luteum obtained at biopsy from a patient aged thirty-two
at termination of a three-month pregnancy. The sera of
patients A-F (table ii) gave a positive reaction. Sera A,
B, and C gave a clumpy staining diffusely throughout the
corpus luteum, serum E a patchy staining, and sera D and
F a confluent pattern of immunofluorescent staining.
Sera A-E also gave a bright immunofluorescent staining
of a layer of cells immediately adjacent to the periphery
of the corpus luteum and in its trabeculae. These cells
were considered to be those of the theca interna. The sera
of 2 other patients with idiopathic Addison's disease gave
positive tests with this human ovary. One gave a weak
granular, membraneous staining of the corpus luteum but
did not react with other steroid-producing cells in human
or rabbit tissue, while the other reacted only with the
theca-interna cells adjacent to the corpus luteum and with
human adrenal cortex. Neither of these 2 patients had
amenorrhoea. The remaining 301 sera tested were negative




Absorption studies with human adrenal and with human
testis extracts showed that the diffuse clumpy staining of
the corpus luteum given by sera A and C could be
absorbed by human adrenal extract or by human testis
extract but that the patchy immunofluorescent staining
given by serum E and the confluent staining given by
serum F could only be absorbed by human adrenal extract
and not by testis extract. Likewise, absorption with either
human adrenal or human testis could prevent the reaction
with the theca interna given by sera A and C, but only
adrenal extract was effective with sera D and E. These
findings confirm that there is more than one antibody
involved in the reaction with steroid-producing cells, but
that all the corresponding antigens are represented in the
adrenal cortex.
Since she was anxious to have full investigation with
regard to the prognosis in relation to her fertility,
laparoscopy with ovarian biopsy was performed on patient
E (table n). The ovaries were of normal size. Biopsy
showed the presence of numerous primordial follicles. As
the follicles enlarged, there was a progressively severe
lymphocytic and plasma-cell infiltration with destruction
of the follicle. Immunofluorescent studies with the
patient's own serum and with serum A showed that the
membrana granulosa of the early follicles is poor in antigen
—reacting very weakly with serum A and not at all with
her own serum. The ova in these follicles reacted strongly
with serum A but not with serum B-F (i.e., including her
own serum). There was, therefore, no evidence of any
immunological attack against her own primordial follicles.
When these follicles attempted to develop under the
influence of her elevated gonadotrophin levels, the
follicular epithelium became antigenic and showed
immunofluorescence staining with her own serum. This
was associated with lymphocytic and plasma-cell infiltra¬
tion in these follicles. The destruction of the follicles was
such as to preclude normal ovarian function. One might
speculate that normal ovarian function might be restored
in this patient by the use of immunosuppressant doses of
steroids.
While the ovarian microscopical appearance in patient A
was that of dysgenesis or agenesis, no chromosome
abnormality was detectable. Since the patient had anti¬
bodies against all ovarian constituents, including ova, the
possibility exists that the destruction of this patient's
IV : 73
16
ovaries may have occurred in early life as a result of an
immunological process.
In conclusion, there is serological and histological
evidence that some cases of premature ovarian failure may
have an autoimmune basis. In such cases, there is a strong
clinical association with idiopathic adrenal insufficiency.
Immunologically this is explained by the sharing of
antigens between the adrenal cortex and the ovary.
We thank Prof. Russell Fraser for permission to report details of
patients C and E, and Miss E. Burton (Department of Gynaecology,
Hammersmith Hospital) for performing the laparoscopy and ovarian
biopsy on patient E. M. M. W. C. is in receipt of a Commonwealth
Scholarship. W. J. I. would like to thank the many physicians in
different countries who have kindly sent him sera from patients with
Addison's disease.
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SUMMARY
Antibodies reactive with the steroid-producing cells in the gonads are described in
the sera of ten patients, the majority of whom were known to have idiopathic
adrenal insufficiency (Addison's disease) associated with premature ovarian
failure. The immunofluorescent staining pattern of these antibodies with steroid-
producing cells in the ovary, testis, placenta and adrenal cortex are illustrated.
The staining patterns and the results of absorption studies indicate that there are a
multiplicity of antibodies reacting with different antigens in the ovary and to a
lesser extent in the testis. Most of these antigens are also represented in the
adrenal cortex, but are not evenly distributed throughout the cortex. Some of these
antigens are not represented in the zona glomerulosa while others are not repre¬
sented in the zona reticularis.
INTRODUCTION
Antibodies to steroid-producing cells in the gonads and placenta, cross-reacting with adrenal
cortex, have been described in the sera of two patients by Anderson et al. (1968) and in the
sera of six patients by Irvine et al. (1968). The latter observed a good correlation between the
presence of these antibodies in the sera reactive with steroid-producing cells in the ovary and
a clinical history of premature or complete failure of ovarian function. Five of the six
patients had idiopathic adrenal insufficiency (Addison's disease) and one had Cushing's
disease. The present paper describes in greater detail some of the characteristics of antibodies
reactive with steroid-producing cells.
Correspondence: Dr W. J. Irvine, Department of Endocrinology, Royal Infirmary, Edinburgh 3.
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MATERIALS AND METHODS
Ten sera (A-J) reacting with ovary, testis or placenta were included in the present study.
Sera A-F have previously been referred to (Irvine et al, 1968). Patients A-E had idiopathic
Addison's disease with premature or complete ovarian failure. Patient F had Cushing's
disease. Patient G was a 72-year-old female with idiopathic Addison's disease, pernicious
anaemia, diabetes mellitus and idiopathic hypothyroidism. Patient H was a 16-year-old
male who developed idiopathic Addison's disease at the age of 15 years and who was not
known to have any associated endocrinopathy although his pubic hair was noted to be
sparse. Patient 1 was a female aged 51 years with idiopathic Addison's disease and was not
known to have any other endocrinopathy. Patient J was a 20-year-old girl with primary
hypoparathyroidism at 2 years, idiopathic Addison's disease at 19 years and who had
normal menstruation (Irvine, 1969; Irvine & Scarth, 1969).
The incidence of antibodies reactive with steroid-producing cells of the gonads in the sera
of patients with Addison's disease has been indicated previously and also the rarity of this
group of antibodies in the sera of patients with other diseases characterized by organ-
specific autoimmunity and in the sera of control subjects (Irvine et al., 1968).
The procedure used in the indirect immunofluorescent antibody technique was as des¬
cribed by Irvine, Chan & Williamson (1969) using horse anti-human IgG-FITC conjugate
with a fluorescein—protein ratio of 0-67. The human tissues used in the fluorescent antibody
technique were obtained as follows: adrenal from patients undergoing bilateral adrenalec¬
tomy for metastatic carcinoma, testis from a 61-year-old male undergoing orchidectomy for
prostatic carcinoma, biopsy specimens from the ovary of a 42-year-old woman undergoing
surgery for uterine fibroids and from the corpus luteum of a 32-year-old woman at termina¬
tion of pregnancy at 12-14 weeks. The human placenta was obtained at a normal full term
delivery. Ovaries were obtained from rabbits in oestrus and in psuedopregnancy. Rabbit
testis was also used. All sera were also tested against rat kidney sections as controls to
exclude the presence of 'M' antibodies (Doniach et al., 1966).
Absorption studies on selected sera were done with veronal buffer extracts of human
adrenal, human testis, rabbit ovary and human placenta and with serum E using extracts of
human thyrotoxic thyroid tissue, mucosa of the body of human stomach and rat liver.
Extracts of these tissues were prepared by homogenizing the tissue with 3 volumes of
veronal buffer, centrifuging at 1750 g for 10 min. Absorption was done by incubating the
supernatant with 1 volume of serum with continuous mixing for hr at room tempera¬
ture, followed by repeat centrifugation.
RESULTS
The results with sera A-J using adrenal, ovary, testis and placenta in the indirect immuno¬
fluorescent antibody test are summarized in Table 1.
Ovary
In the rabbit ovary it was noted that certain sera gave immunofluorescent staining of the
theca interna and also of the outer layer of granulosa cells of the larger Graafian follicles
(Figs. 1, 2 and 3). Whether or not the outer layer of the granulosa cells was stained as well as
the theca cells seemed to depend upon the stage of development of the Graafian follicles.
This aspect was not studied in detail. Staining of the granulosa and theca cells of human






































































































































































































































Fio. 1. Positive reaction given by serum A in the indirect immunofluorescent method with the
outer layer of granulosa cells and with the theca cells of a fairly large Graafian follicle, with
scattered interstitial cells, and with ovum. There was little or no reaction with the granulosa cells
of the small follicle containing the ovum. Dark ground UV-blue light, x 225.
Fig. 2. Positive immunofluorescence with a layer of granulosa cells and a layer of theca cells in
relation to a fairly large Graafian follicle in rabbit ovary using serum E, but negative reaction
interstitial cells and with ovum. Dark ground UV-blue light, x 230.
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Fig. 3. Positive immunofluorescence given by serum A with a layer of granulosa cells in
relation to a fairly large Graafian follicle, and with the hyperplastic interstitial cells characteristic
of the rabbit ovary in pregnancy or pseudopregnancy. Dark ground UV-blue light, x 280.
Fig. 4. Positive immunofluorescence with ova and weakly with the granulosa cells of the
primordial or early follicles in the ovary of patient E using the serum of patient A in the
indirect fluorescent antibody technique. Dark ground UV-blue light, x 360.
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Fig. 5. Positive immunofluorescence staining of human corpus luteum given by serum A showing
a clumpy pattern diffusely throughout the corpus luteum. Dark ground UV-blue light, x 225.
Fig. 6. Same as Fig. 5, but showing in addition brilliant immunofluorescent staining of the
theca cells in the trabeculae of the human corpus luteum. Dark ground UV-blue light, x 250.
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Fig. 7. Positive immunofluorescent staining of human corpus luteum given by serum F showing
a confluent 'squamous-like' pattern throughout the corpus luteum. Dark ground UV-blue
light, x 240.
Fig. 8. Patchy immunofluorescent staining pattern of human corpus luteum and intense
immunofluorescent staining of the theca cells in the trabeculae of the corpus luteum given by
serum E. Dark ground UV-blue light, x 240.
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'
Fig. 9. Positive staining in the indirect immunofluorescent antibody technique of the inter¬
stitial cells and of the spermatids in rabbit testis given by serum A. Dark ground UV-blue
light, x 230.
Fig. 10. Positive staining of human placental trophoblasts in the indirect immunofluorescent
antibody technique given by serum E. Dark ground UV-blue light, x 240.
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Graafian follicles has been illustrated elsewhere (Irvine et at., 1968). Some sera reacted with
the interstitial cells of the rabbit ovary in the oestrus phase (Fig. 1). Marked hyperplasia of
the interstitium is characteristic of the ovary of the pregnant or pseudopregnant rabbit. Sera
A, G and J gave immunofluorescent staining of the hyperpastic interstitial cells while sera A,
B, E, H and J reacted with a layer of granulosa cells in the same sections (Fig. 3). Interstitial
cells were not conspicuous in the human ovarian tissue that was available. Fig. 4 shows that
serum A, for example, also reacted with human ova. The tissue used in Fig. 4 was an ovarian
biopsy from patient E (Irvine et at., 1968; Irvine & Hartog, 1969).
Four clearly distinct immunofluorescent staining patterns were observed when human
ovary in the luteal stage was used. These may be described as:
(1) A clumpy staining pattern diffusely throughout the corpus luteum (Figs. 5 and 6).
(2) A confluent squamous-like staining throughout the corpus luteum (Fig. 7).
(3) A patchy staining of the corpus luteum involving scattered cells with varying intensity
(Fig. 8).
(4) An intense staining of a rim of cells at the periphery of the corpus luteum and in its
trabeculae (Figs. 6 and 8).
The cells mentioned under reaction (4) did not form a continuous rim round the corpus
luteum and the ovarian sections had to be carefully searched for their presence. It was thought
that these cells represented the theca interna.
The results in Table 1 have been presented so as to group together the immunofluorescent
staining patterns noted in relation to the human corpus luteum and its surrounding cells.
Testis
Seven of the ten sera showed a positive immunofluorescent reaction with the interstitial
cells of testis. Six of these reacted with testis of human or rabbit origin, while one (serum G)
reacted only with rabbit testis. An illustration of this type of immunofluorescent reaction is
included in Irvine et at. (1968). A further example is shown in Fig. 9. Fig. 9 also shows posi¬
tive immunofluorescence given by serum A with the spermatids of rabbit testis. Serum J also
reacted with rabbit spermatids and with the interstitial cells of human or rabbit testis in the
same manner as serum A.
Placenta
Fig. 10 illustrates a positive reaction with human placental trophoblasts. Such a reaction
was observed with five of the ten sera.
Adrenal
All ten sera reacted positively by immunofluorescence with human adrenal cortex. Sera A,
C and I showed only a weak but definite reaction, while sera B, D, E, F, G, H and J reacted
strongly. Five of the ten sera stained all three layers of the cortex. Sera B, E, H and I stained
only the lower part of the zona fasciculata and the whole of the zona reticularis (Fig. 11);
they did not stain the zona glomerulosa or the upper part of the zona fasciculata. Serum G
stained only the zona glomerulosa and fasciculata, but not the zona reticularis (Fig. 12).
This difference in staining pattern was quite distinct and was confirmed by using contiguous
sections of the same human adrenal gland for testing the different sera. Consistent immuno¬
fluorescent staining patterns were also obtained using sections from the adrenals of other
patients.
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The results of complement fixation tests with adrenal placenta and testis have been
described previously (Irvine et al., 1968).
Absportion studies
The results of absorption studies with buffered saline extracts of human adrenal and of
human testis on four of the sera with steroid-cell antibodies reactive with extra-adrenal tissue







Fig. 11. Positive immunofluorescent staining of the human adrenal cortex confined to the lower
part of the zona fasciculata and to the zona reticularis, but not involving the zona glomerulosa
or the more superficial part of the zona fasciculata. Indirect immunofluorescent antibody
method with serum E. Dark ground UV-blue light, x 220.
adrenocortical insufficiency whose serum reacted only with adrenal cortex are shown in
Table 2. With sera from patients A, B, D and E, adrenal extract absorbed out or significantly
reduced the titre of antibodies reactive with human adrenal cortex, with the interstitial cells
of human or rabbit testis, with the granulosa or theca cells of the follicular phase of the
human ovary and of the rabbit ovary in oestrus, and with human placental trophoblasts.
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Human testis extract was similarly effective in absorbing antibodies reactive with these
various tissues, indicating that there was a sharing of antigens between human adrenal,
human testis and the other tissues studied. Extracts similarly prepared from human thyro¬
toxic thyroid tissue, from the mucosa of the body of human stomach and from rat liver had
no significant effect on the immunofluorescent antibody titres shown by serum E with




Fig. 12 Positive immunofluorescent staining of the zona fasciculata, but negative reaction
with the zona reticularis of the human adrenal cortex given by serum G in the indirect immuno¬
fluorescent antibody technique. The clumpy staining of the zona reticularis is due to non-specific
autofluorescence from lipid granules which fluoresce a reddish-brown as opposed to the
specific green fluorescence in the zona fasciculata. Dark ground UV-blue light, x 260.
immunofluorescent titre of serum B.1493 with adrenal cortex, indicating that the adrenal
antibody or antibodies in this patient with idiopathic Addison's disease were distinct in
their specificity from at least some of these antibodies reactive with adrenal cortex (and other
steroid-producing tissues) in sera A, B, D and E.
The results of absorption studies on the various immunofluorescent reactions with human
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Table 2. Results of absorption studies using extracts of human adrenal and of the human testis as well as





After absorption with extracts of:
Adrenal Testis Thyroid Gastric mucosa Liver
(human) (human) (human) (human) (rat)









E 32 8 8 32 32 32
B.1493 16 4 16









E 32 4 8 32 32 32
B.1493 neg neg neg









E 32 4 8 32 32 32
B.1493 neg neg neg









E 128 16 32 128 128 128
B.1493 neg neg neg









E 32 8 16 32 32 32













E neg neg neg neg neg neg
B.1493 neg neg neg
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ovary in the luteal phase are summarized in Tables 3 and 4. While the diffuse clumpy
staining of the corpus luteum given by sera A and C could be absorbed by either human
adrenal or by human testis extracts, only adrenal was effective in absorbing the antibodies
that gave the patchy staining (serum E) or confluent staining (serum F) of the corpus
luteum (Table 3). Human adrenal extract absorbed the antibodies in sera A, C, D and E
reactive with the theca cells at the periphery and in the traberculae of the corpus luteum of
Table 3. Absorption studies on sera reactive by immunofluorescence
with human corpus luteum
Pattern of
immunofluorescence Reactivity absorbed by:
Patient staining of
corpus luteum Human adrenal Human testis
A Clumpy: diffuse Yes Yes
C Clumpy: diffuse Yes Yes
E Patchy Yes No
F Confluent Yes No
Table 4. Absorption studies on sera reactive by
immunofluorescence with theca interna cells at the
periphery of the corpus luteum in human ovary
Reactivity absorbed by:
Patient





human ovary but absorption with human testis extract was only effective in preventing this
reaction given by sera A and C and was ineffective with regard to sera D and E (Table 4).
These findings confirm that there must be a variety of steroid cell antigens only some of
which are shared between the human testis and the ovary in the luteal phase, but that they
may be all represented in one or more zones of the adrenal cortex. These findings also indi¬
cate that the theca cells surrounding the corpus luteum in human ovary contain more than
one antigen.
DISCUSSION
This paper establishes that there must be a complex of IgG antibodies reactive with adrenal
cortex and with steroid-producing cells in the ovary, testis and placenta. An attempt has
been made to characterize these different antibodies by their different immunofluorescent
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staining properties. Tt has been demonstrated that antibodies reacting with the corpus
luteum of human ovary cross-react with antigens in the adrenal cortex. It is evident that at
least some of the cross-reacting antigens may not be evenly distributed between the three
layers of the adrenal cortex. The antigens in the corpus luteum, responsible for the patchy
immunofluorescent staining pattern given by sera B, E and H, are not present in the zona
glomerulosa or upper part of the zona fasciculata while the antigens responsible for the
confluent immunofluorescent staining pattern would appear not to be present in the zona
reticularis. That the theca interna cells of the luteal phase of human ovary contain more than
one antigen may be inferred from the observation that IgG antibodies in the sera of four
patient's reactive with this cell type could be absorbed by adrenal extract while an extract
of human testis was only effective in absorbing this antibody or antibodies from the sera of
two of these patients.
The analysis of the data in Table 1 is complicated by the fact that antibodies specific for
components of the adrenal cortex, and not cross-reacting with other steroid-producing
cells, are known to occur in some 50% of the sera of patients with idiopathic Addison's
disease (Irvine el al., 1968). Such antibodies have so far invariably reacted with all three
layers of the adrenal cortex. These adrenal-specific antibodies are likely to be present in a
proportion of the ten sera in the present study.
Although the number of sera available for study that reacted with steroid-producing cells
in the gonads was small, there is a strong indication of three patterns of reactivity. Firstly,
there is the pattern of immunofluorescent staining of all three layers of the adrenal cortex,
diffuse clumpy staining of the human corpus luteum, positive reaction with theca interna
cells surrounding the corpus luteum, reactivity with a layer of granulosa or theca cells in the
rabbit Graafian follicles and a positive reaction with human placental trophoblasts. This
contrasts with the second pattern which is characterized by patchy immunofluorescent
staining of the human corpus luteum, positive reaction with theca cells surrounding the
corpus luteum, positive reaction with granulosa or theca cells of the rabbit Graafian
follicles and a reaction only with the deeper portion of the zona fasciculata and with the
zona reticularis in the human adrenal cortex. The third pattern indicates that antigen at least
in part responsible for the confluent staining pattern of human corpus luteum is not repre¬
sented in the interstitial cells of the testis, or in the placental trophoblasts or in the zona
reticularis of the human adrenal cortex.
From experience so far, it would appear that human corpus luteum is the most suitable
tissue to use when screening sera for antibodies to steroid-producing cells in tissues other than
adrenal. All ten sera in the present study were positive either in relation to the corpus luteum
itself or the surrounding theca cells while only a proportion of the sera were positive with
placenta, testis or ovary in the follicular phase. Human corpus luteum is simpler to obtain at
termination of pregnancy than is human ovary in the follicular phase.
The remarkable correlation between the presence of gonadal antibodies and a clinical
history of premature gonadal failure would suggest that immunological factors may have
some pathogenic role in this condition. To date, with one exception (patient J), in female
subjects it is only patients who have ovarian failure associated with adrenal autoimmunity
that have been shown to have antibodies reactive with the steroid-producing cells of the
gonads. The histological appearance of the ovaries on biopsy in patient E (Irvine et al., 1968;
Irvine & Hartog, 1969) was characterized by lymphocytic and plasma cell infiltration in
the developing Graafian follicles. This would strongly suggest an autoimmune pathogenesis.
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By using frozen sections from this patient's ovarian biopsy, it was shown that her
gonadal antibodies were truly autoimmune. As in other autoimmune diseases, the
mediator of immunological damage may be lymphocytes, as suggested by the adoptive
transfer experiments of McMaster & Lerner (1967) in relation to experimental chronic
thyroiditis and of Levine & Wenk (1968) in relation to experimental chronic adrenalitis.
Nerup, Andersen & Bendixen (1969) have demonstrated using the leucocyte migration
test the existence of a state of organ-specific, anti-adrenal hypersensitivity of the cellular
type in nine out of fifteen patients with idiopathic Addison's disease. Alternatively,
there may be synergism between circulating antibody and lymphocyte-mediated antibody.
The present findings provide the first demonstration that an associated pathology (namely
premature gonadal failure) in relation to what has generally been considered to be an organ-
specific autoimmune disorder (namely idiopathic Addison's disease) may be due to cross-
reacting antibodies.
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SUMMARY
IgG antibody to parathyroid oxyphil cells is described in the serum of one of nine
patients with idiopathic hypoparathyroidism. This serum also reacted with the
chief cells of the parathyroid. Whether other sera from the patients with hypopara¬
thyroidism contained antibody to chief cells in low titre was uncertain.
INTRODUCTION
Idiopathic hypoparathyroidism belongs to the 'club' of organ-specific autoimmune diseases
along with the thyroid autoimmune diseases (thyrotoxicosis, Hashimoto goitre, primary
atrophic hypothyroidism), idiopathic Addison's disease, Addisonian pernicious anaemia
and certain cases of premature ovarian failure (Irvine, 1965; Blizzard, Chee & Davis, 1967;
Irvine, Stewart & Scarth, 1967; Irvine et al., 1968). Blizzard, Chee & Davis (1966) have
described the presence of parathyroid antibodies as detected by the indirect immunofluores-
cent technique in 38% of seventy-four patients with idiopathic hypoparathyroidism, 26%
of ninety-two patients with idiopathic Addison's disease, 12% of forty-nine patients with
Hashimoto thyroiditis and in 6% of 245 control patients. No distinction was made between
antibody to the chief (principal) cells or to the oxyphil cells of the parathyroid. The present
paper describes antibody to the oxyphil cells and discusses some of the difficulties in the
detection of antibody to the chief cells of the parathyroid.
MATERIALS AND METHODS
A limited number of unfixed frozen sections were obtained from a small parathyroid
adenoma from a female patient aged 42 years with hyperparathyroidism. Immediately after
the removal of the adenoma from the patient, the tissue was rapidly frozen and the sections
prepared. Parathyroid tissue was also obtained at routine post mortem from a male subject
aged 50 years with no clinical evidence of parathyroid disorder. The sections were used in the
Correspondence: Dr W. J. Irvine, Department of Endocrinology, Royal Infirmary, Edinburgh, 3.
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indirect immunofluorescent antibody technique. The sera from nine patients with idiopathic
hypoparathyroidism and from nine control subjects matched for age and sex were tested.
Horse anti-human IgG conjugated with fluorescein isothiocyanate isomer I (British Drug
Houses, England) with the fluorescein/protein ratio of 0-67 was used in a dilution of 1:6.
The washing fluid in the immunofluorescent technique was veronal buffer, pH 7-2. Ten per
cent glycerol in veronal buffer was used to mount a coverslip. Full details of the preparation
of the conjugate and of the immunofluorescent staining are given elsewhere (Irvine, Chan &
Williamson, 1969b). The sections were examined under a Leitz orthoplan microscope with a
HBO 200 W lamp, primary filter BG 12 (5 mm), Tiyoda oil immersion supra wide angle
dark ground condenser with numerical aperture 1-20 and secondary filter 530. The results
were read subjectively.
Complement fixation tests were done using a phosphate buffer extract of a second and
larger parathyroid adenoma (adenoma II) that had been stored at — 20°C for some months.
None of the tissue from the second parathyroid adenoma had been snap frozen so that it
was not suitable for immunofluorescence studies. The Takatsy microtitre technique (Irvine,
1966) was used with doubling dilutions of control and test sera and with dilutions of a
veronal buffer extract of parathyroid adenoma II.
The parathyroid cryostat sections were also tested in the indirect immunofluorescent anti¬
body technique with a serum (B.4320) known to contain a high titre of 'M' antibody
(Doniach et a!., 1966). Control cryostat sections of rat kidney were included. Serum absorp¬
tion experiments with a veronal buffer extract of rat liver were also carried out. One volume
of rat liver was homogenized with 3 volumes veronal buffer (M.S.E. homogenizer). After
centrifugation at 1750 g 10 min, the supernatant was used for absorption. One volume
antigen and 1 volume serum were incubated for 3^ hr with continuous shaking at room
temperature (Griffin Flask Shaker). After further centrifugation, the supernatant was
used in complement fixation and immunofluorescence tests. Extracts of other tissues
were used for absorption following the same procedure.
The hypoparathyroid and control sera were also tested against cryostat sections of human
gastric mucosa, thyroid, adrenal, ovary and testis.
RESULTS
The serum of one patient (B.8106) with idiopathic hypoparathyroidism showed clear
immunofluorescent staining of the oxyphil cells of the parathyroid adenoma I (Fig. la) and
of normal parathyroid (Fig. 1 b). The patient was from Puerto Rico and her serum was made
available to me through the kindness of Dr Fillian Haddock from the University School of
Medicine, Puerto Rico, and Dr Robert Blizzard, The Johns Hopkins Hospital, Baltimore.
She is patient J in the paper by Irvine, Chan & Scarth (1969a), and is also referred to in
Irvine (1969a). She developed idiopathic hypoparathyroidism at 2 years and idiopathic
Addison's disease at 19 years.
Serum B.8106 gave a negative reaction in the indirect immunofluorescent test for 'M'
antibodies (Doniach et a/., 1966) when tested against rat kidney, but as described in Irvine
et at. (1969a) gave a positive reaction in the indirect immunofluorescent antibody technique
with all three layers of human adrenal cortex, certain steroid-producing cells in human or
rabbit ovary, interstitial cells of human or rabbit testis, rabbit spermatids and with placental
trophoblasts. Her serum was also positive for antibody to human gastric parietal cell in the
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Fig. 1. (a) Positive reaction in the direct immunofluorescent antibody technique with the
cytoplasm of scattered oxyphil cells in an unfixed cryostat section of a parathyroid adenoma
using serum B.8106 from a patient with idiopathic hypoparathyroidism and anti-human
IgG-FITC conjugate. The cytoplasm of the parathyroid chief cells is also considered to show
positive immunofluorescent staining. Dark ground UV-blue light, x 185. (b) Same as (a) but
with normal post-mortem parathyroid. In this instance the oxyphil cells are present in a
discrete cluster. The bright globules are due to redish orange autofluorescence and not to
the green fluorescence of the specific staining of the cytoplasm of the parathyroid cells.
Dark ground Ultraviolet-blue light, x 400.
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indirect immunofluorescent technique, but gave a negative immunofluorescence test for
antibody to human thyroid epithelial cytoplasm.
Complement fixation tests with serum B.8106 were negative with rat liver and with human
thyroid extracts, but positive with an extract of mucosa from the body of human stomach.
The complement fixation tests with parathyroid adenoma II were equivocally positive on
chessboard titration at a serum dilution of 1:4 and an antigen dilution of 1:4. Serum B.8106
was the only one to give even this degree of reaction in the chessboard titration with a buffered
saline extract of parathyroid adenoma II out of the eighteen sera so tested.
Serum B.4320, which was known to contain high titres of'M' antibody, was tested against
cryostat sections of parathyroid adenoma I and of the normal parathyroid. Positive immuno¬
fluorescent staining of the cells with comparable distribution to the oxyphil cells stained by
serum B.8106 was obtained and the fluorescence was of similar intensity. However, serum
B.4320 gave an intense staining of the renal tubules and of the liver parenchyma when
tested against rat kidney and liver sections, while serum B.8106 gave a negative reaction
with these tissues.
The immunofluorescent staining of the oxyphil cells in the sections of normal para¬
thyroid could not be absorbed out by rat liver extract. The titre of the IgG antibody to
oxyphil cells was 1:16 before and after absorption. In contrast, the titre of serum B.4320
with the oxyphil cells in the normal parathyroid sections was reduced from 1:256 to 1:64
by prior absorption of this serum with liver extract.
Serum B.8106 also gave a distinct and consistent increase in the brightness of fluorescence
of the chief cells in cryostat sections of parathyroid adenoma I and of the normal para¬
thyroid. The titres of the reaction with the parathyroid chief cells given by serum B.8106
and by serum B.4320 before and after absorption with liver extract were comparable to
those recorded, respectively, for the reaction with the parathyroid oxyphil cells. Three of the
other eight sera from patients with idiopathic hypoparathyroidism and one of the nine control
sera were also considered to give a positive indirect immunofluorescence test with the chief
cells of parathyroid adenoma I but the results were not consistent when checked with sections
of the normal parathyroid. The interpretation of a positive or negative immunofluorescence
reaction with the chief cells presented some difficulty. This was because there was no clear
contrast within the specimen itself as in the case of the oxyphil cells and it was necesary to
assess whether the general degree of fluorescence in the cytoplasm of these cells in each
section was greater or equal to that of the controls, there being some slight degree of back¬
ground staining.
The control serum (B.4752) that appeared to give a positive indirect immunofluorescence
test for the cytoplasm of the chief cells in parathyroid adenoma I was shown to contain
antibody to human parietal cells and to human thyroid epithelial cytoplasm but was negative
for 'NT antibodies and for antibodies to steroid-producing cells in the gonads and placenta.
One other control serum gave a positive immunofluorescence test for gastric parietal cell
antibody, but otherwise the control sera were all negative.
DISCUSSION
The occurrence of antibodies that are specific for one or each of the cell types in the para¬
thyroid is what one would anticipate in the sera of at least a proportion of patients with
idiopathic hypoparathyroidism. As already mentioned, this condition is associated clinically
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with other disorders that are characterized by the formation of autoantibodies that are
highly specific for components of individual tissues. The histology of idiopathic hypopara¬
thyroidism is that of atrophy of the parathyroid cells together with lymphocytic infiltration
(see Irvine, 1969b). Lupulescu et at. (1968) have demonstrated that repeated inocculation of
homologous parathyroid tissue into dogs may induce isoimmune hypoparathyroidism with
the characteristic biochemical and histopathological features and the presence of comple¬
ment fixing parathyroid antibodies in low titres in the serum. The isoimmune hypopara¬
thyroidism in dogs was similar to that described by Lupulescu et al. (1965) in rats.
Serum B.8I06 which gave a positive immunofluorescence test with the oxyphil cells in
parathyroid adenoma I and in the normal parathyroid also reacted positively with human
gastric parietal cell cytoplasm and with steroid-producing cells in the gonads. The negative
immunofluorescence reaction with rat kidney tubules and with rat liver sections and with
human thyroid epithelial cytoplasm and the negative complement fixation tests with rat
liver indicate that the positive immunofluorescence reaction with the oxyphil cells was not
due to the presence of tissue non-specific 'M' antibodies. This is confirmed by the failure of
liver extract to absorb the antibody reacting with parathyroid oxyphil cells. The distinction
from 'M' antibodies is an important point to establish as the oxyphil cells are known to be
rich in mitochondria and it has been demonstrated in this paper that 'M' antibodies can
give positive immunofluorescence tests with parathyroid sections in the distribution of the
oxyphil cells. Also in favour of the immunofluorescence reaction of serum B.8I06 being
specific for parathyroid is the observation that 'M' antibodies are rare in the organ-specific
group of diseases (Doniach el al., 1966).
The application of microphotometry (Irvine et al., 1969b) may allow a more confident
distinction to be made between positive and negative immunofluorescent reactions with the
chief cells of parathyroid tissue. The findings in the limited series reported here are in keep¬
ing with those reported in a much larger series by Blizzard et al. (1966). However, in
Blizzard's series it is anomalous, in view of the rarity of idiopathic hypoparathyroidism,
that as many as 6% of this control subjects were positive for parathyroid antibodies pre¬
sumably to chief cells. It is also anomalous that the suitability of parathyroid adenomata for
fluorescence studies could not be predicted and that no confirmatory reports have so far
appeared. Clearly the incidence and characterization of parathyroid antibodies requires
further study. It is not possible on the present evidence to state whether the parathyroid
oxyphil and chief cells have distinct autoantigens one from the other.
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SUMMARY
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A case of primary hypothyroidism, idiopathic Addison's disease,
idiopathic hypoparathyroidism (with preceding moniliasis), Addisonian
pernicious anaemia and primary ovarian failure is described. She died at
the age of 24 years following an illness compatible with adrenal crisis.
At post-mortem there was no recognisable adrenal or ovarian tissue; there
was only a minute portion of probable parathyroid tissue and the uterus was
infantile. Her serum contained antibodies reactive with adrenal cortex,
steroid-producing cells in the gonads, placental trophoblasts and thyroid
epithelial cytoplasm and intrinsic factor.
Her brother, who was known to have gluten enteropathy, died aged
11 years following an illness compatible with adrenal crisis. His adrenal
glands were grossly atrophic at autopsy.
The parents were consanguinous and both showed either clinical or
serological evidence of organ specific autoimmune disease.
INTRODUCTION
The following two cases and family study are described in view of the
rarity of adrenal insufficiency in siblings and to record the details of a case
of primary ovarian failure associated with ovarian autoimmunity with streak
ovaries and with polyendorinopathy.
CASE 1
History
M. L. Female, Born 12.1.1945. Her birthweight was lbs.
(3.7 kilos), the outcome of a normal pregnancy and delivery. Her growth
and development progressed normally to the age of 5 years, when she first
developed patchy alopecia with depilation of the eyebrows and eyelashes.
At 7 years, she spent ten months in a fever hospital with suspected tuberculous
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meningitis, which was never proven. On discharge from hospital, she was
underweight and the alopecia had become complete. Except for one year,
at about the age of 9 years, when there was some regrowth of hair, the
alopecia remained unchanged. Finger-nail dystrophy was first noted
during her stay in the fever hospital and persisted thereafter.
In I960, at the age of 15 years, she was referred to the Endocrine
Clinic of the Mater Misericordiae Hospital, Dublin, by Dr J. Barnes of the
Dermatology Department. She was of small stature (49^/4 inches (124 cms)
in height; 61 lbs. (27 kilos) in weight). Her skin was dry and cold. She
had a red, raw tongue, showing patches of moniliasis. There was marked
moniliasis of the finger nails and alopecia totalis.
There was no history of tetany or steatorrhoea. The menarche had
not occurred. The external genitalia were infantile and there was no breast
development. The systolic B. P. was 92 mms.Hg.
The Haemoglobin was 627o (9gms%), the total white cell count and
differential count and urinalysis were normal. There was no excess of fat
in the stools. Her bone age was only 8 years in contrast to her chronological
age of 15 years, but there was no evidence of oesteoporosis. The serum
cholesterol was 288 mgs.% and an E.C.G. showed low voltage and prolongation
of the Q. T. interval consistent with hypothyroidism. She was considered to
have primary hypothyroidism and treatment was begun with thyroid extract
2 grs. (130 mgms) per day. This was later replaced by 1-thyroxine 0.2 mgms.
per day.
In September 1970, the 24 hour urinary 17-ketosteroid and 17-ketogenic
steroid excretion was 1. 5 mgms. and 0. 8 mgms. , respectively. At about
this time she had an episode of collapse with B. P. = 60/45 mm. Hg, blood
sugar = 44 mgmsfo and serum sodium = 120 mEq/1. She responded to
intravenous dextrose and the blood pressure rose to 100/65 mm. Hg.
A diagnosis of primary idiopathic adrenal insufficiency was made and her
general health was much improved by the addition of steroid replacement
therapy.
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In December 1961, she had her first episode of tetany (serum
calcium = 5.4 mgms%). The response to i. v. calcium gluconate was rapid.
Steatorrhoea was again excluded by stool analysis, d-xylose test and
jejunal biopsy. She was considered to have primary hypoparathyroidism.
Calcium lactate and vitamin D were added to her therapy.
In October 1962 (at the age of 17 years) her bone age was 13 years,
height 56 inches (142 cms) and weight 72 lbs. (32 kilos). Serum calcium =
10.7 mgmsfo, phosphorus =4.3 mgms%, alkaline phosphatase = 11 K.A.
units, haemoglobin = 84% (12.2 gms%). The total 24 hour urinary gonado-
trophins estimated by the mouse uterus test was between 26 and 52 mouse
units. The subsequent progress was complicated by a rise in the serum
calcium to 12. 1 mgms% and the development of a ureteric calculus which
was passed spontaneously. The dosage of calcium and vitamin D were
adjusted.
In September 1966 a macrocytic anaemia and histamine-fast
achlorhydria were demonstrated. The serum vitamin was 100 pg./ml. and
the Schilling test was 0. 05% rising to 23% when repeated with oral intrinsic
factor. i
In 1968, at the age of 23 years (height 61 inches (154 cms), weight
81 lbs. (36 kilos), bone age = 15 years) she had never menstruated and there
was no palpable breast tissue. Gynaecological examination was refused.
She was Barr positive on buccal smear and chromosome studies by lymphocyte
culture gave normal results, 46 XX (Dr Patricia Jacobs, M. R.C. Clinical
and Population Cytogenic Unit, Edinburgh).
Her clinical history is summarised in Table 1. This patient is
patient B in the paper by Irvine et al., (1968) and patient No. 3 of Table IV
and No. 2 of Table V in Irvine (1970a).
Serological findings
The results of her antibody studies on serum obtained in 1966 and
subsequently are shown in Table 2. The details of the serological techniques
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TABLE 1
SUMMARY OF THE MAIN CLINICAL FEATURES OF PATIENT M. L.
Normal delivery and birthweight
Alopecia at 7 years
Moniliasis at 7 years
Primary hypothyroidism at 15 years
Primary adrenocortical failure
(probably idiopathic) at 15 years
Primary hypoparathyroidism at 16 years
Addisonian pernicious anaemia at 22 years
Complete failure of menstruation with no
menarche and no secondary sex
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employed were as previously described (Irvine et al., 1967; Irvine, Chan
and Scarth, 1969) using undiluted serum and anti-human IgG-F. I. T.C.
conjugate in the immunofluorescence technique and 2 MHD of complement
and 50% haemolysis as end-point in the complement fixation test.
Autopsy
While on holiday in the West of Ireland in August 1969 the patient
complained of pyrexia, vomiting and diarrhoea with cramp-like abdominal
pain. These symptoms worsened over the following 12 hours and she lapsed
into unconsciousness and died in the ambulance on the way to the Mater
Misericordiae Hospital.
Macroscopic findings:
The body was completely devoid of hair and the finger-nails were
thickened, longitudinally ridged and reduced to approximately one-third in
area. Some pigmentation was noted at the margins of the tongue and on the
gums. The thyroid weighed 4 grms and the thymus 7 grms. The adrenals
could not be detected macroscopically, the spleen was absent and rudimentary
ovaries and uterus were identified. Other structures were grossly normal.
Histology:
Pituitary gland: normal, with abundant cells in the anterior pituitary
of normal appearance and variety, using H and E stains.
Thyroid: the glandular tissue was almost totally replaced by acellular
fibrotic tissue. Numerous small foci of surviving thyroid glandular tissue
were evident throughout the fibrotic mass. These foci were surrounded and
infiltrated by an intense localised lymphocytic infiltrate similar to that seen
in Hashimoto thyroiditis.
Parathyroids: only one small focus (2 mm) of probable parathyroid
tissue was identified after a careful search.
Adrenal glands: no recognisable adrenal tissue was detectable in
multiple sections from th<2 fatty tissue of both adrenal areas. A focus of
eld haemorrhage in the form of haemosiderin deposit was found in the right
adrenal area.
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Ovaries: represented by thin plaques of fibrotic tissue in which
follicles were not found.
Uterus: the cavity was lined by columnar epithelium resembling
the normal endo-cervical type mucosa. No formed endometrium was
detected.
Thymus: normal with reasonable cortico-medullary differentiation
and no conspicious germinal centre formation in the medulla.
Pancieas: normal with normal islet tissue.
Kidneys: normal apart from some small foci of calcification
present in the epithelium of occasional tubules.
CASE 2
History
S. L. Male, Born 1947. Brother of Case 1. He was investigated
at 7 years of age for coeliac disease and moniliasis of the finger-nails and
mouth. His height then was 47 inches (118 cms) and weight 34 lbs. (15 kilos).
Steatorrhoea was confirmed and a gluten-free diet was started with sympto¬
matic improvement.
At the age of 11 years, patchy alopecia of the scalp was noted.
Later the same year, he was admitted to hospital with vomiting and diarrhoea
of two days duration. He was underweight with monilial infection of the
popliteal fossa of the right leg, of both hands including the nails, and of the
mouth. The tongue was bald and red. The serum calcium was 8. 5 mgm%
and the phosphorus was 4. 5 mgms%. The faeces again contained a large
excess of free fatty acid and occasional globules of neutral fat. His condition
improved on a strict gluten-free diet and the serum calcium levels rose to
10.4 mgmsfo and 10. 8 mgms7o. Six months later he was re-admitted to
hospital with a history of intermittent abdominal pain and vomiting of 10 days
duration. There was no diarrhoea on this occasion. He collapsed and died
within an hour of admission to hospital.
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Autopsy
At post-mortem, moniliasis as described was noted. Both adrenal
glands were extremely thin and atrophic. The thyroid and pituitary glands
were macroscopically normal and the parathyroids could not be identified.
There was marked enlargement of the mesenteric lymph nodes. Histology
of these tissue was not available.
FAMILY HISTORY
The parents of M. L. and S. L. were first cousins. They had two other
children, one of whom was reputed to be in excellent health. The other died
in childhood of gastroenteritis during an epidemic in 1946.
The sera of both parents contained gastric parietal-cell antibodies by
the indirect immunofluorescence test, and the serum of the mother (but not
the father) was weakly positive for intrinsic factor antibody I (5. 5 mg. units/ml.).
Both sera were negative for thyroid cytoplasmic antibodies and for thyro-
globulin antibodies and were also negative for antibodies reactive with adrenal
cortex, ovary (graafian follicles and corpus luteum), testis, placenta,
mitochondria and nuclei.
The surviving sibling had emigrated and was not available for clinical
or serological assessment.
In March 1968 the father (aged 70 years) was found to have a macrocytic
anaemia and achlorhydria and an abnormal Schilling test indicative of vitamin
3312 malabsorption. His general condition improved rapidly with parenteral
vitamin B^ therapy.
The father's sister attends the Mater Misericordiae Hospital with
diabetes mellitus and Addisonian pernicious anaemia.
*
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Fig. 1. Summary of family history.
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In spite of the absence of more precise modern methods of investi¬
gation of adrenal function, there can be little doubt of the diagnosis of
idiopathic adrenal insufficiency in the case of M. L. and of S. L. In M. L.
primary adrenal atrophy and primary thyroid atrophy (with lymphocytic
infiltration) were shown unequivocally at autopsy. Such severe atrophy
would not be produced simply by replacement doses of oral steroids or of
thyroxine. The fact that only remnants of parathyroid tissue could be found
after a careful search at autopsy (both macroscopically and microscopically)
confirmed the clinical diagnosis of idiopathic hypoparathryoidism. In her
brother S. L. the severe atrophy of the adrenals noted at autopsy was in
keeping with the clinical diagnosis of primary adrenal insufficiency.
The association of alopecia, moniliasis, primary hypothyroidism,
primary hypoparathyroidism and Addisonian pernicious anaemia with idio¬
pathic adrenal failure has been documented and reviewed (Carpenter et al.,
1964; Blizzard, Chee and Davis, 1967; Irvine, Stewart and Scarth, 1967;
Irvine, 1968 and 1970 a & b). The association of malabsorptive disease with
idiopathic Addison's disease has been described by Craig, Schiff and Boone
(1955), Whitaker et al. (1956), Morse et al. , (1961) and Goudie et al., (1969).
The association of ovarian failure with idiopathic Addison's disease has been
described clinically by Turkington and Lebovitz (1967) and both clinically
and immunologically by Irvine et al., (1968, 1969) and by Irvine (1970 a & b).
A phenomenon that is shared by many of these conditions is the occurrence
of auto-antibodies in the sera that are specific for constitutents of the organ
that is the site of the disease (e.g. thyroid, parathyroid, gastric mucosa
and adrenal cortex). The situation regarding the ovary is different in that
that there is a sharing of antigen between the steroid-producing cells of the
ovary and the steroid-producing cells of the adrenal cortex (Irvine et al.,
1969). Patients whodevelop an immune response to steroid cell antigens
that are present in the adrenals and also in the gonads are liable to have
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combined adrenal and ovarian failure, whereas patients who develop an
immune response to steroid cell antigens that are only present in the adrenals
do not develop ovarian failure in addition to adrenal atrophy. Extra-adrenal
steroid cell antibodies are generally absent from the sera of patients with
ovarian failure alone and without idiopathic Addison's disease (Irvine, 1970b).
An attractive hypothesis is that the association of clinical diseases described
above (and exemplified particularly in Case M. L. of the present paper) is
accounted for by a genetically determined disorder of immunological
tolerance (Irvine, 1964; Irvine et al., 1967).
Patient M. L. of the present paper with idiopathic Addison's disease
and antibodies in the serum reactive with ovarian steroid-producing cells is
now the second case in the literature in whom ovarian failure has been shown
unequivocally to be associated with streak ovaries. Both patients were
normal Barr positive on buccal smear and both had normal chromosome
patterns on lymphocyte culture. The other case was described by Irvine
et al. , (1968) and by Kolb et al., (1970). While the possibility of mosaicism
cannot be entirely excluded, it would seem likely that the destruction or
failure of development of the ovary in these cases may be due to the develop¬
ment of autoimmunity (humoral and cellular) to ovary at an early age, i.e.
before puberty. In patient (M. L. ), and also in Dr Felix Kolb's patient,
there was abundant clinical evidence that frank autoimmune disease had
developed before puberty and it is therefore probable ths.t the ovary may
have been implicated at that time. These two cases, together with the
finding that the sera of 49 patients with gonadal dysgenesis and chromosomal
defects but without associated Addison's disease were all negative for steroid
cell antibodies (Price and Irvine, 1969), should suffice to question whether
streak ovaries are always associated with chromosome abnormalities. In
some instances streak ovaries may perhaps result from autoimmune
mechanisms at an early age.
In patients with idiopathic Addison's disease and ovarian failure (with
adrenal and extra-adrenal steroid cell antibodies) but in whom a menarche
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has occurred, the ovarian histology is characterised by lymphocytic
infiltration in relation to the developing ovarian follicles (Irvine et al.,
1968; Bayliss and Irvine, 1970).
The combination of idiopathic Addison's disease with hypothyroidism
(Schmidt's syndrome) is sometimes familial and is thought to be an auto¬
somal recessive character (Carpenter et al., 1964; Beaven et al. , 1959).
Dunlop (1963) has stated that all cases of familial Addison's disease have
so far proved to be idiopathic if autopsy was performed. Idiopathic
Addison's disease has been described in two pairs of identical twins (Smith
et al., 1963; Heggarty, 1968). Familial aspects of Addison's disease
have also been reported by Hung, Migeon and Parrot (1963) and by Meechen
and Wynn (1967). Spinner, Blizzard and Childs (1968) made an analysis
of the history from 140 families containing patients with idiopathic Addison's
disease without idiopathic hypoparathyroidism, Addison's disease with
x
hypoparathyroidism and hypoparathyroidism alone. They demonstrated
a significantly greater similarity of clinical and other attributes among
affected persons within the families than among unrelated persons. Some
cases were apparently genetically determined and the distribution of
affected persons within the family was compatible with an autosomal
recessive pattern. Other cases did not fit any Mendelian pattern even
although their families contained more than one affected person.
The present family would be compatible with a genetic tendency to
autoimmunity with both parents carrying the trait as evidenced by clinical
pernicious anaemia in the father and his sister, and the presence of
parietal-cell antibodies in the serum of both the father and mother. The
fact that both parents carried the trait may explain why the manifestations
of autoimmunity were so pronounced and occurred so early in their
children. The fact that the parents were consanguinous would also greatly
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PRIMARY HYPOPARATHYROIDISM,
ADDISON'S DISEASE AND OVARIAN
FAILURE
F. O. Kolb, W. J. Irvine, H. L. Steinbach, L. Goldman
and G. Webb
University of California Medical Center, San Francisco,
and M.R.C. Clinical Endocrinology Unit, Edinburgh.
M.H.,* a baby girl born at full term in 1948, of normal weight and of
normal pregnancy and spontaneous delivery, was in good health until
two years of age when she developed stunting of growth, a pro¬
tuberant abdomen and passage of large foul stools. A tentative
diagnosis of sprue syndrome was made. There appeared an urticarial
rash and frequent respiratory infections, and, finally convulsive
seizures improved by calcium administration. A diagnosis of idio¬
pathic hypoparathyroidism was established with findings of a serum
calcium of 5-9 mg. per cent and serum phosphate of 7-6 mg. per cent.
Injection of parathyroid hormone produced phosphaturia (Ellsworth
-Howard test positive). Treatment with oral calcium, a low phos¬
phate diet and dihydrotachysterol (A.T.10) controlled her seizures
for about three years. In 1954, at six years of age, seizures returned
requiring injections of parathyroid extract with good response. Sub¬
sequently two foetal parathyroid transplants were attempted with
apparent improvement, although her previous medications had not
been stopped until 1956 when she developed mild hypercalcaemia.
Her physicians reported the transplants to be successful (Akers et al.,
1958). Shortly thereafter, however, hypocalcaemic tetany recurred.
She was first admitted to the University of California Medical
Center in 1958, at the age of 10, following an acute tetanic seizure
with choking of the optic discs, severe hypocalcaemia and hyperphos¬
phatemia. Marked skeletal demineralization, a retarded bone age and
malformation of her teeth and hips were noted. The diagnosis of
hypoparathyroidism was confirmed but the nature of her bone disease
* This patient is No. 2 of Table III and No. 3 of Tables IV and V of the
preceding paper.
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remained obscure. Following treatment with vitamin D and alumi¬
nium hydroxide gel, a third transplant of adenomatous parathyroid
tissue placed into four millipore chambers was attempted. Since
serum calcium rose to levels of mild hypercalcaemia, vitamin D was
discontinued four weeks later, while oral calcium and the low phos¬
phate diet were continued.
Six months after the transplant hypocalcaemia returned when oral
calcium was stopped and a high phosphate diet was given. Vitamin
D therapy was resumed and the patient felt well until the age of 12
years, 6 months when she was readmitted with nausea, weakness and
deep pigmentation of her skin and mucous membranes. A small
goitre was noted as well. Hypercalcaemia was present and a diagnosis
of primary Addison's disease was established because of urinary
hydroxycorticoids of 1-6 mg./24 hours, absent ketosteroids and
failure to rise after intravenous infusion of 25 units of ACTH over
eight hours. The protein bound iodine level was 9'8 micrograms per
cent, radioactive T3 uptake of the red cells 18 per cent (Normal 13
to 20) and radioiodine uptake over the thyroid gland 4 per cent in
24 hours with rise to 25 per cent after 5 units of thyrotropic hormone
for two days. A diagnosis of probable thyroiditis was made rather
than primary myxoedema, although thyroglobulin antibody levels
were negative. The urinary gonadotrophin levels were elevated and
an X-ray survey by Dr H. Steinbach suggested the diagnosis of gona¬
dal dysgenesis. Following hydration and hydrocortisone administra¬
tion, serum calcium promptly returned to normal and the patient
rapidly returned to a state of well-being. The four millipore chambers
were removed showing scar tissue and absence of viable parathyroid
cells.
The patient was well for the next two years taking vitamin D and
hydrocortisone; the small goitre disappeared spontaneously. Her
height at 10 years was 127 cm. and at 12 years was 137 cm. i.e. below
the third percentile. In 1964 she was readmitted to hospital because
of failure to mature and the finding of amarkedly retarded bone age.
Buccal smears were chromatin positive. Urinary gonadotrophin
levels were positive at 5 and negative at 80 mouse units. Insulin
tolerance test showed normal sensitivity. Gastric analysis failed to
show free acid before and after histamine stimulation. The Schilling
test was normal. Stool fat excretion was normal. Her serum was
weakly positive for thyroid microsomal antibody by immuno-
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fluorescence and was definitely positive for antibody to adrenocorti¬
cal cells and to parietal cells by immunofluorescence. Her serum was
also positive for intrinsic factor antibody I, using albumin-coated
charcoal radioimmunoassay. These findings suggested that her endo¬
crine deficiency state may be due to autoimmune disease (Kolb et al.,
1965). Thyroxin was given at first to promote growth. Vaginoscopy
showed a small cervix and rectal examination acord-like uterine body.
Chromosomal analysis (Dr D. Lindner) showed 46 chromosomes
with XX pattern. Small doses of oestrogen were given. In 1966, after
a brief hypocalcaemic seizure, the patient fractured her left hip, but
X-ray examination showed a previous spontaneous fracture of the
right hip as well. After immobilization in a hip spica a wedge osteo¬
tomy was performed by Dr W. Murray with good healing and excel¬
lent function except for a slight residual limp in her gait.
Further studies showed autoantibodies to parathyroid on one
occasion (Dr R. Blizzard) and the previously found autoantibodies
to adrenal and parietal cells were confirmed by Dr Blizzard and Dr
H. Fudenberg. No autoantibodies were found in the patient's parents
(Dr Fudenberg). Pituitary growth hormone autoantibodies were
negative (Dr W. Hunter). Autoantibodies to human gonadal tissue,
including theca and granulosa cells, interstitial cells of testis, as well
as to ova and sperm of rabbit and to human trophoblasts were sub¬
sequently demonstrated by immunofluorescence (Irvine et al., 1968).
In view ofthese findings and since gynaecographyhad demonstrated
'streak' ovaries, exploratory laparotomy was performed. Bilateral
'streak' gonads were found, showing absence of follicles, tubules and
no lymphocytic infiltration. Attempts at tissue culture of the streaks
and of skin for chromosomal studies were not successful.
When last examined in 1968 and 1969 the patient had started to
develop normal breasts and axillary and pubic hair on cyclic oestro¬
gen and progesterone treatment, with regular withdrawal bleeding.
Glucose tolerance was normal; there was no evidence of pernicious
anaemia; growth hormone and insulin levels were within the normal
range both before and after arginine infusion. The patient has
attained a height of 153 cm., is mentally alert and fully active except
for a minimal limp and is well maintained on vitamin D, calcium
carbonate and hydrocortisone as well as on cyclic oestrogen.
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DISCUSSION
When multiple endocrine glands were found to be hypofunctioning
it was generally assumed that pituitary failure was present. The more
recent recognition of primary 'idiopathic' end-organ deficiency
states involving multiple endocrine glands has changed this concept
(Christy et ah, 1962; Carpenter et ah, 1964; Turkington and
Lebovitz, 1967). While a possible autoimmune mechanism had been
postulated in the past, the recent introduction ofmodern techniques,
especially immunofluorescence, has confirmed the presence of auto¬
antibodies to both endocrine and non-endocrine tissue in many
patients with primary Addison's disease, hypoparathyroidism,
thyroiditis, pernicious anaemia and, most recently, with primary
ovarian failure (Blizzard et al., 1967; Irvine et ah, 1967; Irvine et ah,
1968). The presence of such antibodies does not necessarily imply
a clinical state of abnormality, but the high frequency of such detect¬
able antibodies may serve as a marker for the possible future de¬
velopment of a deficiency state (Wuepper et ah, 1969). Family
members who may or may not show clinical endocrine dysfunction
likewise may have circulating autoantibodies, suggesting a genetic
background for these disorders (Spinner et ah, 1968; Wuepper et ah,
1967). The finding in our patient with primary hypoparathyroidism
and Addison's disease of streak ovaries and other findings suggesting
gonadal dysgenesis (Turner's syndrome) raised the possibility of a
genetic and autoimmune mechanism rather than a chromosomal
abnormality in cases with this disorder. It may be feasible to preserve
fertility by the early detection of such autoantibodies to gonadal
structures and by the use of immunosuppressive doses of steroids.
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DISCUSSION
Hall: Do you think this patient has in fact a form of Turner's
syndrome with associated autoimmune disease? This would seem
to be the most likely explanation in view of the skeletal stigmata.
Did you do chromosome studies on the streak ovaries and did you
do a skin biopsy? A Turner's mosaic with associated autoimmune
disease would be a possibility.
Kolb: We tried to culture the streak and we also tried to get a skin
biopsy and culture. These were, unfortunately, not successful. It is
our feeling that this very well may be an association of Turner's
syndrome with autoimmune disease. The fact that there have now
been other cases reported where the streaks have had the XX consti¬
tution makes us wonder if the streak ovary of Turner's syndrome
really is a chromosomal phenomenon or may not have other explana¬
tions, such as autoimmunity.
Irvine: The association of Turner's syndrome with autoimmunity
is very uncommon. I think the literature is a bit confused on this
point. Dr W. Price at the Western General Hospital and myself
studied the sera of 51 patients with abnormalities of the sex chromo¬
somes, including 21 patients with Turner's syndrome. We were un¬
able to find any patients with antibodies to adrenal, to other steroid-
producing cells or to ova in these groups. In fact, we were unable to
confirm that patients with chromosome abnormalities do indeed
have any increased incidence of autoimmunity (Price, W. H. and
Irvine, W. J. 1969. Clin. expl. Immun. 4, 365). So there is something
very exceptional about Dr Kolb's patient.
Hartog: Is this instance of fractures in Turner's syndrome un¬
usual? Secondly, do you think that prednisolone treatment, by
analogy say with pernicious anaemia or autoimmune thyroiditis,
might be successful in partially reversing the autoimmune process?
Would its use be possibly justifiable in terms of trying to promote
pregnancy?
Kolb: We have not seen fractures but we have seen similar hip
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deformities and osteoporosis in Turner's syndrome. The fact that she
fractured her hips may be related to her convulsive tendency.
Whether or not it would be safe to use large amounts of corti¬
costeroids remains an open question. In this instance, having
Addison's disease and osteoporosis, we had no choice but to use
physiological doses of corticosteroids. I am not sure whether this
had anything to do with the disappearance of her goitre. I do not
think the use of pharmacologic doses of corticosteroids would have
made any difference in this youngster, because I believe her auto-
immunization probably goes back to intrauterine life. I doubt that
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GASTRIC ANTIBODIES IN DIABETES MELLITUS
Sir,—For some time now we have been testing the sera
of a large number of patients for the presence of gastric
parietal-cell antibody, in an attempt to assess the clinical
significance of a positive finding. It was therefore with
great interest that we read the article by Dr. Moore and
Dr. Neilson (Sept. 28).
Of the sera we have analysed to date, 170 were from patients
with proven diabetes mellitus but in whom there was no clinical
evidence of pernicious anaemia or of thyroid disease. All these
diabetic sera have been examined for gastric parietal-cell
antibody both by the indirect Coons fluorescent-antibody
technique 1 2 and by the method of complement fixation. The
details of the complement-fixation method used in our study
have been given elsewhere 3 and differ in some respects from
those adopted by Moore and Neilson. In our experience the
complement-fixation test varies in reproducibility by plus or
minus one titre when doubling dilutions are used. One of the
main reasons for this is the difficulty of assessing 50% haemo¬
lysis in the indicator system. A positive gastric complement
fixation titre of 1:4 was therefore considered to be valid only
if a positive result was obtained on at least 3 out of 4 con¬
secutive testings or if confirmed by unequivocal staining of
parietal cells by the fluorescent-antibody method. The
fluorescent-antibody method has been shown to be a more
sensitive indicator for the detection of gastric parietal-cell
antibody than the method of complement fixation and has the
advantage of having a clearer and more reproducible end-
point; it also overcomes many of the problems of tissue
specificity.
When our diabetic patients are classified into those who were
diagnosed before the age of forty years (early onset) and those
whose disease became manifest after the age of forty years
(late onset) the results are as shown in table I. These patients
have been analysed according to their sex and their present
age and the serological findings compared with a similar
analysis of the sera of 629 blood-donors. Gastric parietal-cell
1. Taylor, K. B., Roitt, I. M., Doniach, D., Couchman, K. G., Shapland,
C. Brit. med. J. 1962, ii, 1347.
2. Irvine, W. J. Quart. J. exp. Physiol. 1963, 48, 427.
3. Irvine, W. J., Davies, S. H., Delamore, I. W., Williams, A. W. Brit.
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TABLE II—ANTIBODIES AND FAMILY HISTORY IN DIABETICS
No. of
patients Family history
Gastric i.e. Thyroid c.f.t.and/or t.c.h. a.n.f.
5 Pernicious anaemia 1 1
5 Pernicious anasmia
Diabetes 1 2 1
10 Thyroid disease 3
3 Thyroid disease
Diabetes 1
26 Diabetes 4 4 1
49
54
Any of the above







antibody was detected by the fluorescent-antibody method in
3% of 140 female and in 1% of 168 male blood-donors under
the age of forty years, and in 10% of 164 female and in 6% of
157 male blood-donors over the age of 40. On this evidence we
cannot confirm the striking incidence of gastric parietal-cell
antibody in the early-onset type of diabetes described by
Moore and Neilson. We assume from the low incidence of
antibodies in the matched controls that their patients in the
early-onset group are at present of early adult age. When the
incidence of gastric parietal-cell antibody is analysed by
decades using the present age of the diabetic patients and of the
blood-donors, then we find that the diabetic who is presently
middle-aged (40-60 years) has a higher incidence of both
gastric and thyroid antibodies than the blood-donors. This
difference exists but is not pronounced.
A careful family history of addisonian pernicious
anaemia, thyroid disease, and diabetes in the blood
relatives was taken in 103 of the 170 diabetic patients, and
the findings are correlated with the patient's serology in
table II. While there is a higher incidence of thyroid
antibodies and of anti-nuclear factor in the patients with
a positive family history, the present figures do not show
this to be so with regard to antibody to gastric parietal
cells. However, in a study of a larger series of relatives
of patients with addisonian pernicious anaemia (but who
may not have diabetes) we do find a definitely increased
incidence of gastric parietal-cell antibody in their sera.
A detailed clinico-immunological study of a much larger
number of patients with diabetes mellitus may demon¬
strate that these hereditary factors and the age of the
patient at the time the serum is tested are more directly
relevant to understanding the incidence of gastric parietal-
cell antibody in diabetes mellitus than the age of the
patient when the diabetes was first diagnosed.
Departments of Therapeutics and of
Haematology, Royal Infirmary and W. J. IRVINE
S.E. Regional Blood Transfusion q tt twtttt-o
Service, Edinburgh. i-'AVIES.
The Lancet Office,
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17. THE INCIDENCE OF THYROID AND GAS¬
TRIC AUTOIMMUNITY IN PATIENTS WITH
DIABETES MELLITUS
W. J. Irivine, B. F. Clarke, Laura Scarth and
L. J. P. Duncan
Departments of Endocrinology, Diabetes and Thera¬
peutics, Royal Infirmary, and M.R.C. Clinical Endo¬
crinology Research Unit, Edinburgh
The organ-specific autoimmune thyroid diseases and
pernicious anaemia are alleged to occur more fre¬
quently; in diabetic subjects. In the present study, the
incidence of antibodies to thyroid cytoplasm and to
gastric parietal cell cytoplasm was found to be sig¬
nificantly increased (P< 0-001) in the sera of 883 dia¬
betics compared to 866 control subjects when analysed
by age and sex. There was no clear relationship
between the incidence of these antibodies with the
duration of diabetes, but in patients over the age of
40 years at the time of study the incidence was signific¬
antly higher in those who were insulin dependent
(Pc 0-005). Within the insulin dependent group there
was no correlation with the age of onset of the
diabetes. There was no overall difference in the
incidence of antibody to thyroglobulin in the diabetics
compared to controls.
Intrinsic factor antibody I was found more com¬
monly in female diabetics over the age of 40 years
than in female controls of comparable age. Of nine
such patients with intrinsic factor antibody who were
available for study, there was evidence of achlor-
hydria in all, malabsorption of vitamin Bi2 without
anaemia in three, and of adequate vitamin B22 ab¬
sorption in four.
There would appear to be some disturbance of the
immunological system in relation to diabetes with
respect to the formation of autoantibodies and the
occurrence of organ-specific autoimmune disease.
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SUMMARY
The organ-specific autoimmune thyroid diseases and pernicious
anaemia are alleged to occur more frequently in diabetic subjects. In
the present study, the incidence of antibodies to thyroid cytoplasm and
to gastric parietal cell cytoplasm was found to be significantly increased
(p^O. 001) in the sera of 1054 diabetics without clinical thyroid disease or
pernicious anaemia compared to 871 control subjects when analysed by age and
sex. There was no clear relationship between the incidence of these
antibodies with the duration of diabetes, but in patients over the age of 40
years at the time of study the incidence was significantly higher in those
who were insulin-dependent (p^O.OOl). Within the insulin-dependent group
there was no correlation with the age of onset of the diabetes. The incidence
of antibody to thyroglobulin in the diabetics compared to controls was much
less pronounced than was the incidence of antibody to thyroid cytoplasm
and to gastric parietal cell cytoplasm.
Intrinsic factor antibody 1 was found more commonly in female
diabetics over the age of 40 years than in female controls of comparable
age (p<0. 005). Of 9 such patients with intrinsic factor antibody who were
available for study there was evidence of achlorhydria in all, latent pernicious
anaemia (with malabsorption of vitamin B^) in 6 and of adequate vitamin
absorption in 3.
There would appear to be a disorder of the immunological system
in relation to insulin-dependent diabetes with respect to the formation of
autoantibodies and the occurrence of organ-specific autoimmune disease.
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INTRODUCTION
On account of the apparent clinical association between diabetes
mellitus and diseases characterised by the occurrence of organ-specific
12 3 4
autoimmunity, ' ' ' an extensive study was undertaken to determine
the prevelance of gastric and thyroid autoimmunity in diabetics
compared to age and sex matched controls and to find out if there is
any difference in this respect between insulin-dependent diabetics and
insulin-independent diabetics. It was also hoped that these studies
would yield further information on the prevelance of pernicious anaemia,
in its latent form in diabetics.
SUBJECTS STUDIED
The patients with diabetes mellitus consisted of 521 females and
533 males. Care was taken to exclude any diabetic patient with clinic
evidence or personal history of thyroid disease or pernicious anaemia.
The patients were obtained by random selection among those attending
the Diabetic Out-Patient Department until such time as the numbers
obtained in each particular age and sex group were considered adequate
or until further numbers seemed unlikely to be readily forthcoming. The
age of symptomatic onset and the duration of the diabetes was noted for
each patient. In addition information regarding a family history for
diabetes, thyroid disease and pernicious anaemia in the first degree
relatives was obtained from 913 of the total 1, 054 diabetics.
The control subjects consisted of 443 females and 428 males.
They were mainly blood donors, but hospital controls were included at the
extremes of the age range. The hospital controls were not known to be
suffering from clinical diseases associated with autoimmunity.
The age and sex distribution of the diabetic and control subjects
(a total of 1, 925 subjects) is shown in Fig. 1. Table 1 shows the analysis
of the diabetics according to the treatment they required; diet alone, oral
V : 10
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Fig. 1 Age and sex distribution of the total 1054 diabetics
and of the 871 controls included in the present study.
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TABLE 1
ANALYSIS OF THE 1054 DIABETIC PATIENTS
ACCORDING TO THE TREATMENT THEY REQUIRED
Age at time of serological study
0-39 years 4^-69 years
Females Males Females Males
Diet 21) 9) 66) 63)
) 35 ) 21 ) 153 ) 152
Oral hypoglycaemic 14) 12) 87) 89)
agents
Insulin 184 204 149 156
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Fig. 2 The age and sex distribution of insulin-dependent and
insulin-independent diabetics in the total of 1054
diabetics.
V : 13
hypoglycemic: agents, or insulin. Diabetics controlled by diet alone or
oral hypoglycaemic agents are referred to as insulin-independent; those
requiring insulin are referred to as insulin-dependent. Fig. 2 shows the
age and sex distribution of the insulin-dependent and of the insulin-
independent diabetics. There were an approximately even number of
patients in the two groups of diabetics studied in the 5-7th decades
(aged 40-69 years) and they were equally distributed in these three decades.
The number of insulin-independent diabetics in the younger age group
(0-39 years) was small and these patients were mainly in the fourth decade.
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METHODS
Sera were stored at -20°C in small volumes, and tested in
bat ches for the following antibodies :-
Antibody to thyroglobulin, using the tanned cell haemagglutination
test*3 with the reagents as supplied by Burroughs Wellcome,
Beckenham, Kent, England. The test was done in serum
dilutions of 1:5, 1:25, 1:2,500 and 1:25,000. A titre of
greater or equal to 1:25 was taken as being significant.
Antibody to thyroid cytoplasm, using the indirect immuno¬
fluorescence test with snap-frozen air-dried sections of
human thyroid obtained at partial thyroidectomy for
thyrotoxicosis.
Antibody to gastric parietal cell cytoplasm, using the indirect
immunofluorescence test with snap-frozen air-dried sections
of gastric mucosa obtained from the body of human stomach
at partial gastrectomy.
As a check for tissue specificity each serum was tested by the
indirect immunofluorescence method for reactivity with rat kidney, all
three tissues (thyroid, stomach and kidney) being mounted together on
the same slide. The details of the reagents and procedure were as
3,7
described previously.
Sera giving positive reactions with rat kidney (notably staining
of the mitochondria in the renal tubules) were regarded as being negative
for thyroid cytoplasm and gastric parietal cell antibodies, because of the
8
non-tissue-specific nature of the mitochondrial antibodies. The
presence or absence of nuclear staining was also noted in all sections.
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Antibody to intrinsic factor. The sera of all the female diabetics
and of female controls aged 30 years and older were tested
for intrinsic factor antibody I by radioimmunoassay using
9
albumin-coated charcoal as previously described. A
titre of greater or equal to 5. 0 units/ml serum was
regarded as positive.
The incidence of antibodies in the sera of diabetics compared to
| 2the controls was analysed statistically using the Chi test and Yates'
correction using Fisher's "exact test" when applicable. Statistical
significance was assumed when p 0. 05.
Diabetic patients whose sera was positive for intrinsic factor
antibody I were studied with regard to their gastric function and vitamin
H metabolism. The gastric juice secreted during the hour following
lw
intramuscular pentagastrin (6|ig/Kg body weight) was aspirated and
measured without delay for total content of HC1 using a pH meter and an
automatic titrator (type TTT lc "Radiometer", Copenhagen) with 1. ON NaOH.
Achlorhydria was defined as a pH of not less than 6. 0 during the post
stimulation hour. The gastric juice secreted during the post-stimulation
hour was also measured for total intrinsic factor content using radio-
9
immunoassay as previously described. An intrinsic factor secretion
during the post-stimulation hour of greater than 200 units is considered
incompatible with addisonian pernicious anaemia, most patients with frank
or latent pernicious anaemia having an intrinsic factor secretion of less
than 100 units in the post-stimulation hour.
The serum vitamin B level was determined microbiologically.^
1m
Bone marrow smears were studied in the ordinary manner. Intestinal
absorption of vitamin B was determined by the Schillinb test using
5 8
0. 5fi.Gm Co-vitamin B with specific activity l|i Ci/pGm followed
1m
1 hour later by 1000|xGm Cytamen. A 24 hour urinary secretion of more
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than 12. 5% of the oral dose was taken as normal, 7. 5-12. 5% as being
equivocal and less than 7.5% as indicative of malabsorption of vitamin
B . All patients included in the study had adequate renal function.
1m
When the Schilling test wp.s repeated with intrinsic factor, an oral dose
of at least 1000 units of hog intrinsic factor was used.**
Intestinal absorption of vitamin B was also studied by a total
12
body counting technique. A total body count at seven days of less
than 21% of the initial dose is indicative of malabsorption of vitamin
B^, 21-25% equivocal and greater than 25% is indicative of adequate
vitamin B absorption. The total body count estimations of vitamin B
JLi* JLCd
absorption were also done With pentagastrin (6pG/kg) given 10 minutes
58
before the oral dose Co-vitamin B . This amounts to a repeat test,
iw
as previous studies have demonstrated that pentagastrin stimulation






Fig. 3 shows the percentage of the diabetics and of the controls
whose sera were positive for antibodies to thyroglobulin (tanned cell
titre greater or equal to 1:25), to thyroid cytoplasm and to gastric parietal
cell cytoplasm. Antinuclear antibodies and mitochondrial antibodies
were only detected in 1% of the diabetics and of the controls.
In the female control subjects a rising incidence of antibodies to
thyroglobulin, to thyroid cytoplasm and to gastric parietal cell cytoplasm
was observed with age. Although the incidence of antibodies to
thyroglobulin was significantly higher in the diabetics compared to the
controls when the total numbers of diabetics and controls were analysed
(p<0.01), the p values corresponding to the different age groups and sexes
either did not reach significance or did so only marginally. In contrast,
the increased incidences of antibodies to thyroid cytoplasm and to gastric
parietal cell cytoplasm respectively were statistically significant in
diabetics compared to the controls when all subjects were considered
(p< 0. 001) and when sub-groups of subjects according to sex and to age
(<40 years or S40 years) were considered (p*10.005 in all sub-groups).
In Table 2 the incidence of thyroid and of gastric antibodies in the
sera of insulin-dependent and of insulin-independent diabetics is compared
with that in controls of comparable age and sex. In insulin-dependent
diabetics the increased incidence of antibodies to thyroid cytoplasm and to
gastric parietal cell cytoplasm was highly significant in both males and
females, aged 10-39 years as well as in those aged 40-69 years. The
incidence of antibody to thyroglobulin in the insulin-dependent diabetics
compared to controls was not significant in these sub-groups except in
insulin-dependent males aged 40-69 years. In the insulin-independent
diabetics, the difference in the incidence of autoantibodies to thyroid
cytoplasm and to gastric parietal cell cytoplasm compared to controls
V : 18
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Fig. 3 Percentage incidence of autoantibodies specific for
thyroglobulin, thyroid cytoplasm and gastric parietal
cell cytoplasm, respectively, in the total diabetics
(except those aged 0-9 years) and in the controls
according to sex and age in decades.
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was not so striking as in the case of the insulin-dependent diabetics.
Indeed, in insulin-independent diabetics the incidence of antibodies
to thyroid cytoplasm and to gastric parietal cell cytoplasm only
reached statistical significance in three of the eight sub-groups indicated
in Table 2. There was no difference in the incidence of thyroglobulin
antibodies in the different sub-groups of insulin-independent diabetics
compared to controls.
When insulin-dependent and insulin-independent diabetics were
directly compared, the insulin-dependent diabetics were shown to have
a significantly higher incidence of antibodies to thyroid cytoplasm and/or
to gastric parietal cell cytoplasm with p values of <0. 01 for females,
<0. 001 for males and <0. 001 when both sexes were considered together.
There was no significant difference in the incidence of antibodies
to thyroid cytoplasm or to gastric parietal cell cytoplasm in patients who
had had insulin treatment for diabetes for 5 years or longer compared to
the incidence in those who had had insulin for a shorter period. Nor was
there any difference in those who had had insulin for 10 years or more
compared to a shorter period in an analysis of 692 insulin-dependent
diabetics. Likewise in insulin-dependent diabetics there was no significant
difference in the incidence of these antibodies in patients whose diabetes
developed early ( at 0-39 years) or later ( at age 40 years or older).
This would suggest that the duration of diabetes may not be an important
factor in the production of thyroid or gastric autoantibodies.
Out of the 913 diabetics included in the family history study, 25fo
gave a positive family history for diabetes, 9% for thyroid disease and
3% for pernicious anaemia in first degree relatives. A family history
of diabetes showed no correlation with the incidence of thyroid or of
gastric autoantibodies in insulin-dependent, insulin-independent or total
diabetics. When insulin-dependent and insulin-independent diabetics of all
ages and both sexes were considered, an increased incidence of antibodies
to thyroid cytoplasm and/or to gastric parietal cell cytoplasm was noted in
V : 21
those with a first degree family history of thyroid disease (p <-0. 03)
and of pernicious anaemia (p<0. 05) compared to those without such a
family history.
The incidence of intrinsic factor antibody I in the sera of female
diabetics is shown in Table 3. This antibody was not detected in
diabetics in the first 3 decades, but was present in the serum of 13 of
the 380 diabetics aged 30-69 years. The age of the youngest diabetic
with intrinsic factor antibody in the serum in this series was 39 years.
Only one out of the 296 female controls subjects aged 30-69 years was
positive for intrinsic factor antibody: a subject aged 67 years. The
increased incidence of intrinsic factor antibodies in middle aged and
elderly female diabetics was statistically higher than in age and sex
matched control subjects (p< 0.005). As shown in Table 4, eight of the
thirteen diabetics positive for intrinsic factor antibody were insulin-
dependent and 5 were insulin-independent. The incidence of intrinsic
factor antibodies would therefore appear to be related to age rather than
the type of diabetes.
Table 4 also summarises the results of tests of gastric function
and of vitamin status carried out on the 10 diabetics whose sera were
positive for intrinsic factor antibodies and in whom it was possible to do
at least some of these analyses. All those tested for acid secretion had
achlorhydria, using pentagastrin stimulation and aspiration of gastric
juice in 8 patients and the azuresin test ('Diagnex Blue', Squibb) in one
patient. The secretion of intrinsic factor into the gastric juice in the
post-pentagastrin hour was found to be less than 100 units in 7 patients
and greater than this but less than 200 units in one patient. As indicated
in Table 4 difficulty in aspiration of the gastric juice was encountered in
one patient. In five patients (nos. 1, 2, 3, 4 & 6) the results of the Schilling
tests of vitamin B absorption without and with oral intrinsic factor were
lu
typical of addisonian pernicious anaemia, although the serum vitamin B
lw
TABLE3:
INTRINSICFACTORANTIB DYEMALEDIABETI SOTP EVI USLY KNOWNTHAVEPERNICIOUSA AEMIACOMPAREDONT OLSUBJECTS FEMALEDIABETICSFEMALECONTROLS
„(inyears)
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levels were in the equivocal zone in two of those patients and normal
in a third. The bone marrow was normoblastic in all five of these
patients before any parental vitamin EL., was given. These patients
Ml
were therefore considered to have latent pernicious anaemia; that is
to say, they had abnormal vitamin absorption due to lack of intrinsic
factor secretion but the body stores of vitamin B were not sufficiently
12.
depleted to produce a megaloblastic anaemia.
Patient no. 5 was also considered to have latent pernicious
anaemia in view of the achlorhydria and minimal intrinsic factor
secretion and evidence of malabsorption of vitamin B^ by the total body
counting method, together with a low serum vitamin B level. In
iw
patient no. 7 the intrinsic factor secretion measured by radioimmunoassay
was very low (9 units in the post pentagastrin hour) and the total body
count results for vitamin
, absorption were equivocal, but the schilling
test was normal and the serum vitamin B^, level was at the lower limit
of normal. Patients nos. 8 and 9 had adequate B absorption in spite
AW
of the presence of intrinsic factor antibodies in the serum. No






Landing et al found thyroid antibodies using the indirect immuno¬
fluorescence technique in 13. 3% of 83 juvenile onset diabetics under the
age of 16 years, while the incidence in 178 euthyroid non-diabetic children
14 15
was 1.1%. Moore and Neilson studied serum from 83 diabetics and
concluded that gastric complement-fixing antibodies were significantly
more common in early-onset type diabetes.
In their series of 317 diabetics and 624 controls, Simkins'''^ found
evidence that antibodies to thyroglobulin occur more frequently in diabetics
without clinical thyroid disease than in control subjects (p<" 0.01). While
we agree with this overall statistic, the increased incidence of thyroglobulin
antibodies is not nearly so impressive as that for antibodies to thyroid
cytoplasm, gastric parietal cell cytoplasm and intrinsic factor.
Whereas in 200 insulin-dependent diabetics aged 40 years or less
17
Ungar et al found a significantly higher incidence of parietal cell antibodies
in females but not in males, we found these antibodies to be significantly
increased in both sexes in this age group. We agree with these workers
that both male and female insulin-dependent diabetics over 40 years have a
significantly higher incidence of parietal cell antibodies than do controls.
In relation to insulin-independent diabetes, when Ungar's and
the present series are considered together it is doubtful if gastric parietal
cell antibodies are increased in any sub-group. From the present study
it is also probable that the incidence of antibodies to thyroid cytoplasm is
not significantly higher in insulin-independent diabetics of any sub-group
by age or sex. The p value of <0. 014 for antibodies to thyroid cytoplasm
in insulin-independent diabetic males aged 10-39 years compared to controls
may not be sustained if it were possible to study a larger number of patients
17 16
in this sub-group. Neither Ungar et al nor Simkins studied antibodies to
thyroid cytoplasm in their series. The increased incidence of antibodies
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to thyroid cytoplasm and to gastric parietal cell cytoplasm in insulin-
dependent compared with insulin-independent diabetics does not hold
for antibodies to thyroglobulin.
The inheritance of diabetes mellitus is probably complex and
former single gene hypotheses such as simple recessive inheritance with
18
reduced penetrance have been mainly abandoned in favour of a
multifactorial hypothesis, which involves the additive effects of
19
several genes. Such an hypothesis would explain the differences
between juvenile- once, (insulin-dependent) diabetes where genetic
factors are stronger and adult-onset (insulin-independent) diabetes
where genetic influences are less strong and where environmental
factors such as obesity, pregnancy, infection and other stress may
determine the onset of the overt disease.
With regard to intrinsic factor antibody I, the findings in the
17
present study agree with those of Ungar et al in that these antibodies
were only found in middle aged and elderly diabetics, but differ in that
they occurred in an equal number of insulin-dependent and insulin-
independent diabetics. In the present study achlorhydria was
demonstrated in all the intrinsic factor antibody positive patients
17
tested and this was the case in all but one in the series of Ungar et al,
which is in keeping with the general finding that intrinsic factor antibodies
20,21,22
in the serum show a high correlation with advanced atrophic gastritis.
However, a surprisingly high number of diabetic patients with intrinsic
factor antibody in the serum (3 out of 9 in the present series and 4 out of 8
in the series reported by TJngar and her colleagues) had adequate or at
least borderline vitamin B absorption. On the other hand, six out of
our nine patients whose sera were positive for intrinsic factor antibodies




Ungar et al found the prevelance of latent pernicious anaemia
in diabetes (with or without intrinsic factor antibodies in the serum) to be
V : 27
4%, but this incidence must clearly depend on the age and sex
distribution of the population of diabetics studied. In the present
series 3.4% of female diabetics aged 40-69 years had intrinsic factor
antibodies in the serum. As only 50-60% of patients with frank
pernicious anaemia or latent pernicious anaemia are intrinsic factor
23 21 24 25
antibody positive ' ' ' and because a minority of intrinsic factor
antibody patients have adequate vitamin absorption, it can be
estimated that approximately 5 % of female diabetics aged 40 years or
more (insulin-dependent or insulin-independent) have latent pernicious
anaemia. A further percentage will have frank pernicious anaemia,
but these patients were excluded from the present study and no statistic
can be given.
26
In a review of the literature Chanarin states that the frequency
of pernicious anaemia in diabetes mellitus is 3. 9 per 1, 000 which, he
states, is the expected frequency of pernicious anaemia after the age
of 40 years in the general population. Conversely, he states that the
incidence of diabetes in pernicious anaemia is 2.4%, which is not greatly
different from the incidence of diabetes mellitus in the general population
27 28
where it has been reported as 1. 3% and 1.7%. The present studies,
17
together with those of Ung-'.r et al, which unequivocally indicate that
intrinsic factor antibodies occur more commonly in middle aged and
elderly diabetics than in controls, would question the validity of previous
clinical studies. There can be little doubt that pernicious anaemia, at
least in the latent form, is more common in the middle aged and elderly
diabetics than in control subjects. The discrepancies are probably due
to the inadequate diagnostic criteria for pernicious anaemia in some of
the large series of patients with diabetes mellitus included in Chanarin's
review.
When latent pernicious anaemia is defined as in the present paper,
it would seem inevitable that such patients would eventually proceed to
frank pernicious anaemia when their body stores of vitamin B were
ifc*
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depleted. This progression need not occur when the intrinsic factor
secretion, although reduced, is still adequate to maintain vitamin
absorption.
An incidence of 5% latent pernicious anaemia in middle aged to
elderly female diabetics is of considerable clinical importance and it
would be reasonable to screen all diabetics of this sex and age group
for intrinsic factor antibodies and to check their serum vitamin B _
17
levels. Ungar et al noted that only 1 of their 8 intrinsic factor
positive diabetics was male. It is uncertain whether insulin-dependent
diabetics are at greater risk than insulin-independent diabetics for latent
pernicious anaemia.
While circulating antibody to insulin may occur in diabetic patients
29
treated with bovine insulin, insulin antibodies are usually not detected
30
in persons not receiving insulin. The work of Mancini claiming the
occurrence of antibodies to pancreas in untreated diabetics and of
31
Penchev et al claiming that precipitating antibody to insulin can be found
in 20% of untreated diabetics is still to be confirmed.
Lymphocytic infiltration of the islets of Langerhans has been
observed in a few human diabetics prior to insulin therapy, particularly
32 33
in the acute-onset juvenile type . Lee et al claim that this lesion strongly
resembles that of the experimental diabetes that they were able to produce
in New Zealand white rabbits by immunization with bovine insulin in
Freund's adjuvant. Hyperglycaemia or diabetes mellitus developed in
some of the immunized animals. The pancreas of the diabetic animals
showed lymphocytic infiltration of the islets of Langerhans, while rabbits
with insulin antibody but without islet lymphocytes remained nprmo-
glycaemic. This would suggest that if immune mechanisms play some
part in the pathogenesis of diabetes mellitus, delayed hypersensitivity
may be of greater significance than humoral antibodies.
The evidence in the present paper would suggest that insulin-
V : I 9
dependent diabetes is more closely associated with disturbed
immunity (whether specific for the pancreas or not) than is the case
in insulin-independent diabetes. Further work on the role of
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Introduction
Although the first recognized cases of a form
of interstitial lung disease were described un¬
der the title of "acute diffuse interstitial fi¬
brosis of lung," by Hamman and Rich in 1933
(1), there is at least one earlier account of
similar pathologic findings in the lungs of pa¬
tients with progressive pulmonary disease (2).
Because of variations in the course of the dis¬
ease and in the pathologic features, a number
of different terms have been used to describe
individual cases or groups of cases conforming
to a particular pattern. Hence, it has been
recognized by many writers, including Grant
and associates (3), Scadding (4), and Living¬
stone and co-workers (5), that the acute
course originally reported was exceptional, the
process being more accurately described as
"chronic" in the majority of cases.
More recently the term "fibrosing alveolitis"
has been introduced by Scadding (6) on the
grounds that the disease appears primarily to
affect alveolar lining cells and underlying
stroma, and has the features of a chronic in¬
flammatory reaction. Similar pathology has
been described in children (3, 7-12), and a
familial incidence in several series (12-15) has
earned it the term "familial fibrocystic dys¬
plasia" in one paper (12). Other terms used
have included "reticular lymphangitis of the
lungs" (2) and "diffuse interstitial angiosis"
(16). Although it is recognized that the "inter¬
stitial" nature of the disease process is funda¬
mental, it is considered that the fibrosis
merely represents the end result of a disorder
involving other pathologic changes. The term
"diffuse interstitial lung disease" is therefore
more acceptable.
Recent extensive reviews of the literature (5,
17, 18) make it unnecessary to describe in de¬
tail the numerous reports of this disease that
have been published in the past decade. These
1 From the Respiratory Diseases Unit, Northern
General Hospital, Edinburgh, Scotland.
reports suggest that it is a disease process more
common in females, which can occur at any
age and which, without treatment, invariably
follows a progressive course leading to gradual
deterioration and death over a period lasting
from a few months to several years.
Since the report by Grant and associates (3),
a number of cases have been seen in the three
Respiratory Diseases Units in Edinburgh. These
are described in this paper.
Material
The series consisted of 42 patients, 22 females
and 20 males (ages, 12 to 77 years), who have been
seen for the past 12 years. Almost half of the
patients presented with symptoms in their seventh
decade; and, of the 15 patients under 60 years old,
all but 3 were females.
The series was divided into 3 groups: group I,
25 cases in which the diagnosis was histologically
proved; group II, 9 cases without histologic proof,
but in which the diagnosis was fully supported by
the clinical and roentgenologic findings, the results
of respiratory function tests, and the subsequent
course of the illness; and group III, 8 cases incom¬
pletely investigated, in which the diagnosis rested
mainly on the roentgenologic changes and the
clinical features, and in which there were no symp¬
toms or other findings to suggest an alternative
diagnosis.
The diagnosis of diffuse interstitial lung disease
was based on five points: (1) history of dyspnea
without wheeze or significant episodic variation;
(2) finger clubbing; (3) bilateral crepitations on
auscultation of the chest, especially when these
were described as "superficial" or dry in nature;
and (4) respiratory function tests showing a reduc¬
tion in vital capacity of more than 20 per cent of
the predicted value for that patient, and/or arterial
hypoxemia with a normal or low Paco» present,
either at rest or after exercise.
Observations
Pathology
Lung tissue was obtained for histologic ex¬
amination from 25 patients: from 12 by lung
biopsy at thoracotomy, from 11 at autopsy, and
from 2 by lung biopsy and at subsequent au¬
topsy. The pathologic changes found were simi-
939
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Fig. 1. Age distribution of patients.
lar to those recently described in detailed re¬
ports (5, 7, 17). Diffuse fibrosis was the single
predominating feature but, in some patients,
this was so extensive as to obscure its relation¬
ship to alveolar structure. When this was
preserved, the fibrosis was interstitial; and, in
as many as 18 patients, it was associated with
significant infiltration with lymphocytes, plasma
cells, and mononuclear cells. Interstitial edema
was present in 3 patients. There were changes
in the alveolar lining consisting of hyperplasia
of the epithelial cells in 6 patients, and of squa¬
mous metaplasia in 2. Hyaline membrane for¬
mation was not a feature in any patient. In the
more densely fibrotic areas, cystic spaces lined
by connective tissue had replaced normal alveo¬
lar structure.
In 13 patients bronchiolar changes were ob¬
served. These consisted mainly of bronchiolar
dilatation. In 2 patients marked hyperplasia of
bronchiolar epithelium was seen; and, in one
patient, there was squamous metaplasia. Vas¬
cular changes, with thickening of the vessel
wall, chiefly involving the intima, were present
in 12 patients.
In the report by Livingstone and associates
(5) the pathologic process was divided into five
stages. The first three were characterized by
complete or partial preservation of normal
alveolar architecture, and this was seen in 19
of the patients in this series. In the remaining
6 patients there were varying degrees of dis¬
organization with cyst formation, corresponding
to the last two stages.
There is some doubt as to the value of lung
biopsy in the assessment of patients with a
diffuse bilateral pulmonary abnormality. Open
lung biopsy at thoracotomy carries a definite
risk in patients with impaired respiratory func¬
tion, as shown by the occurrence of one post¬
operative death in this series and another re¬
cently reported elsewhere (5). Lung biopsy
with the Jack needle is also not without danger
(20). Furthermore, with this technique, a very
small, and possibly unrepresentative, specimen
from one part of lung is obtained. In the vast
majority of cases the diagnosis can be made
from clinical, roentgenographic, and respira¬
tory function investigations; and, even when
the condition is simulated by other diseases, e.g.,
diffuse pulmonary sarcoidosis, progressive sys¬
temic sclerosis, the management is the same.
There is, therefore, not a strong case for lung
biopsy as a routine diagnostic measure.
It might be expected that the histologic ap¬
pearances at lung biopsy would be of value in
predicting the response of individual patients
to corticosteroid therapy. For example, a better
response might, have been anticipated in those
cases with reversible changes such as cellular
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infiltration and interstitial edema (7), with
preservation of alveolar architecture, than in
those where irreversible fibrosis and disorgani¬
zation had occurred. In the present series, only
2 of the 6 patients in the latter group showed
any response at all; but, among 15 patients with
apparently early changes, as many as 9 did not
improve with treatment. Hence, although lung
biopsy can show which patients are unlikely to
respond to corticosteroids, the presence of early
and apparently reversible changes provides no
guarantee that this treatment is likely to suc¬
ceed.
Some writers have noted the similarity be¬
tween the changes in the alveolar epithelium in
interstitial lung disease and those occurring in
the so-called "alveolar cell carcinoma" (pulmo¬
nary adenomatosis). Spain (21) quoted 9 cases
where this developed on a background of
chronic parenchymal fibrosis, predominantly in¬
terstitial in type. None of the cases under re¬
view here have followed this course, and we
know of only one instance (4) in which histo¬
logic features of pulmonary adenomatosis were
seen in a case otherwise considered typical of
chronic diffuse interstitial fibrosis.
On the other hand, bronchial carcinoma has
been described occasionally in cases of diffuse
interstitial lung disease of the idiopathic type
(4, 5, 22) and of the type associated with rheu¬
matoid disease (23, 24). Three of the patients
in the present series died from bronchial carci¬
noma. These were males, aged 61, 62, and 70
years, all of whom had smoked more than 10
cigarettes daily. In 2, the tumor was a pe¬
ripheral "oat-cell" carcinoma; and, in the third,
a squamous carcinoma of a main bronchus was
found. The occurrence of 3 cases of bronchial
carcinoma among 42 patients with interstitial
lung disease, although perhaps noteworthy, is
not actually significant because of the age dis¬
tribution and the small number of cases in the
series. It might, however, be profitable to ob¬
tain further information on this point by pool¬
ing data from a large number of centers.
The possibility of an increased tendency to
bronchial carcinoma in idiopathic diffuse inter¬
stitial lung disease has also been mentioned by
Livingstone and co-workers (5); and, cer¬
tainly, some of the histologic changes described,
notably bronchiolar epithelial hyperplasia and
metaplasia, have been considered premalignant
by some authorities (25). Reference will be
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made later in this paper to the remarkable over¬
growth of epithelial cells obtained in one tissue
culture from a specimen removed at lung bi¬
opsy from one of our patients; a similar oc¬
currence has been reported by Herbert and
associates (26). These observations may be
relevant to an association between interstitial
lung disease and neoplastic change, and would
appear to warrant further study.
Clinical Features
Dyspnea was the dominant presenting symp¬
tom in all but 5 of the patients, and only 4 of
42 patients had a normal exercise tolerance. For
the purpose of description, dyspnea has been
divided into two grades: grade A, slight or
moderate dyspnea, which occurred on walking
up two flights of stairs at a normal pace but
not on walking at a steady pace on the level;
and grade B, dyspnea present at rest, or on
walking 50 yards or less on the level.
In 29 of the 34 patients whose cases were
fully documented, grade B dyspnea was pres¬
ent. Three of the 8 patients with incompletely
documented cases had normal exercise tolerance.
In these 3 cases the diagnosis was made from
routine chest films. With 6 others in the series
these patients formed a group of 9 cases with
little or no dyspnea. All of these patients were
more than 45 years of age and all but 2 were
more than 55. Some of them would seem to be
examples of a condition affecting older patients,
which is later described, in which there are
roentgenologic changes consistent with inter¬
stitial lung disease without corresponding symp¬
toms or impairment of respiratory function.
Dyspnea in interstitial lung disease is believed
to be due to altered mechanics of breathing
involving increased work of ventilation. In this
series there was no correlation between the de¬
gree of dyspnea and the arterial oxygen satura¬
tion. A surprising feature is the relatively high
vital capacity that may be found in patients
with severe dyspnea. In 6 of 30 patients with
grade B dyspnea, the vital capacity was, at
some stage, over 2 liters. When the lowest vital
capacity recorded in each patient was con¬
verted into a percentage of the predicted vital
capacity, the average value for patients with
grade B dyspnea was 59 per cent, although in
the less breathless it was 72 per cent. The vital
capacity is thus a rough guide to the severity
of the disease.
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There was little correlation between roent-
genographic changes and the degree of dyspnea,
although all 19 patients in whom the diaphragm
was elevated on maximal inspiration films had
grade B dyspnea. Changes in exercise tolerance
and respiratory function had to be gross be¬
fore they were reflected on the chest film, which
would seem an insensitive guide to progress.
Cough was a frequent and often distressing
complaint, being present in all but 4 patients
in this series. It is notable that in patients with
interstitial lung disease a bout of irritating
coughing often follows deep inspiration. It may
be that cough receptors in the lung are sensi¬
tive not only to mucosal and pleural stimuli,
but also to changes in the mechanism of lung
expansion, as in pulmonary venous congestion.
Hemoptysis is described in many reported
cases (18, 22, 27). In this series, it was of grave
significance, having been recorded in only 3 pa¬
tients, all of whom had developed bronchial
carcinoma.
Over half of the patients in this series suf¬
fered from weight loss and/or fatigue. These
symptoms are widely reported in the literature.
The factors that would seem to be responsible
are, first, the increased work of expanding stiff¬
ened lungs and, second, chronic hypoxia and
its effect on metabolism.
Finger clubbing was present in 35 of the 42
patients, and it apparently preceded the onset
of respiratory symptoms by many years in at
least 3. Its exact relationship to the pulmonary
lesion remains obscure; and, in this study, as in
many others, the evidence is confusing. It has
been suggested that clubbing is due to failure
of the lungs to modify some substance passing
through them from the liver and the intestines
to the systemic circulation (28). This could be
due to some form of arteriovenous shunt in the
lung, although there has not been any descrip¬
tion of such shunt in interstitial lung disease.
Alternatively, it might be associated with the
impairment of diffusion of oxygen into the
blood. However, the diffusion block theory is
now questioned by some authorities (29). In
this series clubbing was absent in 4 hypoxic
patients, although frequently present in pa¬
tients with normal oxygen saturation.
Bilateral crepitations were heard on ausculta¬
tion of the chest in all but 6 patients. In most
instances the sounds were described as metallic,
superficial, or dry, with a quality quite distinct
from the coarser and "looser" rales heard in
resolving pneumonia, bronchitis, and bron¬
chiectasis. The superficiality and fine texture of
the sounds suggested that they may have
originated more peripherally in the respiratory
tract than the latter, and might have been pro¬
duced by fluid accumulation in the very small
air passages, where drainage is hampered by
peribronchiolar and interstitial fibrosis.
Treatment
As in all conditions of unknown etiology, the
therapeutic measures hitherto employed in
diffuse interstitial lung disease have been either
empirical or based on etiologic guesswork. Ini¬
tially, on the grounds that the disease might be
caused by some microorganism, a wide range of
antimicrobial agents were tried. Both anti¬
tuberculosis chemotherapy and corticosteroids
came into use during the decade following pub¬
lication of the report by Hamman and Rich
(27), and it is not, surprising that they also
were employed. Certain writers, including
Schechter (30), Read and Holland (31), and
Douglas (19), have reported dramatic im¬
provement with corticosteroids in isolated
cases; but, in the larger series, such as those of
Rubin and Lubliner (17), Scadding (4), and
Livingstone and associates (5), only a minority
of the patients have benefited from the drugs.
In short, there has been no change from the
position in 1956, when Grant and associates
(3) concluded that only a small proportion of
patients with diffuse interstitial lung disease
obtained a useful degree of symptomatic and
roentgenographic improvement from corticoster¬
oid therapy! The disease in those patients who
did show improvement tended to relapse once
the drugs were withdrawn. And, even when no
response to treatment occurred, withdrawal was
often followed by rapid clinical deterioration.
In order to preserve the last group from
unnecessary prolonged corticosteroid therapy,
with its attendant side-effects, it would be valu¬
able to have some method of recognizing the
patients likely to benefit from corticosteroids.
Accordingly, the cases of all of the patients in
the present series who received these drugs were
reviewed in the hope of obtaining guidance in
this matter. Thirty-one of the 42 patients were
given corticosteroids. The effect, as judged by
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symptomatic., clinical, roentgenographic, and
respiratory function assessment, was graded as
follows: category 0—no response; category 1—
significant improvement without complete re¬
mission of symptoms, roentgenographic changes,
or impairment of respiratory function (this
group included those patients who showed ini¬
tial improvement but who subsequently deterio¬
rated, such as in the case reported by Nahmias
and associates (32)); and category 2—excellent
response with complete, or almost complete, re¬
mission. The patients were further analyzed as
to whether or not their disease had relapsed fol¬
lowing withdrawal or reduction of corticoster¬
oids.
The standard regimen currently employed in
Edinburgh consists of 20 mg. of prednisolone
per day initially, this being reduced by 2.5 or
5 mg. per day after four weeks. Previously a
higher initial dose, e.g., 20 to 40 mg. per day,
was employed without producing conspicuously
better results. Subsequent policy in the indi¬
vidual patient depends upon the response to
treatment and on the occurrence of relapse due
to withdrawal of the drug.
The results in this series are outlined in table
1. Only 4 patients achieved a category 2 (ex¬
cellent.) response, this group consisting of 3
young women, aged 29, 33 and 41, and one man,
aged 52. The disease in the youngest patient
only showed a sign of relapse on withdrawal of
the drug. Eight patients showed slight or mod¬
erate improvement; all but one were female,
and only 3 were more than 55 years of age. It
was not possible to assess the tendency of the
disease to relapse in 2 of these patients, but it
was present in 5 of the other 6. Nineteen pa¬
tients showed no response to corticosteroids.
The condition of 5 of these patients deteriorated
when the dosage was reduced or the drug was
withdrawn. In this group, which consisted of 9
TABLE 1
Response to Corticosteroids in Idiopathic







2 1 3 4
1 5 1 2 8
0 5 4 10 1!)
Total 11 8 12 31
males and 10 females, all except one was more
than 55 years old.
These findings confirm previous reports that
corticosteroids are more effective in younger pa¬
tients. However, because of the preponderance
of women among our under-60 patients, no con¬
clusion on the bearing of sex on corticosteroid
response can be drawn from this series.
Some indication of improvement was usually
seen in the first few weeks after treatment was
begun. This was especially evident with patients
showing a category 2 (excellent) response. In 3
of these patients, subjective and objective im¬
provement was observed within the first ten
days. The rate of response was not related to
the length of the previous history: it was as
rapid in one patient with a four-year history as
in another with symptoms of only four months'
duration.
The rate of deterioration in one patient, a
woman of 61, was almost as rapid. She had
suddenly stopped taking her daily dose of 20
mg. of prednisolone, which resulted in a fall in
her exercise tolerance, with corresponding roent¬
genographic deterioration within two weeks. An
even more sudden deterioration was reported by
Schechter (30) in a 31-year-old male who de¬
veloped acute respiratory distress and died
four days after the withdrawal of corticoster¬
oids.
Prognosis and Course
In assessing the prognosis of an individual
patient, the first important point is the degree
of dyspnea. It has previously been mentioned
in this paper that the current series included
a group of 9 patients who, when first seen,
were not suffering from undue dyspnea but who
were referred for a specialist's opinion because
of associated symptoms, e.g., chronic cough, or
because of the incidental finding of finger club¬
bing and/or a diffuse roentgenographic abnor¬
mality. One of these patients died of an "oat-
cell" carcinoma; the other 8 are still living.
Three of these, all women less than 50 years old,
have since started corticosteroid therapy be¬
cause of subsequent deterioration. The remain¬
ing 5 patients are of particular interest inas¬
much as they have survived for over eight
years without treatment, and at least 2 have a
normal exercise tolerance. These patients have
led to the speculation whether there may not
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TABLE 2
Fate of Patients with Grade B Dyspnea Treated with Corticosteroids
Response to Corticosteroids Category 2 Category 1 Category 0
Total number of cases treated 4 8 US
Average duration of dyspnea 1 year, 11 months 2 years 2 years, 4 months
before treatment
Range of duration of dyspnea 4 months to 4 years 0 months to 9 years 1 month to 10 years
before treatment
Number of patients alive 4 3 5
Survival time after treatment 26, and 7 <6 months, 4 10 months, 1 year, 1
started years years, 6 years year, 2 years, 2)2
years
Number of deaths among 0 5 11
treated group
Deaths due to interstitial lung 0 3 6
disease
Time between start of treat¬ — 2, 5, and 7,1-2 years <6 months (4 cases),
ment and death 6 months, 2 years
Death due to causes other than — 2 5
interstitial lung disease
be a benign condition roentgenographically
similar to, but clinically distinct from, other
forms of interstitial lung disease. Unfortu¬
nately, there was no histologic information on
these cases, as lung biopsy was not justified on
diagnostic or therapeutic grounds.
The fate of the patient with grade B (severe)
dyspnea depends upon the response to corticos¬
teroids, as shown in table 2. All those with
category 2 (excellent) response were virtually
free from symptoms between two and a half and
seven years after treatment was started. How¬
ever, of the 8 patients with a category 1 re¬
sponse, 5 have died. In the 3 patients in whom
death was directly due to interstitial lung dis¬
ease, it occurred two or more years after treat¬
ment was started. By contrast, among the 16
patients with grade B dyspnea who showed no
response to corticosteroids, 5 deaths directly
attributable to interstitial lung disease occurred
within a year of starting treatment. In this
group, none has yet survived for more than
three years. These results could be ascribed to
the introduction of corticosteroids at different
stages of the disease process; but there was, in
fact, no appreciable difference among the three
groups with regard to the duration of dyspnea
before corticosteroids were employed.
Respiratory insufficiency, either alone or in
association with a respirator}' infection and/or
congestive cardiac failure, accounted for 9 of
the 20 deaths. Such an end is an unpleasant
one, as the patient literally chokes to death and
(unless heavily sedated) is fully conscious to the
last, without the endogenous anesthetic of re¬
tained carbon dioxide that eases the terminal
bronchitic out of the world.
Sudden unexplained death occurred in 3 pa¬
tients. In 2 of these patients coronary artery
disease was present and might have been re¬
sponsible, although there was no definite patho¬
logic evidence of recent myocardial infarction.
Three other patients died from proved myo¬
cardial infarction and 3, from bronchial carci¬
noma. One 68-year-old man died following lung
biopsy, and another death was due to perfora¬




In their original description, Hamman and
Rich (27) discussed whether their 4 cases of
acute diffuse interstitial lung disease could have
been caused by a virus. Even now, 20 years
later, the evidence for this remains tenuous and
circumstantial, being based on four points:
failure to find any other cause, such as bacterial
infection; nature of the inflammatory reaction;
similarity between the histologic picture and
that of certain human pneumonias of viral or
rickettsial origin; and similarity between the
histologic features and those of certain chronic
interstitial pneumonias of sheep, which are
known to be transmitted by viruses and/or
pleuropneumonia-like organisms.
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ease process was due to the presence of virus in
lung tissue but that this disappeared at a rela¬
tively early stage. Further investigation of early
acute cases might help to clarify this point.
Such investigations should include techniques
designed to detect the presence of pleuropneu-
monia-like organisms that do not always pro¬
duce a cytopathic effect in tissue cultures.
Immune Mechanism Disorder
To show that a virus is responsible for the
lung changes would require three steps: dem¬
onstration that the virus is present in the dis¬
eased organ; isolation and identification of this
virus; and proof that this virus causes the
pathologic changes.
An indirect approach aims at the detection
of a rise in serum titer of antibody to virus
during the course of the disease. This presup¬
poses that the virus is already known and can
be isolated and that the disease process is ac¬
tive during the period of investigation. Neither
of these postulates was, however, necessarily
acceptable in the cases studied in the present
series.
A more direct approach involves examination
of specimens obtained at lung biopsy; this was
undertaken in 4 patients in the series. Cultures
of lung tissue were prepared from three speci¬
mens and examined for changes that might in¬
dicate the presence of virus. Giant cells (33)
were found in all of these, but this does not
constitute specific evidence of virus infection
(34). A feature of the tissue culture from one
specimen (No. 25) was an overgrowth of epi¬
thelial cells. This has previously been reported
by Herbert and his colleagues (26), and has
been discussed elsewhere. Cytopathic changes
suggestive of viral infection were not seen in the
three original tissue cultures. The fluids obtained
from these cultures and those produced by
homogenization of lung tissue from all 4 pa¬
tients were inoculated into tissue cultures of
monkey kidney, human epithelium (H.Ep.2),
and human embryo lung, and incubated for ten
days. Fluids harvested from these cultures were
then inoculated into fresh cultures of the same
cell lines and incubated for a further period of
ten days. All of the cultures so treated were
examined for cytopathic changes, but none
were found. This confirms the finding of Her¬
bert and associates (26).
Finally, an attempt was made to demonstrate
interference activity in the fluids harvested
from all of the tissue cultures, using the
hemagglutinating property of Echo 11 virus
in monkey kidney cells as an indicator. This,
again, failed to produce any evidence of the
presence of virus.
All of the patients investigated had developed
respiratory symptoms at least one year pre¬
viously. It is still possible that the initial dis-
At a time when a variety of diseases of
hitherto unknown pathogenesis have been
shown to be associated with disorders of the
immune mechanism, it is not surprising that
attempts have been made to incriminate these
in the pathogenesis of diffuse interstitial lung
disease. The evidence for this hypothesis in the
present series of cases is briefly summarized
below, taking, as a guide, some of the properties
of the immune disorders outlined by Mackay
and Burnet (35).
Presence of demonstrable antibody against
body components-. The sera of 20 of the pa¬
tients in this series were examined for evidence
of circulating antibodies to thyroid and to gas¬
tric mucosa, and for antinuclear factor and
nonspecific complement-fixing antibody, by
methods previously described (36, 37). Al¬
though antibodies were found in the (jputum) of
5 patients (in 2 patients, to thyroid and in 3, to
gastric mucosa), this is not in excess of what
might have been expected in a series of normal
patients of the same age and sex. Antinuclear
factor and rheumatoid factor were not found
in any of the cases under review, although both
were present in 4 of 6 patients reported else¬
where (38) in whom diffuse interstitial lung dis¬
ease was associated with rheumatoid arthritis.
These findings do not exclude the possibility
that autoimmunity played some part in the
early stages of the disease, as in most of the
cases investigated the lung changes had been
present for a considerable time and the inter¬
stitial fibrosis may merely have represented the
burnt-out relic of a previously active process.
In no case was serum obtained during the first
month or two of relatively acute progressive
interstitial infiltration with cells and fluid. Fur¬
thermore, 10 of the patients were receiving
corticosteroid therapy at the time the serum
was examined, and these agents are known to
suppress antibody production.
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The same sera were also tested for evidence
of antibody to lung tissue, using the indirect
fluorescent antibody technique. The serum un¬
der investigation was added to frozen sections
taken from a normal portion of lung removed
at thoracotomy for bronchial carcinoma. After
washing in buffer solutions, the specimens were
treated with antihuman gamma globulin con¬
jugated with fluorescein. The sections were then
examined under ultraviolet light for localization
of dye to specific cells. Such an occurrence
would have suggested an immune reaction at
that site, but in none of the sera so far tested
was significant staining of parenchymal cells
observed.
Co-existence of other conditions believed to
be immune disorders: There have been numer¬
ous reports of identical clinical and pathologic
manifestations of interstitial lung disease occur¬
ring in the connective tissue disorders since the
original paper describing this in rheumatoid
arthritis (39). The present writers have pre¬
sented in a separate paper an account of 8 pa¬
tients with interstitial lung disease and rheu¬
matoid arthritis seen in Edinburgh during the
same period as the series now under review (38).
Infiltration of affected tissue by mononuclear
cells, lymphocytes, and plasma cells: This has
been described in IS of the 25 patients with
histologic data. The presence of lymphocytes
may be of special significance, as it is thought
that these cells may carry cell-bound antibody
into the tissues. This is a possible explanation
of the failure to demonstrate circulating anti¬
bodies in these patients.
Elevation of serum gamma globulin levels: It
is known that the gamma globulin fraction of
the serum proteins contains the majority of
circulating antibodies. Elevation of this fraction
has been reported in different forms of inter¬
stitial lung disease. In the 17 patients in this
series in whom the serum electrophoretic pat¬
tern was recorded, it was found to be normal
(<1.5 gm. per 100 ml.), in 8, slightly raised
(1.5 to 2 gm. per 100 ml.) in 3, and consider¬
ably raised (>2.0 gm. per 100 ml.) in 6.
Response to corticosteroid drugs: Of the 31
patients treated with corticosteroids, only 12
showed a significant response. Here again, a
possible explanation is that the deleterious im¬
mune process may be active only during the
initial stages. This may account for the dra¬
matic success of corticosteroids in the one acute
case in which they were employed four months
after the onset of symptoms.
At present, the case for diffuse interstitial
lung disease's being an immunity disorder re¬
mains unproved. Although some of these find¬
ings are suggestive, it is difficult to be certain
whether the pathologic and serologic changes
are of pathogenetic significance or only the re¬
sult of some form of tissue damage.
It may, indeed, be that the condition merely
represents the nonspecific response of a mature
tissue that can react in only a few ways to a
variety of different stimuli.
Summary
Forty-two cases of idiopathic interstitial lung
disease are described. The patients consisted of
22 females and 20 males between the ages of 12
and 77 years.
In 25 of these patients, the diagnosis was
confirmed by histologic examination of lung
tissue removed at thoracotomy or at autopsy.
The principal pathologic changes were diffuse
interstitial fibrosis and infiltration with lympho¬
cytes, plasma cells, and mononuclear cells. Lung
biopsy appeared to be of limited value, both as
a diagnostic procedure and in predicting the
response to corticosteroid therapy.
The main symptoms were dyspnea, cough,
weight loss, and fatigue. The principal physical
signs consisted of dry, "superficial" crepitations
on auscultation of the chest and finger club¬
bing.
Thirty-one of the 42 patients received cor¬
ticosteroid therapy. Four obtained complete
remission of symptoms, and 8, slight to moder¬
ate improvement. Relapse, or further deteriora¬
tion of the disease, followed reduction of the
dosage or withdrawal of the corticosteroids in 6
patients who responded to treatment and in 5
who did not respond.
The prognosis seemed to depend upon the
degree of dyspnea and, in those patients with
significant dyspnea, upon the response to the
corticosteroids. Five patients with little or no
dyspnea have survived for more than eight
years without treatment.
No evidence of viral infection was found in
lung tissue obtained at biopsy, and no circulat¬
ing antilung antibodies were identified in the
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sera. It is postulated that the condition may
represent the end result of a pathologic reac¬
tion to a number of different stimuli that are
no longer recognizable by the time the pulmo¬
nary changes are fully established.
sumario
Enfermedad Difusa Interstitial Idiopdtica:
Informe de Cuarenta y Dos Casos
Se describen cuarenta y dos casos de enfermedad
difusa intersticial idiopitica. Los pacientes con-
sistian de 22 hembras y 20 varones, entre las edades
de 12 a 77 anos.
En 25 de ellos, se coufirmo el diagnostico por el
est.udio histologico de tejido pulmonar obtenido
por la toracotomia o la autopsia. Los cambios
histopatologicos predominantes fueron fibrosis
intersticial difusa e infiltracion linfocitica y de
edlulas plasm&ticas y mononucleares. La biopsia
pulmonar fud aparentemente de utilidad limitada,
tanto en el diagnostico como en la prediccion de la
respuesta a la terapia por corticoesteroides.
Los sintomas predominantes fueron disnea, tos,
pdrdida de peso, cansancio. Los hallazgos princi-
pales fueron estertores crepitantes y dedos hi-
pocrfiticos.
Treinta y un pacientes recibieron esteroides; en
4 hubo remision completa y en 8, mejoria de leve a
moderada. Se observo recidiva o progreso de la
enfermedad en (i pacientes en que seredujo la dosis
o se elimino la droga y en 5 sin respuesta favora¬
ble.
El pronostico parecia depender de la severidad
de la disnea y del efecto a los esteroides. Cinco
pacientes con poca o ninguna disnea han sobre-
vivido mds de oeho anos sin terapia alguna.
El tejido pulmonar obtenido mediante biopsia
no revelo infeccion viral y no se hallaron anti-
cueropos anti-pulmon en el suero. Se postula que
la enfermedad puede ser la fase final de una reac-
cion patoldgica provocada por diversos estimulos
que dejan de ser reconocibles una vez manifestada
la neumopatia.
Resume
Maladie interstitielle diffuse idiopathique du
poumon: relation de quarante deux cas
Quarante-deux cas de maladie interstitielle
diffuse idiopathique du poumon sont relates. 11
s'agit de 22 malades de sexe f^minin et de 20
malades de sexe masculin, ftgds de 12 a 17 ans.
Chez 25 de ces malades, le diagnostic a dte cou-
firmd par 1'examen histologique du tissu pulmo-
naire prfileve lors de la thoracotomie ou de l'autop-
sie. Les modifications pathologiques principales
qui ont not^es sont la fibrose interstitielle dif¬
fuse et 1' infiltration a lymphocytes, plasmocytes et
cellules mononucldaires. La biopsie du poumon
est apparue comme dot^e d'une portde limitde,
tant en ce qui concerne sa valeur comme proc^dd
de diagnostic que pour les possibility qu'elle
pourrait offrir pour prddire la rdponse a un traite-
rnent par les corticostyoi'des.
Les symptomes majeurs ont dtd la dyspnde, la
toux, la perte de poids et la fatigue. Les signes
physiques principaux ont consists en crepitations
seches "superficielles" a 1'auscultation et & la
percussion digitale du thorax.
Trente et un des 42 malades dtaient soumis a la
therapeutique par les corticostdroides. Quatre
malades en ont obtenu une disparition complete
des symptomes et 8, une amelioration pouvant,
etre qualifiee de Rgere k moddrfie. Chez 6 malades
qui rdpondaient au traitement et chez 5 qui ne
rfiagissaient pas, une reduction de la posologie ou
la suppression des corticosteroides a ete suivie par
une recidive ou par une aggravation de la maladie.
Le pronostic a sembie dependre du degrd de
dyspnee et aussi, chez les malades avec dyspnde
prononcee, de la reponse aux corticosteroides.
Cinq malades qui ne presentaient pas ou que peu
de dyspnee ont survecu sans traitement pendant
plus de huit aus.
On n'a pas pu mettre en evidence une infection
virale dans les tissus pulmonaires preieves par
biopsie. On n'a pas identifie d'anticorps anti-
poumon circulant dans le serum. On considere que
ce syndrome peut representer le rdsultat terminal
d'une reaction pat.hologique a quantite d'excita-
tions differentes qu'il n'est plus possible d'encore
reconnaitre une fois que les modifications pulmo¬
naires sont completement etablies.
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SUMMARY
The incidence of thyroid and gastric antibodies in patients with clinical and
cytogenetic features of gonadal dysgenesis, in doubly chromatin positive women
and in the parents of patients with gonadal dysgenesis was not found to be
significantly higher than in controls matched for age.
The incidence of antibodies appeared to be appreciably higher in mosaics and in
mosaics whose sex chromosome complement included an isochromosome of the
long arm of the X. Failure to establish the significance of these raised incidences
may be due to inadequate numbers.
The discrepancy between the findings in this series and in previously reported
series is discussed.
INTRODUCTION
In 1961, Engel & Forbes reported a patient with the clinical features of Turner's syndrome
with an XX sex chromosome complement, one X being an isochromosome (46,XXqi), who
had previously suffered from and been treated for Hashimoto's disease of the thyroid.
Two similar cases were reported by Sparkes & Motulsky (1963) and another by Grumbach
& Morishima (1964). In the same year Williams, Engel & Forbes (1964) reported a series
of twenty-five patients who had ovarian dysgenesis and a variety of sex chromosome
abnormalities of whom three had evidence of chronic thyroiditis and thirteen had positive
tests for circulating thyroid antibodies. Thyroid antibodies were also frequently found in
close relatives of these patients by Fialkow (1966) and more recently by Vallotton & Forbes
(1967) who extended the studies on the series first described by Engel & Forbes (1965).
Doniach, Roitt & Polani (1968) have also reported that patients with ovarian dysgenesis
and abnormal sex chromosomes may be particularly prone to develop thyroid antibodies
and also concluded that different chromosomal subgroups differ in their propensities to
antibody production. The parents of the patients did not, however, appear to have a raised
incidence of antibodies in relation to their ages. In this paper we report on the findings of
Correspondence: Dr W. J. Irvine, Department of Endocrinology, Royal Infirmary, Edinburgh 3, Scotland.
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thyroid, gastric and other organ-specific and non-organ-specific antibodies among patients
with gonadal dysgenesis and among women with a 47,XXX sex chromosome complement.
When the parents of patients with gonadal dysgenesis were alive and accessible for investi¬
gation, these too were studied. The frequency of thyroid and gastric antibodies in these
subjects has been compared with the results obtained by the same laboratory among
healthy blood donors of the same age and sex.
PATIENTS STUDIED
The patients had all been referred to the Registry of Abnormal Karyotypes at the
Clinical and Population Cytogenetics Research Unit in Edinburgh. Their age distribution
in decades is given in Table 1. Fifty-one of the patients had gonadal dysgenesis (Turner's
syndrome) and fourteen were doubly chromatin positive on examination of buccal smears.
Gonadal dysgenesis
This diagnosis was based on a history of amenorrhoea, failure to develop secondary
sexual characteristics at puberty, short stature and an abnormal sex chromosome comple¬
ment compatible with this diagnosis. Of the fifty-one patients, thirty-nine had been identified
when they presented with primary amenorrhoea, eight had been referred for investigation
of failure to grow, two for investigation of suspected thyroid disturbances, one for secondary
amenorrhoea and one for obesity.
Twenty-one of these patients had a 45,X karyotype and twenty-four had a chromosome
mosaicism in which one cell line had a 45,X karyotype. The karyotypes of these patients is
shown in full in Table 1. The structural abnormalities and the count distributions are
described elsewhere under the patients' case numbers in the Registry of Abnormal Karyo¬
types (Court Brown et al., 1964; and to be published) given in a footnote to
Table 1.
None of the fifty-one patients had clinical evidence of thyroid disease at the time of this
investigation. However, one had been diagnosed as suffering from thyrotoxicosis (PBI =
13-4 /rg/100 ml) when she was originally referred for chromosome studies, since when she
has been successfully treated with anti-thyroid drugs for 18 months. Eight of the fifty-one
patients had been suspected of suffering from hypothyroidism including seven who had
been treated with thyroid extract but in one instance only was the diagnosis confirmed on
re-investigation and was disproved in the remainder. Another patient had a thyroglossal
cyst excised in childhood. In two patients (108/61; 34/63) the levels of protein bound iodine
(9-2 and 11-2 pg/100 ml) were above the upper limit of normal set by the laboratory. The
l31I uptakes at 6 hr were 52 and 31%, respectively. Neither patient had clinical evidence of
thyroid disease and in both patients the PB131! levels were less than 0-4% of administered
dose at 48 hr. In the remaining thirty-one patients whose PBI was estimated, the values
(4-0-8-2 qg; mean 6-4 //g/100 ml) were within the normal limits.
Doubly chromatin-positive females
Fourteen women included in the study had been identified as doubly chromatin positive
during the routine examination of buccal mucosal smears obtained from patients attending
general hospital clinics and from patients at mental subnormality hospitals. In eleven of
these, the karyotype was 47,XXX and three were mosaics (Table 1). Seven patients were
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mentally retarded and one of these patients had a large firm diffuse goitre and had been
given thyroid replacement therapy for several years. Among the remaining patients one is
Table 1. Chromosome constitution and ages of fifty-one females with evidence of ovarian
dysgenesis and fourteen females who were doubly chromatin positive
Chromosome karyotype
Age (years)
20 20-29 30-39 40^19 50-59 59
Total
Gonadal dysgenesis
45,X 3 12 6 0 0 0 21
46,XXqi 0 5 0 0 0 0 5
46,XXp- 1 0 0 0 0 0 1
Mosaic:s
45,X/46,XX 0 1 1 0 0 0 2
45,X/46,XX/47,XXX 0 0 0 0 0 1 1
45,X/46,XY 1 3 0 0 0 0 4
45,X/47,XYY 0 0 0 1 0 0 1
45,X/46,XXqi 2 6 1 1 0 0 10
45,X/46,XXqi/47,XXqiXqi 1 0 0 0 0 0 1
45,X/46,XXr 1 1 0 0 0 0 2
45,X/46,XXmar 0 2 0 0 0 0 2
45,X/46,Xr+ 0 0 0 1 0 0 1
Doubly1 chromatin positive females
47,XXX 1 3 2 2 1 2 11
45,X/47,XXX 0 0 1 0 1 0 2
46,XX/47,XXX 0 0 0 0 1 0 1
















9/59, 16/59, 54/60, 55/60, 111/60, 162/60, 169/60, 108/61,
169/61, 2/62, 40/62, 95/62, 3/63, 116/63, 61/64, 97/64,
152/64, 78/65, 137/65, 145/65, 314/67.




65/62, 59/64, 179/64, 118/65.
152/60.










said to have suffered from thyrotoxicosis (confirmatory data not available) and is at present
being treated with antithyroid drugs.
VII : 5
368 W. H. Price and W. J. Irvine
Parents ofpatients with gonadal dysgenesis
Twenty-seven mothers (age range 38-69, mean age 53) and twenty-four fathers (age
range 40-77, mean age 55) of patients with gonadal dysgenesis were studied. One of the
mothers had suffered from thyrotoxicosis and been treated by partial thyroidectomy and
two had diffuse thyroid enlargement. None of the fathers examined had clinical evidence
of thyroid disease.
Table 2. Incidence of thyroid and gastric antibodies in healthy controls
Thyroid antibodies Gastric
No. parietal cell
Age of Thyroglobulin* Cytoplasmic) Total antibodies Total
subjects
No. V/o No. V/o No. °//o No. "//O No. V/o
Females
10-19 53 1 1-9 1 1-9 2 3-8 2 3-8 3 5-7
20-29 87 7 80 3 3-4 9 10-3 1 1-1 8 9-2
30-39 78 5 6-4 8 100 9 11-5 7 8-9 15 19-2
40-49 70 6 80 11 15-7 14 200 6 8-0 17 24-3
50-59 70 12 170 16 22-8 10 28-5 7 100 22 30-1
60-69 46 7 15-2 7 15-2 11 23-9 6 130 14 30-4
Total 404 38 9-4 46 11-4 65 16-1 29 7-2 79 19-6
Males
10-19 47 Nil Nil 2 4-3 2 4-3 2 4-3 3 6-4
20-29 75 3 4-0 Nil Nil 3 4-0 2 2-7 4 5-3
30-39 74 2 2-7 Nil Nil 2 2-7 Nil Nil 2 2-7
40-49 84 2 2-4 6 7-1 7 8-3 8 9-5 14 16-7
50-59 58 1 1-7 3 5-2 3 5-2 Nil Nil 3 5-2
60-69 38 1 2-6 Nil Nil 1 2-6 1 2-6 2 5-3
Total 376 9 2-4 11 2-9 18 4-8 13 3-5 28 7-4
* TCH tit re> 1 : 25.
f Positive inimunofluorescent staining± positive complement fixation test.
Controls
The control series consisted of 404 women and 376 men aged between 10 and 69 years.
Those between the ages of 20-59 were attending blood transfusion donor sessions. Those
at the extremes of the age range were hospital control subjects who had no clinical evidence
of thyroid disease, pernicious anaemia, adrenal insufficiency, hypoparathyroidism, diabetes
mellitus or any history suggestive of a gross defect of gonadal function and who had no
gross growth defect. The age distribution by decades and the numbers with antibodies is
given in Table 2.
METHODS
The sera of the patients were examined for antibodies to thyroglobulin by the tanned
cell haemagglutination test (TCH) (Fulthorpe et al., 1961) with serum dilutions of 1:5,
1:25 and serial ten-fold dilutions thereafter. Titres >1:25 were regarded as positive.
Antibody to thyroid cytoplasmic antigen and antibody to the cytoplasm of gastric parietal
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cells were examined by the indirect immunofluorescence test using unfixed sections of
human thyrotoxic thyroid tissue and gastric mucosa from the body of human stomach
using undiluted serum and anti IgG conjugated with fluorescein isothiocyanate (Irvine,
1963; Irvine, Stewart & Scarth, 1967). The method of preparation and properties of the
conjugate are described elsewhere (Irvine, Chan & Williams, 1969). Sections of rat
kidney were included in each test as a control for specificity and, in particular, for the
detection of mitochondrial antibodies (Doniach et al., 1966) and as a further check for
antinuclear factors. Tests giving positive immunofluorescence with thyroid or gastric
sections were tested and titrated by the method of complement fixation using doubling
dilutions of serum starting at 1:2, Takatsy plates, 2 MHD of complement and 50%
haemolysis as end point (Irvine, 1966). The immunofluorescence sections were also
checked for the presence or absence of nuclear staining.
The sera of forty-nine of the patients with gonadal dysgenesis and of the fourteen women
who were doubly chromatin positive were also tested against unfixed cryostat sections of
human and rabbit ovary in the follicular and in the luteal phase, human and rabbit testis,




Of the fifty-one patients with clinical and cytogenetic features of gonadal dysgenesis,
eight had antibodies to at least one thyroid constituent. This is an incidence of 15-7% as
compared with an incidence of 17-0% among 305 controls. Forty-seven of the patients
were under the age of 40 years and of these seven had thyroid antibodies. This is an inci¬
dence of 14-9% which is higher than the incidence of 10-9% in control women aged 20-39
years but the difference is not significant.
Two of the twenty-one patients with a 45,X karyotype (9-6%) had thyroid antibodies
which is not significantly different from controls in the same age group.
Of the twenty-four patients of all ages with mosaicism, six (25%) had thyroid antibodies
and, of the twenty who were under 40 years, five (25%) had thyroid antibodies. Both
incidences are higher than among female controls (16-1 and 9-2%, respectively) but the
differences are not significant. All six patients with thyroid antibodies had a 45,X cell line
and three of them also had a 46,XXqi cell line. The three thyroid antibody patients with
a 46,XXqi cell line were found among a total of eleven patients who were 45,X/46,XXqi
mosaics, an incidence of 27-1%. The other three mosaics who were positive for thyroid
antibodies were constituted as follows: 45,X/46,XX; 45,X/46,XY and 45,X/46,X+mar, the
second cell line being different in each case. The finding of three patients with thyroid anti¬
bodies out of eleven with a 45,X/46,XXqi constitution (27-1%) was not significantly different
than the findings among the controls. Finally, no patient was found to have thyroid antibodies
out of the five studied whose sex chromosome complement was 46,XXqi without mosaicism.
The tanned red cell haemagglutination titre did not exceed 250 in any of the patients
with antibodies. This was also the highest titre among controls under the age of 40 but
there were three control women over this age who had titres greater than 250. The highest
complement fixation titre of cytoplasmic antibodies among all the patients and among
controls under 40 years was 32, but seven of the 305 control subjects over the age of 40 years
had titres greater than 32.
B
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Gastric antibodies
Three of the fifty-one patients with gonadal dysgenesis (5-9%) had gastric parietal cell
antibodies as compared with 7-2% of the female controls. The three patients were between
20-33 years of age so that the incidence is 6-4% as compared with 4-8% of the female
controls aged 20-39 years. This difference is not significant. The karyotypes of the patients
with gastric parietal cell antibodies is shown in Table 3 but the numbers are too small to
consider further analysis. The complement fixation titres on the three patients did not
exceed 1:32.
The sera of forty-nine of the fifty-one patients were tested for intrinsic factor antibody I
and all found to be negative.
Ovarian, testicular, placental and adrenal antibodies
The sera of forty-nine of the patients with gonadal dysgenesis gave negative results for
antibodies to ova, theca interna, interstitial cells and corpus luteum of ovary and inter¬
stitial cells and spermatids of testis, as well as negative results with placental and adrenal
tissue. The sera from the remaining two patients were not available for testing for these
antibodies.
Mitochondrial antibody and antinuclear factors
The sera of forty-nine of the patients with gonadal dysgenesis were negative for mito¬
chondrial antibody and for antinuclear factors. The sera of the remaining two patients were
not available for this purpose.
Doubly chromatin positive females
Two of the fourteen patients who were doubly chromatin positive had thyroid antibodies
and one of these had gastric antibodies. Both patients were over the age of 40 and one was
identified when attending a hospital for treatment of hyperthyroidism. The other patient,
a 45,X/47,XXX mosaic, had clinical thyroiditis and a TRC titre of 2500. This incidence of
antibodies among doubly chromatin females is not significantly raised. No antibodies to
ovarian, testicular, placental or adrenal tissue were detected in these patients.
The results of thyroid and gastric antibody tests are detailed in Table 3 and summarized
in Table 4.
Parents ofpatients with gonadal dysgenesis
Thyroid antibodies
Of the twenty-seven mothers examined, five had circulating thyroid antibodies, an
incidence of 18-5% which compares with an incidence of 18-7% in control women aged
40-69 years. Two of these with antibodies were the mothers of patients with a 45,X karyo¬
type and three were the mothers of patients whose karyotype included a 46,XXqi cell line.
One of the daughters with a 45,X karyotype also had thyroid antibodies.
Of the twenty-four fathers examined, one had thyroid antibodies. His daughter who was
a mosaic with a 46,XXqi cell line had no antibodies and neither had her mother. An
incidence of one in twenty-four males (4-2%) of this age is lower than in the male control
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Gastric antibodies
Three of the twenty-seven mothers (11-1%) and none of the fathers had gastric parietal
cell antibodies. These findings do not differ from controls in the same age range, 10-2% of
the control women and 5% of the control males age 40-69 years having gastric antibodies.
DISCUSSION
In a group of fifty-one patients with clinical and cytogenetic features of gonadal dysgenesis
(Turner's syndrome) and in fourteen women whose buccal smears were doubly chromatin
positive, the incidence of thyroid and gastric antibodies was not significantly raised above
that in normal controls. Antibodies were also not detected more frequently in a group of
parents of patients with gonadal dysgenesis. These findings are in striking contrast to those
of Vallotton & Forbes (1967) and of Doniach et al. (1968) who found the overall incidence
of thyroid antibodies amongst patients with gonadal dysgenesis to be raised (51 and 39-7%,
respectively).
Table 4. Incidence of thyroid and gastric antibodies with different sex chromosome constitution
Thyroid antibodies Gastric antibodies
Karyotype No. of -
patients No. % No. %
45,X 21 2 9-6 2 9-6
46,XXqi 5 0 0 0 0
46,XXp- 1 0 0 0 0
All mosaics 24 6 2-5 1 4-2
Mosaics with XXqi cell line 11 3 27-1 1 9
Doubly chromatin positive females 14 2 18-3 1 14-2
Female controls 404 65 161 29 7-2
The patients we studied were not randomly selected samples of patients with Turner's
syndrome or of doubly chromatin positive women but we are not aware of any factors in
the selection of the patients which would exclude those with thyroid antibodies. Our
patients were considerably younger than those of Vallotton & Forbes, the respective mean
ages being 26 and 42 years. This could be an important difference as it is well known that
the incidence of antibodies increases with age, but when this younger age of our patients
is allowed for and the results compared with findings in women under the age of 40, it was
still not possible to demonstrate any increase in the incidence of antibodies. Furthermore
the patients studied by Doniach et al. (1968) were in fact younger than our patients so the
discrepancy with their series cannot be attributed to an age difference.
Our patients could be equally divided into those who had presented at endocrine clinics
and those who had presented at gynaecology clinics and the incidence of antibodies was
the same in patients from both sources. All but four patients were under investigation for
primary amenorrhoea or for failure to grow. Many of the patients studied by Vallotton &
Forbes (1967), however, were attending hospital for a variety of conditions which may or
may not be associated with the chromosomal abnormality (Engel & Forbes, 1965). A higher
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incidence of antibodies has been reported amongst women in the hospital populations by
Hackett, Beech & Forbes (1960) so that it is possible that the way in which patients with
gonadal dysgenesis present may influence the incidence of thyroid antibodies. Unfortu¬
nately the mode of presentation of the patients is not recorded by Doniach et at. (1968).
Among our patients only the mosaics appeared to have an appreciably higher incidence
of thyroid antibodies. Although this increase was not significant, this could be due to
insufficient numbers, and it is noteworthy that Doniach and her colleagues also found the
highest incidence of antibodies among patients with sex chromosome mosaicism. The
largest subgroup of the mosaics we studied had an XXqi cell line and half the antibody
positive cases were in this group, whilst the others were distributed among mosaics with
a variety of second cell lines. It is of interest that cases which first drew attention to a
possible association between autoimmune thyroiditis and Turner's syndrome were remark¬
able in that they all had a sex chromosome complement which included an isochromosome
of the long arm of the X, and it was the possible association with additional X chromosome
material that prompted the inclusion of women with XXX sex chromosomes in this survey.
It may be significant that the only patient with clinical thyroiditis was in this group.
One of us (Irvine et ai, 1968) has reported the incidence of two cases of gonadal dys¬
genesis with normal chromosome constitution in whom there was a strong association
with autoimmune disease; idiopathic adrenal atrophy, idiopathic hypoparathyroidism in
the first case and these conditions plus primary atrophic hypothyroidism and pernicious
anaemia in the second. Both of these patients had a high incidence of autoantibodies of
the organ-specific type in the serum.
The parents of only twenty-seven patients with gonadal dysgenesis were studied but again
we are not aware of any circumstances which would lead to the exclusion of those having
thyroid antibodies and we cannot account for the difference between the incidences of
antibodies in this series and in the parents studied by Vallotton & Forbes (1967). Doniach
et at. (1968), however, were also unable to show a raised incidence of antibodies in parents
of patients with gonadal dysgenesis.
It is difficult to account for the differences between our findings in patients with gonadal
dysgenesis and those previously reported, except on the basis of differences in the selection
of patients. It is clear that in order to determine the significance of apparently high inci¬
dences of antibodies it is important that comparisons be made with controls matched not
only for age but also for mode of presentation. However, the relatively high incidence of
antibodies to thyroid and gastric mucosal cells in the general population will probably
make it necessary to study large numbers in order to establish or exclude significant
differences. The negative findings in tests for other organ-specific antibodies do not suggest,
however, that there is an increased risk of autoimmunity in general among these patients.
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The thymus is generally believed to be situated in the
mediastinum, and to be inaccessible unless by splitting
the sternum. A new approach to the thymus through a
cervical incision, developed at the Royal Infirmary,
Aberdeen, has allowed us to obtain thymic material for
histological study from patients with various thyroid
disorders, including autoimmune thyroid disease.
Methods
Operative technique.—A biopsy specimen was taken from the
thymus of 103 patients undergoing thyroid surgery through
the standard thyroidectomy incision at Aberdeen Royal
Infirmary. The technique, which will be described in detail
elsewhere (Gunn and Michie 1964), depends upon identifica¬
tion of the cornua of the thymus in the fibrofatty tissue at the
root of the neck. It may readily be found lying on the inferior
thyroid veins, immediately deep to the lower portion of the
sternothyroid muscles. A constant fibrous cord connects the
apex of the thymus to the inferior aspect of the thyroid lobe,
and it is along this " thyrothymic axis " that the inferior
parathyroid is generally found. This parathyroid often
surmounts the thymic apex, and risk of interference is greatly
reduced by biopsy of the thymic lobe 0-5 cm. below its apex.
Tissues for histology were fixed in 4% formaldehyde-acetate.
Sections were stained with hxmalum and eosin, Unna-
Pappenheim, and the Gordon and Sweet method for reticulin
fibres.
Results
Thymus.—One or two blocks were taken from each bionsv
* At present surgical registrar, Aberdeen Royal Infirmary,
t Now at the M.R.C. Clinical Endocrinology Research Unit, Edinburgh.
specimen. On histological section, thymus tissue wa*
demonstrated in 95 specimens (92%). The remainder revealed
only fibrofatty tissue. There was no doubt surgically that
thymus had been identified, and this may represent the state
of affairs in the apex of the thymus in a proportion of cases.
The thymus was considered abnormal when lymphoid follicles
with active germinal centres were seen in the medulla. The
follicles were usually small, and they sometimes had irregular
margins (fig. 1), in contrast to the large regular follicles
characteristically found in myasthenia gravis (fig. 2).
Medullary lymphoid follicles were identified in thymic
biopsy specimens from 18 patients of whom 16 had thyro¬
toxicosis, 1 non-toxic nodular goitre, and 1 Hashimoto's disease
without evidence of hyperthyroidism:
Thyroid disease ^bsTm medU"ary lymphoid
Thyrotoxicosis . 34* 16
Non-toxic goitre 43 2*
Total .... 77 18
* One patient had Hashimoto's disease.
The only other case of Hashimoto's disease included in the
series was thyrotoxic, but the thymus-biopsy material showed
no abnormality. The prevalance of medullary lymphoid
follicles in the thymus was much greater in thyrotoxic patients
than in those with non-toxic goitre (p<0 01\
Fig. 1—Thymus from a patient with thyrotoxicosis, showing characteristicall>






Thyroid histology.—An average of four blocks was taken from
each specimen of thyroid. Lymphoid follicles with germinal
centres were identified in thyroids from 36 patients in the
series. The prevalance of thymic medullary lymphoid follicles







It could be argued that this may not be a valid association
because the group of patients with thyroid lymphoid follicles
will include an unduly high proportion of thyrotoxic patients
in whom thymic medullary lymphoid follicles are common.
We have therefore investigated the prevalence of thyroid and
thymic lymphoid follicles in our patients with thyrotoxicosis,
and shown that in this disease there is an association between
these abnormalities (p < 0 05):
Thyroid lymphoid Thymus medullary lymphoid follicles
follicles Absent Present
Present .... 11 11
Absent .... 23 5
Total .... 34 16
Fig. 2—Thymus from a patient with myasthenia gravis, showing large lymphoid
follicle in the medulla. (Haemalum and eosin x 60.)
Antithyroid antibodies.—Sera from 93 patients were tested,
(a) for anti-thyroglobulin by the tanned-red-cell agglutination
technique and the Ouchterlony-precipitin test, (b) for antibody
to thyroid microsomes by the complement-fixation technique
and immunofluorescence, and (c) for antibody to the second
colloid antigen (anti-CA2) by immunofluorescence. The
apparent correlation in the whole series between thymic
medullary lymphoid-follicle formation and the presence of
thyroid antibodies (p < 0 05) does not hold when the group of
thyrotoxic patients is studied (p > 0-2), and it may therefore be
owing to the higher proportion of thyrotoxic patients in the
group with thymic abnormalities:
Thymus medullary lymphoid follicles
Antithyroid antibodies Whole series Thyrotoxicosis
Absent Present Absent Present
Present .. .. 22 11 13 9
Absent .... 53 7 20 7
Total .... 75 18 33 16
Discussion
Although there have been previous reports of lymphoid
follicles in the thymus in thyrotoxicosis (see Sloan 1943),
this is the first in-vivo study of the thymus in a large
group of patients with pathological changes in the thyroid.
The most prominent thymic abnormality in this series of
patients with thyroid disease is the presence of lymphoid
follicles in the medulla: they are small and somewhat
irregular in outline, and they are formed of a halo of
lymphocytes surrounding an active germinal centre in
which mitoses are seen infrequently. These follicles are
similar to the small medullary lymphoid follicles in the
thymus of patients with rheumatoid arthritis (Burnet and
Mackay 1962) and systemic lupus erythematosus (Mackay
et al. 1963, 1964), and they have the same general structure
as the large active germinal centres found in the thymic
medulla in myasthenia gravis (Castleman 1960, White
and Marshall 1962, Strauss 1963). In view of the impor¬
tant role of the thymus in normal and abnormal
immunological reactions (Miller 1961, 1962, 1963,
Burnet 1962, Burnet and Holmes 1963), it is noteworthy
that thymic medullary lumphoid follicles have rarely been
reported in diseases which are not associated with the
presence of autoantibodies (Mackay et al. 1964). Medul¬
lary lymphoid follicles have been found in NZB/BL mice,
many of which develop spontaneously autoimmune
haemolytic anaemia sometimes associated with a disease
resembling systemic lupus erythematosus (Burnet and
Holmes 1963).
Only 2 patients with Hashimoto's disease were included
in the series. In 1, who was euthyroid, medullary lymphoid
follicles were recognised in the thymus, but no thymic
abnormality was found in the other patient who had
thyrotoxic symptoms; this difference could be explained
by the sampling error inherent in small biopsy specimens.
The abnormal thymus observed in one case ofHashimoto's
disease, however, is similar to that reported in other
autoimmune diseases.
The most remarkable finding has been the high inci¬
dence of thymic medullary lymphoid follicles in patients
with thyrotoxicosis. None of these patients had any of the
clinical manifestations of other diseases associated with
autoimmunity. While it is possible that the thymic
abnormality has been induced by the high level of
circulating thyroid hormone or the action of antithyroid
drugs, it seems likely that the medullary centres are a
manifestation of disordered immunological reactions, and
that some cases of thyrotoxicosis may have qn autoimmune
basis. This has been suggested recently (Anderson 1964),
because long-acting thyroid stimulator is associated
closely with the gamma-globulin fraction of the serum-
proteins (Adams and Kennedy 1962, McKenzie 1962),
and it is known to occur in thyrotoxic patients where
it is thought to have a pathogenetic role (Adams and
Purves 1956, McKenzie 1958, Munro 1959). Further¬
more there is considerable clinical evidence of an
increased frequency in thyrotoxicosis of other diseases
associated with autoimmunity, such as myasthenia gravis
(McEachern and Parnell 1948), pernicious anasmia
(McNicol 1961), and idiopathic Addison's disease
(Blizzard and Kyle 1963, Irvine 1963a). If the hypothesis
that some cases of thyrotoxicosis have an autoimmune
pathogenesis should prove valid, it might help to explain
the high prevalence of antigastric antibodies in both
thyrotoxicosis and Hashimoto's disease (Doniach et al.
1963, Irvine 1963b).
The frequency of thymic medullary lymphoid follicles
in thyrotoxic patients correlates with the presence of
lymphoid follicles in the thyroid but not with thyroid
antibodies in the serum. It is therefore tempting to
speculate that in these patients thymic medullary lymphoid
follicles might be an indicator of cellular immunity of the
delayed hypersensitivity type, which is thought to be the
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basic pathogenetic mechanism in autoimmune disease
(Doniach and Roitt 1962).
Summary
Using a new technique, the thymus has been biopsied
in 103 patients undergoing surgery for thyroid disease.
Thymus medullary lymphoid-follicle formation has
been found in association with thyrotoxicosis, and the
abnormality can be correlated with the presence of
lymphoid follicles in the thyroid.
It has not been possible to correlate these changes with
the presence of circulating thyroid antibodies.
This raises the possibility that autoimmunity may be a
factor in the pathogenesis of some cases of thyrotoxicosis.
This study was begun after a discussion with Prof. M. F. A.
Woodruff, of the department of surgical science, Edinburgh Univer¬
sity. We are grateful to Dr. J. Swanson Beck, of the department of
pathology, University of Aberdeen, who has supervised the his¬
tological and immunological studies and assisted in the preparation
of this paper. We are grateful also to Dr. J. S. Brodie, of the City
Hospital, Aberdeen, for thyroid autoimmunity tests. One of us
(A. G.) was in receipt of a grant from endowment funds through the
Board of Management, Aberdeen General Hospitals.
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Unless the thymus is grossly enlarged owing to a cyst
or tumour, conventional radiographs and tomograms will
not reveal any abnormality. The normal or moderately
enlarged thymus can only be outlined if gas is used to
separate the structures in the anterior mediastinum.
Pneumomediastinography was developed by Condoreli
(1936) and Lissner (1959), and observations on the
thymus in patients with systemic lupus erythematosus
have been reported by Hare and Mackay (1963) using this
method.
We have assessed the size of the thymus in patients with
thyroid disease associated with circulating autoantibodies,
and made a comparable study in patients with thyroid
disease but in whom no such antibodies could be detected.
The size of the thymus has been assessed in patients
suffering from other conditions associated with autoim¬
munity, and in patients in whom pneumomediastinography
was used to clarify the nature of an intrathoracic lesion
that had been indicated by conventional radiography.
Thus we hoped to obtain further knowledge about the
role of the thymus in relation to autoimmunity.
Patients
Pneumomediastinography was carried out on 44 patients
with thyroid disorders—17 with lymphadenoid goitre (Hashi¬
moto's disease), 18 with thyrotoxicosis, 3 with primary hypo¬
thyroidism, 1 with primary hypothyroidism and pernicious
anaemia, 1 with primary hypothyroidism and rheumatoid
arthritis, 1 with a colloid adenoma and chronic thyroiditis in
the remainder of the gland, and 3 with simple goitre.
The clinical diagnosis of thyrotoxicosis and of primary
hypothyroidism was confirmed by radioactive-iodine tests, and
estimation of the serum protein-bound iodine. The diagnosis
of lymphadenoid goitre was confirmed by needle biopsy or, in
one case, by partial thyroidectomy. The patients with simple
goitre were studied before partial thyroidectomy, and the
clinical diagnosis was confirmed histologically. All patients
were euthyroid at the time of the investigation, having been
treated with radioactive iodine or antithyroid drugs or thyroxine.
Of the remaining 13 patients, 7 had other disorders that may
be autoimmune in nature (2 with myasthenia gravis, 2 with
pernicious anaemia, 1 with ankylosing spondylitis, 1 with
rheumatoid arthritis, and 1 with idiopathic hypochromic
anaemia associated with antinuclear factor), 3 had systemic lupus
erythematosus and were under treatment with steroids, and 3
were found to have no disorder that might be expected to
influence the size of the thymus—1 with aortic dilatation with
negative serological tests for syphilis, 1 with an old tuberculous
lesion, and 1 with a parathyroid adenoma.
Patients with large vascular goitres, tracheal compression,
upper-respiratory-tract infection, a platelet-count of less than
100,000 per cmm. or disturbed coagulation mechanism were
excluded. Where the examination was done for research
purposes the object, and details of the procedure, were explained
to the patient, and the examination was only carried out if his
cooperation was obtained.
Pneumomediastinography was repeated in 1 patient with
lymphadenoid goitre after a 3-week course of steroid therapy.
Methods
Pneumomediastinography
After sedation with quinalbarbitone sodium 100-200 mg. and
atropine 0-6 mg. intramuscularly, the patient is placed supine
with his neck extended. In the retrotracheal technique, a fine
straight needle (no. 21) is inserted through the skin immediately
below the thyroid isthmus. The needle is carefully advanced
through the anterior tracheal wall, and then through the
posterior tracheal wall to lie immediately in front of the
oesophagus. Frequent aspiration is performed to ensure that
the needle has not entered any vascular structure. 100 c.cm.
of nitrous oxide is injected with repeated intermittent aspiration
under fluoroscopic control using an image intensifier. This is
followed by 150-400 c.cm. of oxygen. The patient feels slight
discomfort during the introduction of the gas, and this
indicates that satisfactory filling of the mediastinum is taking
place. The examination causes little distress to the patient.
Insufflation is adequate when the gas has reached the diaphragm.
A fuller account of the technique is to be published
(Sumerling and Irvine 1965).
In patients with large goitres, where the retrotracheal
technique may be. difficult or impossible, the retrosternal
approach may be used. A curved needle (no. 19) is inserted
through the skin at the suprasternal notch, and is carefully
advanced behind the manubrium. The same volume of gas is
injected with the same precautions. This produces good filling
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of the anterior mediastinum, but the risk of puncturing vascular
structures in the mediastinum may be slightly greater.
In both methods the thymus is outlined by lateral tomo¬
graphy. The maximum cross-sectional area of the thymic
shadow in the lateral tomograms is measured by planimetry.
The dimensions of the thyroid gland can also be outlined, and
this has proved helpful in carrying out needle biopsy of the
thyroid in patients with small goitres.
Tests for Autoantibodies
The serum of each patient was tested for antibodies to
• Thyroid or gastric antibodies, antinuclear factor, or rheumatoid factor in patient's serum.
A Thyroid or gastric antibodies, antinuclear factor, or rheumatoid factor absent.
Fig. 1—Cross-sectional area of thymus in
44 patients with various thyroid dis¬
orders, with and without autoimmunity.
Fig. 4—Cross-sectional area of thymus in 13
patients with non-endocrine diseases
with and without autoimmunity.
thyroglobulin by the agar precipitation test and by the method
of tanned-cell agglutination (Fulthorpe et al. 1961); to the
second colloid antigen (Balfour et al. 1961); to thyroid cyto¬
plasm using the technique of complement fixation (Irvine et al.
1962); to gastric parietal cell cytoplasm using the methods of
complement fixation and indirect fluorescent staining (Irvine
et al. 1962, Irvine 1963a); and to intrinsic factor (Irvine 1965).
The sera were also examined for antinuclear factors using
human gastric mucosa and for rheumatoid factor using the
differential sheep-cell test. The serum electrophoretic pattern
was determined in each patient.
Results
Fig. 1 summarises the findings in the 44 thyroid patients
studied. There is a wide range in the size of the thymus
shadow, from 24-5 sq. cm. in a patient with lymphadenoid
goitre to TO sq. cm. in a patient with thyrotoxicosis (but
no detectable autoantibodies in the serum). The size of
the thymus shadow did not exceed 6 0 sq. cm. in any of
the 10 thyroid patients who had no serum autoantibodies.
25 of the 34 thyroid patients with autoantibodies had a
thymus shadow greater than 6-0 sq. cm. The thymus
shadow was greater than 6-0 sq. cm. in 13 of the 17 patients
with lymphadenoid goitre. The mean size of the thymus
in the 34 thyroid patients with autoantibodies in the
serum was 9-3 sq. cm. with a standard deviation of 4-9.
The mean size of the thymus in the 10 thyroid patients
without autoantibodies was 3-6 sq. cm. with a standard
deviation of 1-8 sq. cm. Using Student's t-test, this
difference is statistically significant (p < 0-001).
A thymus shadow which is considered to be small and
within normal limits (4-4 sq. cm.) is shown in fig. 2. The
patient, a woman aged 24, had thyrotoxicosis controlled
by carbimazole. An example of an enlarged thymus
shadow (13-9 sq. cm.)—in a euthyroid woman of 46 with
untreated lymphadenoid goitre—is illustrated in fig. 3.
This patient was subsequently given a 3-week course of
prednisolone at a dose of 60 mg. per day; the size of her
goitre decreased notably, and, on repeat pneumomedia-
stinography, the maximum cross-sectional area of the
thymus in the sagittal plane was reduced to 7-5 sq. cm.
The ages of the 44 thyroid patients studied varied from
24 to 65, but no relationship between the age of the patient
and the size of the thymus shadow could be found. There
was no correlation between the size of the thymus and
generalised obesity. Only 2 men with thyroid disease
were included in this study: one, aged 51, with lymph¬
adenoid goitre, had very slight thymic enlargement
(6-6 sq. cm.); and the other, aged 26, was thyrotoxic, had
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autoantibodies in the serum and had a thymus shadow
estimated at 4-5 sq. cm.
Fig. 4 shows the findings in relation to thymus size in
the 13 other patients studied. The most remarkable of
these patients was a man aged 53 with myasthenia gravis
of sudden onset. Conventional chest radiography
showed no abnormality. After a 3-week period of
stabilisation with neostigmine, pneumomediastinography
was done and a grossly enlarged thymus (40-3 sq. cm.) was
found. Thymectomy was performed 6 weeks later, and a
large cystic thymoma was removed. The patient made an
excellent recovery, has now returned to work, and requires
much less neostigmine than before his operation. This
case is illustrated in another paper (Sumerling and Irvine
1965). A second patient with myasthenia gravis was
studied. She has had this condition for 15 years with only
temporary changes in its severity. The myasthenia was
well controlled with pyridostigmine and ephedrine. At
pneumomediastinography the maximum cross-sectional
area of the thymus shadow was 7-6 sq. cm.
In 2 patients with pernicious anaemia the thymus
Fig. 2—Lateral tomogram of chest of a 24-year-old woman with thyrotoxicosis treated with
carbimazole.
By pneumomediastinography, the two cornu of a thymus that is judged to be of
normal size are demonstrated. This patient had no serological evidence of autoimmunity.
Fig. 3—Lateral tomogram of a 46-year-old woman with untreated lymphadenoid goitre
confirmed by thyroid biopsy.
An enlarged thymus is demonstrated by pneumomediastinography. The patient's serum
was strongly positive for thyroid antibodies.
VIII : 14
8
shadow was shown to be 7 0 sq. cm. in one, and 7-4 sq. cm.
in the other. The thymus shadow in a male patient, aged
28, with untreated ankylosing spondylitis was 8 0 sq. cm.,
and in another male patient aged 32, with rheumatoid
arthritis treated by salicylates only, the thymus shadow
was 3-8 sq. cm. A woman aged 30, with hypochromic
anaemia and strongly positive antinuclear factor, had a
thymus shadow of 11-8 sq. cm. The thymus shadow in
each of 3 patients who were under treatment with steroids
for systemic lupus erythematosus was less than 3 sq. cm.
Fig. 4 includes 3 patients in whom pneumomediastin-
ography was used to study the nature of an abnormal
shadow found on conventional radiography, but who had
no evidence of autoimmune disorder. One was a man of
65 with aortic dilatation but negativeWassermann reaction
and Kahn test; the size of the thymus on X-ray was
4-5 sq. cm. Another was a young man of 26 with a healed
tuberculous lesion of some years' standing, and no sign
of further tuberculous activity; his thymus shadow was
2-8 sq. cm. The 3rd patient was a woman, aged 55, with a
parathyroid adenoma and hyperparathyroidism; her
thymus shadow was 3-2 sq. cm.
Discussion
According to Hammar (1921) and Boyd (1932) the
maximum size of the thymus in man is reached about the
12th year, when its average weight is approximately 35 g.
Growth of the thymus then ceases and involution begins.
This involution involves only a gradual decline in the
actual weight of the organ, although the reduction in the
amount of lymphoid tissue—particularly in the cortex
but also in the medulla—is more pronounced. If illness
occurs, the thymus may temporarily undergo rapid
involution.
The separation of the tissues during pneumomediastino-
graphy is likely to be no less effective than the dissection of
the thymus at operation or at necropsy, but the assessment
of the size of the thymus in the present study is limited to
measurement in one plane only. In the 10 patients with
thyroid disease in whom serum autoantibodies could not
be detected, in the 3 control patients, and in the 3 patients
receiving steroid therapy, the maximum cross-sectional
area of the thymus in the sagittal plane was 6 0 sq. cm. or
less. This order of measurement is in keeping with the
normal dimensions of the thymus in the adult. There can
be little doubt that a cross-sectional area considerably
greater than 6 0 sq. cm.—as recorded in many of the
thyroid patients with serum autoantibodies—represents
enlargement of the thymus gland. Since no correlation
was found between generalised obesity of the individual
and the size of the thymus shadow, we infer that at the
time of the examination, or previous to it, the amount of
lymphoid tissue within the thymus must have been
greater than normal, or that the thymus was enlarged
owing to the presence of a tumour or cyst. Radiological
studies can give no indication of the relative amounts of
lymphoid tissue, connective tissue, or fat within the thy¬
mus at the time of the examination. The only X-ray that
suggested the presence of a thymic tumour or cyst was that
of the patient with myasthenia gravis in whom a thymic
cyst was later found at operation. The reduction in the
size of the thymus shadow in response to steroid therapy in
a patient with lymphadenoid goitre accords with the known
effect of steroids on the thymus, and presumably the
reduction was in the amount of lymphoid tissue within
the thymus.
The radiological evidence for thymic enlargement in
some patients with thyroid disease, and in patients with
myasthenia gravis, is in keeping with earlier histological
studies (Sloan 1943, McEachern and Parnell 1948).
Gunn et-al. (1964) found a correlation between the degree
of lymphocytic infiltration within the thyroid and the
presence of germinal centres within the thymus. They
state that the correlation between the presence ©f auto¬
antibodies in the serum and histological evidence of thymic
abnormalities was poor. Until more is. known about the
function of the thymus, it cannot be said whether it is an
abnormality of the thymus in the past that matters or
whether that abnormality has to be continuous in order to
account for the persistence of autoimmunity. Thymic
medullary lymphoid follicles may be related to cellular
immunity of the delayed hypersensitivity type, while gen¬
eralised hyperplasia of the thymus may be more directly
related to the production of self-reacting gamma globulin.
Further studies in which the radiological appearances
are combined with thymus biopsy are required.
Radiological evidence of thymic enlargement in patients
with myasthenia gravis, pernicious anaemia, ankylosing
spondylitis, and idiopathic hypochromic anaemia »with
positive antinuclear factor indicates that disturbance of
endocrinological control of the thymus cannot be the only
explanation for its enlargement. Some patients with
thyroid disease had a history of hyperthyroidism while
others had been hypothyroid; all patients were euthyroid
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at the time of study. No correlation could be found
between the history of thyroid function and the radiological
appearance of the thymus. Hare and Mackay (1963) did
not consider that there was radiological evidence of
thymic enlargement in 2 patients with untreated systemic
lupus erythematosus, 1 patient with pernicious anaemia
and 1 patient with advanced polymyositis and chronic
hepatitis. Kreel et al. (1964) have described a patient
with myasthenia gravis and a large thymic shadow who
received replacement treatment for hypothyroidism. The
normal radiological appearance of the thymus using
pneumomediastinography is not yet fully described, and
must await improvements in technique and the accumula¬
tion of data on patients who have no evidence of immune
or endocrine disorder.
Increase in size of the thymus may indicate hyperplasia,
either at the time of the investigation or in the past; it
does not necessarily mean that the gland is hyperactive.
Compensatory hyperplasia causing an enlarged thymus
may be a response to some inherent abnormality, but the
overall effect may be a deficiency of thymic function.
Sutherland et al. (1965) have reported that a positive
Coombs test commonly develops in rabbits after neonatal
removal of the thymus, and appendix. In the NZB/BL
strain of mice that develop autoimmune disease spon¬
taneously, neonatal thymectomy does not prevent the
development of the autoimmune process (Helyer and
Howie 1963). In man, systemic lupus erythematosus and
lymphadenoid goitre have been found to develop after
thymectomy for myasthenia gravis (Alarcon-Segovia et al.
1963, Simpson 1964). Adner et al. (1964)—in a study of
48 patients with myasthenia gravis—found a high fre¬
quency of antibodies against normal tissue, and a reduced
ability to express delayed (cellular) hypersensitivity
reactions. While there is evidence that thyroid auto¬
immunity may result from impaired immunological toler¬
ance (Irvine 1964), these observations on myasthenia by
Adner et. al have still to be reconciled with the idea that
cellular immunity of the delayed hypersensitivity type is
probably the basic pathogenic mechanism in thyroid auto¬
immune disorder (Doniach and Roitt 1962, Irvine 1963b).
Summary
Pneumomediastinography was carried out on 44 patients
with various thyroid disorders. In 10 of these patients
there was no serological evidence of autoimmunity, and
the maximum size of the thymic shadow in the sagittal
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plane varied from 10 to 6 0 sq. cm. In 25 of 34 patients
with autoimmunity the thymic shadow was larger than
6-0 sq. cm. The degree of thymic enlargement in thyroid
disease associated with autoimmunity is statistically
significant.
Radiological evidence of thymic enlargement was also
observed in 2 patients with myasthenia gravis, 2 with
pernicious anaemia, 1 with ankylosing spondylitis, and 1
with idiopathic hypochromic anaemia and a positive test
for antinuclear factor. The thymus was of normal size in
3 patients without thyroid disease or serological evidence
of autoimmunity.
The possible significance of thymic enlargement in
relation to autoimmunity is discussed.
We are grateful to our clinical colleagues for their cooperation and
to Mr. Kenneth Marwick, Miss Laura Scarth, and Miss Irene Park
for their technical and secretarial assistance.
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Pneumomediastinography [Summary]
by M D Sumerling mrcp ffr
and W J Irvine Bsc MRCPEd
(Departments ofDiagnostic Radiology and
Therapeutics, Royal Infirmary and the MRC
Clinical Endocrinological Unit, Edinburgh)
The technique of pneumomediastinography is
not well known in this country but has been used
in Europe for many years. A percutaneous
method is the technique of choice and we have
preferred Condorelli's retrotracheal method
(Condorelli 1936, Condorelli et at. 1951). One of
us (M D S) was fortunate in learning the tech¬
nique from Dr J Lissner at Frankfurt (see
Lissner 1959).
The patient is fasted and sedated, and under
local anaesthesia a fine needle (No. 21 SWG) is
introduced through the trachea into the retro¬
tracheal space; 300-500 ml of gas is injected
slowly under fluoroscopic control. A series of
tomograms in the anteroposterior and lateral
planes show stripping of the pleura off the peri¬
cardium, and the superior vena cava, aorta,
great vessels, pulmonary artery, azygos vein and
the thymus are demonstrated. The outer walls
of the main bronchi are outlined and on occasions
the ligamentum arteriosum is visible.
In some patients with gross thyroid enlarge¬
ment the retrosternal method of inserting the
needle behind the manubrium over the supra¬
sternal notch has been used. Kreel et al. (1964)
have also described a transsternal approach.
Ninety-two patients have been investigated,
and the examinations have been followed by no
morbidity. The technique has been used largely
to demonstrate the size and shape of the thymus,
particularly in relation to thyroid disease and
autoimmunity (Irvine & Sumerling 1965).
In a series of 44 patients with thyroid disease,
radiological evidence of thyroid enlargement was
frequently found in patients with auto-antibodies
in the serum and not in those with negative
serology.
Fig 1 is an example of a thymus shadow that is
considered to be within normal limits, while in
Fig 2 the thymus is markedly enlarged.
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Fig 1 Lateral tomogram of chest of a 38-year-old
euthyroid woman treated by partial thyroidectomy for
thyrotoxicosis three years previously. The thymus gland
is considered to be within normal limits
Fig 2 Lateral tomogram of chest of a 31-year-old
euthyroid woman with untreated lymphadenoid goitre
(Hashimoto thyroiditis). The thymus gland is markedly
enlarged
In 12% of patients with myasthenia gravis
thymic tumours may be discovered at operation
(Keynes 1949). In a man of 55 with myasthenia
gravis pneumomediastinography revealed a large
mass in the anterior mediastinum, and at opera¬
tion a large thymic cyst was removed. Similar
cases have been described by Hare & Mackay
(1963) and by Kreel et al. (1964).
Masses in the mediastinum may not always be
demonstrated by conventional methods and may
be missed if they do not alter the radiographic
contours. A man of 55 who had lymphosarcoma
of cervical and axillary glands showed no ab¬
normality in conventional X-ray films and tomo¬
grams, but the investigation revealed enlarged
mediastinal glands. It is anticipated that small
glands of 1-2 cm diameter may be detected by
the technique.
The chest X-ray of a woman aged 55 with
suspected hyperparathyroidism demonstrated a
mass lying in the superior mediastinum. This
mass simulated an aneurysm of the innominate
artery, but the outlining of the mass by gas
showed that it was a separate tumour lying
adjacent to the innominate artery. At operation a
parathyroid adenoma with cystic degeneration
was excised. Posen et al. (1964) have described
a similar case, but in their patient the mass was
not demonstrated on the conventional X-ray
films.
A preliminary investigation was made to
determine the value of the technique in assessing
the operability of carcinoma of the bronchus,
particularly at the left hilum. In the absence of
lung disease, gas diffuses between the aorta and
the pulmonary artery and along the main
bronchi. In a patient with inoperable carcinoma
(left phrenic and left recurrent palsies were
present) there was failure of dissection and a
plaque of growth was shown at the left hilum.
In a second patient with a large mass at the left
hilum gas diffused between the aorta and the
main pulmonary artery down to the left pulmon¬
ary artery, and the ligamentum arteriosum was
shown. The aortic window and the superior
mediastinum were shown to be free of glandular
involvement. These findings were confirmed at
operation when a successful pneumonectomy
was performed.
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THE study ot the mediastinum by con¬ventional roentgenography is limited
because the component tissues have similar
densities. The internal lumen of the various
vascular structures of the mediastinum
may be demonstrated by the techniques of
venography, angiocardiography, aortog¬
raphy and intraosseous venography, and
these methods have all been employed in
the investigation ot mediastinal pathology.
The lumen of the esophagus may be out¬
lined by barium sulfate paste and the
trachea and bronchi may be studied by the
techniques ot tomography and bronchog¬
raphy.
Condorelli developed 2 methods for the
demonstration of the mediastinal structures
by the injection of gas into the mediasti¬




Straight roentgenograms of the chest and
thoracic inlet are made to ensure that there
is no untoward compression or deviation of
the trachea. The patient is fasted before
the examination and sedated with a short
acting barbiturate (cyclobarbitone 100-200
mg.) together with atropine sulfate 0.6 mg.
intramuscularly. The neck is hyperex-
tended over a pillow and the skin and sub¬
cutaneous tissues either just above or be¬
low the thyroid isthmus, are infiltrated with
1 per cent lignocaine solution. The lower
route just below the thyroid isthmus is pre¬
ferred, but if there is a prominent aortic
arch the higher route above the thyroid
isthmus is used. Infiltration is continued
down to the trachea and the needle is ad¬
vanced between 2 tracheal rings into the
lumen of the trachea. Two cubic centi¬
meters lignocaine solution are then injected
into the trachea. The patient will cough at
this stage, indicating the correct positioning
of the needle. The needle is withdrawn and
a child's lumbar puncture needle (size 21)
is inserted along the same route into the
trachea. The needle is then further ad¬
vanced until resistance to continuous as¬
piration proves that the point of the needle
has just passed through the posterior
tracheal wall. Gas is then injected in ali-
quots of 50 cc., drawn into a syringe from a
cylinder through a three-way tap. Aspira¬
tion before injection ensures that the
needle has not entered a blood vessel in¬
advertently. Nitrous oxide is employed for
the first 100 cc., and if dissection by the gas
proceeds normally, this is followed by 200-
400 cc. of oxygen. Nitrous oxide or carbon
dioxide used alone is absorbed too rapidly
and if further roentgenograms are required
most of the gas may have been absorbed.
The progress of the examination is checked
by frequent fluoroscopic control—using a
Philips television 9 inch intensifier system.
During the induction, the patient experi¬
ences some slight discomfort of the chest
and on auscultation characteristic crepita¬
tions may be heard. No changes have been
observed in the electrocardiogram, pulse
rate or blood pressure taken at intervals
during the insufflation. A satisfactory ex¬
amination is indicated by the separation of
the mediastinal pleura from the pericardial
sac down to the level of the diaphragm.
Linear tomograms are taken in lateral and
anteroposterior projections. In a patient of
60 kg. the exposure factors would be 75 kv.
and 100 mas. for anteroposterior roentgeno¬
grams and 90 kv. and 160 mas. for lateral
* From the Departments of Diagnostic Radiology and Therapeutics, Royal Infirmary; and the M.R.C. Clinical Endocrinology Re¬




roentgenograms. When the thymus is to be
delineated, less exposure is required: 71 kv.
and 100 mas. for the anteroposterior tomo¬
grams and 75 kv. and 100 mas. for the
lateral tomograms. Following the examina¬
tion, the patient is confined to bed for 6
hours.
In this method, there is good filling of
both the anterior and posterior compart¬
ments of the mediastinum and the patient
experiences little discomfort.
retrosternal
In some patients the transtracheal
method was contraindicated because of
thyroid enlargement sometimeswith trache¬
al deviation or compression. In these cases
the retrosternal method was used. A fine
curved needle (size 20) is inserted per-
cutaneously through the suprasternal notch
so as to just enter the anterior mediastinum
behind the manubrium. Injection of the
gas will lead to good filling of the anterior
mediastinum but filling of the posterior
mediastinum is less satisfactory. Discom¬
fort is minimized by introducing the gas
into the anterior mediastinum slowly. In
the retrosternal method there is theoreti¬
cally a greater risk of encountering a vascu¬
lar structure but in our experience this com¬
plication has not occurred.
Using the above techniques, pneumo-
mediastinography by either the trans¬
tracheal or retrosternal method has not
been followed by any morbidity. Stringent
precautions were taken against the possibil¬
ity of gas embolism. The examination must
not be undertaken it there is any evidence
of upper respiratory tract infection and
full asepsis must be maintained. The ex¬
amination is contraindicated in patients
with a bleeding diathesis. With careful
positioning, the esophagus should not be
punctured during the retrotracheal method.
This may have occurred on one occasion in
the present series but with no ill effect.
CLINICAL OBSERVATIONS
The examination of pneumomediastinog-
raphv has been carried out in 110 patients
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suffering from a variety of conditions. For
the present paper, a number of cases of par¬
ticular interest has been selected in order to
illustrate and discuss the application of this
technique.
normal appearances
The appearance of the "normal" medi¬
astinum as studied by pneumomediastinog-
raphy is shown in Figures I and 2.
In the anteroposterior view, the gas out¬
lines the left innominate vein and the supe¬
rior vena cava, which tends to move to the
right. The azygos vein may be seen in the
right tracheobronchial angle. The aorta,
innominate artery, left carotid artery and
left subclavian artery can readily be dem¬
onstrated in a series of anteroposterior
Fig. i. Anteroposterior tomogram showing normal
anatomy. Gas has outlined the aorta, main pul¬
monary artery, ligamentum arteriosum, azygos
vein, left subclavian artery and superior vena
cava. Gas also diffused around the trachea and
main bronchi, outlining their walls.
M. D. Sumerling and W. J. Irvine
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Fig. 1. Lateral tomogram showing the two lobes of
the thymus outlined by gas in the anterior medi
aatinum. The trachea, esophagus, left innominate
vein and superior vena cava are also seen. Gas has
diffused between the right ventricular outflow tract
and the aorta.
tomograms. When sufficient gas has been
injected into a patient with a normal medi¬
astinum, dissection will occur around the
main pulmonary artery and aortic arch,
outlining the aortic window (Pig. i). The
outer walls of the trachea and bronchi can
be outlined as far as the primary divisions
and in many cases the ligamentum arterio-
sum can be identified. The thymus may be
distinguished in the appropriate antero¬
posterior tomogram as i thin shadows on
either side of the mid-line. The right lobe of
the thymus is closely related to the superior
vena cava.
The lateral tomograms following the in¬
sufflation of gas are particularly suitable
tor outlining the thymus. The i lobes ot
what is considered to be a normal thymus
are demonstrated in Figure 2. The thymus
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may be seen roentgenological^ to extend a
variable distance inferiorly in the anterior
mediastinum. Also, in the lateral tomo¬
grams the left atrial wall may be clearly
visualized and the external surface of the
esophagus may be demonstrated.
During pneumomediastinography, the
gas diffuses into the neck and anteroposte¬
rior tomograms will clearly delineate the
lobes of the thyroid gland (Fig. 3).
disorders of the thymus
An assessment of the size of the thymus
can be made by measuring with the aid of a
planimeter the area of the thymic shadow
in the sagittal tomogram. Three examples
of thymic disorder are described below.
Case i. j.B. This 56 year old woman pre¬
sented with non-goitrous idiopathic primary
hypothyroidism. The clinical diagnosis was
confirmed by a low serum level of protein bound
Fig. 3. Anteroposterior tomogram of the cervical
region shows the two lobes of the thyroid gland
outlined by gas immediately below the larynx.
VIII
and W. J. Irvine October, 1966
Case ii. W.B. A lumberjack, aged 53 years,
suddenly developed the symptoms of myasthe¬
nia gravis. The classic clinical picture was
confirmed by the dramatic improvement follow¬
ing the administration of anticholinesterase.
Conventional chest roentgenograms showed no
abnormality. After a 3 week period of stabiliza¬
tion with neostigmine, pneumomediastinogra-
phy was performed and a grossly enlarged
thymus was demonstrated (Fig. 5). The cross-
sectional area of the thymus shadow in the
sagittal tomogram was 40.3 cm.2 and the shape
of the shadow indicated the presence of a thy¬
moma. Thymectomy was performed 6 weeks
later and a large cystic thymoma was removed
(Fig. 6). The cyst contained 35 ml. of fluid. The
patient made a good recovery and for a period
of some months his requirement for neostigmine
was low, but subsequently large doses were
again necessary to control his myasthenia.
This case illustrates that conventional
chest roentgenograms may not always
Fig. 4. Case 1. Lateral tomogram. Moderately en¬
larged thymus in a patient with primary hypo¬
thyroidism and whose serum contained thyroid
antibodies.
iodine (P.B.I. = 1.5 fig. per cent) and a low thy
roid gland uptake of I131 following an oral dose
of 20 /uc (48 hr. uptake= 0.9 per cent). Pneumo-
mediastinography was performed after 4months
replacement treatment with thyroxine, 0.2 mg.
per day. The thymus is considered to be dif¬
fusely enlarged with a cross-sectional area in the
sagittal tomogram of 13 cm.2 (Fig. 4). At the
time of the roentgenographs examination,
the patient's serum contained antibody to thy-
roglobulin in a titer of 1:250 using the tanned
cell hemagglutination technique.6
A possible relationship between roent¬
genologic evidence of hyperplasia of the
thymus in patients with thyroid disease
associated with auto-immunity has been
the subject of a separate paper.11 It was ob¬
served that abnormally large thymic shad¬
ows were a common occurrence in patients
with thyroid disease and who had organ-
specific antibodies demonstrable in the
serum.
Fig. 5. Case 11. Lateral tomogram. Myasthenia
gravis of recent onset. Gas has outlined a clearly
defined large mass lying immediately in front of
and to the side of the aorta in the anterior medi¬
astinum.
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Fig. 6. Case 11. Operative specimen (cut longi¬
tudinally into 2 parts). The thymus is considerably
enlarged due to the presence of a large cyst, the
wall of which contained thymoma tissue.
demonstrate thymic enlargement even
when this takes the form of a thymoma of
considerable size. The thymoma was read¬
ily demonstrated at pneumomediastinog-
raphy.
Case hi. C.B. This 26 year old woman pre
senteci with an 8 month history of a dry irritat¬
ing cough and breathlessness on severe exertion.
A conventional roentgenogram of the chest
showed a mass in the superior mediastinum and
the possibility of an aortic aneurysm was con¬
sidered by the referring physician. A scintigram
(I131) showed a normal distribution of thyroid
tissue. Pneumomediastinography using the
retrosternal method showed that there was a
large lobulated mass lying in the anterior medi¬
astinum closely applied to the aorta and in close
relationship to the pulmonary artery. Gas failed
to separate the mass from the aorta (Fig. 7 and
8). The mass extended across the mid-line as
far as the right border of the sternum. There
was no evidence of thymic tissue apart from the
mass and it was, therefore, concluded that the
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mass was either a tumor or cyst arising from the
thymus or that the thymus was the site of some
other pathology, e.g., reticulosis. There was no
evidence of any other mass or of glandular in¬
volvement elsewhere in the mediastinum.
At thoracotomy, a large lobulated mass was
found in the anterior mediastinum adherent to
the aorta. Most of the mass was removed but a
small part of the tumor could not be removed
because of infiltration into the aorta. Histologic
examination showed the tumor to be a lym-
phadenoma and although no thymic tissue
could be identified the tumor was presumed to
have arisen in the thymus.
Pneumomediastinography in this pa¬
tient demonstrated that the mediastinal
mass was adherent to the aorta, and, in
retrospect, one might have concluded that
the tumor was inoperable and that the pa¬
tient might have been treated by radio¬
therapy alone.
Fig. 7. Case in. Lateral tomogram. Lymphadenoma
possibly arising in thymus. The gas has outlined a
mass lying in the anterior mediastinum anterior to
the ascending arch of the aorta. Gas failed to dis¬
sect between the aorta and the mass and at opera¬




Fig. 8. Case hi. Anteroposterior tomogram (same
patient as in Figure 7) shows an extensive mass
extending across the whole aiiteiiui mediastinum.
Gas fails to pass between the mass and the sur¬
rounding structures.
parathyroid adenoma
Case iv. iVI.R. This 55 year old woman pre¬
sented with urinary infection. On investiga¬
tion, she was found to have a large stag horn
calculus in the pelvis of the right kidney. The
serum Ca++ was 12.2 mg. per cent, serum inor¬
ganic phosphate was 1.92 mg. per cent and the
seiuiii alkaline phosphatase was 9.5 units. Ex¬
amination of the neck showed 2 nodular dis¬
crete swellings in the region of the thyroid, but
a scintigram (I131) showed normal distribution
of functioning thyroid tissue. A chest roentgeno¬
gram showed a rounded mass in the superior
mediastinum on the right side. The mass was
seen to be situated mainly behind the trachea
and to the right of the esophagus. The roent¬
genologic diagnosis rested between an aneurysm
of the innominate artery and a tumor mass
lying in the anterior mediastinum. Pneumo-
mediastinography clearly demonstrated the
rounded mass in the right of the superior medi¬
astinum and showed it to be situated lateral to
the trachea and posterior to the superior vena
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cava and separate from the innominate artery
(Fig. 9). There was no evidence of aberrant
parathyroid tissue in the anterior mediastinum.
Some enlargement of the right lobe of the thy¬
roid was demonstrated.
The neck was explored and an enlarged lower
parathyroid gland was found within the upper
mediastinum and removed. Histologically, the
parathyroid gland was adenomatous and had
undergone cystic degeneration.
This case illustrates the application of
pneumomediastinography to the investiga¬
tion of parathyroid adenoma.
mediastinal lymphadenopathy
Case v. A.C. This 62 year old man presented
with bilateral cervical and axillary lympha-
denopathy of undetermined duration. Cervical
lymph node biopsy established a diagnosis of
lymphosarcoma. Although conventional roent¬
genograms of the chest showed no abnormality,
mediastinal lymphadenopathy was clearly dem¬
onstrated at pneumomediastinography (Fig.
10). Ten months later he required abdominal
Fig. 9. Case iv. Anteroposterior tomogram. Hyper¬
parathyroidism. Large mass in the right superior
mediastinum outlined by gas. The azygos vein and
aortic knuckle are also shown. In other tomo¬
graphic cuts, the innominate artery could be
identified medial to the mass. At operation, a
parathyroid adenoma with cystic degeneration
was excised.
VIII
Vol. 98, No. 2 Pneumomediastinography
Fig. 10. Case v. Anteroposterior tomogram of a
patient with lymphosarcoma of cervical and axil¬
lary lymph nodes. Gas has outlined an enlarged
lymph node in the right superior mediastinum.
There are probably 1 other small lymph nodes
present, 1 in each hilus.
radiation therapy following the development of
a central abdominal lymphoid mass.
This case illustrates that conventional
roentgenography may fail to demonstrate
mediastinal lymphadenopathy. The use ot
pneumomediastinography may enable more
accurate assessment ol tumors of the
reticulo-endothelial system.
carcinoma of bronchus
Case vi. W.C. A male patient, aged 63
years, with a carcinoma of the left main bron¬
chus had evidence of left recurrent laryngeal
and left phrenic palsy, together with a Horner's
syndrome. The clinical evidence indicated an
inoperable tumor and pneumomediastinogra¬
phy revealed a failure of dissection of the gas
around the left hilus and the pulmonary artery.
A linear opacity was demonstrated alongside
the mediastinum at the level of the left hilus
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and this was presumed to be a plaque of neo¬
plastic tissue (Fig. 11).
Case vii. J.B. This male patient, aged 63
years, was admitted complaining of a 2 month
history of hemoptysis. A chest roentgenogram
demonstrated a large opacity in the anterior
segment of the left upper lobe. Pneumomedi¬
astinography showed that gas had passed along
the main pulmonary artery and into the aortic
window. The first part of the left pulmonary
artery was also outlined by gas. The ligamen-
tum arteriosum could be identified (Fig. 12).
The aortic window was free of enlarged lymph
nodes and no enlarged lymph nodes were dem¬
onstrated elsewhere in the mediastinum. At
operation a solid, firm neoplasm, 5 cm. in diam¬
eter, was found near the hilus, surrounding the
upper lobe bronchus. The tumor had extended
along the left pulmonary artery to a point 1
inch distal to the ligamentum arteriosum. There
Fig. 11. Case vi. Anteroposterior tomogram. In¬
operable carcinoma of the left bronchus. Gas
failed to diffuse between the main pulmonary
artery and the aorta and a mass is present adjacent
to these structures—? plaque of neoplastic tissue.
VIII : 29
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Fig. 12. Case vii. Anteroposterior tomogram. Large
malignant mass arising from the left main bron¬
chus. Gas diffuses between the aorta and the main
pulmonary artery as far as the left pulmonary
artery. The ligamentum arteriosum can be identi¬
fied just internal to the pleural reflection. The lung
containing the tumor was removed without diffi¬
culty.
was no involvement of the mediastinum. A
pneumonectomy was performed without dif¬
ficulty. On histologic examination, the tumor
was found to be a squamous cell carcinoma, and
it had infiltrated to a point 1 cm. distal to the
divided bronchus.
These i cases (Case vi and vii) illustrate
the possibility of using pneumomediasti-
nography to determine the operability of
bronchial carcinoma, particularly when left
hilar involvement is questioned.
discussion
Condorelli4 in 1936 published his paper
on the retrosternal method of pneumomedi-
astinography. This method succeeds in
producing adequate filling of the anterior
mediastinum and is the technique which
we have favored |for the outlining of the
thymus. Marchand,17 from fluid injection
studies in autopsy material, concluded that
fascial sheaths enclosed the great vessels,
esophagus and trachea, and that these pre¬
vent the free circulation of fluid injection
into the mediastinum. In common with
Hughes et al9 we have found that the
mediastinum behaves differently when gas
is injected. Gas tends to diffuse widely
through the mediastinum and also upwards
into the neck. After injection of gas into the
anterior mediastinum using the retrosternal
method, gas will pass into the posterior
mediastinum, particularly if the patient is
turned into the prone position. However,
filling of the posterior mediastinum is not so
adequate compared with the transtracheal
method.
Other techniques of pneumomediastinog-
raphy include the injection of gas through a
needle inserted directly through the raanu-
briosternal joint into the anterior mediasti¬
num.14 Baccaglini,1 Betoulieres et al.,3 Isard
et al.,12 and Tapiovaara20 used the pre¬
sacral method of insufflation, allowing the
gas in the retroperitoneal space to pass up¬
wards into the mediastinum. This method
was employed because the danger of gas
embolism was considered to be less than in
the direct approaches. According to Hughes
et al.,9 the presacral method is unreliable
and in our experience a large amount of gas
must be injected, producing much discom¬
fort. Simecek and Holub,19 while investigat¬
ing patients with suspected bronchial car¬
cinoma, injected gas through a needle in¬
serted through the tracheal wall during
bronchoscopy. Berne et al.2 performed
routine scalene lymph node biopsies in pa¬
tients with suspected bronchial carcinoma,
and as an extension of the procedure they
injected gas through a catheter introduced
into the mediastinum through the operation
site. When the retrosternal technique
could not be used because of masses lying
in the thoracic inlet, Hughes et al.9 inserted
a needle upwards into the anterior medi¬
astinum behind the xiphisternum.
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In our experience the retrosternal method
gives satisfactory delineation of the thymus
although the technique cannot distinguish
between the relative proportions of lymph¬
oid tissue, fat and connective tissue within
the thymus. In a series of 44 patients with
thyroid disease, roentgenologic enlarge¬
ment of the thymus was frequently noted in
those who had evidence of auto-immunity.11
The retrosternal method was used by Hare
and Mackay7 in the investigation of 12 pa¬
tients with other disorders associated with
auto-immunity.
Keynes,13 in a series of 155 patients with
myasthenia gravis subjected to thoracot¬
omy, found that 11.6 per cent had tumors
in the thymus. Kreel, Blendis and Piercy14
believe that it is important to recognize
tumors preoperatively in order to plan the
correct treatment. Pneumomediastinogra-
phy will clearly outline thymic tumors as in
the case reported in this paper. Harper and
Guyer8 believe that tumors of the thymus
should always be delineated by tomograms
taken at suitable depths and with suitable
projections. Kreel15 has been able to dem¬
onstrate small tumors by pneumomediasti-
nography in 1 patients with severe myas¬
thenia gravis where straight roentgeno¬
grams and tomograms revealed no abnor¬
mality. A similar case is described in the
present paper. If a thymic tumor does not
encroach on the mediastinal borders, it is
unlikely to be visualized by conventional
roentgenography.
Posen et al.ls described a patient with
primary hyperparathyroidism who had
normal conventional roentgenograms, but
on pneumomediastinography a mass was
demonstrated in the superior mediastinum,
and this proved to be a parathyroid
adenoma at operation. In Case iv of the
present paper, a parathyroid adenoma was
clearly delineated at pneumomediastinog¬
raphy and at subsequent operation a para¬
thyroid adenoma was removed. The clear
demarcation of the thyroid at pneumo¬
mediastinography together with I131 scinti¬
scans also helps to resolve the differential
diagnosis of a superior mediastinal mass
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seen by conventional roentgenography.
Delineation of the thyroid by gas may also
be ot value in providing an objective mea¬
surement of thyroid size and be helpful in
performing a needle biopsy of the thyroid.
In Case v of the present paper, the chest
roentgenograms were negative in a patient
with lymphosarcoma involving cervical
and axillary lymph nodes. At pneumo¬
mediastinography, enlarged mediastinal
lymph nodes were clearly demonstrated.
This finding is of some importance in deter¬
mining the grading of the disease, its treat¬
ment and its prognosis. It is anticipated
that lymph nodes of 1 cm. in diameter
might be identified by this means.
While the diagnosis of carcinoma of the
bronchus may be established by the use of
techniques including roentgenology, bron¬
choscopy and possibly lung biopsy, the
possibility of a successful resection is much
more difficult to determine before thora¬
cotomy. While venography and angiog¬
raphy may determine, to some extent, the
degree of lymph node involvement and
mediastinal spread, these methods are
limited. Only lymph nodes that lie close to
the superior vena cava will cause distortion
of that structure. Bronchial arteriography
will not necessarily show up all the lymph
nodes involved and may not indicate the
extent of the spread of the tumor. Thoracic
surgeons have particular difficulty in as¬
sessing the spread of growth from a left
hilus tumor towards the mediastinum.
Simecek and Holub,19 using the pertracheal
method during bronchoscopy, examined
500 patients with carcinoma of the bron¬
chus and found the method of considerable
value in assessing involvement of the medi¬
astinal lymph nodes and the extent of
mediastinal infiltration. They claim to be
able to exclude patients who have inoper¬
able tumors from unnecessary thoracotomy
and from the roentgenologic appearances
claim that they can differentiate between
enlargement of mediastinal lymph nodes
due to tumor from those due to inflamma¬
tion. Ikins et al.10 introduced a catheter




scalene lymph node biopsy. Large amounts
of carbon dioxide, from 1 up to 8 liters, were
injected into the mediastinum. In a series of
31 patients with bronchial carcinoma, they
found the method of considerable value in
assessing the degree of lymph node metas¬
tases and mediastinal infiltration. We have
performed insufficient examinations to as¬
sess fully the usefulness of the method but
believe that pneumomediastinography has
a place in the investigation of patients with
carcinoma of the bronchus with a view to
excluding patients with inoperable car¬
cinoma from unnecessary thoracotomy.
SUMMARY
Pneumomediastinography is a safe pro¬
cedure provided the technique is carried out
with proper precautions against gas em¬
bolism. The transtracheal and retrosternal
methods of Condorelli4 have been per¬
formed on no patients without morbidity.
The method has been employed for the
investigation of the thymus, the parathy¬
roid glands, mediastinal lymphadenopathy
and the thyroid gland. The possibility of
using the method to assess operabilitv of
bronchial carcinoma is discussed.
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SUMMARY
Normal and thymectomized outbred guinea-pigs were immunized with extracts
of calf thymus, calf skeletal muscle or calf heart muscle emulsified in Freund's
complete adjuvant. Immunization with either thymus or skeletal muscle produced
a significant incidence of thymitis and a partial neuromuscular block in contrast to
control animals either untreated or injected with an extract of calf lymph node or
saline in Freund's complete adjuvant. The incidence of thymitis and partial neuro¬
muscular block in animals that were injected with an extract of calf heart muscle in
Freund's complete adjuvant was found not to be significant when compared to the
control animals.
Neuromuscular transmission was studied using Copeland-Davis clip electrodes
or a bipolar silver wire electrode threaded through the flexor digitorum muscle.
The development of partial neuromuscular block in the test animals was found to
be dependent on the presence of the thymus. All animals with a partial neuro¬
muscular block had evidence of experimental thymitis.
These findings are in keeping with the hypothesis that a factor released by the
thymus may be important in the development of the neuromuscular block character¬
istic of myasthenia gravis.
INTRODUCTION
The thymus gland in myasthenia gravis has one of three histological appearances (Castle-
man, 1966). About 10% of patients have thymomas. Of the remaining patients, the thymus is
normal macroscopically and microscopically in 20% while in the other 80% germinal centres
are conspicuously present in the thymic medulla. In about 35% of myasthenia patients with¬
out a thymoma and in approximately 95% of patients with associated thymoma, serum
autoantibody can be demonstrated reacting with striations of skeletal muscle and heart
muscle and with the cytoplasm of the thymus myoid cells (Strauss et al., 1965). In attempts
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to produce similar histological appearances and antibodies with similar reactivity in
experimental animals, Marshall & White (1961) reported that the formation of germinal
centres in the thymic medulla could be produced by intrathymic injection of a typhoid-
paratyphoid vaccine or diphtheria toxoid. Namba & Grob (1966) succeeded in raising
skeletal muscle antibodies in rabbits by the repeated injections of a human skeletal muscle
ribonucleoprotein in Freund's complete adjuvant (CFA). Goldstein & Whittingham
(1966, 1967) and Goldstein & Hofman (1968) showed that guinea-pigs or rats injected with
heterologous or homologous thymus or skeletal muscle in CFA developed a thymitis,
serum antibodies to skeletal muscle and thymus myoid cells and also a partial neuro¬
muscular block. In contrast to these positive findings, negative results in similar experiments
have been reported by Strauss (1963) and by Parkes (1966).
This paper describes our own experience in the attempt to produce an experimental model
of myasthenia gravis in guinea-pigs.
MATERIALS AND METHODS
Animals
Outbred guinea-pigs of both sexes, 4-6 months old were used.
Antigen preparation
Fresh thymus, skeletal muscle, heart muscle and lymph node from a young calf were
homogenized in phosphate buffered saline, pH 7-2 (20% w/v). The homogenates were
centrifuged for 15 min at 5000 rev/min and the supernatant emulsified in an equal volume of
Freund's complete adjuvant (CFA).
Table 1. The number of animals injected with a given antigen
subdivided according to the twomethods used forelectromyography







10 Calf skeletal muscle+ CFA
4 Calf lymph node + CFA
Group B
9 Calf thymus+ CFA
8 Calf skeletal muscle + CFA
9 Calf heart muscle+ CFA
5 Calf lymph node + CFA
8 Saline +CFA
10 No treatment
7 Calf thymus + CFA
8 Calf skeletal muscle+ CFA
4 Calf lymph node + CFA
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Immunization
Each animal was injected with 0-1 ml antigen in CFA in each hind footpad. The number of
animals injected with a given antigen is as shown in Table 1. The animals were subdivided
into two groups A and B according to the two different methods used for electromyography.
In addition five thymectomized animals were immunized with 0-1 ml of a crude guinea-pig
extract in CFA and given a boosting injection after 3 weeks in order to demonstrate that
these animals could still develop an experimental autoimmune disease.
Skin tests
The development of delayed hypersensitivity to the antigen used for immunization was
tested after 2 weeks by the intradermal injection of calf thymus, calf skeletal muscle and
calf lymph node extracts prepared as for immunization except that their concentration was
50% w/v. Animals immunized with calf heart muscle in CFA were also skin tested with a
50% w/v calf heart muscle extract. In each instance 0-1 ml of saline and of the different
antigen preparations were injected intracutaneously at different sites on the abdomen after
the animals had been shaved. The tests were read 30 rnin, 1 hr and 24 hr after the injection,
and the results were recorded positive if at the injection site an erythema with oedema
developed with a diameter ^ 1 cm.
Detection of circulating antibodies
The indirect fluorescent antibody test (Weller & Coons, 1954) was used. Air dried unfixed
sections of thymus, skeletal muscle, heart muscle and smooth muscle were cut at 4 /( using
a SLEE cryostat at — 20°C. Tissue specimens obtained from a young calf, a 2-week-old
guinea-pig and from the experimental animals were frozen to — 70°C in an acetone-solid
C02 mixture immediately after the animals were killed.
Two antisera were used for the demonstration of antibody. First a polyvalent rabbit anti-
guinea-pig y-globulin serum obtained from Hyland (Hyland Division, Travenol Labora-
tories, Los Angeles) and secondly a rabbit anti-guinea-pig IgG serum prepared in our
laboratory by immunization of a rabbit with the IgG fraction of normal guinea-pig serum.
The IgG fraction was prepared by using a combined salt precipitation and chromatographic
procedure (Fahey & Terry, 1967) and the absence of other immunoglobulins was confirmed
by immunoelectrophoresis.
The protein content of both antisera was adjusted to 10 mg protein/ml with normal
unbuffered saline and the pH was then raised to approximately 9 with a carbonate-bicarbon¬
ate buffer.
Fluorescein isothiocyanate isomer I(FITC I) (British Drug Houses Ltd, Poole, England)
was used in a concentration of 1 mg for each 100 mg protein. The conjugation was done in
the cold at 4°C over a period of 18 hr. The uncoupled FITC I was removed by passage
through a Sephadex G-50 column. The filtrate was precipitated with two-thirds of its
volume of saturated ammonium sulphate and the precipitated fraction dialysed overnight
against veronal buffer, pH 7-2. The final fluorescein-protein ratio was calculated on a Zeiss
P.M.Q. II spectrophotometer at a wavelength of 495 and 280 m/n The protein-fluorescein
ratio was found to be 0-5 for the conjugated antiserum to polyvalent immunoglobulin and
0-56 for the conjugated antiserum to IgG.
All the animals were bled 14-17 days after immunization and the sera stored at —20°C.
Undiluted serum and serum diluted 1:8 was applied to the frozen sections for 20 min. The
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sections were then washed in veronal buffer (pH 7-2) for 30 min with continual gentle
agitation. The fluorescein conjugated antisera were applied in a dilution 1:8 for 20 min and
the sections were then given a final wash in veronal buffer, pH 7-2, for 1 hr with continual
gentle agitation. The sections were mounted in 10% glycerol in saline and examined using
a Gillet and Sibert microscope with a 100-W Iodine-Quartz lamp with primary filter 30/063
and ocular filter 10/285.
The indirect fluorescent antibody test was also used to detect the presence of antinuclear
factor in the sera of the experimental animals, using frozen guinea-pig liver sections and the
polyvalent anti-guinea-pig y-globulin conjugated as described above.
Passive haemagglutination test
Fresh tanned sheep red cells were prepared according to the method described by Herbert
(1967). Tanned sheep cells were sensitized with extracts of a guinea-pig thymus, skeletal
muscle, heart muscle, smooth muscle, lymph node, thyroid and saline in a concentration of
0T-0-25 mg tissue protein/ml. The sensitized sheep cells were incubated overnight at room
temperature with doubling dilutions of the sera from the test and from the control animals.
The test was read positive when haemagglutination was found in a titre ^ 1:20.
Absorption procedures
The specificity of the serum antibodies in the experimental animals immunized with
thymus, skeletal muscle or heart muscle in CFA for thymus lymphocytes and for thymus
myoid cells and skeletal muscle and heart muscle striations was studied by absorption
experiments. Calf and guinea-pig tissue extracts of thymus, skeletal muscle, heart muscle,
smooth muscle, thyroid, lymph node and liver were prepared as for immunization. Two parts
of tissue extract and one part of undiluted serum were incubated in a water-bath at 37°C
and shaken for 1 hr. The absorption of the antibody was then studied using the indirect
immunofluorescence technique with the polyvalent rabbit anti-guinea-pig y-globulin serum
conjugated with FITC I.
Other serological procedures
To determine whether the serum antibodies were complement fixing all the sera were
inactivated by heating at 56°C for 30 min. Cryostat sections of guinea-pig thymus, skeletal
muscle, heart muscle and smooth muscle were tested in duplicate. In each instance one of
the sections was treated with inactivated serum followed by the polyvalent rabbit antiserum
against guinea-pig y-globulin conjugated with FITC 1 (see above). The other section was
treated with guinea-pig serum and one drop of fresh complement and then with rabbit anti¬
serum against guinea-pig complement conjugated with FITC I (F-P ratio 0-417).
Cryostat sections of thymus, skeletal muscle and heart muscle tissue from all the animals
were tested by the direct immunofluorescence method for the in vivo binding of y-globulin
using a polyvalent rabbit serum against guinea-pig y-globulin conjugated with FITC I.
To test if the serum autoantibodies of animals immunized with skeletal muscle in CFA
were directed against a muscle ribonucleoprotein, frozen guinea-pig muscle sections were
incubated for 1 hr at 45°C with a bovine pancreas ribonuclease (British Drug Houses Ltd,
Dorset, England) in a concentration of 5 mg/ml in phosphate buffered saline, pH 7-2, and




Specimens of guinea-pig thymus, spleen and cervical lymph nodes were fixed in Carnoy
solution overnight. One tissue block of skeletal muscle, of heart muscle and of smooth
muscle (stomach wall) was fixed in 10% formol saline. All tissue sections were stained with
haematoxylin and eosin (H & E) and the thymus sections were stained also with methyl
green pyronin, periodic acid-Schilf (PAS) and silver impregnation.
Electromyography
Fourteen to 17 days after immunization each guinea-pig was anaesthetized with
Nembutal®, 35 mg/kg body weight.
Two techniques were used to record the compound muscle action potential.
In the animals of Group A, a fine insulated silver wire (0-05 mm diameter) was used for
recording. A loop of this wire was attached to the amplifier imput and soldered connections
checked by noting the absence of 50 cycle interference. The loop was then twisted and drawn
through the exposed flexor digitorum of the animal's right front leg using a small suture
needle. The end of the twisted double wire was cut, and the ends of each wire were bent
to make small hooks. The resulting micro-bipolar electrode system was then drawn back
into the muscle body (Fig. 1). During recording the exposed muscle was maintained at
Fig. 1. Shows the silver wire micro-bipolar electrode system ready to be drawn back into the
muscle body. The insulation is removed from a very small area at the end of each wire.
body temperature by covering with paraffin heated to 39°C. In animals of Group B,
Copeland-Davies clip electrodes (Copeland & Davies, 1964) supplied by Electro-Physio¬
logical Instruments Ltd, Edinburgh, were used. The clips penetrated the unexposed muscle
through the skin. Each clip measured 1 cm across. The two clip electrodes were placed as
close together as possible. By this method recordings were made on both front limbs
after they had been shaved.
In both Groups A and B the median nerve was exposed in the axilla and stimulated using
silver wire electrodes (diameter 0-5 mm and shaped as small hooks) 2 mm apart. The nerve
stimulation was supramaximal with a pulse duration of 100 msec. In each instance a single
compound muscle action potential was observed at a sweep speed of 2 msec/cm. For tetanus
a stimulation frequency of 50/sec was used and the first ten muscle action potentials observed
at a sweep speed of 20 msec/cm. The first twenty-five muscle action potentials were also
observed at a sweep speed of 50 msec/cm. The effect of Tensilon® on a single action potential
as well as on a tetanus was tested 5-10 min after the injection of 50 pg Tensilon® intra¬
muscularly into the right hind leg. A double pulse unit (2 GIRO, Electro-Physiological
Instruments, E.P.I. Edinburgh) was used for stimulation and a recording system was
designed by Electro-Physiological Instruments Ltd, Edinburgh, E.P.I. Its pre-amplifier had
a gain of 1000 and was used at a time constant of 25 msec. It was incorporated in a Tele-
equipment oscilloscope Model (D52). For photographic recording a Tektronix oscilloscope
502 was used with a Shackman polaroid camera (Model No. P.L.I.).
Twisted silver wire
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Chi-square analysis was performed to measure the significance of the incidence of thymitis
in the experimental and in the control animals. Statistical evaluation of the thymus weightand




Thymitis was considered to be present if there was an accumulation of small and medium
Fig. 2. Sections of guinea-pig thymus, (a) Thymus of a guinea-pig 2 weeks after immunization
with calf heart muscle in CFA. Note the accumulation of lymphocytes around the Flassall's
corpuscles in the thymic medulla. H & E, x70. (b) Normal thymus from a control animal
showing an even dispersion of lymphocytes in the medulla. H & E, x70.
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sized lymphocytes in the thymic medulla. The accumulation of lymphocytes tended to
occur around the Hassall's corpuscles (Fig. 2a). This picture was quite distinct from the
histology of the normal thymus gland in the guinea-pigs in which there is a relatively even
dispersion of small lymphocytes throughout the medulla of the thymus (Fig. 2b). Staining
with silver impregnation showed that in some of the thymus glands there was a breakdown
of the fine medullary reticulum fibre structure with the formation of a reticulum fibre
barrier at the cortico-medullary border. This change was not dependent on the presence of
thymitis, since it was also observed in guinea-pig thymus that was otherwise normal. There
appeared to be no differences in the plasma cells, Hassall's corpuscles or cortex in the
presence or absence of thymitis.
Table 2. Incidence of positive delayed hypersensitivity and incidence ofexperimental thymitis in experimental
and control guinea-pigs 14 days after immunization
Positive delayed hypersensitivity* (test tissue) Incidence Thymus
Thymus No. of Antigen of weight
status animals injected Skeletal Heart Lymph thymitis (mean + SD)
Thymus muscle muscle Node Saline
Intact
Thymectomized
19 Thymus 18 13 NTf 16 0 11 0-49 + 0-25
18 Skeletal muscle 16 13 NT 11 0 9 0-56 ±0-24
9 Heart muscle 9 8 9 8 0 2 0-51 ±0-16
9 Lymph node 7 6 NT 8 0 1 0-55 + 0-16
8 Saline 0 0 NT 0 0 1 0-47±0 11
10 - 0 0 NT 0 0 0 0-5 ±0-22
8 Thymus 6 4 NT 6 0 - -
7 Skeletal muscle 7 6 NT 7 0 - -
4 Lymph node 4 1 NT 4 0 - -
* No. of animals with positive skin reactions after 24 hr.
t NT, Not tested.
The incidence of thymitis (Table 2) recorded in animals injected with calf thymus
in CFA (eleven out of nineteen) and in those immunized with calf skeletal muscle in
CFA (nine out of eighteen) is significantly higher than the incidence in control animals
(two out of twenty-two) with P values of <0-001 and <0-01, respectively. The occurrence of
thymitis in two out of nine animals immunized with heart muscle in CFA was not significant
when compared with that in the control animals (P>0-5). Likewise there was no statistical
difference in the incidence of thymitis in animals injected with lymph node in CFA (one out
of nine) or in animals injected with saline in CFA (one out of eight) compared to untreated
guinea-pigs (none out of ten).
Thymus weight
The weight of the thymus in the different animal groups is given in Table 2. No significant
differences were observed between the groups (P>0-2).
Histology of other tissues
No abnormalities were noted in sections of spleen, lymph node and smooth muscle either
in the experimental or in the control animals. In one guinea-pig immunized with thymus an
inflammatory reaction was found in a muscle section taken from the proximal part of the
A*
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right hind leg. In one animal immunized with skeletal muscle an inflammatory focus in
the myocardium was recorded. A small perivascular focus of inflammation was also observed
in the myocardium in two of the guinea-pigs injected with heart muscle in CFA. No abnorm¬
alities in skeletal muscle or myocardium were noted in the remaining test or control animals.
All guinea-pigs immunized with a crude thyroid extract in CFA after thymectomy developed
histological evidence of mild to severe thyroiditis.
Delayed hypersensitivity
The number of animals giving a positive skin reaction for delayed hypersensitivity after
24 hr is shown in Table 2. No tissue specific reaction was obtained. In about 30% of the
immunized animals the skin reaction showed a central necrosis after 24 hr. No immediate
type of reaction was seen in any of the animals at 30 min and 1 hr after the injection. None
of the animals injected with saline and none of the untreated guinea-pigs gave a positive
reaction to any of the test tissues. No difference was recorded in the development of delayed
hypersensitivity in guinea-pigs when the thymus was intact or after thymectomy (Table 2).
Circulating antibodies
The antibodies detected in the serum 14 days after immunization with the various tissues
is given in Table 3. Results obtained in the indirect immunofluorescence test using heterolo¬
gous (calf) homologous (2-week-old guinea-pigs) and autologous tissue sections were
similar.

















Intact 19 Thymus 17 0 0 0 5
18 Skeletal muscle 0 17 17 17 6
9 Heart muscle 0 3 5 5 5
9 Lymph node (8) 0 0 0 3
8 Saline 0 0 0 0 0
10 - 0 0 0 0 0
Thymectomized 8 Thymus 7 0 0 0 (2)
7 Skeletal muscle 0 7 7 7 (1)
4 Lymph node (4) 0 0 0 0
Numbers in parentheses indicate that the reactions are only weakly positive.
* Using autologous tissue sections and serum dilutions 1:8.
t Using homologous guinea-pig liver sections and undiluted serum in the indirect fluorescence test.
In about 10% of the control animals the undiluted sera gave weak but definite fluorescence
reactions with the striations of skeletal muscle and heart muscle and the cytoplasm of
lymphocytes and myoid cells of the thymus. When the test sera were diluted 1:8 no positive
staining was found with the sera of the control animals. No significant difference (f>0-5)
IX : 10
Experimental thymitis 327
was recorded in the incidence of circulating antibodies in thymectomized and intact animals.
Out of twenty-seven guinea-pigs injected with thymus twenty-five gave a positive fluores¬
cence reaction with the cytoplasm of the thymus lymphocytes (Fig. 3). No reaction was
recorded with skeletal muscle or with heart muscle sections. A similar but weak reaction was
found in seven out of nine guinea-pigs injected with lymph node. Twenty-four out of
Fig. 3. Indirect immunofluorescence test using a cryostat section of guinea-pig thymus and the
serum of a guinea-pig 2 weeks after immunization with calf thymus in CFA. There is a positive
reaction with the cytoplasm of the thymus lymphocytes, x 320.
twenty-five animals immunized with skeletal muscle and five out of nine animals with heart
muscle showed positive fluorescence reactions with the cytoplasm of the thymus myoid
cells (Fig. 4a), and with the striations of skeletal muscle (Fig. 4b) and heart muscle (Fig. 4c).
A few sera also showed positive fluorescence reactions with Hassalfs corpuscles and weak
staining of the connective tissue septa in the thymus (Fig. 4a). None of the sera reacted with
smooth muscle. Identical fluorescence reactions were obtained using conjugates prepared
from a rabbit anti-guinea-pig polyvalent y-globulin serum and from a rabbit anti-guinea-pig
IgG serum.
Table 4 shows the distribution of the antibody titres in the test and control animals. In
general the results compare favourably with those obtained by the indirect immunofluores¬
cence test. In animals immunized with thymus in CFA the tanned red cell titre ranged up to
1:1280, and in animals sensitized with skeletal muscle in CFA the titres ranged up to
1:2560 (Fig. 5). The results demonstrate the tissue specificity of the serum antibodies raised
in the experimental animals injected with different tissue homogenates, since guinea-pigs
immunized with thymus in CFA reacted only with thymus or lymph node sensitized red
cells and not with erythrocytes sensitized with skeletal muscle, heart muscle, smooth muscle
or thyroid extracts nor with the saline control. A similar but weaker reaction pattern was
found in guinea-pigs immunized with lymph node in CFA. Animals injected with skeletal
muscle or heart muscle in CFA reacted only with these tissues, with the exception of three
J. R. Kalden et a/.
Fig. 4. Indirect immunofluorescence tests using sections of guinea-pig thymus, skeletal muscle
and heart muscle and the serum from a guinea-pig 2 weeks after immunization with calf skeletal
muscle in CFA. (a) Positive reaction with the cytoplasm of a thymus myoid cell and with a
Hassall's corpuscle. There is also weak reaction with the connective tissue septa. x280.
(b) A positive reaction with the cross striations of skeletal muscle, x 630. (c) A positive reaction
with the cross striations of heart muscle. x630.
Table4.Serumantibodytitrofexpe im ntalndco trgui ea-pigstainebyhpassivehaema gl t nationf r14d ysim u iz ti Testtissue ThymusNo.ofAntigenSm oth statusanimalinjectedThymSk le lmuscleH rtLy phnodroine 1:2045=1:80>1:1:80>1:2042 46—7 — 338471 —43_____ 2 ____________ —213 1 _________Intact19Thymus5* 18Skeletalmuscle3 9Heartmuscle— 9Lymphnode4 8Saline 10—— Thymectomized8Thymus3 7Skeletalmuscle1 4Lymphnode1 *No.ofanimalsshowingtibodytitrete umdilu i nsindica ed.
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guinea-pigs which in addition showed a weak reaction with thymus sensitized cells. This
latter finding is explained by the presence of a common antigen in skeletal muscle, heart
muscle and thymus.
The serum antibodies in guinea-pigs immunized with thymus or lymph nodes could be
selectively absorbed with thymus or lymph node extracts (calf or guinea-pig) prepared as
for immunization. Similar extracts of calf and guinea-pig skeletal muscle, heart muscle,
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Fig. 5. Passive haemagglutination tests demonstrating the reaction pattern of serum antibodies
from a guinea-pig 2 weeks after immunization with calf skeletal muscle in CFA. Agglutination
occurred with sheep red cells sensitized with skeletal muscle (Sk.M) or with heart muscle
(FI.M) but not with cells sensitized with thymus, smooth muscle (Sm.M), lymph node (L.N) or
thyroid (Thyr) extracts.
guinea-pigs immunized with skeletal muscle were readily absorbed by an extract of skeletal
muscle but only weakly by an extract of heart muscle. Antibodies in the sera of animals
immunized with heart muscle were readily absorbed by either skeletal muscle or heart muscle.
The detection of the antibodies by the indirect immunofluorescence test was not dependent
on complement. Inactivation of the sera did not affect the results. Consistently negative
results were obtained when positive sera by the indirect immunofluorescence method were
inactivated, applied to the appropriate tissue sections, the sections then treated with fresh
guinea-pig complement and counterstained with a rabbit anti-guinea-pig complement con¬
jugate.
Definite positive tests for antinuclear factor were found in seven out of nine guinea-pigs
immunized with thymus in CFA, six out of eighteen animals immunized with heart muscle
and skeletal muscle in CFA and three out of nine guinea-pigs immunized with lymph node
in CFA. Weak reactions for ANF were observed in three out of five guinea-pigs thymecto-
mized before immunization with thymus or skeletal muscle (Table 3). No correlation was
found between the incidence of thymitis and the presence of ANF in the serum.
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Direct immunofluorescence tests for guinea-pig y-globulin in thymus, skeletal muscle and
heart muscle sections gave negative results in both the experimental and in the control
animals.
Pretreatment of skeletal muscle, heart muscle and thymus sections with a ribonuclease
prevented positive immunofluorescence reactions with skeletal muscle and heart muscle
striations as well as with thymus myoid cell cytoplasm, but it did not prevent positive staining
of the Hassall's corpuscles and connective tissue septa in the thymus.
i 1
20 msec
Fig. 6. Record of the muscle action potentials in the flexor digitorum following supramaximal
nerve stimulation at a rate of50/sec using Copeland-Davies clip electrodes, (a) Normal response
in which the height of the successive muscle responses is maintained. The height of the first
action potential as shown is foreshortened by the photographic tube, (b) Decreasing response
in an animal immunized with calf heart muscle in CFA and in which thymitis was present. The
tenth action potential is 36-6% of the first.
IX : 15
332 J. R. Kalden el al.
Neuromuscular transmission
The behaviour of the first ten muscle action potentials during tetanic supramaximal nerve
stimulation was used to study neuromuscular transmission (Harvey & Masland, 1941).
The ratio of the amplitude of the tenth to the first action potential was noted. In the control
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Fig. 7. The electromyographic response to supramaximal nerve stimulation at a rate of 50/sec
in animals ofGroups A and B combined before the injection of Tensilon. In animals ofGroup
B, the individual results shown are the mean of the recordings in each front limb. From the
findings in control animals, a decline in the height of the tenth action potential to less than 81%
of the first was unlikely (PcO-Ol). Seven of the thymus-immunized, seven of the skeletal
muscle-immunized and two of the heart muscle-immunized animals had a significant decline in
the muscle action potentials compared to the tetanus pattern observed in the control animals.
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smaller than this is unlikely (F<0-01). Therefore, guinea-pigs showing a ratio of less than
0-81 were regarded as having abnormal neuromuscular transmission (Fig. 6a and b).
In the animals of Group A, three out of ten guinea-pigs immunized with thymus in CFA
and four out of ten animals immunized with skeletal muscle in CFA showed a decline in the

















Eight saline + CFA





Nineteen calf thymus + CFA
Eighteen calf skeletal
muscle +CFA
Nine calf heart muscle
+ CFA
Thymectomized
Seven calf thymus + CFA
Eight calf skeletal muscle
+ CFA
Four calf lymph node
+CFA
After Tensilon
Fig. 8. The same as Fig. 7 but 10 min after 50^ttg Tensilon intramuscularly. The lower
confidence limit in the control animals was 87%. Note, in comparison to Fig. 7, the improve¬
ment in the tetanus muscle reaction in all animals with a partial neuromuscular block. In six
guinea-pigs, however, the tetanus pattern was still subnormal.
59-3 + 6-0% of the initial action potentials, respectively. In contrast, in the control animals
of this group an increase in the action potentials to 118-3 + 36-9% was observed (Fig. 7).
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In those animals with a partial neuromuscular block a significant improvement in their
successive muscle action potentials was observed 5-10 min after the intramuscular injection
of 50 /(g Tensilon (jP<0-05 for thymus-immunized, and PcO-02 for skeletal muscle-immu¬
nized animals, respectively). The tetanus pattern, however, remained subnormal. No marked
affect was found in the tetanus pattern of control animals after Tensilon (Fig. 8).
In the animals of Group B, two out of nine guinea-pigs immunized with heart muscle in
CFA showed a decline to 60-6+ 10-0% (mean + SD) in the right and to 71-4 + 2-2% in the
i 1
20 msec
Fig. 9. Muscle action potentials in the flexor digitorum following supramaximal nerve stimula¬
tion at a rate of 50/sec. The recordings were made before and after the injection of Tensilon in a
guinea-pig with thymitis 2 weeks after immunization with calf thymus in CFA. (a) Before the
injection of Tensilon the height of the tenth action potential is 32% of the first, (b) Ten minutes
after the injection of Tensilon the decremental response is markedly improved, the tenth muscle
action potential being 65% of the first. The height of the first action potential as shown is
foreshortened by the photographic tube.
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left front limb. Three out of eight animals immunized with skeletal muscle in CFA showed
a decline in their muscle action potentials over the first ten stimuli to 64+ 28-1% in the
right and to 51 + 11-7% in the left front limb. In four out of nine guinea-pigs immunized
with thymus in CFA, a decline was found to 62-8 + 29-6% in the right and to 66-9+ 10-7%
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Fig. 10. The change in a single compound muscle action potential after the injection of Tensilon
in animals ofGroups A and B. In guinea-pigs of Group B, the results for the individual animals
are shown as the mean of the recordings in the right and left front limbs. From the results
obtained in the control animals a rise in a single compound action potential after Tensilon of
more than 29% was unlikely (/><0 01). The action potentials of six guinea-pigs immunized
with thymus, six immunized with skeletal muscle and one immunized with heart muscle in
CFA showed a significant increase after the injection of Tensilon.
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difference in the muscle tetanus pattern was found between the front limbs with a decline
in the successive muscle responses to 78-9% in the right and to 40% in the left front limb.
In the control guinea-pigs of this group an increase in the successive muscle responses to
111-3 + 23-5% in the right and to 110-4+ 25-6% in the left front leg was recorded. A
similar increase to 113-1 ±17-5% in the right and to 110-4 + 20-1% in the left front limb
was found in those animals which were thymectomized and 1 week later immunized with
either thymus or skeletal muscle in CFA. Again after the injection of 50 jig Tensilon® a
significant improvement in the muscle tetanus pattern was observed in animals showing a
partial neuromuscular block (P<005, P<0-02 and P<0-01 for animals immunized with
heart muscle, skeletal muscle and thymus, respectively), but the tetanus pattern did not
revert to a completely normal picture in all animals (Fig. 9a and b). In the control animals
of this group no effect was seen (Fig. 8) after the injection of Tensilon.
In those animals of Group A in which a significant decline in the successive muscle
responses was observed, the height of a single muscle action potential following a single
nerve stimulus was 3-0 + 0-57 mV (mean + SD). This was not significantly different from the
mean height of a single action potential in the control animals of this group, 3-6 + 0-48 mV
(P>0-1). The mean height of a single action potential in guinea-pigs of Group B which had
shown a partial neuromuscular block during tetanic nerve stimulation was 7-17 + 2-84 mV
in the right and 7-14 + 3-85 mV in the left front limb. This was significantly different (P<0-01)
from the single muscle responses of 9-59 + 2-4 mV in the right and 10-85 + 6-24 mV in the
left front leg of the control animals and of the guinea-pigs thymectomized prior to immuniza¬
tion. The height of a single action potential in animals thymectomized prior to immunization
(with 12-44 + 6-02 mV right and 11-73 + 4-4 mV six out of eight) was not significantly different
(P>0T) from that recorded in the control animals of this group.
From the study in the control animals, it could be said that a rise in a single muscle
action potential after the intramuscular injection of 50 jig Tensilon by more than 29% would
be unlikely (PcO-01). However, out of the forty-six animals in Groups A and B, thirteen
guinea-pigs showed an increase in a single muscle action potential after the injection of
Tensilon beyond 29% with a range between 29 and 73%. All these animals had evidence of
a partial neuromuscular block during tetanic supramaximal nerve stimulation. In one guinea-
pig immunized with thymus in CFA, one immunized with skeletal muscle in CFA and in
one immunized with heart muscle in CFA with a significant decline in the successive muscle
responses during tetanic supramaximal nerve stimulation, an increase in a single action
potential of only 20-25% was recorded after the injection of Tensilon (Fig. 10).
DISCUSSION
In contrast to the negative findings published by Strauss (1963) and by Parkes (1966), who
were unable to produce a model of myasthenia gravis in experimental animals, the present
paper describes the production of thymic abnormalities and of partial neuromuscular block
in guinea-pigs by immunization with either calf thymus or calf skeletal muscle extract
emulsified in CFA. Our findings are similar to those reported by Goldstein & Whittingham
(1966, 1967).
The thymic abnormalities consisted of an accumulation of small and medium sized lymph¬
ocytes around the Hassall's corpuscles in the thymic medulla. This is referred to as a thymitis.
Germinal centres were not seen. A distortion of the fine reticulum fibre structure in the
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thymic medulla, with the formation of a reticulum fibre barrier at the cortico-medullary
border, did not always correspond with the presence of thymitis as described by Goldstein &
Whittingham (1967). Our own unpublished experiments as well as recent results obtained by
Goldstein & Hofmann (1968) and Goldstein, Strauss & Pickeral (1969) show that the
incidence of thymitis may be increased by immunization of rats or guinea-pigs with homo¬
logous thymus or skeletal muscle tissue in CFA.
Experimental thymitis was also produced in two out of nine animals immunized with calf
heart muscle in CFA which was, however, statistically not significantly different from the
control animals. Both these animals showed evidence of partial neuromuscular block. The
potency of heart muscle to initiate an experimental thymitis is probably due to a common
antigen shared by skeletal muscle, heart muscle and thymus myoid cells (Van der Geld
& Strauss, 1966; Beutner et ah, 1962). The low incidence of thymitis using heart muscle as
antigen may be explained by a smaller content of thymus specific antigens in heart muscle
tissue. In a careful study by Goldstein et at. (1969) on the capacity of thymus and skeletal
muscle tissue to induce experimental thymitis, thymic tissue was found to be much more
antigenic than skeletal muscle tissue, probably because of a smaller content of thymus
specific antigen in the muscle tissue.
Lymphorrhages in skeletal muscle and/or myocarditis have been described in about 23%
of myasthenia gravis patients (Fenichel, 1966; Mendolow & Genkins, 1954). Comparable
histological changes were only observed in one out of twenty-seven guinea-pigs immunized
with thymus in CFA which showed a lymphocytic infiltration in a muscle section from the
upper hind limb. In one out of twenty-five guinea-pigs injected with skeletal muscle in CFA
a local lymphocytic infiltration with necrosis of the muscle tissue was seen in the myocar¬
dium. Both these animals showed the features of experimental thymitis and a partial neuro¬
muscular block. In two out of nine animals immunized with heart muscle in CFA a local
lymphocytic infiltration in the myocardium was observed. The low incidence of myocardial
lesions in our experiments compared to that described by Davies et ah (1964) is probably
due to the different methods used for antigen preparation and to the different immunization
schedules. Furthermore, a higher incidence of myositis in skeletal muscle may have been
achieved if tissue had been examined from a larger selection of sites. None of the control
animals showed lymphorrhages in skeletal muscle or myocarditis.
We were not able to correlate the development of thymitis with any pattern of delayed
hypersensitivity or circulating antibody response. Guinea-pigs immunized with thymus or
lymph node in CFA developed serum autoantibodies reacting with the thymus lymphoid
cells but not with the myoid cells or with skeletal muscle or heart muscle probably because
of insufficient myoid antigen in the calf thymus extract used for immunization (Van der Geld
& Strauss, 1966). Guinea-pigs immunized with skeletal muscle or heart muscle in CFA
developed antibodies against the striations of skeletal muscle, cross-reacting with heart
muscle striations and thymus myoid cells. In this respect, the antibodies raised in the experi¬
mental animals had the same reactivity as serum antibodies found in patients with myasthenia
gravis. Flowever, in patients with myasthenia, there are two types of antibody reacting with
muscle antigen; one of them is complement fixing and reacts with skeletal muscle only and
the other is not complement fixing and reacts with both skeletal muscle and heart muscle
(Van der Geld & Strauss, 1966; Beutner et ah, 1962). Complement fixing antibodies reactive
with muscle antigens could not be produced in the guinea-pig.
A rapid decline in successive muscle responses to supramaximal nerve stimulation and
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reversion to a normal tetanus pattern in response to an anticholine-esterase drug is character¬
istic of myasthenia gravis (Harvey & Masland, 1941; Desmedt, 1966). We have confirmed
results reported by Goldstein & Whittingham (1966) that a similar pattern of a neuro¬
muscular block can be produced in experimental animals by immunological techniques.
More recently Goldstein & Hofmann (1968) have been able to demonstrate in rats with
experimental thymitis a decrease in the miniature muscle end-plate potentials which is
another characteristic feature of myasthenia gravis in man (Hofmann & Stemmer, 1963;
Thesleff, 1966).
In contrast to bipolar needle electrodes which are frequently used for electromyographic
recordings, we employed either Copeland-Davies clip electrodes or a fine twisted silver wire
drawn through the muscle as recording systems. Both these techniques were found to be
superior to bipolar needle electrodes for electromyography in guinea-pigs in terms of stability
in the recording of a constant number of muscle fibre action potentials during the test
procedure. Using Copeland- Davies clip electrodes a larger number of contracting units
were recorded than by the fine silver wire method. Both these methods, however, have the
same limitation as the bipolar needle electrodes in so far that they do not record the same
constant number of contracting units in different animals. This fact may explain why the
single action potential following supramaximal nerve stimulation in animals with experi¬
mental thymitis was not always significantly lower than the action potentials recorded in
the control animals. Thus, when these types of electrodes are used, the recording of the
muscle tetanus pattern during supramaximal nerve stimulation is the better parameter for
detecting partial neuromuscular block.
The fact that in some of the animals Tensilon did not significantly improve the height of
single compound action potentials and that in some animals with a partial neuromuscular
block Tensilon did not restore the tetanic muscle reaction to normal may have been due to
insufficient dosage of Tensilon, particularly as this was given intramuscularly. On the other
hand, in patients with myasthenia gravis Tensilon does not invariably restore neuromuscular
transmission to normal (Osserman & Genkins, 1966).
The occurrence of a marked difference in the muscle tetanus pattern in the front limbs of
one guinea-pig immunized with skeletal muscle in CFA suggests that the degree of neuro¬
muscular block produced in experimental animals may not be the same throughout the
whole of the skeletal musculature.
The presence of thymitis in all animals with a partial neuromuscular block and the
observation that a neuromuscular block could not be induced in thymectomized animals
by immunization procedures indicate that the thymus gland is important in the production of
experimental myasthenia gravis. Furthermore, in patients with myasthenia gravis of short
duration thymectomy may be beneficial. Thymectomy in animals with thymitis and partial
neuromuscular block has been shown to restore neuromuscular transmission to normal
within 3-4 days in contrast to hemi-thymectomy or sham-thymectomy in such animals when
it takes 7-10 days for the neuromuscular transmission to come back to normal (Kalden,
Williamson & Irvine, 1969 in preparation). These observations support the hypothesis that
an autoimmune mechanism may be important in at least some cases of myasthenia gravis.
Strauss et al. (1966) and Goldstein (1966) have suggested that the thymus may be a source
of a factor which has normally a regulative influence on neuromuscular transmission but
which blocks neuromuscular transmission when secreted in excess, as may happen in the
presence of thymitis. However, attempts to extract from the thymus a substance with such
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properties have so far produced only equivocal results (Wilson, Obrist & Wilson, 1953;
Rider, 1955; Parkes & McKinna, 1967; Goldstein, 1968).
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EXPERIMENTAL MYASTHENIA GRAVIS
Sir,—Dr. Vetters and his colleagues (July 5, p. 28)
report that they are unable to confirm the findings of
others 1-6 that experimental myasthenia gravis can be
produced by immunological techniques. These workers
might, perhaps, have referred to two important positive
contributions 4'5 published at the end of 1968 and at the
beginning of 1969. In the first of these Goldstein and
Hofman 4 demonstrated a significant decrease in the
miniature end-plate potentials, in association with thymitis,
in rats immunised with homologous-thymus extract in
complete Freund's adjuvant (c.f.a.). In the second paper,
Goldstein et al.5 showed that muscle tissue was effective
in producing thymitis and neuromuscular block in doses
down to 50 jig. while thymus was effective in amounts as
little as 5 |xg.
The production of thymitis is an essential step in pro¬
ducing partial neuromuscular block.1'6 It appears that
Dr. Vetters and his colleagues have not succeeded in
producing significant changes in the thymus, although
their immunisation procedure was similar to that used by
others.1-3'6 They do not mention whether their immunised
animals produced circulating antibodies or showed delayed
hypersensitivity to thymus or skeletal-muscle antigen.
Immunisation experiments are difficult to standardise
and it is hazardous to read too much into negative results
from one batch of animals.
1. Goldstein, G., Whittingham, S. Lancet, 1966, ii, 315.
2. Goldstein, G., Whittingham, S. Clin. exp. Immunol. 1967, 2, 257.
3. Oppenheim, T. J., Goldstein, G. Nature, Lond. 1969, 222, 192.
4. Goldstein, G., Hofman, W. W .J. Neurol. Neurosurg. Psychiat. 1968,
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A. Nerve Stimulation
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Fig. 1—Electromyographic response of rat forearm muscle to
indirect (A) and direct (B) supramaximal stimulation at a
rate of 50 per second.
The recording was made two weeks after immunisation with
homologous thymus in c.f.a.
Dr. Vetters and his colleagues raise a number of points
about electromyographic techniques. They found that
bipolar needle electrodes were not suitable for electro¬
myographic muscle recordings. We use either Copeland-
Davies clip electrodes 7 or a fine twisted silver wire." The
comment that the recording of the first 10 muscle responses
to a fast (fifty-per-second) train of stimuli is " not suitable
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Fig. 2—Electromyographic response of rat forearm muscle to
indirect (A) and direct (B) supramaximal stimulation at a
rate of 50 per second in a control animal.
for comparable measurements unless it can be guaranteed
that the muscle contraction is isometric," has been checked
in the following way. A recording of the first 25 muscle
responses to supramaximal nerve stimulation (routinely
done in all our experiments) gives the same results as
the first 10 successive muscle responses. In animals
showing a rapid decline in the first 10 muscle action
potentials during tetanic nerve stimulation, no significant
increase was observed thereafter. The same results were
obtained as regards the presence or absence of neuro-
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muscular block, whether the front limbs were fixed by pins
through the elbow joint and wrists, or whether the wrists
alone were fixed.
In the experiment illustrated in fig. 1, we studied the
first 10 successive muscle responses to supramaximal
nerve stimulation, and subsequently to supramaximal
direct muscle stimulation, in the flexor digitorum of both
front limbs. For stimulation and for recording a pair of
Copeland-Davies clip electrodes was used (diameter of
clip, 0-5 cm.). Indirect and direct stimulation was done
without altering the position of the recording electrodes.
We used female inbred Wistar rats of about 200 g. body-
weight, immunised with homologous thymus extract in
c.f.a. (11 animals), or with saline in c.f.a. (10 animals).
With indirect stimulation, 5 of the thymus-immunised
rats showed a significant (p<001) decline in the first 10
successive muscle responses, but a normal muscle tetanic
pattern when the flexor digitorum was stimulated directly.
All the animals with a partial neuromuscular block showed
thymitis on histological examination, as previously des¬
cribed.2'6'6 There was no significant decline in the first
10 muscle responses, nor any significant difference in the
muscle-reaction pattern to direct or indirect stimulation
in the control animals (fig. 2). These findings, which
indicate that a block in neuromuscular transmission may
indeed be produced in thymus-immunised rats, are in
keeping with the more precise experiments of Goldstein
and Hofman.4 But, if no thymitis is produced, there will
be no neuromuscular block.
M.R.C. Clinical Endocrinology Unit,
2 Forrest Road, Edinburgh. J. R. KALDEN.
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The Royal Infirmary,
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SUMMARY
Experimental thymitis and a partial neuromuscular block were
produced in guinea-pigs by immunisation with homologous thymus or
skeletal muscle tissue in complete Freund's adjuvant. A boosting
injection with the specific antigens three weeks after the initial immuni¬
sation did not markedly increase the incidence of thymitis or of partial
neuromuscular block.
In animals with a partial neuromuscular block, thymectomy was
followed by return of the muscle tetanus pattern to normal within two to
three days. In contrast, the partial neuromuscular block persisted for
fo r days after hemithymectomy and in some animals for as long as 10 days
after sham thymectomy.
These findings are in keeping with the hypothesis that experimentally
induced thymitis may result in the release of a factor from the thymus which
blocks neuromuscular transmission.
INTRODUCTION
An experimental model of human myasthenia gravis can be induced
in guinea-pigs or rats by immunisation with either thymus or skeletal
muscle homogenates emulsified in complete Freund's adjuvant (CFA)
(Goldstein & Whittingham, 1966, 1967; Goldstein & Hofmann, 1968;
Goldstein, Strauss & Pickeral, 1969; Kalden et al., 1969; Kalden & Irvine,
1969). Affected animals show both thymitis and a partial neuromuscular
block similar to that of human myasthenia gravis.
It has been demonstrated (Goldstein & Whittingham, 1966; Kalden
et al., (1969) that the development of the partial neuromuscular block in
the experimental animals is dependent on the presence of thymitis, and that
thymectomy prior to immunisation prevents the development of a block in
neuromuscular transmission.
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To establish further the pathogenic importance of the thymus in
relation to the partial neuromuscular block in experimental myasthenia
gravis, it was decided to investigate the effect of thymectomy, hemi-
thymectomy and sham thymectomy in guinea-pigs with electromyographic
evidence of a partial neuromuscular block occuring 14-16 days after the




Female Hartley guinea-pigs of 400-500 g. body weight derived from an
outbred strain from animal suppliers (London Ltd. ) were used for immuni¬
sation. Tissue antigens were prepared from young Hartley guinea-pigs
weighing about 100 g.
Antigen preparation
Fresh thymus, skeletal muscle and heart muscle tissue were homo¬
genised (20 ro w/v) in phosphate buffered saline pH 7.2. The homogenates
were centrifuged for 15 minutes at 2500 g. and the supernatants lyophilised.
The thymus and skeletal muscle tissue powders were prepared for injection
by dissolving the lyophilisates in distilled water to a concentration of 50 mg. /ml.
The tissue extracts and phosphate buffered saline, respectively, were emul¬
sified with equal volumes of complete Fruend's adjuvant (CFA) (Difco.).
Immunisation
Each animal was injected with 0. 1 ml. emulsion into each hind foot pad.
Fifteen animals immunised with thymus, and 15 animals immunised with
skeletal muscle (both in CFA) received tissue doses of 5 mg. Eight animals
immunised with heart muscle in CFA received a tissue dose of 8 mg.
Fifteen control animals were injected with phosphate buffered saline emulsified
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in CFA (fig. la, Table 1).
Guinea-pigs which did not show symptoms of a partial neuromuscular
block 14 days after the initial immunisation received the same amount of
the corresponding antigen in CFA three weeks after the initial immunisation.
Nine control animals received a boosting injection with saline in CFA
(fig. lb).
Immunofluorescence test
The indirect immunofluorescence test (Weller & Goods, 1954) was used.
Undiluted serum or serum dilutions 1:8 were applied to unfixed air-dried
cryostat sections of guinea-pig thymus, skeletal muscle and heart muscle
for 20 minutes. The sections were then washed in veronal buffer (pH 7.2)
for 30 minutes.
A polyvalent rabbit anti-guinea-pig gamma globulin serum (Hyland
Division, Travenol Laboratories, Los Angeles) was conjugated with
fluorescein isothocyanate isomer 1 (British Drug Houses Ltd., Poole, Dorset,
England) and subsequently dialysed as previously described (Kalden et al.,
1969). The protein-fluorescein ratio was found to be 0.5. The fluorescein
conjugated antiserum was applied in a dilution 1:8 for 20 minutes. After
a final wash for one hour in veronal buffer (pH 7.2) the sections were mounted
in 10 "a glycerol in saline and examined using a Gillet and Sibert microscope
with a 1#0V iodine-quartz lamp with primary filter 30/063 and ocular filter
10/285.
Histology
Specimens of thymus, diaphram and heart muscle were fixed overnight
in Carnoy solution and sections were prepared in the usual way and stained
with hematoxilin and eosin. Slides were read without knowledge of the
groups to which the animals belonged. A marked degree of lymphocytic
aggregation around the Hassall's corpuscles in the thymic medulla was
interpreted as thymitis (fig. 2a).
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Electromyography
Electromyographic recordings were made in both front limbs. For
stimulating and for recording, a pair of Copeland-Davies clip electrodes
were used (1 cm. across the clip) supplied by Electro - Physiological
Instruments Ltd., Edinburgh. The stimulating electrodes were clipped
through the shaved skin of the axilla so that the tips of the clips were close
to the median nerve. The recording electrodes penetrated the unexposed
flexor digitorum through the shaved skin and were placed as close together
as possible. In each animal at least three recordings from three different
muscle areas were made.
The nerve stimulation was supra-maximal with a pulse duration of
100 m. sec. In each instance a single compound muscle action potential
was observed at a sweep speed of 2 m. sec. /cm. For tetanus, a stimulation
frequency of 50/sec. was used and the first ten muscle action potentials
observed at a sweep speed of 20 m. sec. /cm. The first 25 muscle action
potentials were observed at a sweep speed of 50 m. sec./cm.
A double pulse unit (2 GIRO, Electro-Physiological Instruments Ltd.,
Edinburgh) was used for stimulation. The electromyographic response
was recorded with a 'Tektronix 564' storage oscilloscope with a '2B67'
time base and a '3A72' dual trace amplifier unit. Representative pictures
were taken with a 'Tektronic C-12 Land Polaroid' camera (Tektronic Inc.,
Portland, Oregon)i
Plan of experiments
Fourteen to sixteen days after the initial immunisation all the guinea-
pigs were anaesthetized with Nembutal 35 mg/kg body weight.
The 19 animals (fig. 1) which showed a neuromuscular block were
divided into three groups. Six of these animals were thymectomised at
day 15 and the electro-myographic studies repeated on the second and
third day after the operation.
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Five of the animals were hemithymectomised and eight were sham
thymectomised at day 16 after the initial immunisation. In both these
groups electromyography was repeated at days fourandten after the
operation.
The controls, immunized with saline in CFA, comprised six
thymectomized animals and nine unoperated animals.
In the case of the animals which did not show a partial neuromuscular
block 14-16 days after the initial immunisation, the electromyographic
studies were repeated one week after the boosting injection.
After the final electromyographic study the animals were killed with
o
chloroform and bled. The sera were stored at -20 C.
RESULTS
Incidence of neuromuscular block
The behaviour of the first ten muscle action potentials during supra¬
maximal tetanic nerve stimulation was used to study the neuromuscular
transmission. The ratio of the amplitude of the tenth to the first action
potential was noted. From the recordings in the 15 control animals a
decline in the height of the tenth action potential to less than 87 of the
first one seemed to be unlikely (P^O.Ol). Therefore 10 out of 15 guinea-
pigs immunised with thymus in CFA, 7 out of 15 immunised with skeletal
muscle in CFA and 2 out of 8 immunised with heart muscle in CFA were
regarded as having abnormal neuromuscular transmission (fig. la).
Of those animals which did not show a disturbance in the neuro¬
muscular transmission 14 days after the initial immunisation and which
had received a boosting injection on day 21, 1 out of 5 immunised with
thymus, 3 out of 8 immunised with skeletal muscle and 1 out of 6 immunised
with heart muscle were found to have a significant decline (P<.0.01) in the
successive muscle responses one week after the boosting injection (fig. lb).
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Height ot the actionpotential asX of first actionpotential during supramaximal





















































Electromyographic response to supra-maximal nerve stimulation
at a rate of 50/sec. The individual results shown are the means of the
readings in each front limb
a) 15 days after immunisation. From the recordings in the control animals
a decline in the height of the tenth action potential to less than 87 per cent of
the first was unlikely (PS0.01). Therefore, 10 of the guinea-pigs immunised
with thymus, 7 immunised with skeletal muscle and Z immunised with heart
muscle were considered to have a disturbance in neuromuscular transmission.
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Height of the tenth actionpotential aslof first, during supramaximal nerve
stimulation(50/sec.)2Bdays after the initial immunisation and 7days after








































The same as Fig. la but one week after a boosting injection on day 21
in animals without electromyographic evidence of a partial neuromuscular
block 15 days after the initial immunisation. The lower confidence limit
in the control animals was 88 per cent. Note that a boosting injection was
followed by a significant decline in successive muscle responses only in
one animal immunised with thymus, three animals immunised with skeletal
muscle and one guinea-pig immunised with heart muscle.
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Fig. 2a + b
Thymus histology and electromyographic record of a guinea-pig
immunised with homologous thymus tissue in C.F.A.
a) Thymus histology 15 days after immunisation. Note the dense
lymphocytic infiltration around the Hassall's corpuscles in the medulla.
This histological appearance is referred to as thymitis.
H & E x 100
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ELECTROMYOGRAPHIC RESPONSE OF GUINEA-PIG FOREARM
MUSCLE TO SUPRAMAXIMAL NERVE STIMULATION AT A
RATE OF 50/sec
A. Before Thymectomy
B. Three Days after Thymectomy
20m.sec
Fig. 2b
Muscle action potentials in the flexor digitorum following supra-*
maximal nerve stimulation at a rate of 50/sec. Note that before thymectomy
on day 15 after immunisation, the tenth muscle action potential is 53. 1 per
cent, of the first in contrast to the normal muscle tetanus pattern three days
after thymectomy.
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Fig. 3a + b
Thymus histology of electromyographic record of a control animal
immunised with saline in C. F. A.
a) In contrast to Fig. 2a normal guinea-pig thymus showing a
comparatively even distribution of lymphocytes throughout the thymic medulla.
H fa E x 100.
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ELECTROMYOGRAPHIC RESPONSE OF GUINEA-PIG FOREARM
MUSCLE TO SUPRAMAXIMAL NERVE STIMULATION AT A
RATE OF 50/sec
A. Before Thymectomy




Muscle action potentials in the flexor digitorum following supra¬
maximal nerve stimulation at a rate of 50/sec. In contrast to Fig. 2b
















































Fig. 4a + b
The effect of thymectomy (day 15), hemithymectomy (day 16) and sham
thymectomy (day 16) on the neuromuscular transmission of guinea-pigs with
evidence of a partial neuromuscular block at day 15 after the antigen injection.
For each individual control animal the mean of the recordings made on each
of the different post-operative days is shown. The nerve stimulation was
always supra-maximal at a rate of 50/sec.
a) Electromyographic recordings two and three days after thymectomy
in six control animals and six immunised animals. The lower confidence
limit in the control animals was 81 per cent. Note that within either two or
three days the muscle tetanus pattern of the animals with a partial neuro¬
















































Electromyographic recordings four days and ten days after a
hemithymectomy or sham thymectomy. From the recordings in the
unoperated controls, a decline in the height of the tenth action potential
to less than 75 per cent, of the first was unlikely (PS0.01). In contrast
to Fig. 4a three of the hemithymectomised animals and seven of the sham
thymectomised animals still showed electromyographic evidence of a
partial neuromuscular block after four post-operative days. L four sham
thymectomised animals a partial neuromuscular block was still demonstrable
ten days after the operation.
TABLE1
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The effect of thymectomy, hemithymectomy and aham thymectomy
As shown in fig. 2b and 4a thymectomy in all six animals with
a partial neuromuscular block was followed by a complete reversion of
the tetanus pattern to a normal picture within either two or three days.
No changes were found in the muscle tetanus pattern before and after
thymectomy in the control animals (fig. 3b and fig. 4a).
In the case of the five guinea-pigs with a partial neuromuscular
block which were hemithymectomised 16 days after the initial immunisation,
three animals were still showing four days after the operation a significant
decline in the successive muscle responses to supra-maximal nerve
stimulation (fig. 4b). However, 10 days after hemithymectomy the muscle
tetanus pattern had returned to normal in all the guinea-pigs.
Seven of the eight animals with a partial neuromuscular block
which had been sham thymectomised 16 days after immunisation still showed
evidence of a partial neuromuscular block 4 days later. In 4 of these the
partial neuromuscular block was still present 10 days after sham thymectomy
(fig. 4b).
The mean amplitudes of a compound single action potential to supra¬
maximal nerve stimulation recorded in the controls and in the different
groups of immunised animals before and after thymectomy, hemithymectomy,
sham thymectomy or a boosting injection were not significantly different from
each other (P always > 0.05).
Incidence of thymitis
Table 1 shows the incidence of thymitis in the immunised and control
guinea-pigs obtained at different times after the primary antigen injection
or 1 week after a boosting injection on the 21st day after the initial immuni¬
zation. The incidence of thymitis in 10 out of 15 animals immunised with
thymus in CFA and in 10 out of 15 animals immunised with skeletal muscle
in CFA is significantly higher (P< 0. 02) than the incidence in the control
animals (3 out of 15). The occurrence of thymitis in 3 out of 8 animals
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immunised with heart muscle in CFA was not significant when compared with
that in the control animals.
Correlation between partial neuromuscular block and thymitis
All the immunised guinea-pigs with a partial neuromuscular block
which were thymectomised or hemithymectomised 15 and 16 days after the
immunisation showed histological evidence of thymitis. However, although
by day 26 (which is 10 days after the operation) none of the 5 hemithymectomised
animals had evidence of a partial neuromuscular block (fig. 4b), thymitis
was still present in the second thymus lobe in two of these animals (Table 1).
Thymitis was present in all four of the eight sham thymectomised guinea-
pigs which still had evidence of a partial neuromuscular block 10 days after
the operation (i.e. 26 days after the immunisation) (fig. 4b).
In animals with no evidence of abnormal neuromuscular transmission
14 days after the primary antigen injection a boosting injection three weeks
after the initial immunisation induced a thymitis in 1 out of 5 immunised
with thymus, 4 out of 8 immunised with skeletal muscle and in 2 out of 6
immunised with heart muscle (Table 1). With the exception of one animal
immunised with skeletal muscle and one immunised with heart muscle all
the guinea-pigs with thymitis also developed a partial neuromuscular block
(fig. lb).
Muscle histology
One of the animals immunised with thymus showed a focal inflamm¬
atory reaction in the diaphram and one of the animals ijnmunised with
skeletal muscle and one immunised with heart muscle showed a myositis
in the diaphram and a focal myocarditis. A focal myocarditis was also
found in three guinea-pigs which has been immunised with heart muscle
and which had received a boosting injection. No abnormalities in skeletal
muscle of myocardium were noted in the remaining test or control animals.
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Immunofluorescence for serum antibodies
Undiluted serum from nearly all the test and control animals gave
an immunofluorescence staining of thymus lymphocytes and of the cross
striations of skeletal and heart muscle. When the sera were diluted 1:8
only 3 out of 15 thymus immunised animals gave a definite reaction with the
cytoplasm of thymus lymphocytes and 3 out of 15 skeletal immunised guinea-
pigs with the cross striations of skeletal muscle and of heart muscle and with
the cytoplasm of thymus myoid cells. Four out of eight animals immunised
with heart muscle showed only a weak reaction with the cross striations of
heart muscle tissue when the sera were diluted 1:8. None of the sera of the
control animals showed positive immunofluorescence at this dilution.
Positive controls were performed using guinea-pig sera with a hightitTe of
skeletal muscle or thymus lymphocyte antibodies.
DISCUSSION
Immunisation with either homologous or heterologous thymus
or skeletal muscle homogenates in CFA has been shown to be effective in
inducing a thymitis and a partial neuromuscular block in guinea-pigs and
rats (Goldstein & Whittingham, 1966, 1967; Goldstein et al., 1969; Kalden
et al., (1969). The autoimmune nature of the experimental thymitis has
been further established by the production of thymitis in inbred Lewis rats
immunised with histo-compatible Lewis rat thymus (Goldstein and Hofmann,
1968). The effectiveness of skeletal muscle and of heart muscle as antigens
in the production of thymitis has been explained on the basis of a common
antigen in skeletal muscle, heart muscle and thymus myoid cells (Van der
Geld & Strauss, 1966, Beutner et al,, 1962).
The development of abnormal neuromuscular transmission in the
immunised animals has been shown to be dependent on the presence of
thymitis (Goldstein and Whittingham, 1966, Kalden et al., 1969). It has been
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suggested that the partial neuromuscular block in the immunised animals
is caused by a factor secreted from a thymus which is the site of an
immunopathogenic thymitis. Goldstein and Hofmann (1969) have published
experimental evidence showing that the thymus may secrete a factor which
may have physiological importance in the regulation of neuromuscular
transmission. However, attempts to extract from thymus tissue a substance
influencing neuromuscular transmission have so far produced only equivocal
results (see Goldstein, 1968, for references).
In the present experiments, evidence for a partial neuromuscular
block in test and control animals was looked for by electromyography using
Copeland-Davies clip electrodes as the recording system. In this system
the parameter for detecting a partial neuromuscular block is the recording
of the muscle tetanus pattern during supra-maximal nerve stimulation.
Since the number of single muscle fibre units picked up during a recording
is dependent on the particular location of the clip electrodes, the height of
a single compound muscle action potential does not give any specific
information about a pathological change in the neuromuscular transmission.
The results presented in this paper give further support to the
hypothesis that the thymus which is the site of an immunologically induced
thymitis may indeed be the source of a neuromuscular blocking factor.
Thymectomy in animals with a disturbance in neuromuscular transmission
15 days after immunisation was followed by reversion of the muscle tetanus
pattern to normal within two or at most three days. In contrast, the block
persisted for at least four post-operative days in all the animals subjected
to hemi or sham thymectomy and for 10 post-operative days in half of the
sham thymectomised animals.
In human myasthenia gravis thymectomy is most likely to be
beneficial in young female patients with thymitis (referred to as thymic
dysplasia by Goldstein, 1966) and when the operation is performed shortly
after the onset of the disease (Simpson, 1958; Keynes, 1954). Thymectomy
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is likely to be of little help if the duration of the disease has been long with
irreversible structural changes in the motor endplates (Woolf, 1966), or in
the muscle fibres (Fenichel, 1966) or if ectopic thymus tissue is present
(Harvey, 1948; Fisher, 1964).
The fact that only half of the sham thymectomised animals still
showed a neuromuscular block 10 days after the operation (that is 26 days after
the immunisation) correlates with the transcience of experimental thymitis.
The brief duration of experimental thymitis produced by immunisation with
either thymus tissue or skeletal muscle tissue in CFA is comparable to that
of experimental thyroiditis (Jones & Roitt, 1961).
No attempt was made to grade the severity of thymitis within the
medulla of the gland. The number of histological sections of each thymus was
limited and it is therefore possible that a focal leBion may have been considered
to be generalised. This is the most likely explanation for the fact that not all
the animals with histological evidence of thymitis had a partial neuromuscular
block. It may also explain why histological evidence of thymitis was present
10 days after the operation in one of the 8 sham thymectomised guinea-pigs,
although in these guinea-pigs the muscle tetanus pattern had returned to
normal.
As reported in relation to other experimental animal models of
auto allergic disease, such as experimental adrenalitis (Andrada et al., 1968),
immunisation of the guinea-pigs with one injection of thymic tissue in CFA
seemed to suffice for the development of a high incidence of thymitis and
subsequently of a neuromuscular block (Table 1, fig. 1). In the case of
immunisation with skeletal muscle tissue in CFA, however, 4 out of 8
guinea-pigs developed thymitis after a boosting injection three weeks
following the initial antigen injection. Three of these animals had evidence
of a neuromuscular block. One explanation for this enhancing effect of the
boosting injection could be the smaller amount of antigen reactive with thymus
in skeletal muscle tissue used for the initial immunisation (Goldstein et al., 1969)
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In the present experiments homologous tissue extracts were used
for immunisation and only weak antibody titres were found in a small number
of the immunised animals. These results, which demonstrate the lack of
correlation between the incidence of experimental thymitis and circulating
auto-antibodies, are in keeping with other animal experimental models
(Terplan et al., 1961; Andrada et al., 1968; Davles et al., 1964).
Some recent publications (Vetters et al., 1969; Kaufman et al.,
1969) deny that a myasthenia-like 3yndrome can be induced in experimental
animals by immunological techniques. However, these papers do not give
a histological description of thymitis. According to the hypothesis discussed
above a partial neuromuscular block would not be expected in the absence of
experimental thymitis.
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SUMMARY
Adult and 5-day-old New Zealand Black (NZB) and Ju control strain mice were
injected with sheep red blood cells. At various times after injection they were
killed and the spleens, lymph nodes and thymus tested for haemolysin-producing
cells. When the response was expressed as plaque-forming cells (PFC) per million
viable cells, the response curve of the spleens of baby NZB mice was very similar
to the response in the spleens of the adults, and the response in the lymph nodes
of the babies was as high and more sustained than that of the adults. In Ju control
strain baby mice of this age, the response in the spleen and the lymph nodes was
both reduced and delayed compared with the adults. Neither strain gave a signifi¬
cant response in the thymus. The spleen and lymph nodes of adult NZB mice
showed a response which was delayed but not reduced as compared with the adults
of the Ju control strain, whereas in baby NZB mice the spleen and lymph nodes
showed a response which was advanced and increased (particularly in the lymph
nodes) compared with control strain babies (Ju, Swiss, C57B1, CBA). The NZB
mice did not reach this level of responsiveness until they were 4-5 days old.
INTRODUCTION
New Zealand Black (NZB) mice are a strain developing spontaneous autoimmune haemo-
lytic anaemia and other manifestations of autoimmunity (Helyer & Howie, 1963; Holmes
& Burnet, 1963; Howie & Helyer, 1965; Mellors, 1966a). They provide a useful experimental
system for the study of idiopathic autoimmune disease. Autoimmune disorders may,
theoretically, be caused by defects or abnormalities in the antibody-forming system, and
in NZB mice structural abnormalities of the thymus (Abbot & Burnet, 1964; Burnet &
Holmes, 1964; Siegler, 1965), spleen (Holmes & Burnet, 1963; East, de Sousa& Parrott, 1965)
and the lymphoid system in general (East el ah, 1965; Mellors, 1966b) suggest this as an
explanation.
Correspondence: Mrs M. M. Evans, Medical Research Council Clinical Endocrinology Research Unit,
2 Forrest Road, Edinburgh, 1, Scotland.
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Functional abnormalities of the antibody-forming system have been investigated by
studying the response of the animal to heterologous antigens. Diener (1966) has found that
the spleens of adult NZB show a reduced and delayed response to sheep red blood cells
compared with a control strain. Playfair (1967) in similar experiments with baby NZB found
an increased response compared with controls. The present experiments explore these
results further, in particular comparing the response curve of the babies in spleen, lymph
nodes and thymus with that of the adults.
MATERIALS AND METHODS
Animals
NZB mice have been maintained at M.R.C. Clinical Endocrinology Research Unit for
five generations. They are a stock which was obtained from the Department of Surgical
Science, University of Edinburgh, where they had been bred for five generations since being
obtained from Dr M. Bielschowsky in New Zealand. They have been inbred by sibling
matings for over sixty generations altogether.
Ju mice, which were used as a control strain, are also maintained at CERU. They are a
stock developed by the Department of Animal Genetics, University of Edinburgh, and have
been inbred by sibling matings for over forty generations. They do not produce autoanti¬
bodies to red blood cells.
The Swiss mice used in this study were a non-inbred closed colony maintained by CERU.
C57BI and CBA mice were kindly provided by Dr J. Carr of the British Empire Cancer
Campaign.
Antigen challenge
Adult mice were 150-320 days old when challenged at which time many of the NZB
animals showed serum anti-red cell autoantibodies detectable by the Coombs test. Adult
mice were injected intraperitoneally with 0-25 ml (approximately 4x 109) washed, packed
sheep red blood cells (SRBC) and were killed between 2 and 8 days after injection.
Baby mice were challenged at 5-6 days old, except where stated otherwise. They were
injected intraperitoneally with 0-025 ml washed, packed SRBC, and were killed 3-9 days
after injection. Mice represented on the figures as being killed at 0 days were uninjected
controls.
Detection of antibody-forming cells
The mice were killed with ether, partially bled out and the spleens, limb-draining lymph
nodes and, in some animals, the thymus, were removed, placed in ice-cold Eagle's medium
and disrupted by gentle homogenization in a Griffith tissue grinder. The viable cells,
identified by using a trypan blue exclusion test, were counted on a haemocytometer. A
slightly modified form of the Jerne, Nordin & Henry (1963) technique was used for the
detection of haemolytic plaque-forming cells (PFC). 0-1 ml of lymphoid cell suspension,
I drop 1:15 v/v SRBC and 1 drop preserved guinea-pig serum (Stayne's) were added to
0-5 ml 0-6% agar in Eagle's medium at 47°C and immediately spread over a glass slide on
a level surface. When the agar had set, the slides were incubated at 37°C for 2 hr and the
number of plaques counted under a dissecting microscope in dark field. Where the volume
of cell suspension allowed, five replicates were done for each tissue.
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Analysis of results
Logarithmic means were calculated for each point (0 being treated as 1) and the standard
error is shown. Where significant differences are stated they are at the 5°/ level and have
been calculated by the randomization method. Regression lines were plotted for Fig. 4, and
the significance of the differences in the regression coefficients was determined at the 5%
level.
RESULTS
Fig. 1 shows the response curves of the spleen of both strains of adult mice and 5-day-old
baby mice injected with antigen. The responses of the adult and baby NZB mice both rose
Fig. 1. The immune response of the spleen, expressed as plaque-forming cells (PFQ/106
viable cells, (a) NZB, and (b) Ju mice. Adult mice (•) were injected with 0-25 ml packed washed
SRBC. Baby mice (o) were injected with 0 025 ml packed washed SRBC at 5 days old. The mice
were killed 2-9 days after injection. The points are logarithmic means, the limits represent the
standard error and the numbers in parentheses indicate the number of animals.
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to a maximum at 5-6 days after injection, the adults producing a log mean response of
363 PFC/106 viable cells and the babies 194 PFC/106. There was no significant difference
between the adults and babies at 5, 6 or 7 days after injection, showing that the response
of the baby NZB mouse was very similar to that of the adult NZB. The peak response of
the adult Ju mice occurred 4 days after antigen challenge with a mean of 480 PFC/106 viable
(3)./ (3)0 (5)„ (!0)o , i (4)y,
02 456789
Days since injection
Fig. 2. The immune response of the lymph nodes, expressed as PFC/106 viable cells, (a) NZB,
and (b) Ju mice. Adult mice (•) were injected with 0-25 ml packed washed SRBC. Baby mice
(o) at 5 days old were injected with 0-025 ml packed washed SRBC. The mice were killed 2-9
days after injection. The points are logarithmic means, the limits represent the standard error
and the numbers in parentheses indicate the number of animals.
cells, while the babies did not reach their peak response until 7 days after antigen challenge
when they gave a mean of only 49 PFC/106 viable cells—one-tenth that of the adults. This
difference is significant. The adult NZB reached their maximum response 1-2 days later
than the Ju adults, but the difference in the peak heights is not significant. The baby NZB
mice showed their maximum response 1-2 days before the baby Ju mice and the peak is
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significantly higher. The number of plaques produced by the uninjected Ju mice was negli¬
gible. The number of plaques produced by the uninjected NZB mice, both adults and babies,
was greater than that of the Ju mice but in only two cases (one adult and one baby) was the
number of PFC greater than 3/106 viable cells.
Fig. 2 shows the response of the lymph nodes. The adult NZB mice showed the peak of
their response at 6 days after antigen challenge with a mean of 110 PFC/106 viable cells









Fig. 3. The immune response of the spleens and lymph nodes of various strains of baby mice:
■ , NZB; □, Ju; x , Swiss; a, C56B1; a, CBA. They were injected at 5 days old with 0-025 ml
packed washed SRBC and killed at various times after injection. The results are expressed either
as the number of PFC/106 viable cells in the organ or as the number of PFC per whole spleen
or per the dissected lymph nodes (the same ones in all cases) from each animal. The points are
logarithmic means, the limits represent the standard error and the numbers in parentheses
indicate the number of animals.
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355 PFC/106 viable cells and this number was not reduced by 9 days. The difference in the
height of the response of the adult and baby NZB mice at 6 days is not significant, but the
difference at 7 and 8 days is. The adult Ju mice reached their peak response at 5 or 6 days
after the challenge with a mean of 126 PFC/106 viable cells, while the baby Ju mice did not
reach their peak until 8 days with a mean of only 11 PFC/106. This difference is significant.
There is also a significant difference between the heights of the peaks of the adult Ju and
NZB at 5 days, but none at 6 days. The peak in antibody production in the baby NZB mice
occurred 1-2 days before that in the baby Ju mice and the peak in the baby NZB mice was
significantly higher. The lymph nodes of the uninjected mice gave negligible responses in
all cases.
In many of these mice the thymus was also tested, but in no case was there more than a
very slight increase in the numbers of PFC and in the few cases where this occurred it could




3 4 5 6 7 8 9
Days since injection
Fig. 4. The number of viable cells in the spleens and dissected lymph nodes (the same ones
in all cases) of baby NZB and baby Ju mice. They were injected at 5 days old with SRBC and
killed at various times after injection. The points are logarithmic means and the limits represent
the standard error. The lines were plotted by regression. ■, NZB spleen; □, Ju spleen; a, NZB
lymph nodes; A, Ju lymph nodes.
To ensure that the difference in response in the spleens and lymph nodes of the two strains
of baby mice was not due to a peculiarity in the Ju control strain rather than the NZB mice,
baby C57B1, CBA and Swiss mice were tested at 6, 7 and 8 days after injection. Fig. 3 shows
the results for the babies of all strains, plotted as PFC/106 viable cells or as PFC per whole
spleen or dissected lymph nodes (the same ones in all cases). It can be seen that the organs
of the babies of the other control strains gave responses which were similar to the Ju or
which differed even more from that of the baby NZB mice.
When the number of viable cells per spleen or in the dissected lymph nodes was plotted
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against time (Fig. 4), the spleens were found to be the same size and to grow at the same
rate in baby mice of NZB and Ju strains (the difference in the regression coefficients not
being significant), but the lymph nodes were found to grow significantly faster in the baby
NZB mice.
Baby mice were injected with SRBC neonatally or when 3 or 5 days old and were tested
6 days after injection. The results (Table 1) suggest that immunological reactivity is not
fully developed until the mice are 4-5 days old.
The plaques produced by the baby mice were smaller than those produced by the adults,
and the plaques produced by the lymph nodes of the babies were smaller than those produced
by the spleen, suggesting that the baby mice produced less antibody per active cell than the
adults.
Table 1. The immune response of the spleen and the lymph nodes of baby
NZB mice challenged with 0 025 ml washed packed SRBC at 0, 3 and 5






Individual mice log mean Individual mice log mean
0 0, 1, 1-5, 76 3-3 0, 0, 0, 77 3 0
3 57, 40, 8, 3-5 30 450, 435, 132, 8 120
5 868, 341, 314, 289,
76, 75, 50, 44
155 913, 745, 455, 304
266, 127, 75
DISCUSSION
Hechtel, Dishon & Braun (1965) have shown that AKR mice do not produce PFC to
SRBC when challenged younger than 5 days old, and that Ha/ICR and C57B1 mice do not
respond when younger than 7 and 10 days, respectively. They have also shown that the
spleen develops competence before the lymph nodes. Their findings are not inconsistent
with the results for the Ju baby mice in the present experiments, where the response in
lymph nodes and in the spleen was very much reduced and delayed compared with that in
the adults. The results obtained with other strains suggest that this is probably a typical
immature response of the mouse. The NZB babies show a very different pattern. Even when
challenged at 5 days old the spleen gives a response very little different to that of the adult
while the lymph nodes give a response which is more sustained than that given by the adult
animals. The difference in peak height given by lymph nodes from baby and adult animals
was not statistically significant.
Artificial tolerance is produced more easily and with longer lasting effects if the tolerance
producing stimulus is given in the neonatal period (see Nossal, 1966) and its maintenance
seems to depend upon the persistence of antigen in the animal (Aust, Rogers & Guttman,
1965; Mitchison, 1965). It is tempting to speculate that natural tolerance may also be due
to the exposure of the immunological system to small amounts of self-antigens at an age
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when it is not capable of responding by antibody formation, thus inducing tolerance which
is maintained in later life by the self-antigens present in the system. If this were the case,
early maturation or hyperactivity of the immunological system could result in natural
tolerance being less firmly established and thus in a tendency to autoimmunity. This explana¬
tion is probably too simple and it does not explain why the mice are several months old
before showing signs of autoimmune disease, nor why the tolerance should break down only
toward specific tissues.
It is likely that the thymus is involved in the development of autoimmunity. In normal
mice the thymus is necessary both for the appearance of lymphocytes in the peripheral
tissues and for their sensitization to antigen, although it does not appear to be necessary
for the proliferation of the cells once they are sensitized (Miller, Mitchell & Weiss, 1967;
Zinzar & Svet-Moldavsky, 1967). In NZB mice the thymus shows definite abnormalities.
In young mice the reduction of the epithelial component has been reported (de Vries &
Hijmans, 1967) and in adult mice 'germinal centres' have been found in the medulla (Abbot
& Burnet, 1964; Burnet & Holmes, 1964; Seigler, 1965), although from the present experi¬
ments it seems that these do not produce antibody to heterologous antigens. The relationship
of the thymus to the development of autoimmunity in NZB mice is not yet clear. It does
appear to have a positive effect since grafts of neonatal NZB thymus into the newborn of
other strains induce autoimmunity to develop in the recipients later in life, and grafts of
neonatal thymus from normal strains into newborn NZB mice do not prevent the appearance
of autoimmunity (Howie & Helyer, 1966). Neonatal thymectomy does not prevent the
appearance of autoimmunity (Holmes & Burnet, 1966; Howie & Helyer, 1966; East et at.,
1967a), showing that the thymus has either affected the immune system before birth or that
the thymus is not the only organ involved. Transfer of thymus cells from autoimmune
adults to young non-autoimmune NZB mice does not induce autoimmunity although spleen
cells similarly transferred will do so (Holmes, 1965), suggesting that the thymus is only
effective in the juvenile state or that the mice are only susceptible when very young. A
possible explanation is that the thymus induces an abnormal state of immunological
responsiveness in the lymphocytes of the embryo and baby NZB mice, perhaps by premature
appearance of the humoral factor. This abnormality is revealed a few days after birth by
the rapid appearance of immunological responsiveness which may be greater than in the
mature normal animal and by the degeneration of epithelial cells in the thymic medulla.
It is impossible to say whether the early competence of the immunological systems of
NZB mice is the direct cause of the later development of the autoimmune state or simply
another effect of an underlying dysfunction but it seems at least that the basis of the disorder
lies in some developmental abnormality of the antibody forming system, whether genetically
determined (Bielschowsky & Bielschowsky, 1964; Burnet & Holmes, 1965) or induced by
the virus particles found in axenic NZB mice (East et al., 1967b; Mellors & Huang, 1967).
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SUMMARY
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Twenty one day old rats were hypophysectomised or sham operated
and challenged with sheep red blood cells 5 or 21 days after operation.
Although the sizes of the bodies and lymphoid organs were greatly
decreased in the hypophysectomised animals no significant difference
was found in the numbers of plaque forming cells or serum antibody titres
against the sheep red blood cells. The histology of the hypophysectomised
rats showed a cell depletion in the perifollicular zone of the spleen follicles,
but no obvious histological differences in the thymus.
It is concluded that pituitary hormones are not directly necessary for
the formation of humoral antibodies.
INTRODUCTION
Observations in experimental animals of the effects of treatment
with different hormones on the thymus and peripheral lymphatic tissue
suggests that a critical hormone balance regulates the growth and develop
ment of these organs (Ernstrdm, 1965; Branceni, 1968; Dougherty, Berliner,
Schneebeli and Berliner, 1964; Bearn, 1968). The involutionary effect of
corticosteroids and gonadal hormones (Branceni, 1968; Dougherty et al. ,
1964; Warner and Burnet, 1961; Lundin, 1958) seems to be antagonised by
growth promoting and developmental hormones such as growth hormone and
thyroxin (ErnstrOm, 1965; Lundin, 1958).
More recently, Pierpaoli and Sorkin (1967a) demonstrated changes in
the hypophysis in neonatally thymectomised mice suggesting a functional
relationship between the hypophysis and the thymus. Other experiments
using mice treated with antiserum to pituitary hormones (Pierpadli and Sorkin,
1967b, 1968, 1969 a, b) or using a hypopituitary dwarf strain of mice (Baroni,
1967; Baroni, Fabris and Bertoli, 1967, Pierpaoli, Baroni, Fabris and
Sorkin, 1969) suggests a relationship between immune function and .the pituitary.
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It was decided to elucidate further the role of pituitary hormones by
testing the effect of the removal of the pituitary on the immune response to
sheep red blood cells (SRBC).
MATERIALS AND METHODS
Animals
Male Sprague-Dawley strain rats hypophysectomised or sham
hypophysectomised at the age of 21 days were obtained from the Charles
River Breeding Laboratories Inc., Boston, Mass., U.S.A. When the
animals were killed the completeness of hypophysectomy was determined by
macroscopic observations of the pituitary fossa, by palpation of the gonads
and by regression in the weight of the adrenals and the whole body. Animals
with pituitary remnants, unregressed gonads, or high body or adrenal
weight were rejected.
Antigen Challenge
Rats were injected intraperitoneally with 0. 1 ml. washed packed sheep
9
erythrocytes (SRBC) (2 x 10 ) 5 days after hypophysectomy or sham operation
(26 days old). In a later experiment the animals were injected with the
same quantity of SRBC at 21 days after hypophysectomy (42 days old) and for
this experiment the controls were unoperated Sprague-Dawley rats of the
same age.
Detection of immune response
The rats were killed 4, 7 and 10 days after injection in the case of the
rats injected 5 days after operation, and 6 days after injection in the case of
the rats injected 21 days after operation. The rats were weighed and blood
taken for assay of serum haemolysin and haemagglutinin titres. The serum
o
was stored at -20 C until the experiments were complete, and estimations
made at the same time on all the sera. Spleens, thymuses and adrenal
glands were removed and weighed. Twenty thymuses and 4 spleens of
hlypophysectomised and 12 thymuses and 4 spleens of sham operated animals
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were fixed in Carnoy solution overnight. The sections were stained with
Haematoxylin and Eosin. The remainder of the spleens were assayed for
haemolysin plaque forming cells (PFC) by the method of Jerne, Nordin
and Henry (1963) as modified by Evans, Williamson and Irvine (1968).
Serum protein
Standard methods (Ouchterlony, 1967) were used for immunoelectro-
phoresis. The antiserum used was a polyvalent goat anti-rat-gamma¬
globulin serum (Highland Division, Travenol Lab. Inc., Los Angeles,
California). The slides were washed and dried and stained with Amido Black.
Quantitative cellulose acetate electrophoresis was kindly performed by the
Chemistry Department, Royal Infirmary, Edinburgh, by standard methods.
Statistical analysis
Geometric means and standard errors of all parameters were
determined, and the significance of the differences calculated by Student 't'
test. P> 0.05 were classed as not significant.
RESULTS
The effect of hypophysectomy on body and adrenal weight
The effectiveness of hypophysectomy was clearly evident when the
weights of the body and lymphoid organs (Fig. 1) and of the adrenals
(Table 1) were compared in hypophysectomised and sham operated animals.
Fig. la shows the weights of the rats at 4, 7 and 10 days after injection,
that is 30, 33 and 36 days of age or 9, 12 and 15 days after operation. The
weights of the sham operated animals continued to increase, while that of
the hypophysectomised animals began to decrease between 12 and 15 days
after operation. The same trends were seen for the adrenal weight. The
differences between both the mean body and adrenal weights of the sham
operated and hypophysectomised animals were significant at the p < 0. 001
level, at the three time intervals.
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Fig- 1
The sizes of the body and the lymphoid organs of hypophy-
sectomised (0 -- 0) and sham operated (0 0) rats. (a) Body weight;
(b) thymus weight; (c) spleen weight; (d) number of viable spleen cells
£
x 10 . The rats were operated on at 21 days of age, challenged with
sheep red cells 5 days after operation and measured 4, 7 and 10 days
after antigen challenge. The points are geometric means, the limits
are standard errors and the number of animals in each group is indicated
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The effect of hypophysectomy on the structure of the lymphoid organs
Fig. lb and Fig. lc show the weights of the thymuses and the spleens
of the same rats. Obvious differences were seen between the hypophy-
sectomised and the sham operated animals and these differences were
significant at the p < 0.001 level (except in ti.s case of the thymus weight
7 days after injection, where the difference was only significant at the
0.01 level). Again the weights of the lymphoid organs of the sham operated
animals increased over the period of the experiment, while those of the
hypophysectomised animals began to decrease between 12 and 15 days after
operation. This difference was particularly marked in the spleen.
Furthermore, in proportion to the total body weight, the spleens in the
hypophysectomised animals were significantly smaller than in the sham
operated controls (p < 0.001). Although the thymuses were also proportion¬
ately smaller in the hypophysectomised animals the difference compared
to the controls did not reach statistical significance.
The results for the viable cell count per spleen were similar to those
obtained by measuring the weight of the spleen. The differences between
the hypophysectomised and sham operated animals were again significant
at the p < 0.001 level.
Histology
In the spleen the outstanding feature was an atrophy of the follicles
with a cell depletion in the perifollicular zone. No obvious histological
changes were found in the thymus.
The effect of hypophysectomy on the function of the lymphoid organs
Fig. 2 shows the results when the spleens of the hypophysectomised
and sham operated animals were assayed for plaque forming cells. At no
time and by none of the methods of calculation were the results for the
hypophysectomised and sham operated rats significantly different from one
another.
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Fig- 2
Plaque forming cells in hypophysectomised (0 -- 0) and sham
operated (0 0) rats. (a) PFC per 10^ viable spleen cells, (b) PFC
per whole spleen, (c) PFC per gm. body weight, (d) PFC per mg.
spleen weight. The rats were operated at 21 days of age, challenged
with sheep red cells 5 days after operation and measured 4, 7 and 10
days after antigen challange. The points are geometric means, the
limits are standard errors and the number of animals in each group is
indicated in parenthesis on graph (a).
IX : 71
TIME SINCE INJECTION (DAYS)
Fig. 3
Serum antibody response of hypophysectomised (0 -- 0) and
sham operated (0 0) rats. (a) Reciprocal haemagglutinin titres,
(b) reciprocal haemolysin titres. The rats were operated at 21 days
of age, challenged with sheep red cells 5 days after operation and
measured 4, 7 and 10 days after antigen challenge. The points are
geometric means, the limits are standard errors and the number of
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As shown in Fig. 3 there was no significant difference in the
haemolysin titres in the hypophysectomised versus sham operated controls
following challenge with sheep red cells (day 4 after injection p > 0. 1, day 7
p >0.4, day 10 p > 0.2 ). The haemagglutinin titres in the sham operated
and hypophysectomised animals on days 4 and 10 were not significantly
different (p < 0.2, p< 0. 5 respectively) but on day 7 there was a difference
which just reached significance (p < 0. 05). Taking the other results into
consideration it is doubtful that this indicates an important difference between
the hypophysectomised and sham operated animals.
In case the five days that we had allowed to elapse between hypophy-
sectomy to become fully apparent (although considering the effects on the
weight of the animals and the weight of the lymphoid organs, this does not
seem likely), six animals were injected at 21 days after hypophysectomy
and tested six days after injection. The controls for this group were eight
unoperated Sprague-Dawley rats of the same age. Once again the weights
of the bodies and of the spleens were significantly lower in the hypophy¬
sectomised animals, while the antibody response was not (Table 2).
Serum protein
Quantitative electrophoresis revealed no significant differences in
the content of any of the serum fractions between the hypophysectomised
and control animals. The sera from all the animals challenged with
antigen five days after hypophysectomy was subjected to immunoelectro-
phoresis using a polyvalent anti-rat-gammaglobulin serum. No differences
in the gammaglobulins of the hypophysectomised and control animals were
observed.
DISCUSSION
From the marked changes in the adrenal and total body weights and
from autopsy inspection of the pituitary fossa, it is clear that hypophysectomy
was effective. Even if microscopic amounts of pituitary tissue had remained,
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Lundin (1958) has shown histologically that such animals show no
differences in the lymphatic tissue compared to totally hypophysectomised
animals.
Our experiments show that there was no significant difference in
the immune response of Sprague-Dawley rats hypophysectomised at 21 days
of age and challenged with sheep red blood cells 5 or 21 days later, when
compared to controls. The half lives in the plasma of growth hormone (GH)
(Cornblable et al. , 1965) and thyroid stimulating hormone (TSH) (Kirkham,
1966) are 20-30 minutes although the biological activity may last somewhat
longer. Therefore pituitary hormones are unlikely to be directly necessary
for the immune response.
Since the spleens of the hypophysectomised animals are significantly
smaller than the spleens of the sham operated controls, it would be expected
either that the reduction has occurred in antibody-forming cells to an equal
degree with the non-antibody-forming cells in which case total PFC would be
reduced, or that the reduction has been only in the non-antibody-forming cells
in which case the proportion of PFC would be increased in the hypophysectomise
animals. Since the results suggest that both these have occurred to a slight
degree it is concluded that while reduction in size and cellularity of the spleen
involves some of the antibody-forming elements it involves a larger proportion
of non-antibody-forming cells.
The spleens of the hypophysectomised animals showed an atrophy of
the lymph follicles with a loss of the parafollicular area which is in agree¬
ment with other observations in hypophysectomised animals (JLundin, 1958;
Ernstrbm, 1965). However, as Osoba and Miller, (1964) originally showed
in neonatally thymectomised animals, cellular depletion of the spleen does not
result in reduction of the immune response provided the thymic humoral factor
is present. The cellular depletion of the lymphoid tissues observed in
hypophysectomised animals may be part of a generalised phenomenon since
it has been shown by Crean (1968) that hypophysectomy in 4-6 week old rats
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causes a reduction in the stomach weight and in the mass of the gastric mucosa
with a proportional decrease in the number of the parietal cells.
It has been suggested (Baroni et al. , 1967; Pierpaoli et al. , 1969;
Pierpaoli and Sorkin, 1968, 1969a, b) that thyroxin and/or growth hormone
may play a role in the immune response. This hypothesis is based on two
main lines of experimentation. The first involves the hereditary pituitary
dwarf Snell-Bagg mouse. These animals, when compared to normal litter
mate controls, show an extreme reduction in the ability to produce PFC to
sheep red cells (Baroni, 1967; Baroni et al. , 1967; Pierpaoli et al. , 1969).
The response could be restored to normal by treatment with growth hormone
or thyroxin, or most successfully with both together (Pierpaoli et al. , 1969).
The other line of experimentation involves the treatment of mice with anti-
pituitary, anti-GH or anti-TSH sera. This resulted in a wasting syndrome
in most of the mice treated at 15-30 days old, similar to that seen in neonatally
thymectomised mice (Pierpaoli and Sorkin, 1967b, 1968, 1969a, b).
Although our animals virtually stopped growing they did not show wasting.
In addition, Pierpaoli et al. , (1969) and Pierpaoli and Sorkin (1969a) have
reported an absence of production of precipitating antibody to rabbit gamma¬
globulin in young male Charles River mice of 5-8 weeks of age treated with
anti-GH or anti-TSH sera. These responses could be restored to normal
by treatment with either GH or TSH.
The most probable explanation, and one which Pierpaoli et al.(1969)
have also suggested, is that the hormones act in the development of immune
responsiveness (perhaps by influencing the thymic control of the maturation
of the peripheral antibody-forming organs) and that once the animals are
immunologically mature, the action of the hormones is no longer necessary.
Indeed, Pierpaoli et al. (1969) have mentioned preliminary experiments in
the dwarf mouse strain, indicating that after 20 days of hormone treatment,
reconstituted dwarf mice did not lose their antibody-forming capacity for at
least 30 days. This is analogous to the case for thymectomy.
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This hypothesis could explain the results with the hypopituitary dwarf
mice, but not the results with anti-GH and anti-TSH treatment. In the latter
experiments some of the mice were treated at an age which was comparable
to that when our rats were hypophysectomised. Therefore, either the anti-
GH and anti-TSH sera worked by cross reaction with an antigen in some
other tissue (perhaps a minor but important component of lymphoid tissue)
or, alternatively, strain differences between their mice and our rats may be
important. The results with the dwarf mice could be due to a pleieotropic
effect of the dw gene and the reconstitution of the immune response with the
pituitary hormones due to a non specific growth or metabolism-promoting
effe ct.
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SUMMARY
Experimental thyroiditis was produced by a single injection of homologous
thyroglobulin in Freund's complete adjuvant when this was given along with an
intracutaneous injection of Bordetel/a pertussis vaccine. Severe thyroid lesions
were observed as early as 8 days. There was no significant difference in the inci¬
dence and severity of thyroiditis and antibody formation when the thyroglobulin
was injected into lymph nodes or into a hind footpad.
INTRODUCTION
Pertussis vaccine has been shown to have an enhancing effect on the development of
experimental autoallergic diseases in laboratory animals (Lee & Olitsky, 1955; Levine &
Wenk, 1967, 1968; Hargio, Malkiel & Berkelhammer, 1968; Paterson & Drobish, 1968).




Female inbred Wistar rats 4-6 weeks old were obtained from animal suppliers (London)
Ltd, and used for immunization.
Immunization schedule
According to the injection route animals were immunized either with 0-1 ml of an
emulsion containing 2 mg rat thyroglobulin in Freund's complete adjuvant (CFA) into a
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hind footpad or by the injection of 0-01 ml emulsion containing 0-2 mg of rat thyroglobulin
in CFA in each of two cervical lymph nodes using a 28-gauge needle and a tuberculin
syringe. Control animals received the same volumes of an emulsion of saline and CFA.
The animals were killed 8, 14 and 17 days after the immunization. Half the animals immun¬
ized into a hind footpad were injected with 2x 109 Borcletella pertussis organisms intra¬
dermal^ into the dorsum of the same foot used for antigen injection. Half the rats immun¬
ized into two cervical lymph nodes were also injected with 2x 109 B. pertussis organisms
intradermally into the inner site of the neck skin. The pertussis vaccine injections were
always made immediately after the antigen administration. A concentrate of pertussis
vaccine containing 80 x 109 organisms/ml was generously supplied by Wellcome Research
Laboratories, Langley Court, Beckenham, England.
Circulating antibodies
Immunofluorescence and tanned red cell tests were employed for the detection of thyroid
circulating antibodies as previously described (Kalden et al., 1968).
Histology
The rat thyroids were fixed in formol saline (4%) and stained with haematoxylin and
eosin (H & E). The degree of thyroiditis was scored as follows: — = normal thyroid
structure, + = focal thyroiditis, + + = more severe thyroiditis, + + + = diffuse thy¬
roiditis with altered thyroid structure, and + + + + = severe thyroiditis with goitre. The
arithmetic mean score of the thyroid lesions is given for each group.
RESULTS
Histology
As shown in Table 1 the injection of B. pertussis vaccine immediately after the antigen
injection increased significantly (FcO-OOl) the incidence and severity of the thyroid lesions.
Regardless of the route of antigen injection severe thyroiditis was found as early as 8 days
after immunization provided B. pertussis was used (mean scores 2-3 and 3 for immunization
into lymph nodes or into a hind footpad, respectively) (Fig. 1). The highest mean score
3-2 of thyroid lesions was found 17 days after immunization in rats immunized into a hind
foot. There was no significant difference in the grade of thyroiditis in rats immunized by
the intra-lymph node injection route and rats immunized in a hind footpad with or without
the additional use of B. pertussis vaccine.
When B. pertussis vaccine was not used as an additional adjuvant only mild thyroiditis
was produced in rats immunized via the cervical lymph nodes or hind footpad.
Circulating antibodies
Rats immunized with thyroglobulin and CFA produced higher (R<0-02) thyroglobulin
antibody titres when B. pertussis vaccine was used as additional adjuvant. Production of
thyroglobulin antibodies was apparent by 8 days.
The finding with the indirect immunofluorescence test using fixed rat thyroid sections
confirmed the results obtained by the tanned red cell test. Immunofluorescence using
unfixed thyroid sections did not detect any antibody against rat thyroid cytoplasm.
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Fig. 1. Thyroid of a rat 8 days after the immunization with 2 mg rat thyroglubulin in Freund's
complete adjuvant into a hind footpad followed immediately by the intradermal injection of
2x 109 B. pertussis organisms. Note the severe inflammatory reaction (grade 4) with involve¬
ment and destruction of the follicles. H & E, x 96.
DISCUSSION
The observation of a more rapid and more severe production of experimental thyroiditis
in rats when B. pertussis vaccine is given along with the antigen injection is in keeping with
the findings reported briefly by Paterson & Drobish (1968) who used a crude thyroid
extract in CFA for immunization. The present paper indicates that moderate to severe
thyroiditis may be established within 8 days with the production of circulating thyro-
globulin antibody but not thyroid complement fixing antibody.
In agreement with Home & White (1968) and in contrast to Newbold (1964, 1965), we
could not show any superiority of the intra-lymph node injection route over the usual
footpad injection in terms of induction of cell mediated hypersensitivity and circulating
antibody response. One advantage of the intra-lymph node route is the smaller amount of
antigen needed for the production of specific organ lesions and circulating antibody.
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SUMMARY
The auto-allergic thyroiditis produced in rats by the injection of rat thyroglobulin
in complete Freund's adjuvant can be suppressed by the administration of the
IgG immunoglobulin fraction of heterologous (horse) anti-lymphocytic serum
(ALS-IgG). ALS-IgG also suppressed the formation of circulating antibodies
against rat thyroglobulin.
INTRODUCTION
The ability of anti-lymphocytic serum to suppress a variety of cell mediated and humoral
immune responses is well documented and has been recently reviewed (James, 1967, 1968).
In particular it has been demonstrated that anti-lymphocytic serum suppresses the develop¬
ment of autoallergic encephalomyelitis (Waksman, Arbouys & Arnason, 1961; Leibowitz,
Lessop & Kennedy, 1968), of Freund adjuvant arthritis (Currey & Ziff, 1966, 1968) and of
haemolytic anaemia in NZB mice (Denman, Denman & Holborow, 1967). The present




Two- to 3-month-old male rats derived from a random bred Wistar strain maintained in
the breeding station of the University of Edinburgh were used for immunization.
Preparation of thyroglobulin
Rat thyroids (stored at — 20°C prior to use) were minced and then disrupted in 2 volumes
of phosphate-buffered saline, pH 7-2, in a ground glass homogenizer. The resultant suspen¬
sion was centrifuged at 4°C for 10 min at 30,000 g and the crude thyroglobulin was precipi¬
tated from the supernatant with ammonium sulphate (saturation between 40 and 42%).
The precipitate was dialysed and freeze dried.
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Preparation of anti-rat lymphocyte serum and normal horse IgG
The ALS was produced in a horse by the intravenous injection of thoracic duct lympho¬
cytes obtained following the cannulation of random bred Wistar rats. The horse received six
injections at weekly intervals followed by a seventh injection after a further 2 weeks. Each
injection consisted of 1-2-1 -5 x 109 cells of which 87-95% were viable. Two weeks after the
last injection, the animal was bled and the serum obtained was inactivated by incubation at
56°C for 30 min.
Immunoglobulin G fractions were prepared from this antiserum and from normal horse
serum by a combined salt precipitation and chromatographic procedure. The initial step
involved the precipitation of a crude globulin concentrate by the addition of 1 volume of
28% (w/v) sodium sulphate. The precipitate was re-dissolved in 0-15 m-sodium chloride and
re-precipitated as above. This material was then dissolved in and dialysed against 0-02 m-
phosphate buffer, pH 6-5, and then batched as Whatman DE11 diethyl-aminoethyl cellulose
exchanger with an ion exchange capacity of 1-0 mEq/g. The final products were concentrated
by lyophilization and reconstituted when required in 0-06 m-phosphate buffered saline, pH
7-2, containing 0-15 m-sodium chloride. The 1 g/100 ml anti-lymphocytic IgG solution so
obtained was then absorbed with one-quarter its volume of rat erythrocytes to remove
erythrocyte agglutinins. Both preparations of the ALS-IgG and normal horse IgG (NH-
IgG) were finally sterilized by filtration through an 0-22 mp millipore filter. Immunoelectro-
phoretic analysis using a rabbit anti-horse serum indicated that the products contained
several IgG components. The reciprocal lympho-agglutination and lymphocytoxic titres of
the anti-rat lymphocyte IgG were both 256 while the normal horse IgG possessed negligible
amounts of anti-lymphocyte activity (Abaza & Woodruff, 1966).
Immunization schedule
Each of the thirty rats was injected intracutaneously into the base of the tail with 0-05
ml emulsion containing 2 mg of the rat thyroglobulin preparation in complete Freund's
adjuvant (CFA). The injection was repeated 21 days later. Ten control rats were immunized
with 0-05 ml saline in CFA and injections were also repeated 21 days later. The animals were
killed after 4 weeks and serum stored at — 20°C.
Treatment schedule
The thirty test animals were divided into three equal groups. Taking the time of the first
sensitization to rat thyroglobulin as day 0, the first group of ten animals was injected
with 3 ml of 1 g/100 ml ALS-IgG solution intraperitoneally on days —3, —2 and — 1. From
day 2 on and on every 2nd day thereafter, these animals were given 2 ml ALS-IgG solution
intraperitoneally. The second group of test animals (ten animals) were treated with 1 g/100
ml NH-IgG solution following the same schedule. The third group of ten test animals
received no treatment. One of these animals died. A further group of ten control rats
received saline in CFA but were not treated with ALS-IgG or NFI-IgG (Table 1).
Detection of circulating antibody
Tanned sheep red cells were sensitized with one of the following antigens: (1) 2 mg/ml rat
thyroglobulin, (2) 5 mg/ml solution of ALS-IgG, or (3) 5 mg/ml solution of NH-IgG, and
incubated overnight at room temperature with doubling dilutions of the sera from the test
and control animals (Herbert, 1968).
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The indirect Coombs test was also employed to detect antibody to thyroglobulin. Goat anti-
rat y-globulin (Hyland Division, Travenol Laboratories Inc., Los Angeles) was conjugated
with fluorescein isothiocyanate and incubated with cryostat sections of rat thyroid 4-6
thick and fixed in methanol at 56°C for 3 min. In order to test for complement fixation,
fixed thyroid sections were incubated with inactivated test sera and guinea-pig complement
and then with anti-guinea-pig complement serum conjugated with fluorescein isothiocyanate.
Both of these immunofluorescence methods were also employed to unfixed sections of rat
thyroid to detect thyrocytoplasmic antibody in the test sera.
Histology
The thyroid gland, thymus, lymph nodes and spleen were fixed overnight in Carnoy
solution and the sections were stained by haemotoxlin and eosin (H & E), methyl-green-
pyronine, and PAS. The kidneys were fixed in formol saline (4%) and stained with H & E
alone.
Scoring of thyroiditis
The degree of thyroiditis was scored as follows:
— = Normal thyroid structure.
+ = Focal thyroiditis.
+ + = More severe thyroiditis.
+ + + = Diffuse thyroiditis with altered thyroid structure.
+ + + + = Severe thyroiditis with goitre.
The arithmetic mean score for each group of animals was obtained by totalling the
number of ' + 's for the thyroid lesions and dividing by the number of animals. The thyroid
sections were randomized before they were read.
Absolute lymphocyte counts were obtained from total white cell haemocytometer counts
and differential counts on Pappenheim stained blood smears and are expressed as counts per
cubic millimeter blood.
RESULTS
Treatment with ALS-IgG prevented the development of thyroiditis in response to sensitiza¬
tion with thyroglobulin in CFA. Rats sensitized with rat-thyroglobulin in CFA and treated
with saline developed histological evidence of thyroiditis with the mean score of 1-4, and a
similar degree was seen in thyroglobulin immunized rats treated with NH-IgG (mean score
1-0) (Fig. 1). In contrast, the thyroid of animals treated with ALS-IgG closely resembled
those of animals given only saline in CFA (Table 1).
Furthermore, ALS-IgG also prevented the development of antibody to thyroglobulin in
rats subsequently sensitized with rat thyroglobulin in CFA. NH-IgG had no such effect
(Table 2). The tanned red cell titres in the animals sensitized with rat thyroglobulin CFA that
were not given any heterologous globulin ranged up to 1: 1280 and, in those animals given
NH-IgG, the titres ranged up to 1:640. None of the tanned red cell titres was positive in
those immunized rats that received ALS-IgG treatment.
The findings with the indirect immunofluorescence test using fixed rat thyroid sections
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Fig. 1. (a) Thyroid of a rat treated with normal horse IgG and subsequently sensitized to
rat thyroglobulin in CFA. Note the inflammatory reaction with involvement and destruction
of some follicles. H & E, x 85. (b) Thyroid of a rat treated with horse anti-rat lymphocytic
IgG and subsequently sensitized to rat thyroglobulin in CFA. The thyroid shows an intact
structure. FI & E, x 85.
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confirmed the results of the tanned cell method insofar that staining of the colloid was not
seen in the animals treated with ALS-IgG, except in one doubtful case.
Immunofluorescence using unfixed thyroid sections did not detect any antibody against
rat thyroid cytoplasm whether or not the sensitized animals had been treated with ALS-IgG.
Table 1. The effect of anti-rat-lymphocytic serum (ALS-IgG) on the production of experimental
thyroiditis in the rat by sensitization with rat thyroglobulin in complete Freund's adjuvant
No. of Severity of thyroiditis* Meant
Sensitization Treatment rats — score
- + ++ +++ ++++
Rat thyroglobulin Saline 9 3 2 2 1 1 1-4
+ CFA
Rat thyroglobulin NH-IgGt 10 4 3 2 1 0 1 0
+ CFA
Rat thyroglobulin ALS-IgG§ 10 9 1 0 0 0 0-1
+ CFA
Saline+ CFA None 10 10 0 0 0 0 0
* Gradation of thyroid lesions as described under 'Materials and methods',
t Lesions were scored as follows: — =0;+ = 1;+ + =2;+ + + = 3;+ + + =4.
% Normal horse IgG.
§ Anti-rat-lymphocytic serum.
Likewise, indirect immunofluorescence methods did not demonstrate any fixation of
complement in the control and sensitized animals either with regard to the colloid or to the
thyroid cytoplasm.
Fig. 2 shows the fall in the absolute peripheral lymphocyte count in animals treated with
ALS-IgG in contrast to the animals given no treatment or only normal horse serum. Four
Table 2. The effect of ALS-IgG on the production of antibody to thyro¬







9 Rat thyroglobulin None 6
+ CFA
10 Rat thyroglobulin NH-IgG 5
+ CFA
10 Rat thyroglobulin ALS-IgG 0
+CFA
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hours after a single injection of ALS-IgG, there was a significant fall in the peripheral
lymphocyte count and this depression was maintained with continuous treatment for
approximately 3 weeks after which it rose to almost normal levels in spite of continuing





Fig. 2. The effect of various treatments on the peripheral lymphocyte count in immunized rats.
Note the rapid initial fall in the animal group receiving anti-lymphocytic IgG and its eventual
recovery. A, Horse anti-lymphocyte globulin; +, normal horse IgG; O, no treatment.
Although the ALS-IgG suppressed the formation of anti-thyroglobulin antibodies, it
failed to suppress the development of circulating antibodies against itself. The antibody titres
against horse immunoglobulin determined by the tanned red cell method were equally high
in rats treated with ALS-IgG or NH-IgG (Table 3).
Table 3. Tanned cell titres of antibodies to horse immunoglobulin in
rats after 4 weeks treatment with NH-IgG or ALS-IgG
No. of
rats Treatment
No. of rats and titre of antibodies
<1:20 1:20 1:1280 1:2560
10 NH-IgG 10
10 ALS-IgG 9 1
19 None 18 1
I II I II I I I II I 3
i i i i i i i i i i i i i i i i i i i i i i i- i i
10 17 21 24 lTJ
I I *
Injection of 2mg rot Boosting injection of 2mg
thyroglobulin in C FA rot thyroglobulin in C FA
The spleen and lymph nodes of one of the ALS-IgG treated rats showed lymphocytic
depletion and a decrease in the number of germinal centres. Histological examination of the
kidneys showed no abnormalities in any of the experimental animals.
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DISCUSSION
Chronic thyroiditis in man is closely associated with autoimmune phenomena in which the
mechanisms of humoral antibody formation and of delayed hypersensitivity are involved
(Glynn & Holborow, 1965). In animals, thyroiditis can be produced experimentally by
sensitization with thyroglobulin in complete Freund's adjuvant (Witebsky & Rose, 1956;
Terplan et al., 1960; Jones & Roitt, 1961).
Anti-lymphocytic serum is known to suppress the production of delayed hypersensitivity
and of primary antibody formation (reviewed by James, 1967, 1968). The observations
reported in the present paper confirm that this is so in relation to autoimmune experimental
thyroiditis in rats. These observations are in keeping with studies previously reported on
autoimmune allergic encephalomyelitis in guinea-pigs (Waksman et al., 1961; Leibowitz
et al., 1968). ALS has also been shown to prevent the development of Coombs positivity in
NZB mice if treatment is commenced at 2 months of age (Denman et al., 1967). In contrast,
however, these investigators also showed that ALS was ineffective in suppressing Coombs
positivity in NZB mice once this has developed. Furthermore, anti-lymphocytic-globulin
treatment also failed to prevent the onset of renal disease in (NZB x NZW) Fj hybrid mice
(Denman, Denman & Holborow, 1966). Indeed, in animals treated with ALS, the albumi¬
nuria was more pronounced than in control animals receiving normal IgG. However, as
suggested by Denman et al. (1966) it is possible that ALS treatment commencing at an
earlier age than 3 months could prove to be effective. ALS has also been shown to prevent the
development of Freund's adjuvant arthritis in rats (Currey & Ziff, 1966, 1968) but again was
relatively ineffective in suppression of already established disease.
Studies are now in progress in our laboratory to determine whether ALS has any sig¬
nificant effect on previously induced experimental thyroiditis in rats. It may be anticipated
from the known properties of ALS that it might have relatively little effect on circulating
thyroglobulin antibody titres. In this context, it is of particular interest that Leibowitz et al.
(1968) noted that the clinical signs of autoimmune allergic encephalomyelitis could be
suppressed by the administration of ALS, but there was no change in the appearance of the
brain lesions including perivascular infiltration of inflammatory cells. The same authors were
also able to demonstrate that treatment of already paralysed animals with ALS was capable
ofprolonging the survival time in four out of eleven animals with marked improvement of the
physical manifestations. Again there was no improvement of the brain lesions.
The rapid initial fall in the peripheral lymphocyte count of animals following ALS
administration and subsequent recovery, even during prolonged treatment, has been widely
observed (reviewed by James, 1968). Recently these observations have been attributed to
repopulation of the lymphocyte pool by short-lived small lymphocytes, the number of long-
lived immunologically completent lymphocytes remaining markedly depleted (Denman,
Denman & Embling, 1968).
The rat treated by ALS-IgG or NH-IgG developed antibodies against horse IgG but these
antibodies had no effect on the immunosuppressive properties of ALS-IgG. In spite of the
high antibody titres against horse immunoglobulin, there were no signs of serum sickness or
of anaphylactic reactions during the course of treatment. No histological changes were
observed under light microscopy in the kidneys of the ALS-IgG treated rats.
In man, ALS treatment is associated with a number of local and systemic complications,
the most troublesome being severe pain at the site of the injection and thrombocytopenia
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(Starzl et al., 1967; Kashiwagi et al., 1968) and in dogs there is evidence of nephrotoxicity
(Iwasaki et al., 1967). Therefore, the use of ALS in patients with autoimmune diseases of the
organ-specific type (such as chronic thyroiditis) should await the further study of its applica¬
tion in established experimental thyroiditis in animals and the development of less toxic and
more specific ALS preparations.
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SUMMARY
The autoallergic thyroiditis produced in rats by the injection of rat thyro-
globulin in Freund's complete adjuvant can be suppressed by the administration
of the IgG immunoglobulin fraction of heterologous (horse) anti-lymphocytic
serum when treatment is started immediately after the antigen injection. In con¬
trast anti-lymphocytic IgG failed to prevent the development of thyroiditis when
given only 4 hr after the antigen nor did it show any suppressive effect on
previously induced thyroiditis. Similar results were obtained when anti-lympho¬
cytic IgG treatment was tested for its effect on the primary immune response to
rat thyroglobulin.
INTRODUCTION
Recent investigations have clearly demonstrated that heterologous anti-lymphocytic
antibody preparations will suppress the development of a number of experimentally
induced or spontaneously occurring autoimmune diseases providing that the treatment is
commenced prior to the induction or onset of the disease (Denman, 1969). These include
autoallergic encephalomyelitis (Waksman, Arbouys & Arnason, 1961; Leibowitz, Lessof &
Kennedy, 1968a, b), autoallergic thyroiditis (Kalden et ai, 1968), Freund's adjuvant
arthritis (Currey & Ziff, 1968) and the autoimmune haemolytic anaemia of NZB mice
(Denman, Denman & Holborow, 1967). In contrast to the above, anti-lymphocytic anti¬
body has been found to be relatively ineffective in established autoimmune diseases (Den¬
man et a!., 1967) or if treatment was delayed until after the administration of the inducing
antigenic preparation (Currey & Ziff, 1968). However, it has recently been shown that anti-
lymphocytic antibody may have certain beneficial effects in established autoimmune
diseases for it was found to protect guinea-pigs from the paralysis accompanying experi¬
mentally induced allergic encephalomyelitis even though it did not significantly suppress the
histological lesions (Leibowitz et ah, 1968a, b). Because of these observations and the
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growing use of anti-lymphocytic antibody therapy in the treatment of autoimmune disorders
in humans (Pichlmayr el al., 1968; Traeger et al., 1968; Trepel et al., 1968) it seemed
desirable to study the effect of this material on another established autoimmune disease
namely, autoallergic thyroiditis in rats. In addition experiments have also been performed
to determine the capacity of anti-lymphocytic antibody to prevent the development of auto¬
immune thyroiditis if administered shortly after the inducing antigen.
MATERIALS AND METHODS
Animals
Two to 3-month-old female rats derived from an inbred Wistar strain from Animal
Suppliers (London Ltd) were used for immunization.
Preparation of antigen and antibody
The preparation and properties of the rat thyroglobulin, horse anti-rat lymphocytic IgG
and normal horse IgG were the same as previously described (Kalden et al., 1968). The
reciprocal lympho-agglutination and lymphocytotoxic titres of the anti-rat lymphocyte
IgG were both 256 while the normal horse IgG possessed negligible amounts of anti-
lymphocyte activity.
Immunization schedule
Fifty rats were injected with 0-1 ml emulsion containing 2 mg rat thyroglobulin prepara¬
tion in Freund's complete adjuvant (CFA) into a hind footpad. Immediately after
the antigen injection each animal received 2xl09 Bordetella pertussis organisms intra¬
dermal^ into the dorsum of the same foot. Ten control animals were immunized with 0-1
ml saline in CFA and were also injected with 2x109 B. pertussis organisms.
Treatment schedule
The rats were divided into six groups and treated as shown in Table 1. Animals in Groups
1 and 2 were injected intraperitoneally with 2 ml of 1 g/100 ml anti-lymphocytic (A) or
normal horse (B) immunoglobulin G. The initial injection was given at the same time
(Groups 1A and I B) or 4 hr after (Groups 2A and 2B) the injection of the rat thyroglobulin
and thereafter on alternate days, the rats receiving a total of eight injections. Animals of
Groups 3 and 4 received daily intraperitoneal injections for 7 days of 2 ml of I g/100 ml
normal horse IgG or of 1 g/100 ml anti-lymphocytic IgG solution respectively commencing
on day 17 after immunization while rats of Group 5 received a similar course of treatment
with normal sterile saline. The control rats (Group 6) which were immunized with saline
in CFA received no treatment.
Detection of circulating antibodies
Tanned sheep cells were sensitized with one of the following antigens: (1) 2 mg/ml rat
thyroglobulin, (2) 2 mg/ml solution of normal horse IgG, or (3) 5 mg/ml solution of anti-
lymphocytic IgG, and incubated overnight at room temperature with doubling dilutions of
this sera from the test and from the control animals (Herbert, 1967).
The indirect Coons test was also employed to detect antibody to thyroglobulin. Goat
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anti-rat y-globulin (Hyland Division, Travenol Laboratories Inc., Los Angeles) was con¬
jugated with fluorescein-isothiocyanate and incubated with cryostat sections of rat thyroid
4-6 n thick and fixed in methanol at 56°C for 3 min. The conjugation of the anti-serum
with fluorescein isothiocyanate was done as previously described (Kalden et at., 1969b).
The protein-fluorescein ratio was 0-5. The immunofluorescence method was also used with
unfixed sections of rat thyroid to detect thyrocytoplasmic antibody in the test sera.
Histology
The thyroid gland, thymus, spleen and kidneys were fixed in formol saline (4%) and
sections were stained by haematoxylin and eosin (H & E).
The scoring of thyroiditis was as follows:
— = normal thyroid structure;
+ = focal thyroiditis;
+ + = more severe thyroiditis;
+ + + = diffuse thyroiditis with altered thyroid structure; and
+ + + + = severe thyroiditis with goitre.
The arithmetic mean score for each group of animals was obtained by totalling the
number of' + 's for the thyroid lesions and dividing by the number of animals. The thyroid
sections were randomized before they were read.
Absolute lymphocyte counts were obtained from total white cell haemocytometer counts
and differential counts on Pappenheim stained blood smears and are expressed as counts per
cubic millimeter blood.
RESULTS
From Table 1 and Fig. 1(a) it will be observed that treatment with anti-lymphocytic IgG
Table 1. The effect of anti-rat-lymphocytic serum (ALS-IgG) on the development and on previously induced
experimental autoallergic thyroiditis in rats
Days
between Mean Significance
Group Sensitization* No. of Treatment Start of sensitiza¬ Score of between the
(using CFA) animals treatment tion and thyroid different
killing lesionsf groups!
1A Rat thyroglobulin 5 ALS-IgG ±0 17 0-2 P<0-01
IB 5 NH-IgG 2-0 NS§
2A Rat thyroglobulin 5 ALS-IgG + 4 hr 17 2-1 NS
2B 5 NH-IgG 20 NS
3 Rat thyroglobulin 10 ALS-IgG + 17 days 24 2-4 NS
4 Rat thyroglobulin 10 NH-IgG + 17 days 24 2-3 NS
5 Rat thyroglobulin 10 Saline + 17 days 24 2-4 NS
6 Saline 10 — — 24 0-3 P<0001
* Plus 2x 10g B. pertussis organisms.
t Gradation of thyroid lesions as described under 'Materials and methods'.
{ Student's /-test.
§ NS, Not significant.
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Fig. 1. (a) Thyroid of a rat after a course of treatment with horse anti-rat lymphocytic IgG
started immediately after immunization with 2 mg rat thyroglobulin in CFA. The thyroid shows
an intact structure, (b) Thyroid of a rat after a course of treatment with horse anti-rat lympho¬
cytic IgG started 4 hr after immunization with 2 mg rat thyroglobulin in CFA. There is a
marked inflammatory reaction with involvement and destruction of the follicles. H & E, x 92.
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Fig. 2. (a) Thyroid of a rat after a course of treatment with sterile saline commencing 17 days
after immunization with 2 mg of rat thyroglobulin in CFA. (b) Thyroid of a rat after a course
of treatment with horse anti-rat lymphocyte IgG commencing 17 days after immunization with
2 mg of rat thyroglobulin in CFA. Note in both pictures the similar degree of severe inflam¬
matory reactions with involvement and destruction of follicles. H & E, x 92.
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prevented the development of thyroiditis in rats in response to sensitization with thyro-
globulin in CFA provided this was started immediately after antigen administration (mean
score of thyroid lesions 0-2). In contrast anti-lymphocytic IgG failed to suppress the develop¬
ment of autoallergic thyroiditis when treatment was delayed until 4 hr after immunization
(mean score of thyroid lesions 2-1) (Fig. lb). Furthermore anti-lymphocytic IgG did not
show any suppressive effect on already established thyroiditis when it was injected daily
for 1 week starting on day 17 after the immunization, the incidence and severity of the
thyroid lesions being similar to that observed in normal IgG and saline treated controls







a a a a a T
a
Fig. 3. log2 titres of circulating antibodies to rat thyroglobulin in rats immunized with rat
thyroglobulin in CFA and treated with horse immunoglobulins G as follows: (a) treatment
started immediately after the antigen injection, (b) 4 hr and (c) 17 days after the immunization.
Note that a significant (F<001) suppression of humoral antibody formation to rat thyro¬
globulin was achieved only in those rats in which treatment was commenced immediately after
the antigen injection, (d) log2 titres of circulating antibodies in rats immunized with rat thyro¬
globulin in CFA and treated with saline and in untreated control animals immunized with
saline in CFA. O, ALS-IgG; •, NFl-IgG; A, saline; A, untreated control.
Comparable results to the effect of anti-lymphocytic IgG treatment on the early develop¬
ing phase of thyroiditis or on established thyroiditis were obtained when its effect was tested
on the circulating antibody response to rat thyroglobulin. Thus a significant suppression
of the humoral response was only achieved in those rats in which anti-lymphocytic antibody
treatment was initiated immediately following thyroglobulin administration. On the other
hand in those animals where treatment was not commenced until 4 hr or 17 days after
immunization the tanned cell titres were not significantly different (P> 0-5) from those
observed in rats treated with normal horse IgG (Fig. 3).
I
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Table 2. Tanned red cell titres of antibodies to horse immunoglobulin in rats after treatment with ALS-
IgG or NH-IgG
No. Period of *No. of No. of rats and titre of antibodies
Group(s) of Treatment treat- injec-







10 ALS-IgG 17 8 1 3 6
10 NH-IgG 17 8 5 2 3
10 ALS-IgG 7 7 3 7
10 NH-IgG 7 7 2 6 2
20 None — — 20 —
N.B. The antibody titres were determined in serum samples obtained on the day of killing (see Table I).
* Two millilitres of 1 g/100 ml solution of horse anti-rat-lymphocytic IgG (ALS-IgG) or normal horse
IgG (NH-IgG).
The findings with the indirect immunofluorescence test using fixed rat thyroid sections
confirmed the results of the tanned red cell method. Staining of the thyroid colloid was
noted with the sera of the animals immunized with thyroglobulin in CFA except in those
rats in which anti-lymphocytic IgG treatment had been started simultaneously with the
antigen injection. Sera of the control animals gave negative results. Immunofluorescence
using unfixed sections did not detect antibody against rat thyroid cytoplasm in any of the
test or control animals.
Using the sensitized tanned cell technique circulating antibodies to equine IgG were
detected on the day of killing in the sera of all groups of rats treated with normal or anti-
lymphocytic IgG of equine origin (see Table 2).
j t | Startof
IP 153U.
Day 0+4hr 2 10 17 24 injections
♦ IP
Injection of 2mg rat thyroglobulin CFA
and 2 xlO^B.pertussis organisms i.e.
Fig. 4. The effect of ALS-IgG ( ), NH-IgG ( ) and saline (— • — • —) treatment
on the peripheral lymphocyte count in immunized rats. Note the rapid initial fall in the animal
groups receiving anti-lymphocytic IgG and its eventual recovery. The various courses of
treatment were commenced; immediately following (x, Groups la and lb), 4 hr after (a,
Groups 2a and 2b), or 17 days after antigenic challenge (□, •, O, Groups 3, 4 and 5, respec¬
tively).
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The effect of the various courses of anti-lymphocytic IgG treatment on the peripheral
blood lymphocyte count is illustrated in Fig. 4.
Four hours after a single injection of anti-lymphocytic IgG, there was a significant fall
in the peripheral lymphocyte count but this depression rose to almost normal levels within
17 days in spite of continuous treatment with anti-lymphocytic IgG.
Finally, light microscopy of spleen, thymus and kidney specimens did not reveal any
histological abnormalities in any of the experimental animals.
DISCUSSION
In animals, thyroiditis can be produced experimentally by sensitization with thyroglobulin
in Freund's complete adjuvant (Terplan et al., 1960; Jones & Roitt, 1961). In experimental
thyroiditis, delayed hypersensitivity is likely to play a major part in the manifestation of
the thyroid lesions (Roitt & Doniach, 1967). The development of experimental thyroiditis
in rats can be enhanced by the injection of pertussis vaccine immediately after the antigen
injection (Kalden et al., 1969a). The fact that the rats injected with B. pertussis did not
develop a blood lymphocytosis is explained by the use of the intracutaneous route of the
vaccine injection (Morse, 1965).
Anti-lymphocytic serum (ALS) is known to suppress the production of delayed hyper¬
sensitivity and of primary antibody formation (reviewed by James, 1967a, 1969). This has
been confirmed in relation to the development of experimental encephalomyelitis (Waksman
et al., 1961; Leibowitz et al., 1968a, b), of experimental thyroiditis (Kalden et al., 1968)
and of Freund's adjuvant arthritis (Currey & Ziff, 1968) when ALS treatment was started
before or at the time of immunization with the appropriate antigen in CFA. In contrast,
however, ALS was ineffective in suppressing Coombs positivity in NZB mice once this
has developed (Denman et al., 1967) and furthermore ALS also failed to prevent the onset
of renal disease in (NZB x NZW)Fj hybrid mice when treatment was commenced at the
age of 3 months (Denman, Denman & Holborow, 1966).
The experimental results presented in this paper clearly demonstrate that the daily
injection of anti-lymphocytic antibody for the period of 1 week had no significant effect on
previously induced experimental thyroiditis. ALS also failed to suppress the development of
thyroiditis when treatment was started 4 hr after the immunization with thyroglobulin in
CFA. Only when the injection of anti-lymphocytic antibody was commenced immediately
after the antigen injection could the development of thyroid lesions be prevented. These
findings are in keeping with results reported by Currey & Ziff (1968) that delayed ALS
treatment had only little effect on the manifestation of Freund's adjuvant arthritis. Although
Leibowitz et al. (1968a, b) found that in experimental allergic encephalomyelitis ALS
treatment given during a period of 10-18 days after the immunization protected the animals
from paralysis, anti-lymphocytic antibody did not suppress the manifestation of histological
brain lesions. Furthermore these authors showed that ALS treatment in already paralysed
animals was capable of prolonging the survival time in four out of eleven animals with
marked improvement of the physical manifestations. Again these animals showed histo¬
logically extensive areas of demyelination. This finding suggests that anti-lymphocytic
antibody may have some suppressive effect on an established autoimmune process though
the mechanism of this effect is not yet clearly understood.
The failure of anti-lymphocytic antibody treatment to suppress the formation of humoral
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antibody to thyroglobulin when injected 4 hr or 17 days after antigen administration
confirms the results of previous investigators in other systems (Berenbaum, 1967; James
1967b).
On the basis of the present results it appears once more that anti-lymphocytic antibody
has limited access to central lymphoid tissue (Denman et at., 1967; Levey and Medawar,
1967; Denman & Frenkel, 1968) being relatively incompetent in inactivating memory
cells or preventing plasma cell proliferation in these sites (see review Denman, 1969).
Nevertheless, it is possible that more prolonged courses of anti-lymphocytic antibody
treatment combined with other forms of immunosuppression, including cytostatic drugs
and other antisera (Willoughby & Coote, 1966) may be of value in treating established auto¬
immune diseases in man.
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synopsis The method of latex particle precipitation has been applied to the detection of circulating
antibody to a crude extract of thyroid. The sensitivity of the method is intermediate between that
of the agar diffusion and the tanned cell haemagglutination techniques. If only the grosser degrees
of latex precipitation are taken as being significant, the method would appear to be of equal value
as the agar diffusion test in the diagnosis of lymphadenoid goitre.
The use of inert particles such as latex, bentonite,
and collodion has provided an additional simple
method for detecting circulating antibody. The
particles are coated with the appropriate antigen and
the presence of the corresponding antibody is indi¬
cated by agglutination or precipitation of the
particles.
Polystyrene latex particles have been used in this
way by Singer and Plotz (1956, 1958) and Olsen
and Rantz (1958) for the detection of rheumatoid
factor and more recently by Christian, Mendez-
Bryan, and Larson (1958) and Fessel (1959) for the
detection of LE factor, and by Kelen and Labzoffsky
(1960) for the detection of antibodies to Leptospira.
The purpose of this paper is to evaluate the useful¬
ness of antigen-coated latex particles in the detection
of thyroid antibodies and to compare this method
with the established procedures of tanned cell
haemagglutination and agar gel diffusion.
laboratory methods
saline extract of thyroid and liver Human thyroid
tissue was obtained at thyroidectomy or from a fresh
cadaver. Liver tissue was likewise obtained at an early
necropsy. The tissues were frozen immediately in a
vacuum flask surrounded by an alcohol and solid carbon
dioxide mixture. They were then cut into small pieces
and homogenised in the cold for two minutes at high
speed in an M.S.E. homogeniser with an equal volume of
saline. After the addition of a further volume of saline
the homogenate was frozen and thawed three times and
left to extract overnight at 4°C. The coarse sediment was
removed by centrifugation for five minutes at 2,000 r.p.m.
Received for publication 29 August 1961.
in an M.S.E. major refrigerated centrifuge, and the
supernatant centrifuged at 59,310 g in a preparative
Spinco. The supernatant was used as the antigen. It was
stored at - 20°C.
polystyrene latex A suspension of Difco latex par¬
ticles, 0-81 u in diameter, was used as supplied by
Baird & Tatlock, Ltd., London.
glycine buffer Glycine in 1% NaCl 01 M, was ad¬
justed to pH 8-2 with a solution containing 2-5 ml.
N/1 NaOH/litre and with 10% citric acid. This pH was
found to give optimal precipitation of the antigen-coated
latex particles.
latex test After preliminary studies using dilutions of
antigen (thyroid extract) up to 1:1,000 it was found
necessary to use dilutions of 1 in 5, 1 in 10, and 1 in 25.
Maximal precipitation for a given serum was found to
take place with any one of these three dilutions in an
unpredictable manner. Dilutions of antigen higher than
1 in 25 in no case enhanced the degree of precipitation.
The antibody in the form of test serum was used in an
undiluted state, since dilution of the serum did not
increase the degree of precipitation. The sera had been
stored at — 20°C. for two to three years and had been
inactivated for previous diagnostic tests. Further heating
was not carried out.
Dilutions of the latex suspension of 1 in 10 and 1 in 20
were made in the glycine buffer. The 1 in 10 latex dilution
was used to prepare the stock suspension of antigen-
coated latex particles by mixing with an equal volume of
each of the three antigen dilutions. The mixtures were
then shaken and left on the bench for 30 minutes to allow
adsorption of the antigen to take place. With the addition
of merthiolate to 1 in 10,000 these mixtures were stable
at 4°C. for at least one month. Two drops of the antigen-
latex suspension at each dilution of the antigen were
148
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then transferred to 3 in. x J in. tubes and two drops of
undiluted serum were added to each. After shaking, the
mixture was drawn up into capillary tubes which were
placed in plasticine racks. The 1 in 20 dilution of un-
coated latex suspension was used to set up a control test
for each test serum.
The capillary tubes were kept on the bench and
examined after three, 24, and 48 hours for precipitation.
No further precipitation occurred after 48 hours. Incubat¬
ing at fixed temperatures in the range of 4° to 56°C. was
not found to enhance the degree of precipitation. The
degrees of precipitation were designated by the digits 0,
1, 2, 3, and 4, according to the length of the fragmented
column of precipitated particles, 0 signifying no precipita¬
tion and 4 maximal precipitation, with 1, 2, and 3 inter¬
mediate degrees respectively (Fig. 1). The degree of
precipitation was apparent in the majority of cases over¬
night but was finally read at 48 hours. The strongest
degree of precipitation observed in any of the three tubes
was taken as the final reading.
gel diffusion test The agar double diffusion technique
(Oudin, 1948) was used as modified by Oakley and
Fulthorpe (1953).
tanned red cell test The test using thyroglobulin-
coated sheep red cells was that used by Roitt and Doniach
(1958) after Rose and Witebsky (1956). Purified thyro-
globulin prepared after the method of Derrien, Michel,
and Roche (1948) was used.
clinical material
The sera were selected from specimens which had been
kept after examination for thyroid antibodies for diag¬
nostic purposes (Irvine, 1960a). No attempt is made in
the present study to determine the incidence of positive
immunological tests in unselected thyroid patients. Each
serum was given a number and all tests were carried out
in ignorance of the diagnosis and the results of other tests.
The following sera were used:—
Fifty-three sera from 32 histologically proven cases of
lymphadenoid goitre, 21 of which were obtained from 10
patients who, at the time, had had no surgical interference
or only biopsy, and the remaining 32 sera were obtained
from 22 patients who had had a partial or hemithyroi-
dectomy, anything from a few days to 10 years previously.
Fifty-eight sera were from 51 cases of lymphadenoid
goitre diagnosed clinically without histological proof.
Twenty-two sera were obtained from 17 cases of spon¬
taneous adult hypothyroidism.
Thirty-six sera were from 31 patients with simple goitre,
20 of whom had subsequent histological proof.
Twenty sera were from 16 cases of carcinoma of the
thyroid, all histologically proven but sera obtained either
before or after treatment.
Twenty-nine sera were from 22 cases of thyrotoxicosis.
Two sera were from two cretinous children.
Four sera were from four patients with subacute (de
Quervain's) thyroiditis. In two cases histology was avail¬
able.
fig. 1. The five capillary tubes illustrated are selected
from tests described in the text using various negative and
positive sera at the different antigen dilutions. Reading
from left to right the tubes have been arranged to show
degrees of precipitation graded as 0, 1, 2, 3, and 4. The
degree ofprecipitation is assessed according to the length
of the fractionatedcolumn ofprecipitated particles. To the
naked eye the consistency of the latex is that ofa suspension
in tube 0 and is clearly fioccular in tube 4, although this is
difficult to illustrate in a photograph.
Fifty-one sera were from 51 cases of rheumatoid
arthritis. All these sera had strongly positive Rose-Waaler
tests.
Six sera were from six cases of systemic lupus erythe¬
matosus (S.L.E.).
Seventy sera were from 70 healthy antenatal patients
(normal controls).
results
Table I shows the distribution of 0, 1, 2, 3, and 4
reactions in the latex capillary test. It will be seen
that while none of the 70 normal sera precipitated
the coated particles some degree of precipitation
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TABLE 1
DISTRIBUTION OF REACTIONS IN LATEX CAPILLARY TEST
Diagnosis No. of Sera Degrees ofLatex Agglutination
0 1 2 3 4
Lymphadenoid goitre (clinically ± histology) 111 32 17 10 7 45
Spontaneous hypothyroidism 22 7 5 7 — 3
Simple goitre 36 27 5 4 — —
Carcinoma thyroid 20 15 3 2 — —
Thyrotoxicosis 29 20 4 1 2 2
Cretins 2 2 — — — —
Subacute thyroiditis 4 2 1 — — 1
Rheumatoid arthritis 51 39 5 5 2 —
S.L.E. 6 2 — 4 — —
Normal (ante-natal) 70 70 — — — —
Totals 351 216 40 33 11 51
TABLE II
SERA GIVING POSITIVE AGAR DIFFUSION TESTS
Tanned Cell Lymphadenoid Goitres Spontaneous Simple Goitre Carcinoma Thyroid Thyrotoxicosis


























was caused by a proportion of the sera from each of
the other groups studied. It is also apparent that the
highest proportion of sera giving three and four
reactions occur in the lymphadenoid goitre group
while lesser degrees of precipitation (0-2) are en¬
countered in other types of thyroid diseases.
Table II shows the number of sera in each group
of patients that gave a positive agar diffusion test for
thyroglobulin antibody. They correspond closely
with the number of sera giving three and four latex
reactions. Five sera gave a 3 to 4 latex reaction, but
a negative agar diffusion test, while two sera gave a
positive agar diffusion test but did not give 3 or 4
latex precipitation. This table also compares the
latex and agar diffusion tests with the tanned cell
haemagglutination test using thyroglobulin-coated
sheep red cells. It will be seen that the positive agar
diffusion test and the 3 + 4 latex reactions are dis¬
tributed towards the higher end of the tanned cell
haemagglutination titre scale. The tanned cell haem¬
agglutination titres are widely distributed in thyroid
disease, and it is of interest that three cases of
carcinoma of the thyroid gave a high titre and yet
both the agar diffusion and the latex capillary tests
were negative. It is also of interest that two sera from
one patient with histological proof and two sera from
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TABLE III
LYMPHADENOID GOITRE HISTOLOGICALLY PROVEN












Patients 3 to 4 Latex Positive Agar Patients 3 to 4 Latex Positive Agar
Reactions Diffusion Test Reactions Diffusion Test
— 6
— 4 — —
1 1 — —
1 1 1
11
3 4 3 4
6 22 5 5
two cases diagnosed clinically as having lymph-
adenoid goitre gave tanned cell haemagglutination
titres of 270 or less, but still gave positive 3 and 4
latex reactions.
A small proportion of sera from patients with
rheumatoid arthritis and S.L.E. precipitated thyro-
globulin-coated latex particles (1,2, and 3 reactions),
but such sera can be distinguished by the fact that
they will also cause precipitation of the uncoated
latex control particles or of latex particles coated with
human liver antigen. Such non-specific precipitation
did not occur with any of the 232 thyroid sera in
spite of the fact that the incidence of rheumatoid
arthritis and of lupus erythematosus antinuclear
factor is known to be raised in lymphadenoid goitre
(Buchanan, Crooks, Alexander, Koutras, Wayne,
and Gray, 1961; Weir, Holborow, and Johnson,
1961). These results, together with the absence of
any degree of precipitation by the 70 normal sera,
indicate the specificity of the test for thyroid anti¬
bodies.
The main clinical interest attached to the detection
of thyroid antibodies is in the diagnosis of lymph-
adenoid goitre. The results in this disease are shown
in Table 111, where the patients are divided into two
series. First, a small series of 10 patients from whom
sera were obtained before thyroidectomy and,
secondly, a larger series of 22 patients in whom
serological tests were carried out at various intervals
after surgery. It is again seen that there is a close
parallel between the agar diffusion test and the latex
method.
DISCUSSION AND CONCLUSIONS
A method of using latex particles for the detection
of thyroglobulin antibody is described which is
both extremely cheap and easy to perform. The time
of reading the test is shorter than with the agar
diffusion method, in which eight days should be
allowed to elapse before pronouncing the result to
be negative. The sensitivity of the capillary latex
method for the detection of thyroglobulin antibodies
is appreciably greater than that of the agar diffusion
test, but markedly less than the tanned cell haem¬
agglutination test. However, when only three and
four reactions are taken into account as being signi¬
ficant the sensitivity of the method and its specificity
within the range of thyroid diseases make the
capillary latex test and the agar diffusion test of equal
diagnostic value in lymphadenoid goitre.
No figures can as yet be given to indicate the true
incidence of positive capillary latex tests in the
various thyroid disorders. In the case of lymph¬
adenoid goitre this would require the serological
test to be done before treatment in patients in whom
the diagnosis was subsequently established on the
basis of adequate histology. As far as we are aware
no such series of patients has yet been published even
for the agar diffusion test. In the present series the
incidence of positive agar diffusion tests of 60% in
those lymphadenoid goitre patients who had not had
thyroidectomy and of some 25% in those patients
in whom thyroidectomy had been performed up to
10 years previously is consistent with current views.
A similar incidence is found with the capillary latex
test when 3 to 4 reactions are used.
The main objections to the capillary latex tech¬
nique is the interpretation ofwhat constitutes a grade
I or 2 precipitation as opposed to grades 3 or 4.
With experience of the method this difficulty is
readily overcome and consistent results obtained.
An improved method of grading might be to measure
the total length of the discrete fragments in a positive
column (seeFig. 1). Failure to grade the test results in
loss of diagnostic specificity for lymphadenoid goitre.
The same problem arises with the tanned red cell
technique where there is uncertainty in selecting an
arbitrary titre of diagnostic value in lymphadenoid
goitre. On the other hand the agar diffusion test in
the majority of cases gives a clear positive or negative
result although a weak reaction can cause consider¬
able difficulty.
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It is necessary to carry out control tests using
uncoated latex particles to exclude the possibility of
obtaining false positive results with rheumatoid or
systemic lupus erythematosus sera.
In conclusion, while the tanned cell haemagglu-
tination technique (Roitt and Doniach, 1958) and
the complement-fixation test (Trotter, Belyavin, and
Waddams, 1957) remain as the techniques for the
sensitive and quantitative measurement of circulating
thyroid antibodies, the capillary latex method may
prove to be of value as a rapid screening test in
cases suspected clinically of having lymphadenoid
goitre, possessing as it does the combined virtues of
cheapness, ease of performance and readability, and
a specificity for this disease equal to that of the agar
diffusion test. Diagnostically, however, the capillary
latex method is likely to have the same limitations as
the agar diffusion test because it will fail to reveal
those patients with Hashimoto disease with negative
or insignificant titres of thyroglobulin antibody but
high titres of circulating antibody directed against
intracellular antigen detected by the method of com¬
plement fixation (Trotter et al., 1957) or cytotoxicity
(Irvine, 1960b, 1961a, 1961b). Conversely the com¬
plement-fixation test per se would not detect those
patients who only possess antibody to thyroglobulin.
It would therefore appear that a combination of these
two types of test is required for diagnostic purposes.
Our thanks are due to Professor Robert Cruickshank for
his interest in the development of the capillary latex test.
We are also indebted to Professor Sir Derrick Dunlop
and Dr. J. S. Robson for allowing us to study their
patients, and to the many other clinicians (in particular,
Dr. W. R. M. Alexander of the Rheumatic Unit at the
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J. R. P. and W. J. I. wish to acknowledge grants from
the Medical Research Council and A.E.S. from the
Secretary of State for Scotland through the Advisory
Committee for Medical Research.
REFERENCES
Buchanan, W. W., Crooks, J., Alexander, W. D., Koutras, D. A.,
Wayne, E. J., and Gray, K. G. (1961). Lancet, 1, 245.
Christian, C. L., Mendez-Bryan, R., and Larson, D. L. (1958).
Proc. Soc. exp. Biol. (N. Y.), 98, 820.
Derrien, Y., Michel, R., and Roche, J. (1948). Biochem. biophys. Acta,
2, 454.
Fessel, W. J. (1959). Ann. rheum. Dis., 18, 255.
Irvine, W. J. (1960a). The Diagnosis of Lymphadenoid Goitre. Lewis
Cameron Post-graduate Prize Essay. Edinburgh University.
(1960b). Scot. med. J., 5, 511.
(1961a). Advances in Thyroid Research, Trans. 4th int. Goitre
Conference, London, 1960, p. 154 (ed. R. Pitt-Rivers).
Pergamon Press, Oxford.
(1961b). Clark Fellowship Lecture, Edinburgh. To be published.
Kelen, A. E., and Labzoffsky, N. A. (I960). Canad. J. Microbiol., 6,
463.
Oakley, C. L., and Fulthorpe, A. J. (1953). J. Path. Bact., 65, 49.
Olsen, C. R., and Rantz, L. A. (1958). Arthr. and Rheum., 1, 54.
Oudin, J. (1948). Ann. Inst. Pasteur, 75, 30.
Roitt, I. M., and Doniach, D. (1958). Lancet, 2, 1027.
Rose, N. R., and Witebsky, E. (1956). J. Immunol., 76, 417.
Singer, J. M., and Plotz, C. M. (1956). Amer. J. Med., 21, 888.
, (1958). Arthr. and Rheum., 1, 142.
Trotter, W. R., Belyavin, G., and Waddams, A. (1957). Proc. rov. Soc.
Med., 50, 961.




Automated Determinations of Thyroid and
Gastric Complement Fixing Antibody; Comparison with the
Fluorescent Antibody and Manual Complement Fixation Methods
W. J. Irvine
TIECHNIC0N If!T& iMAtlO IAL • Arditey(Chauncay),flewYorktrSQS
X : 8
Automated Determinations of Thyroid and Gastric
Complement Fixing Antibody
Comparison with the Fluorescent Antibody and Manual
Complement Fixation Methods
w. J. IRVINE
Gastric and thyroid serological tests have become
part of the routine investigations of haematological
and thyroid problems in clinical medicine. Alt¬
hough there are a number of gastric and thyroid
antibodies, those that are detectable by the method
of complement fixation are among the most signifi¬
cant in the diagnosis of atrophic gastritis and chro¬
nic thyroiditis (1, 5).
The basis of the complement fixation test is that
certain types of antigen-antibody reaction are char¬
acterised by the fixation of complement. The fixa¬
tion of complement is detected in vitro by an in¬
dicator system consisting of sheep red cells and
haemolysin. The haemolysin will only destroy the
red cells if complement is still freely available. The
Takatsy microtitre apparatus is recommended for
doing manual complement fixation tests (2). Alt¬
hough this method is in many ways satisfactory, the
results in different laboratories and in the same la¬
boratory may vary on account of the subjective in¬
terpretation of the end point and because of the
mental fatigue that occurs when large numbers of
sera are to be tested. Two papers have been publi¬
shed on the automation of the complement fixation
test for the detection of gastric and thyroid antibo¬
dies (2, 3). The present paper reports the results of
further studies.
Figure 1 shows the currently recommended flow
diagram. Antigen, complement and antibody, each
in separate channels, are fed into the Analyzer
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Edinburgh, Scotland, Great Britain.
through a 10 roller Proportioning Pump. These
reagents are then brought together and mixed in a
double mixing coil for 2lU minutes. They pass to a
37.5° C thermostat (oil bath) with a delay coil to
encourage the antigen-antibody reaction to take
place and for complement to be fixed. The flow rate
is such that the incubation time is 9 minutes. After
this stage sheep red cells sensitised with haemolysin
347
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(haemolytic system) are introduced. Following a
further period of mixing (single mixing coil) and
incubation at 37.5° C the degree of lysis of the red
cells is detected hy a photocell using a turbidity fil¬
ter with a transmission of 660 m|i. Figure 2 shows
the fitting of the flow cell debubbler that has been
developed. T his is helpful in obtaining a maximal
flow to the flow cell with minimum risk of carrying











Figure 2: Detail of
Debubbler
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Complement (guinea pig). Preserved in Richard¬
son's solution (Stayne's Laboratories, High Wy¬
combe, Bucks., England).
Diluent. Veronal buffer at pH 7.2 (Oxoid BR 16).
This diluent is filtered prior to use.
Sheep red blood cells in Alsever solution (Stayne's
Laboratories).
Rabbit anti-sheep haemolytic serum (Stayne's
Laboratories). 0.08°/o haemolytic serum is added to
1 °/o erythrocytes to form the haemolytic system.
Antigen. Saline extracts of various tissues as
previously described (2).
Known positive sera for the antibodies being stu¬
died.
Tween 20. 1 drop per 500 ml diluent.
30 sera are tested per hour with a sample to wash
ratio of 1:5. The whole process from start to finish
takes 24 minutes. It is essential to have a perfect
bubble pattern and to wash out the machine after
use with a detergent solution (e.g. Decon 75) follo¬
wed by a prolonged wash with distilled water over¬
night. From time to time the plastic tubing should
be replaced and the glassware (including the flow
cell) washed with dichromate cleaning fluid and
thoroughly rinsed.
Calibration of Photocell
Figure 3 shows the calibration of the apparatus
for varying concentrations of red cells passing
through the photocell (from 2°/o down to 0.05%
red cells and 2% cells that have been fully lysed).
The recorder system is sensitive to small reductions
in the concentration of red cells in suspension but is
insensitive to the amount of haemoglobin released
as a result of lysis of the red cells.
Complement Fixation Test
The complement fixation is done in 3 stages:
(a) Titration of complement
(b) Titration of antigen
(c) Testing of sera for complement fixing antibody.
Titration of Complement
To do a complement titration serial dilutions of
complement may be placed in the automatic samp¬
ler. Diluent is substituted for antigen and for anti¬
body. As shown in Figure 4 the recorder is adjus¬
ted so that it reads at the lower end of the scale
when only buffer is going through the machine.
With the addition of red cells the recorder gives a
prompt deflection to the other end of the scale.
With the introduction of samples of complement,
haemolysis results. In this experiment the dilutions
of complement were 1: 10, 15, 20, 25, 30, 32.5, 35,
40 and 50. Each dilution of complement was sam¬
pled for 20 seconds. The complement titration was











Figure 3: Standardisation of Colorimeter
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sampling
then repeated in the presence of antigen and an
almost identical tracing obtained.
One important characteristic of the AutoAnaly-
zer is that the haemolytic reaction for a given dilu¬
tion of complement may not be maximal when it is
sampled for only a short period. Thus, when a dilu¬
tion of complement is sampled for 20 seconds (as
for example a dilution of 1: 25), only a proportion
of the red cells are lysed. If the complement at the
same dilution (1: 25) is fed into the machine conti¬
nuously then 100% lysis is obtained over a period
of 6 minutes. This is important in selecting the ap¬
propriate complement dilution that is to be used for
the titration of antigen or for the detection of anti¬
body, for under these conditions complement is
supplied to the machine continuously.
Since the reproducibility of the complement fixa¬
tion test largely depends on the accuracy withwhich
complement is titrated, it is preferable to titrate
complement by continuous rather than by intermitt¬
ent sampling (Figure 5). Each strength of comple¬
ment is sampled continuously for 3 minuteswithout
any wash periods. In this way the minimum hae¬
molytic dose of complement can be determined. In
this particular experiment one minimum haemolytic
dose of complement was given by a complement
dilution of 1: 100 using 0.25% suspension of red
349
cells sensitised with 0.02% haemolytic serum. The
method of continuous sampling is much more sen¬
sitive and precise than is that of intermittent samp¬
ling. Before doing a complement titration it is im¬
portant to prime the Analyzer by passing through
a 1: 10 dilution of complement for 5 to 10 minutes.
Complement requires to be titrated each day. Dur¬
ing the day's testing a reservoir of complement at
the appropriate dilution must be kept at 4°C in an
ice bath.
Titration of Antigen
It is necessary to carry out a titration of the tissue
extract in order to find the highest dilution of the
extract that still contains sufficient antigen to fix all
the available complement in the presence of excess
antibody. To do this, the antigen line is attached to
the automatic sampler, the cups of which contain
the tissue extract in doubling dilutions. The com¬
plement line is placed in a reservoir of the appro¬
priate complement dilution (chosen to provide 1.5
minimum haemolytic dose) and the antibody line
is placed in a reservoir of a serum that is known to
have a high titre of antibody for that particular an¬
tigen (manual complement fixation titre !> 128).
Some few minutes are allowed for the system to
come into equilibrium with regard to complement
and antibody before introducing the samples of an¬
tigen.
Figure 6 shows the titration of a saline extract of
pig gastric mucosa. It is advisable to start with the
most dilute samples of tissue extract (1: 128, 64, 32,
16, 8, 4, 2) because high concentrations of protein-
GASTRIC ANTIGEN TITRATION ( G 168 I
ANTIBODY o- B/1.152 DILUTED 1:16 x NIL >
Figure 6: Titration of gastric antigen
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aceous material may well result in precipitation
within the machine with resultant interference with
the turbidity measurements of the colorimeter. The
known positive serum used as a source of gastric
complement fixing antibody had a titre in the ma¬
nual of Si 512; this serum was diluted 1:16 before
use. The antigen titration should be repeated in the
absence of antibody to check on the nonspecific
absorption of complement and the turbidity of the
different antigen dilutions. When sampled for 20
seconds an antigen dilution that causes considerable
but not total fixation of complement in the presence
of excess antibody is suitable for the screening ot
test sera. In Figure 6 a dilution of gastric extract of
1: 16 was chosen as suitable. Gastric parietal cell
antibody is not species-specific and pig gastric extract
has been found suitable as antigen (4). The tissue
extracts need only be titrated once, provided the
extracts are stored thereafter at —20° C in small
aliquots.
Screening of Sera for Complement Fixing Antibody
Having titrated the complement and the tissue
extracts we are now in a position to test large num¬
bers of sera for the presence of complement fixing
antibodies. Complement and antigen at appropriate
dilutions are fed continuously into the Analyzer
and the antibody line is attached to the automatic
Sampler. The cups of the Sampler contain a series
of test sera in a dilution of 1: 4.
In any complement fixation test it is essential to
confirm the tissue specificity of the reaction and to
exclude anti-complementary effects and errors due
to the turbidity of the sera. When looking for thyr¬
oid complement fixing antibodies, for example, the
sera must be tested against thyroid antigen and also
in the absence of antigen or against liver extract as
a control. A direct comparison between the test run
and the control run can be obtained by splitting the
serum sample (using fitment PT. 2) so that the test
serum goes to each of two circuits arranged in pa-
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rallcl (Figure 7). The results of the test and the
control run are recorded simultaneously on a dual
pen recorder.
ONE STAGE PROCEDURE
Figure 7: One stage procedure for direct comparison of
test with control
In Figure 8 the upper tracing is the complement
fixation test with a number of sera using thyroid
extract as antigen and the lower tracing is the con¬
trol run without antigen. 1.0% suspension red cells
sensitised with 0.08% haemolytic serum were used
in this experiment. 1.5 minimum haemolytic doses
of complement were employed. There is a formalin
peak at the beginning and end of the tracing. The
first formalin peak is followed by a titration (1: 64,
128, 256 and 512) of a known positive serum as a
standard for the thyroid antibody test. Thereafter
30 sera were tested at a dilution of 1: 4. A signifi¬
cant difference in the height of the peaks between
the two tracings indicates that a complement fixa¬
tion reaction has occurred between the test serum
and the thyroid extract. When both tracings show
that haemolysis has been completely inhibited, the
serum should be retested in a higher dilution. Fre¬
quently, however, the shape of the peaks indicates
whether complement fixing antibody in addition to
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The sera are run through the Analyzer once more
using gastric extract and liver extract to test for
gastric parietal cell antibody and for tissue specifi¬
city. For screening against thyroid, stomach, liver
and for anticomplementary activity and turbidity
control a total of 0.2 ml serum is required.
Carry-over from a strongly positive serum to the
next sample is not a common problem in the rou¬
tine screening of sera from endocrine and haemato-
logical clinics with a sample to wash ratio of 1: 5.
When it does occur the strongly positive serum
should be titrated (see Figure 9) and the following
serum retested. To avoid carry-over, the flow dia¬
gram could be altered so that the antigen-antibody-
complement reaction took place in the sampler
cups. Sampler cups would then require to be incub¬
ated on the Sampler Jt at 37°C. The antigen and
complement could be dispensed into the cups from
reservoirs via the Proportioning Pump using trans¬
mission tubing of suitable calibre. In addition to
avoiding carry-over such a modification might lead
to considerable saving of antigen and complement.
The criticism of such a modification might be that
(1) the smaller the volumes of reagents used the big¬
ger the error in the dispensing of these reagents into
the sampler cups and that (2) mixing may be inade¬
quate. In the present study, however, carry-over
was not a serious problem and the supply of suit¬
able human thyrotoxic glands and of pig gastric
mucosa provided an adequate source of antigen.
Likewise, there was no difficulty in the supply of
complement, although to use it in smaller quanti¬
ties would have been more economical.
Results
Tables I and II show the correlation between the
height of the peak on the AutoAnalyzer tracing and
the titre obtained with the same serum in the ma¬
nual complement fixation test in a study of gastric
and thyroid complement fixing antibodies, respec¬
tively. In this study the flow diagram used was that
described in an earlier publication (2) using a 2°/o
erythrocyte suspension and complement titrated by
the intermittent method. Sera that gave a good titre


































Difference in peak heights given by test and control
sera on the AutoAnalyzer.
> 45 units = + + +
> 12 < 45 units = + +
> 3 < 12 units = +
Using percentage transmission paper.
TITRATION OF SERA FOR C F THYROID ANTIBODY
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Difference in peak heights given by test and control
sera on the AutoAnalyzer.
> 45 units = + + +
St 12 < 45 units = + +
S 3 < 12 units = +
Using percentage transmission paper.
in the manual method (i> 1: 32) gave a strong peak
on the AutoAnalyzer using 2% red cells. The
reproducibility of the manual method is ± one
doubling dilution. It is therefore not surprising that
there is some discrepancy in the results between the
two methods with weakly positive sera. When com¬
pared to the immunofluorescent technique for de¬
tecting the same antibodies, no false positives were
recorded by the AutoAnalyzer for either thyroid or
gastric complement fixing antibodies in the 309 sera
tested. A similar study using the flow diagram as
shown in Figure 1 with 1% red blood cells and using
1.5 minimum haemolytic doses of complement is
presently in progress.
Titration of positive Sera
Test sera giving a strong organ-specific reaction
in a dilution of 1: 4 can be titrated. Figure 9 illu¬
strates the titration by doubling dilution of 5 sera
for thyroid antibodies by the Analyzer using the
flow diagram previously published (2). There is a
formalin peak at the beginning and end of the trac¬
ing to assist localisation. The titres determined in
this manner correspond very closely with those ob¬
tained by the manual technique (Takatsy) which are
also included in Figure 9 (1: 256; 1: 64; 1: 32; 1: 16;
1: 4, respectively).
Acknowledgements: I am grateful to Mr. Kenneth
Marwick, F. I. M.L.T., for his invaluable technical
assistance. Figs. 3, 4, 6 and 8 and Tables I and II are
reproduced by permission of the Editor and Publisher
of Clin, exper. Immunol.
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Resume
Les auteurs ont mis au point une technique automatique pour le depistage et le titrage des anticorps s6riques fix-
ant le complement, produits en rdponse k des antigenes gastriques (cellules pari6tales) et thyro'idiens microsomati-
que. La methode automatique fournit une sensibilitd comparable k celle de la technique manuelle de fixation du
complement, mais elle est un peu moins sensible que la methode indirecte des anticorps fluorescents. Par rapport
a la technique manuelle de fixation du complement, la mbthode automatique presente l'avantage d'une precision
et d'une reproductibilite bien sup£rieures et supprime tout facteur d'interpretation personnelle. Elle reclame moins
d'habilete de la part du technicien. La methode automatique utilise seulement de faibles quantites de s6rum mais
elle consomme une quantity considerable d'antigene et de complement. Dans la pr£sente dtude, on a utilis6 un
antigene d'origine humaine.
X : 14
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Summary
An automated technique has been established for the screening and titration of sera for complement fixing anti¬
body to gastric (parietal) cell and thyroid microsomal antigens. The automated method is of equal sensitivity to
the manual complement fixation technique but slightly less sensitive compared to the indirect fluorescent antibody
method. The automated method has the advantage over the manual complement fixation test of much greater
accuracy and reproducibility and the element of subjective interpretation is removed. It is less demanding on
technician skill. The automated method requires only small amounts of sera but it consumes considerable amounts
of antigen and of complement. Human antigen has been used in the present study.
Zusammcnfassung
Ein automatisches Verfahren fur die serienmaGige Bestimmung und Titration von Seren fiir komplementbin-
dende Antikorper auf gastrische Zellen und auf zur Schilddriise gehorende Plasmosom-Antigcne wurde entwik-
kelt.
Die automatische Methode entspricht der Empfindlichkeit der manuellen Komplementbindungsreaktion, zeigt
jedoch eine geringere Empfindlichkeit beim Vergleich mit der indirekten Fluoreszenz-Antikorpermethodc. Die
automatische Methode hat liber die manuelle Komplementbindungsreaktion den Vorteil groGerer Genauigkeit
und Reproduzierbarkeit. Das Element der subjektiven Interpretation ist somit entfernt worden. Die Method'e er-
fordert wenig Geschick vom technischen Personal, kleine Serenmengen, verbraucht jedoch bctrachtliche Mengcn
an Antigen und Komplement. Zu den hier vorliegenden Studien wurde menschliches Antigen angewandt.
Automated determinations of thyroid and gastric complement-
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AUTOMATED DETERMINATIONS OF THYROID AND
GASTRIC COMPLEMENT-FIXING ANTIBODY;
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AND MANUAL COMPLEMENT-FIXATION METHODS
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and Department of Therapeutics, Royal Infirmary,
Edinburgh
(Received 20 January 1966; accepted 11 February 1966)
SUMMARY
An automated technique has been established for the screening and titration of
sera for complement-fixing antibody to gastric (parietal) cell and thyroid micro¬
somal antigens. The automated method is of equal sensitivity to the manual
complement-fixation technique but slightly less sensitive compared to the indirect
fluorescent antibody method. The automated method has the advantage over the
manual complement-fixation test of greater accuracy and reproducibility and
the element of subjective interpretation is removed. It is less demanding on
technician skill. The automated method requires only small amounts of sera but
it consumes a considerable amount of antigen. Human antigen has been used in
the present study.
The automated method for complement-fixation reactions has some advantages
over the manual method for both routine clinical purposes and for the research
laboratory.
A positive test for complement-fixing autoantibody to thyroid (Trotter, Belyavin &
Waddans, 1957) has been shown to correlate in man with histological evidence of chronic
thyroiditis (Roitt & Doniach, 1960; Buchanan et al., 1962; Senhauser, 1964). Likewise, the
presence of gastric complement-fixing antibody in the serum (Irvine et al., 1962; Taylor et
al., 1962; Irvine, 1963) correlates with histological and functional evidence of chronic
gastritis (Irvine et al., 1965; Irvine, 1965). The detection of these autoantibodies is of value
to the clinician when thyroid disease or atrophic gastritis is suspected. They are also of
value in studying the familial aspects and the natural history of thyroid and gastric disorders.
As both thyroid and gastric disorders are common, the number of sera which the clinical
laboratory may be asked to examine may be large. An automated technique would therefore
be valuable. The second reason for attempting to automate the complement-fixation
method is to obtain better standardization in the technique itself. A preliminary report has
been made (Irvine, 1966).
Correspondence: Dr W. J. Irvine, M.R.C. Clinical Endocrinology Research Unit, 2 Forrest Road, Edinburgh.
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METHODS
Automated Complement-Fixation Method
Technicon Auto-Analyzer equipment was used (Technicon, Chertsey, Surrey, England;
Chauncey, New York) and is illustrated in Fig. 1. It consists of an automatic sampler,
proportioning pump (10 roller), double coil oil bath, colorimeter and recorder. The principle
of the method is the same as the manual complement-fixation technique {vide infra) but the
reagents are drawn into a system of transmission tubing where they are mixed and incubated.
The rate of transmission through the system is determined by the internal diameter of the
transmission tubing that is placed in the manifold of the proportioning pump. Mixing is
achieved by putting the samples through a coil of glass tubing with the longitudinal axis
Fig. 1. The Auto-Analyzer consisting of (from right to left) the automatic sampler, proportion¬
ing pump, double coil oil incubating bath, colorimeter and recorder.
horizontal. Incubation without additional mixing is achieved using a glass coil with a
vertical longitudinal axis. The duration of mixing and of incubation is determined by the
length and the diameter of the tubing used. The internal diameter of the tygon plastic
transmission tubing and of the glass mixing and incubating coils was T6 mm. Polyethylene
tubing of 0-034 mm internal diameter was used to convey the individual reagents to the
proportioning pump.
The samples to be tested were placed in the individual cups of the automatic sampler,
while the other reagents were used continuously at a constant rate. The automatic sampler
can be adjusted for the number of samples tested per hour and also for the period of samp¬
ling and for the period of washing between different samples. The fluid within the trans-
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mission tubing is broken up into short segments by the introduction of bubbles of air at
frequent and constant intervals; this minimizes diffusion of reagents within the system. The
ratio of fluid to air in the system should be approximately 2:1, but the air must be removed
before the samples pass through the colorimeter. 0-2 ml Bryj was added to each 500 ml of
complement-fixation test diluent to act as a detergent and to adjust the surface tension of
the fluid passing through the Auto-Analyzer so that a correct bubble pattern was obtained.
INCUBATION PROPORTIONING PUMP REAGENT ml/min
15 mm TUBULAR FLOWCELL PROCESS TIME = 23 mm
Fig. 2. The flow design for the automation of complement-fixation tests using saline tissue ex¬
tracts and human sera. The approximate internal diameters of the tubes passing through the
proportioning pumps in the order shown are: 0 073, 0 056, 0 045, 0 045, 0 073, 0 056, 0 040
and 0 090 in.
All reagents were added through capillary tubes using Technicon junction pieces. All
joins in the system must be made perfectly. After each day's experiments the system was wash¬
ed through with distilled water. The transmission tubing was replaced approximately every
2 weeks and all glass tubing and the flow cell was disassembled and washed with dichromate
cleaning fluid and thoroughly rinsed. Attempts to wash the plastic tubing with various
detergents resulted in erroneous complement titrations in spite of repeated washing with
water and buffer. The flow diagram is shown in Fig. 2. The flow rates of the various reagents
X : 19
344 W. J. Irvine
was determined by direct measurement. The internal diameters (inches) of the tubing in the
manifold of the proportioning pump were as follows: sampler wash, 0-073; air, 0-056; antigen,
serum and complement, 0-045; re-sample, 0-073; air, 0-056; sensitized red cells, 0-040; and
from flow cell, 0-090. It is to be noted that if a 5 roller proportioning pump is to be used
the flow rates will be considerably greater. The success of this flow design depends on a
perfect bubble pattern.




















Fig. 3. Standardization of the Auto-Analyzer colorimeter with red cell suspensions of known
concentrations. The colorimeter is sensitive to small changes in the concentrations of red
blood cells in suspension but is insensitive to the amount of haemoglobin released as a result
of lysis of the red cells.
human thyrotoxic tissue, of the mucosa of the body of human stomach obtained at partial
gastrectomy for duodenal ulcer, and of rat liver; preserved guinea-pig complement (Stayne
Laboratories Ltd, High Wycombe, Buckinghamshire, England); sera from patients with
thyrotoxicosis, Hashimoto goitre, primary hypothyroidism, pernicious anaemia, simple
atrophic gastritis and from random patients with unknown immunological status; fresh
defibrinated sheep red cells obtained from the abattoir and used within 7 days; rabbit
haemolytic serum (Stayne Laboratories Ltd, High Wycombe, Buckinghamshire, England);
complement-fixation test diluent containing barbitone 0-575 g, sodium chloride 8-500 g,
magnesium chloride 0-168 g, calcium chloride 0-028 g and barbitone soluble 0-185 g/1
X : 20
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(Oxoid. London, England). The saline tissue extracts were made by obtaining the fresh
tissue at operation. The tissue was cut up finely and homogenized with an equal volume of
complement-fixation test diluent. Three further volumes of the diluent were then added
and mixed thoroughly with the homogenate which was then filtered through a layer of
eight-ply gauze and centrifuged for 10 minutes at 1150 g. The supernatant, which contains
the antigen, was pipetted off and stored at — 20°C in 5 ml amounts. All sera were inactivated
at 56°C for 30 min before use. The sheep red cells were washed in saline at least three times
or until the supernatant after centrifugation was clear of haemoglobin and then centrifuged
in buffer. A 2% suspension of the red cells was then sensitized with 0-16% rabbit haemolytic
serum (haemolysin) at 37°C for 5 min. The cells were kept in suspension by a magnetic
stirrer. The complement and the antigen in selected dilutions were kept in separate containers
in an ice bath. All reagents, with the exception of the sera and diluent, were filtered through
gauze before use. The diluent was filtered through Watman No. 1 paper.
As in the manual method the degree of complement fixation is assessed by the inhibition
of haemolysis of the sensitized sheep red cells. In the automated method this was assessed
colorimetrically using a turbidity filter (660 m/<). The results were recorded on optical
density paper. The colorimeter and recorder were calibrated using complement-fixation test
diluent (buffer) alone, suspensions of sheep red cells in known concentrations and haemo-
lysed sheep red cells (Fig. 3).
Complement titration
A complement titration was done initially in the absence of antigen; the antigen and
serum pick-up lines were placed in buffer and the complement pick-up line was attached
to the automatic sampler which carried a series of cups containing the appropriate dilutions
of complement. The complement titration was then repeated in the presence of the antigen
dilution that had been selected (vide infra) for the screening of test sera for the corresponding
antibody. Complement titrations in the presence and absence of thyroid antigen are shown
in Fig. 4.
With the flow diagram as shown in Fig. 2, the haemolytic reaction for a given dilution of
complement may not be maximal due to loss in concentration of the reagent by diffusion as
it passes through the system when it is sampled for only a short period. This is illustrated
in Fig. 4 by the observation that when a 1:25 dilution of complement is sampled for 20 sec
only a proportion of the red cells are lysed (peak at 0-18 and 0-20 optical density scale in
the absence and presence of complement, respectively). But if complement at the same
dilution is fed into the machine continuously then 100% lysis is obtained over a period of
6 min. This is important in selecting the appropriate complement dilution that is to be used
for the titration of antigen or for the detection of antibody; under these circumstances
complement is supplied to the machine continuously. The sensitivity of the method for the
detection of antigen or antibody is of course dependent on the amount of complement that
is made available. The dilution of complement that is appropriate for the titration of antigen
or detection of antibody has been found to be that dilution which when supplied at the rate
of thirty samples per hour with a sample to wash ratio of 1:5 gives a recorded deflection
of 0-7 optical density divisions (e.g. in Fig. 4 from a non-lytic base line of 0-90 to a peak
height at 0-20 in the presence of the antigen dilution that is to be used in subsequent tests).
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A complement titre is required at the beginning of each day's experiments and once the
complement dilution has been constituted it must be kept in an ice-bath to minimize
complement decay.
Titration of antigen
A titration of antigen was done in order to find the highest dilution that would still
contain sufficient antigen to fix all the available complement in the presence of excess
antibody. The antigen line was attached to the automatic sampler, the cups of which











With antigen (human thyroid 1:32)
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Complement
at 1:25
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Fig. 4. Titration of preserved guinea-pig complement in the absence and presence of thyroid
antigen (diluted 1:32). The dilutions of complement (1:10 to 1:50) are shown opposite
each peak on the tracing. The complement titre was selected as 1:40. When the complement
is sampled continuously in this dilution complete haemolysis is achieved in a period of 3 min.
The difference between the colorimeter readings at the beginning and end of the tracing is due
to the turbidity of the preparation of thyroid extract (see Fig. 5).
reservoir of the appropriate complement dilution and the antibody pick-up line was placed
in a reservoir of a known positive serum that may be suitably diluted for the purposes of
economy. Some few minutes were allowed for the system to come into equilibrium with
regard to complement and to antibody before introducing the samples of antigen. This
resulted in 100% haemolysis of the sensitized sheep red cells and established the base line,
which was determined by the setting of the colorimeter and the turbidity of the serum. It
is useful for localization purposes on the recorder paper to fill the first and last cups on
the automatic sampler with 1 % formalin in buffer. This results in a peak on the recorder
chart at the beginning and at the end of the experiment as formalized cells are not susceptible
to the lytic action of haemolysin and complement.
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Fig. 5 illustrates the titration of a saline extract of human gastric body mucosa (G168).
It is advisable to start with the most dilute samples because higher concentrations of
proteinaceous material may well result in precipitation with resultant interference with the
turbidity measurements of the colorimeter. The antigen titration should be repeated in the
absence of antibody to check on the non-specific absorption of complement and the degree
of turbidity of the different antigen dilutions. When each dilution of the antigen is sampled
Antibody * B/1452 diluted 1:16 Nit >
Fig. 5. Titration of a saline extract of human gastric mucosa (G.168) for antigenicity. A
serum (B/4152) from a patient who was known to have high titres of gastric specific comple¬
ment-fixing antibody was used in a dilution of 1:16. Complement was sampled continuously at
the appropriate dilution (in this case 1: 35). A control series of antigen dilutions is included
without antibody to determine the non-specific binding of complement and the turbidity of the
various dilutions of tissue extract. A titre of 1:16 was chosen as appropriate. When sampled
continuously the antigen at this dilution would be sufficient so that the antigen-antibody
reaction would be capable of fixing all the complement available.
for only 20 sec there is loss in concentration of the sample due to diffusion as it passes
through the system. When sampled in this manner an antigen dilution that causes consider¬
able but not total fixation of complement in the presence of excess antibody was found to
be suitable for the screening of test sera for the corresponding antibody. In Fig. 5, for
example, the dilution of antigen that was selected as suitable for the next stage in the
procedure was 1:16. Gastric, thyroid and liver extracts were titrated in this manner
using the corresponding organ-specific or non-organ-specific complement-fixing antibody.
H
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Provided the saline extracts are stored in their concentrated form at — 20°C and made up
to the desired dilutions when required it was not necessary to repeat the antigen titrations
except at infrequent intervals.
Screening and titration of sera for complement-fixing antibody
With complement and antigen being continually fed into the machine from reservoirs
containing these reagents at the appropriate dilutions, the antibody pick-up line was
attached to the automatic sampler, the cups of which contained a series of test sera in a
Human thyroid (T227) No antigen
Fig. 6. The screening of eighteen sera for organ-specific complement-fixing thyroid and gastric
autoantibodies using the Auto-Analyzer. The same sera were put through the machine four
times with a different component on each occasion. A formalin peak is placed at the beginning
and end of each run. For this initial screeening test all sera were used in a dilution of 1:4
after inactivation in a water bath at 56°C for 30 min.
dilution of 1:4. As before, the first and last cup of the automatic sampler should contain
1 % formalin in buffer to help localization on the recorder chart. The same series of sera
were retested using different antigens and in the absence of antigen to check for organ
specificity and for anti-complementary effects. An example of such a series is shown in
Fig. 6. For screening against thyroid, stomach, liver and for anti-complementary activity
a total of 0-2 ml serum is required.
As in the titration of complement and of antigen using the automatic sampler, the reaction
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is not maximal when the test serum is sampled for only 20 sec. Consequently, a peak on the
tracing to be regarded as positive need only be a few optical density divisions (e.g. 0-03
divisions) provided the test sera does not give a similar peak with the liver extract or in the
absence of antigen. Test sera giving an organ-specific reaction in a dilution of 1:4 can be
titrated against the appropriate antigen as shown in Fig. 7.
Analysis ofprocedure
The various stages of the automated procedure were analysed. It is possible to reduce
the amount of reagents used below those indicated in Fig. 2, but when this is done there is
a tendency for adjacent peaks to overlap. It is likely that the internal diameter of the trans¬
mission tubing throughout the system would require to be narrower if smaller volumes of
reagents are to be used.
A prolonged period of washing between each sample is required when the reagents have
such a high protein content. A sample to wash ratio of 1:5 prevents any overlap between
adjacent positive peaks except when the test sera or test antigen is present in high titre.
Various methods of joining the reagent lines after they have passed through the propor¬
tioning pump were studied. The most satisfactory results were obtained when capillary
tubes were used for the addition of reagents to the main stream. The capillary tubes carrying
reagents should lie so that bubbles of air are not trapped at their junctions with the main
stream.
The most suitable incubation temperature and time for the reaction between antigen,
antibody and complement was studied. It was found that the reaction was not closely
dependent on temperature; it would occur at room temperature (20°C) about as efficiently as
at 37-5°C. With prolongation of incubation more complement is fixed but there is a tendency
for adjacent samples to contaminate each other and for complement to decay. It is therefore
necessary to achieve a compromise between these three factors. Because the reservoirs of
complement and of antigen require to be kept in an ice bath it was decided that a period of
incubation at 37-5°C should be included.
Only a single mixing coil is necessary to achieve an even suspension of the sensitized red
cells. The period of incubation for the lysis of the red cells was studied. At this stage the
decay of complement is no longer important, but the contamination of adjacent samples
with increased incubation is a complicating factor with prolonged incubation. Once again
a compromise is achieved between allowing the reaction to go to completion and avoiding
diffusion of reagents.
It is estimated that in the flow design as shown in Fig. 2 the fixation of complement and
the lysis of the sheep red cells achieve approximately 80% completion.
Manual Methods for Detecting Thyroid and Gastric Complement-Fixing Antibody
In the indirect fluorescent antibody technique fresh unfixed air-dried sections of snap
frozen human gastric mucosa from the body of the stomach were used (Irvine, 1963). The
test serum (undiluted) was applied, the sections washed in buffer and then treated with
horse anti-human globulin conjugated with fluorescein iso-thiocyanate (Progressive
X : 26
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Laboratories Ltd, Baltimore; Lot 3122) and then washed in phosphate buffer at pH 7-0.
The duration of each stage was 20 min and the whole procedure was done at room temp¬
erature. The fluorescein—protein ratio of the conjugate was 8-8 /tg/mg. The conjugate was
absorbed with liver and dialysed free of fluorescein. A cover slip was mounted using 10%
glycerine in buffer and the sections were examined under ultraviolet light using a Zeiss
standard Universal microscope with 200 HBO mercury vapour lamp, dark ground con¬
denser and filters BG 12 and 53. The intensity of staining of the parietal cells was graded
as + + , or +, or negative, subjectively.
In the manual complement-fixation method the complement was titred in test tubes. A
series of ten dilutions of complement was made in complement-fixation test diluent at
1:10, 1:20, 1:30, . . . 1:100. Two rows of test tubes were then set out. One volume
(0-2 ml) of the corresponding dilution of complement was placed in each of the tubes
according to the tube number from 1 to 10. Two volumes of complement-fixation test
diluent were added using an automatic pipette to each of the tubes in row I and I volume
of the diluent was added to each of the tubes in row II. One volume of the antigen in the
dilution to be subsequently used in the screening of test sera was placed in each of the tubes
in row II. One volume of 2% sheep red cells sensitized with haemolysin was then added to
all tubes in rows I and II. The tubes were then mixed and placed in a 37°C water bath for
30 min. The complement titre was taken as the tube showing 100% lysis at this time.
The sera were screened and titred using the microtitre equipment supplied by Cooke
Engineering Co., 735 North St Asaph Street, Alexandria, Virginia, U.S.A. All sera prior
to testing were inactivated at 56°C for 30 min. In two rows of the microtitre trays duplicate
doubling dilutions from 1:2 to 1:1024 were prepared for each serum using capillary
loops (0-025 ml capacity). A control was added to the end of the first row and this contained
saline in place of serum. An equal volume (0-025 ml) of antigen at the appropriate dilution
(vide infra) was added to all the wells of the first row using the microtitre dropping pipette
(1 drop). An equal volume of saline was added to all wells in the second row using a similar
dropping pipette. Then to all wells in both rows was added 0-025 ml complement solution
containing 2-0 minimum haemolytic dosestperm-tf After shaking, the plates were incubated
at 37°C for 1 j; hr. Then to each well was added 0-025 ml 2% sensitized sheep red cells, the
trays shaken and incubated for a further 45 min. The trays were then removed, gently
shaken once more and replaced in the incubator for a further 30 min. The trays were then
left at 4°C overnight and read next morning when they had reached room temperature.
The end-point was taken as 50% haemolysis and was read by eye.
To determine the antigenicity of a tissue extract a chessboard titration was done in the
microtitre plates using the same procedure as above but with dilutions of a known anti¬
serum titrated against dilutions of the antigen.
ANALYSIS OF RESULTS WITH THE AUTO-ANALYZER
The findings obtained with the Auto-Analyzer using the flow design as shown in Fig. 2
were compared with the results obtained with the Takatsy microtitre complement-fixation
method and the fluorescent antibody technique for gastric parietal cell antibody (Table 1)
and for thyroid microsonal antibody (Table 2). The height of the peak of complement
fixation shown by the Auto-Analyzer when the test sera were used in a dilution of 1:4
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correlated well with the titre of the gastric complement-fixing antibody indicated by the
manual method and the intensity of staining in the indirect fluorescent antibody technique.
The sensitivity of the Auto-Analyzer method is similar to that of the manual technique but
slightly less than that of the indirect fluorescent antibody technique. It is to be noted that
undiluted serum was used in the fluorescent antibody technique. No false positive results
were obtained out of the 232 sera tested for gastric complement-fixing antibody. With regard
to thyroid complement-fixing antibody, a similar correlation was found between the results
of the manual, immunofluorescence and automated technique using the same sera (Table
2). The tires of complement-fixing thyroid antibody as determined in fourteen sera by
the automated and by the manual methods are compared in Fig. 8. Provided the criteria
for the selection of the complement titre in the automated method was strictly adhered to,
the reproducibility of the titre for complement-fixing antibody as determined by the Auto-
Analyzer was extremely precise on account of the graded height of the peaks as the anti¬
body was titred out. The height of the individual peaks on repeated titration was also
highly reproducible. By comparison the reproducibility in the manual method was poor
at + 1 doubling dilution.
Automated complement-fixation tests
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Fig. 8. Correlation between the titres of complement-fixing antibody as determined in fourteen
sera by the Auto-Analyzer and the Takatsy manual method.
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DISCUSSION
An automated technique for the detection of complement-fixing antibody to thyroid and to
gastric mucosa has been established. The method has the advantage over the manual
complement-fixation test of greater precision and reproducibility; a larger number of sera
can be tested in a given period and the technique is not so demanding on technician skill.
The subjective element in the interpretation of results has been removed. In an ordinary
day's work, forty sera can be screened against thryoid, stomach, liver and in the absence of
antigen. A disadvantage of the method as presently designed is the volume of antigen used.
So far only human thyrotoxic tissue and human partial gastrectomy specimens have been
studied. In large hospitals a sufficient number of thyroidectomies are likely to be done to
ensure an adequate supply of thyroid tissue but this may not be the case with regard to
gastrectomies. The species specificity of pareital cell antibody is wide and it is likely that
the gastric mucosa from other species may prove to be suitable. Preliminary studies have
suggested that pig gastric mucosa, but not dog, may be used as a source of parietal cell
antigen. Further studies are required to determine the most suitable method of preparing
the tissue antigens for use in the Auto-Analyzer in the hope that the period of washing
between individual test sera may be reduced This would accelerate the rate of sampling
and reduce the consumption of antigen per serum tested.
The Auto-Analyzer method should have general application to the clinical laboratory
for the routine screening and titration of sera for gastric and thyroid complement-fixing
antibody. It also has application to the research laboratory on account of the greater
accuracy and reproducibility in the titration of sera and antigens.
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SUMMARY
This paper is an account of our experience in the use of the Leitz microphotometer
equipment in the attempt to quantitate the degree of specific fluorescence in the
indirect immunofluorescent antibody technique using the human gastric parietal
cell antigen-antibody system. The main limitation of the equipment at present is the
variability of the HBP 200 W lamp. This fact, together with the biological variation
within the tissue section, makes multiple readings necessary. The method is,
therefore, time consuming and perhaps mainly applicable to the investigation of
standardization of the immunofluorescent technique itself and of the reagents used
rather than the quantitation of results obtained in a routine manner using an
accepted technique.
INTRODUCTION
Standardization in the immunofluorescent antibody technique can only be achieved if
quantitation is used in each stage of the procedure, including microscopy. Microphoto-
metry has been studied by a number of investigators (Mansberg & Kusnetz, 1966; Pittman,
et al., 1967; Goldman, 1967) but so far no instrument has been described that is suitable for
the ordinary immunology laboratory. A few of the largest manufacturers are now making
microphotometry equipment available. The following is an account of our experience in
Correspondence: Dr W. J. Irvine, Department of Endocrinology, Royal Infirmary, Edinburgh, 3.
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attempting to standardize the indirect immunofluorescent antibody technique using micro-
photometry applied to the parietal cell antigen-antibody system in man with equipment




A Leitz Orthoplan large research microscope with a binocular head, phototube and beam¬
splitter was used. For the present measurements, a fluorite system oil immersion objective
F1 95/1 -32—1 -10 with iris diaphragm was used in conjunction with a periplan GF x 10 eye¬
piece in the phototube and dark field oil condenser N.A. 1-20. The viewing eyepieces in the
binocular head were periplan GF x 12.
Light source andfilters
The light source was a high pressure mercury vapour lamp Osram HBO 200 W fitted in
Leitz lamp housing 250 with a reflector and a glass collector. The controls for positioning
the lamp, reflector and condenser are placed outside the housing so as to provide rapid and
precise centring of the illuminating beam. In addition to a built-in heat absorption filter
KG1 2-mm, the lamp housing also included a filter changer which accommodated four
transmission filters. These can be inserted in the beam in any desired order by external levers.
A neutral diffusing filter together with blue BG12 filters of 5 and/or 3 mm thickness were
used for fluorescence excitation. Secondary filter K150 was used for suppression. The micro¬
scope was also fitted with a tungsten light source. The object could be examined either under
ultraviolet-blue or tungsten light.
Photometer
Microscope photometer MPV with the Knott light measuring device type MFLK, BN
5001 T was used. The light meter consisted of the photomultiplier measuring head type
SKV 317 V, photomultiplier type 6094A (S II cathode) and the highly stabilized power
supply 500-2500 V, 5 mA type NSH M. As shown in Fig. I, the MPV photometer attachment
consisted of a basic body fitted with a viewing telescope, a variable measuring diaphragm
(which may be circular or rectangular), housing for a pilot lamp (8 V, 0-3 A) to illuminate the
image of the measuring diaphragm, a dividing plate operated by a lever to expose the photo¬
multiplier attachment to light from the object or to enable the image of the measuring
diaphragm to be illuminated by the pilot lamp.
The eyepiece (GF x 12) of the viewing telescope had a graticule for reading the aperture of
the measuring diaphragm. The aperture of the diaphragm can be adjusted to any position
throughout a continuous range from full field down to an area of approximately 0-5 or
0-5 g in diameter.
The Scalamp Galvanometer (Pye, Cambridge, England) served as a measuring instrument.
It provided four ranges of sensitivity; full, 1/20, 1/100, 1/1000.
The adjustment of the condenser and objective was carried out in accordance with standard
methods of microscopy using tungsten light. The centring of the mercury vapour lamp was
checked. The condenser, object slides and coverglasses were thoroughly cleaned. The thick-
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ness of the object slides should be between 0-9 and 1 • 1 mm. For the sake of uniformity, slides
of 1 -05 mm thickness measured by micrometer were used throughout the present experiment.
Coverglass of thickness as near to 0-17 as possible were chosen. Photometer measurements
were made in the evenings when powerful electrical equipment in the vicinity was not in use,
thus avoiding major fluctuations in the voltage supply which might occur in spite of stabiliza¬
tion.










Fig. 1. Diagram of microphotometer attachment.
Fluorescent antibody technique
The indirect fluorescent antibody technique (Coons & Kaplan, 1950) was used.
Sera
Serum 52214 was strongly positive for parietal cell antibody and was obtained from a
patient with pernicious anaemia.
Serum 58805 was negative for gastric parietal cell antibody and was obtained from a con¬
trol subject. The sera were stored at — 20°C. Freezing and thawing were carried out as
rapidly as possible.
Tissue
Mucosa from the body of human stomach was obtained from a patient undergoing
gastrectomy. The fresh tissue was cut into rectangular blocks of approximately 2-3 mm
thickness, placed in small glass vials and rapidly frozen to — 70°C in acetone-solid C02
mixture. The blocks were stored at — 20°C until required for sectioning. Sections were cut as
uniformly as possible at 4/u using a Pearce cryostat at — 20°C, air dried by fan for 4 hr,
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stored at 4°C and used within 3 days. During storage, the sections were protected in poly¬
thene bags from condensation and prior to use the sections were allowed to come to room
temperature before being removed from the polythene bag.
Conjugate
Fluorescein in the form of fluorescein isothiocyanate (chromatographically pure isomer 1)
was conjugated with monovalent antiserum-anti-human IgG in our own laboratory. The
horse anti-human IgG was obtained from the Central Blood Transfusion Laboratory,
Netherlands Red Cross, Amsterdam. For the purposes of conjugation, the globulin fraction
was diluted to approximately 10 mg/ml with carbonate-bicarbonate buffered saline at pH 9.
Chromatographically pure isomer 1 fluorescein isothiocyanate (F1TC) was used at a con¬
centration of 1 mg/100 mg protein. The conjugation was done at 4°C for 18 hr. Free
fluorescein was removed by filtration through Sephadex G-50 followed by overnight dialysis
in veronal buffer, pH 7-2 (Oxoid, England) at 4°C. The fluorescein-protein absorption ratio
was 0-67 as determined by Zeiss PMQ II and M4Q 111 spectrophotometer equipment using
wave band 495 m/( for fluorescein and 280 for protein.
The same batch of conjugate (GG4 Lot 11) was used throughout the studies described in
this paper.
Immunofluorescent staining
Undiluted and diluted serum, after warming to room temperature, was applied to each
section for 20 min at room temperature. The sections were then washed in veronal buffer
(pH 7-2) for 30 min with continual gentle agitation on a rolamix machine (Luckham,
England), the buffer being changed once during this procedure. The fluorescein-protein
conjugate (anti-human IgG-FlTC) was applied for 20 min at room temperature. The sections
were then given a final wash in veronal buffer for 1 hr with continuous agitation and changing
of the buffer every 20 min. The sections were then mounted in 10% glycerol in veronal buffer.
Fluorescent standard
A small qunatity of Zn-Cd sulphide fluor, lot 1023, was obtained through the kindness of
Dr Morris Goldman, Department of Immunology, Bionetics Research Laboratories Inc.,
Falls Church, Virginia. An amount smaller than visible by the naked eye was placed on a
clean glass slide. The preparation was then mounted with a coverslip using non-aqueous
univert mountant (Gurr, England). After allowing the mounting medium to set firmly, a
single crystal was selected as fluorescent standard using the same objective (x 95), condenser
and other optics as above. The iris of the objective was always set in the closed position.
RESULTS
Standardization ofmicroscope
The intensity of a new lamp HBO 200 W falls off rapidly within the first few hours of its
life and then enters a plateau phase. Using the fluorescent standard, as described above, it
was apparent that the intensity of the beam from the HBO 200 W lamp in its plateau phase
may remain constant over a period of several hours but that it may suddenly fluctuate by up
to 15-20% due to instability of the arc of the lamp.
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Assessment of optima! dilution of conjugate
Sections of gastric mucosa were stained in the indirect immunofluorescent technique using
positive antiserum B2214 diluted 1:2 in veronal buffer and using serial dilutions of anti-
human IgG-FITC conjugate (1:2, 1:4, 1:6, 1:8, 1:10, 1:16 and 1:20). The fluorescence
of the cytoplasm was measured in fifty parietal cells in each slide, there being one slide for
this purpose for each dilution of the conjugate. The cells were chosen at random throughout
the section provided they had an area of cytoplasm large enough to accommodate the
square area determined by the measuring diaphragm (10x10 on the eyepiece graticule
14 r
Neat 1:2 1:4 1:6 1:8 1:10 1:16 1:20
Dilution of conjugate
Fig. 2. Determination of optimum dilution of conjugate for use in the indirect immuno¬
fluorescent antibody technique. The photometer readings for the contrast between specific (•)
and non-specific (x) fluorescence correlate well with the subjective assessment, indicating that
a dilution of conjugate at 1:6 is optimum. Positive serum B2214 was used in a dilution of 1:2
throughout. Primary filter 5 mm BG12. The results are shown as the average of measurements
on fifty cells for each dilution of conjugate.
of the viewing telescope). Care was taken to ensure sharp focus on the parietal cell cytoplasm
and that the area to be measured did not overlap onto the nucleus. This reading was designa¬
ted as 'specific fluorescence'. The reading from an area of the same size adjacent to each cell
was measured in each instance and designated the 'non-specific fluorescence'. The difference
between the 'specific' and the 'non-specific' fluorescence is referred to as 'the contrast'. The
primary filter in this experiment was Schott 5 mm BG12. The microphotometer readings
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were made as quickly as possible (2-3 sec) in order to avoid undue exposure of the tissue
section to ultraviolet-blue light. The light beam was switched to tungsten light whenever
measurements were not being taken.
Duplicate slides were read subjectively for brightness of parietal cell fluorescence (specific
fluorescence) and for brightness of background tissue staining (non-specific fluorescence).
The results were correlated with the mean value of the photometer readings for each slide
and are shown in Fig. 2. It is seen that the optimum dilution of conjugate to give maximum
contrast between specific and non-specific fluorescence was found to be 1:6 both by micro-
photometry and by subjective assessment.
Table 1. Average of micrometer readings of fifty cells in
each of ten slides stained with a positive serum and on each
of eight slides stained with a negative serum
Average of fifty readings
Specific Non-specific Contrast
Undiluted -t-ve serum B2214
Slide 1 15 7-15 7-85
2 14 6-20 7-80
3 14-34 6-78 7-56
4 11-74 5-95 5-79
5 11-67 5-78 5-89
6 13-00 6-54 6-46
7 12-10 6-10 6-00
8 12-94 6-50 6-44
9 11-55 5-60 5-95
10 11-47 5-25 6-22
Undiluted — ve serum B8805
Slide 1 8-55 7-68 0-87
2 7-67 6-78 0-89
3 6-18 5-45 0-73
4 6-48 5-84 0-64
5 6-73 5-94 0-79
6 7-16 6-50 0-66
7 8-88 5-21 0-67
8 5-96 5-23 0-73
Reproducibility of readings from gastric parietal cells showing positive immunofluorescence
Ten slides of gastric sections stained with undiluted positive serum B2214 and eight slides
stained with undiluted negative serum B8805 were studied. The conjugate was used in a
dilution of 1:6. Measurements were carried out on different days but always within 2 hr of
staining.
As in the above experiment, the fluorescence of the cytoplasm was measured in fifty
parietal cells in each slide. The measurements were conducted in the same way as above.
The findings are shown in Table 1. The standard deviation for the contrast between specific
and non-specific fluorescence for the fifty parietal cells measured in slide 10, as an example,
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was +1-104 with a mean of 6-22 and a range of 4-8-9-1. There was no consistent decline in
the immunofluorescent readings to indicate that loss of fluorescence had occurred because of
exposure to ultraviolet-blue light of those parietal cells that were read towards the end of the
series in each slide using intermittent exposure.
Titre of antibody determined by microphotometry and by subjective assessment
Serial doubling dilutions of positive serum B2214 were tested against duplicate slides and
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Fig. 3. The correlation between the microphotometry readings and the subjective assessment
of possitivity with serial dilutions of positive serum B2214. Measurements were made on
duplicate slides for each dilution of the serum. The results are expressed as the mean of the
measurements on fifty parietal cells on each slide. Primary filter 5 mm BG12.
parietal cells compared to that of adjacent tissue being measured in each slide. The results
of photometry were correlated with the subjective grading of positivity in each of the slides.
The anti-human IgG-FITC conjugate was used in a dilution of 1:6. Duplicate slides were
always examined with the same microphotometer settings and on the same day (1-4 kV,
sensitivity 1/20, primary filter 5 mm BG12). The results are shown in Fig. 3.
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Photodecomposition offluorescein conjugate on exposure to ultraviolet-blue light
Fig. 4 shows the fall-off in intensity of fluorescence in the gastric parietal cell antigen-
antibody system on continuous exposure of individual cells to ultraviolet-blue light using
primary filter 5 mm BG12 and primary filter 5 + 3 mm BG12. It is clear that the fall-off in
immunofluorescence is more rapid with the 5 mm BG12 filter as compared to the 5 + 3 mm
BG12 filter although the intensity of fluorescence is much higher, especially initially with
only the 5-mm filter. However, a greater contrast between the specific staining and the
non-specific staining is obtained for a longer period with the 5 + 3 mm BG12 filters.
Minutes continuous exposure
Fig. 4. The microphotometer readings of the cytoplasm of gastric parietal cells stained in the in¬
direct immunofhiorescent antibody technique (specific fluorescence) and of the adjacent
gastric tissue (non-specific fluorescence). The readings were taken during continuous exposure
to ultraviolet-blue light using primary filters 5 mm BG12 and 5 + 3 mm BG12, respectively.
• , Specific (primary filter 5 mm BG12); x , non-specific (primary filter 5 mm BG12); o, specific
(primary filter 5 + 3 mm BG12); a, non-specific (primary filter 5 + 3 mm BG12).
At this juncture, a new mercury HBO 200 W lamp was introduced giving a much greater
intensity of illumination than the previous lamp that had been used for many hours. The
setting of the photometer had to be altered entirely with regard to voltage sensitivity. Fig. 5
shows the effect of continuous exposure on specific staining to excitation using a 5 + 3 mm
BG12 blue primary filter compared to the effect of intermittent exposure when the beam
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was switched to tungsten light between the readings, each of which lasted from 2 to 3 sec.
Fig. 5 shows that the greater the initial intensity of the fluorescence the more rapid is the
photodecomposition, as illustrated by curves 1-4 which are consecutive during the early
hours of the lamp's life. The greater intensity of illumination produced by excitation with
5 mm BG12 filter caused more rapid photodecomposition of fluorescence than a weaker
intensity of illumination produced by 5 + 3 mm BG12. Intermittent exposure by radiation
produced by the combination of 5 + 3 mm BG12 gave very little fading of fl uorescence and
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Minutes
Fig. 5. Photometer readings from the cytoplasm of gastric parietal cells stained in the indirect
immunofluorescent antibody technique with serum B2214. Curves 1-6 are consecutive. The
cells were subjected to continuous exposure to ultraviolet-blue light except in experiment 5,
when the exposure was intermittent (approximately 2 sec for each measurement). Primary filters
as shown, a, 5 mm BG12, continuous exposure; x , 5 + 3 mm BG12, intermittent exposure;
• , 5 + 3 mm BG12, continuous exposure.
Comparison of intensity of immunofluorescence ofgastric parietal cells in the upper and lower
part of the gastric crypts
Four sections of gastric mucosa were stained with neat positive serum B2214 and the
anti-IgG-FITC conjugate in a dilution of 1; 6. Forty parietal cells were measured for each
t
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slide, twenty chosen from cells in the region of the mucous neck glands and twenty chosen
from deep in the gastric crypts. The cells were selected from the superficial and deep parts of
the gastric sections alternately using tungsten light. The exposure of the gastric sections to
ultraviolet-blue illumination was intermittent and for the measurement of fluorescence only.
Primary filters 5 + 3 mm BG12 were used. The aperture of the measuring diaphragm was
10 x 10 as throughout the whole of the series of experiments. The results of this study are
shown in Fig. 6. It is clear that the intensity of fluorescence of the deeper cells is statistically
greater than is the immunofluorescence intensity of the more superficial gastric parietal cells.





Fig. 6. Illustrates the difference in the intensity in positive immunofluorescence (specific minus
non-specific) in the cytoplasm of human gastric parietal cells in the upper (•) and in the
deeper (o) part of the crypts. Four sections were stained by the indirect immunofluorescent
method with serum B2214. Twenty superficial and twenty cells deep in the gastric mucosa were
measured with the microphotometer. The results are shown as the mean values ± 1 SD.
DISCUSSION
One inherent defect in the present system is the instability of the arc of the HBO 200 W
lamp. This may be overcome by substituting an HBO 100 lamp. The stability of the arc of
this latter lamp would merit the provision of a highly stabilized voltage unit for that lamp.
The variation in stability of the HBO 200 W lamps in their plateau phase was estimated to
be 15-20% in the present study and the oscillation within that range was random. For
periods of variable length, the lamp could be quite stable (±1%) and then oscillate. The
fluctuation in the intensity of the light source would, therefore, be compensated for to some
/V
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extent by taking multiple readings and determining the mean value with standard deviations
where necessary.
Biological as well as instrumental variability must also affect the degree of reproducibility
of the photometer readings. Even if the perfect tissue section could be cut so as to be of
uniform thickness throughout, the cytoplasm of different parietal cells would be cut at
varying angles so that different thicknesses of fluorescing material may be available for
different cells. As shown in Fig. 6 of the present paper, parietal cells situated in different
parts of the gastric section vary in their intensity of fluorescence in the fluorescent antibody
technique. Cryostat sections are not perfect sections. They are likely to vary in average
thickness and in thickness within each section. This must affect the amount of fluorescence
emitted, particularly when transmitted rather than incident light is used. Again, as with the
light source, the variation in these factors would be random or can be randomized. Hence,
remarkably reproducible results may be achieved (see Figs. 2 and 4) when the mean read¬
ings from fifty cells are plotted for duplicate slides with serial dilutions of antiserum.
In spite of the extreme sensitivity of the microphotometer, it is of interest that, at least
with regard to the gastric parietal cell antigen-antibody system, the findings with micro-
photometry correlate very closely with the subjective interpretation. This was particularly
clear in the titration of an antiserum.
The main application of microphotometry in immunofluorescence work at the present
time would appear to be in defining the procedure of preparing immunofluorescence
specimens to give optimum results. Microphotometry should be useful in determining the
best buffer to use as diluent, the optimum dilution of conjugate and its staining characteris¬
tics (Pittman et at., 1967) in comparison to a standard conjugate, washing times for sections
to give optimal contrast between specific and non-specific fluorescence, the most suitable
mounting medium for fluorescence preparations, the most appropriate primary and
secondary filters and the choice of other optics to give maximum contrast and minimum
background fluorescence and as a check on the performance of the lamp.
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